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The Road goes ever on and on 
Down from the door where it began. 
Now far ahead the Road has gone, 
And I must follow, if! can, 
Pursuing it with eager feet, 
Until it joins some larger way, 
Where many paths and errands meet. 
And wither then? I cannot say. 
The Road goes ever on and on 
Down from the door where it began. 
Now far ahead the Road has gone, 
And I must follow, if I can, 
Pursuing it with weary feet, 
Until it joins some larger way, 
Where many paths and errands meet. 
And wither then? I cannot say. 
The Road goes ever on and on 
Out from the door where it began. 
Now far ahead the Road has gone, 
Let others follow it who can! 
Let them a journey new begin, 
But I at last with weary feet 
Will turn towards the lighted inn, 
My evening-rest and sleep to meet. 
I R. R. Tolkien 
The Lord of the Rings 
Acknowledgements 
I would like to extend my thanks to the following people: 
Dr. R. M. Paton for all his assistance both theoretical and practical over the duration of my 
PhD. 
Dr. K. Baker, Dr. A. Cessford, Dr. J. Murphy and Mr I. Smellie for their endless advice and 
assistance that made for a healthy working environment. 
Thanks to those who made my time at this university enjoyable. 
Mr M. Tackett for his work on the nitrite sulphide chemistry. 
Mr K. Bailey for his assistance with the microwave work. 
Mr D. Benstead and Mr R. Tyas for their assistance with the high-pressure hydrogenations. 
Mr J. Millar and Mr W. Kerr from NMR. 
Mr A. Taylor and Mr H. McKenzie  from mass spectrometry. 
Dr A. Dawson, Dr A. Parkin and Dr S. Parsons for the x-ray crystal structures. 
Finally, special thanks should go to my parents, sister and grannie without whose 
encouragement none of this would have been possible. 
IN 
Lecture Courses and Conferences Attended 
Organic section seminars- 3 years attendance. 
Departmental colloquia- 3 years attendance. 
Inorganic synthesis- 5 lectures, Dr C. Pulliam. 
Molecular machines- 5 lectures, Prof. D. Leigh. 
Combinatorial Chemistry- 4 lectures, Glaxo SmithKline, October 2000. 
Safety Workshop Edinburgh, 08/11/00, Sigma-Aldrich. 
Crystals Workshop Edinburgh 21/11/01, 1 Day, Dr S. Parsons (Edinburgh) & Dr R. 
Cooper (Oxford). 
Chemical Database Service (Darsbury) workshop Edinburgh Aug. 2001, 1 
Afternoon, Mr A. Parkin (Edinburgh). 
RSC Perkin Divisional Meeting 2000- Heriot-Watt University. 
RSC Perkin Divisional Meeting 2001- Glasgow University. 
RSC Perkin Divisional Meeting 2002- Dundee University. 
12th  SCI Graduate Symposium on Novel Organic Chemistry- University of 
Strathclyde, 2001. 
13th SCI Graduate Symposium on Novel Organic Chemistry- University of St 
Andrews, 2002. 
RSE Carbohydrate in Disease- Targets for Therapies. George St- 27/09/01. 
Research Councils' Graduate Schools Programme- University of Paisley, Ayr-
05/08/02-10/08/02. 
V2 Day Organic Symposium, University of Edinburgh, 29/01/03, Various speakers. 
Postgraduate Course in NMR: NMR Spectroscopy in Drug Discovery and 
Development, 19th-20th March 2003, various speakers. 
Firbush Postgraduate Talks 7th91h April 2003; 3rd year seminars. 
Researchers in Residence Initiative: Balwearie High School, Kirkcaldy. 
Iv 
Glossary of Terms, symbols and Abbreviations 
chemical shift 
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lit, literature 
LUMO lowest unoccupied molecular orbital 
m multiplet 
m/z mass to charge ratio 
M+ molecular ion 
Me methyl 
Ms methanesuiphonyl 
MTAD 4-methyl-1 ,2,4-triazoline-3,5-dione 
q quartet 
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Abstract 
1,3-Dipolar cycloaddition chemistry has been employed in the production of a series of 
higher monosaccharides and C-glycosides. Two approaches were used; the first involved the 
cycloaddition of nitrile oxides to a series of sugar-derived alkenes, the second required the 
generation of pyranosyl nitrile sulphides from readily available precursors. 
The sugar-derived alkenes were prepared using three methods; in the first hex-5-
enofuranoses were generated in good yields from the corresponding 5,6-dimesylates using 
Tipson-Cohen conditions; the second employed an aprotic Bamford-Stevens reaction to give 
the 1-methylene sugar from the analogous pyranosyl tosylhydrazone. The final approach 
gave a series of 1-methylene sugars in moderate to good yields (50-82%) by the methylation 
of sugar lactones with dimethyl titanocene (Petasis Reagent). 
The reactions of the nitrile oxides, R—CN--O (R = Ph, CO2Et, Br) with 3-O-benzoyl-5,6-
dideoxy- 1 ,2-O-isopropylidene-a-D-xylo-hex-5-enofuranose (58) gave 2-isoxazolines (4,5-
dihydroisoxazoles, 67-69%) with m-facial selectivity for the newly formed stereocentre at the 
5-position (5R:5S 85:15). Attempted hydrogenolysis of the cycloaddition products afforded 
only the unreacted starting material. 
The 1,3-dipolar cycloaddition reactions of the nitrile oxides with the 1-methylene sugars 
gave spiroisoxazolines in moderate to good yields (42-82%), with a high degree of 
stereo selectivity (>95:5). The structures of these cycloadducts were established, by nOe 
experiment and x-ray crystallography, to be in the a-anomeric form. 
The s piroisoxazolines resulting from the c ycloadditions with the 1 -methylene su gars were 
reductively cleaved employing hydrogen and Peariman's catalyst, to give the corresponding 
'y-amino alcohols, in good yields (89-95%) as a mixture of isomers. 
VI 
The enamines N-benzyl-2-methylene-pyrrolidine (153) and N-benzyl-2-methylene-piperidine 
(154) were generated from N-benzyl-2-pyrrolidone and N-benzyl-2-piperidone (155), 
respectively, by reaction with the Petasis reagent. Cycloaddition with benzonitrile oxide gave 
6-benzyl-3 -phenyl- 1 -oxa-2,6-diazaspiro[4.4]non-2-ene (159) and 6-benzyl-3 -phenyl- 1 -oxa-
2,6-diazaspiro[4.5]dec-2-ene (160), respectively, in moderate yields over two steps (23.24%) 
The products were characterised by mass spectrometry and 1 H and 13C NMR spectroscopy. 
The 	D-glucose derived enamine N-Boc-2,6-anhydro-3 ,4,5 ,7-tetra-O-benzyl- 1 -deoxy-D- 
gluco-hept- I -enitol (60) was synthesised from N-Boc-2,3 ,4,6-tetra-O-benzyl-D-glucono-ö-
lactam (178) by methylation with the Petasis reagent. Cycloaddition with benzonitrile oxide 
gave (5R,7S,8R,9S, 1 OR)-N-Boc-8,9, 1 O-tris(benzyloxy)-7-benzyloxymethyl-3 -phenyl- 1 -oxa-
2,6-diazaspiro[4.5]dec-2-ene (186) as a single isomer. 
A variety o f c onditions were employed to generate p yranosyl nitrile s ulphides b y thermal 
decarboxylation of 5-pyranosyl-1,3,4-oxathiazol-2-ones. The oxathiazolones, which were 
prepared by treatment of the corresponding amide with chlorocarbonylsulphenyl chloride, 
showed unusually high thermal stability. Heating 5-(l ',2',3',4'-tetra-O-acetyl-ci-D-gluco-
pentopyranos-5 '-yl)- 1,3 ,4-oxathiazol-2-one (204) in mesitylene (162-164°C) with ethyl 
cyanoformate resulted in the formation of the corresponding pyranosyl nitrile together with 
traces (1%) of ethyl 3-( 1 ',2' ,3 ',4'-tetra-O-acetyl-a-D-gluco-pentopyranos-5 '-yl)-1 ,2,4-
thiadiazole-5-carboxylate (213). When a similar reaction was carried out in a microwave 
reactor, starting material was recovered, although a small amount of ethyl 3-(1',2',3',4'-
tetra- 0-acetyl-a-D-gluco-pentopyranos- 5 
-(1', ', '
O t l-a- -gluco-pentopyranos-5 '-yl)- 1 ,2,4-thiadiazole-5 -carboxylate (213) was 
identified. 
VI I 
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Higher monosaccharides are monosaccharides with a backbone o f greater than six carbon 
atoms. They are rare in Nature, but are found as monomer units of some biopolymers.1 This, 
along with their potential as non-toxic inhibitors of biosynthetic pathways, makes higher 
monosaccharides attractive synthetic targets.2 
The work presented in this thesis examines the feasibility of synthesising higher 
monosaccharides and C-glycosides from readily accessible monosaccharides using 1,3-
dipolar cycloaddition chemistry, eg nitrile oxide, nitrile sulfide and nitrone chemistry. These 
routes allow predictable and repeatable stereoselective extension of the carbon chain. It is 
anticipated that this will allow access to heptoses and octoses including ulosonic acid and 
deoxynojirimycin analogues and various C-glycosides. 
1.2 	1,3-Dipoles 
1.2.1 	What is a 1,3-Dipole? 
A 1,3-dipole is a system where four it-electrons are delocalised over three atoms.3 The origin 
of the name is twofold, firstly the dipole term originates from the inability to produce a 
resonance structure over the three atoms, without charges, where the electron requirement of 
each of the three atoms is satisfied (Scheme 1.1). The "1,3" term refers to the points of 
bonding to the dipole by some dipolarophile, rather than the localised positions of the 
charge.3 
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There are two principle types of 1,3-dipole (Table 1. 1), firstly the allyl type (Figure 1 .1) that 
contains a double bond and where the central atom is sp2 hybridised. The double bond that is 
present in this type of 1,3-dipole results in it having a bent structure. Secondly, there is the 
propargyl-allenyl type (Figure 1.2); this contains a third bond that is orthogonal to the second 
resulting in the central atom being sp hybridised. The structure is, therefore, linear.3 
Table 1.1: Examples of 1,3-Dipoles 
Allyl type 
Azomethine Betaines Carbonyl Betaines 
R2CNRCR2 Azomethine Ylides R2COCR2 Carbonyl Ylides 
R2CNRNR Azomethine Imides R2CONR Carbonyl Imides 
R2CNRO Nitrones R2COO Carbonyl Oxides 
Propargyl-allenyl type 
Nitrilium Betaines Diazonium Betaines 
RCNO Nitrile Oxides NNCR2 Diazoalkenes 
RCNNR Nitrile Imides NNNR Azides 
RCNCR2 Nitrile Ylides NNO Nitrous Oxide 
RCNS Nitrile Sulfides NNS Dinitrogen Sulfide 
410 	0 
Figure 1.1 Figure 1.2 
1.2.2 	Properties of 1,3-Dipoles 
The most important property of 1,3-dipoles is their ability to undergo 1,3-dipolar 
cycloaddition reactions with dipolarophiles. The reactivities of 1,3-dipoles are dependent 
upon the atoms present, which alter the energy levels of the highest occupied molecular 
orbital (HOMO) and lowest unoccupied molecular orbital (LUMO).3 
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1.3 	Nitrite Oxide Chemistry 
1.3.1 	Generation of Nitrite Oxides 
There are a number of possible methods to obtain nitrile oxides.4 The most common routes 
are dehydration of a primary nitroalkane (1) using eg phenyl isocyanate with a catalytic 
amount of triethylamine to produce a nitrile oxide, commonly known as the Mukaiyama 
method,' and dehydrohalogenation of a hydroximoyl halide (2) using triethytamine.34 Other 
dehydrohalogenation agents employed are Na2CO3, A1203 and alkali metal fluorides.4 A 
variety of methods have been used to halogenate the oxime, these will be discussed later. 
Another option is to convert the aldoxime (3) directly to the nitrile oxide in a one-pot 
reaction; this may be achieved using alkaline sodium hypochlorite6 or hypobromite7 and 
chloramine-T.8 Lead tetraacetate has also been utilised for the dehydrogenation of syn 
aldoximes.9 Another potential route is the thermal cycloreversion of the nitrile oxide dimers, 
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1.3.2 	Reactions and Reactivity of Nitrile Oxides 
Once generated, there area number of reactions that nitrile oxides may undergo (Scheme 
1.3); which reactions occur is dependent upon what is present in the reaction mixture as well 
as the nitrile oxide being used. One consequence of the high reactivity of nitrile oxides is 
their tendency to dimerise to give the furoxan (4)34  Alternative dimerisation pathways may 
also take place to give 1 ,2,4-oxadiazol-4-oxides (5) and 1 ,4,2,5-dioxadiazines (6).' The 
formation o f the dimers i s dependent upon the half-life of the nitrile o xide, which varies 
from seconds to minutes for aliphatic nitrile oxides to several hours or days for some 
4 aromatic nitrile oxides. Some stable nitrile oxides have been shown to thermally rearrange 
3 
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to give isocyanates (7), while nucleophilic addition gives substituted oximes (8). Finally, 
nitrile oxides may undergo cycloaddition reactions with dipolarophiles such as alkenes and 
alkynes to afford isoxazolines (4,5-dihydroisoxazoles, 9) and isoxazoles (10) respectively.4 
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Scheme 1.3 
Reactivity in 1,3-dipolar cycloaddition reactions of nitrile oxides is dependent upon the 
nature of the reactants involved, as discussed by Sustmann.'°" The cycloaddition reactions 
of nitrile oxides were classified into three types. Type I reactions are those which involve 
electron rich dipoles, that is to say the nitrile oxide contains an electron donating group, 
which results in the frontier orbitals of the dipole being high in energy. The cycloaddition 
reactions of these nitrile oxides are described as being HOMO controlled or nucleophilic. 
This type of behaviour can be enhanced be adding electron donating groups to the dipole or 
electron withdrawing groups to the dipolarophile (Figure 1.3). 10 The second family of 
reactions are known as Type II; where the cycloadditions are both LUMO and HOMO—
dipole controlled. These can involve either electron rich or electron poor dipolarophiles 
(Figure 1.3).10.11  The final class of cycloaddition reactions are Type III; these nitrile oxides 
are electron deficient with low-lying frontier orbitals that favour interaction of the LUMO of 
the dipole with the relatively high energy HOMO of the dipolarophile.'° As a result these 
nitrile oxides are electrophilic and their cycloadditions are LUMO controlled (Figure 1.3) 10 
2 
Introduction 
1,3-Dipole Alkene 	1,3-Dipole Alkene 	1,3-Dipole Alkene 




Type I 	 Type II 	 Type lii 
Figure 1.3 
1.3.3 	Mechanism of Nitrile Oxide Cyctoadditions 
Using the reaction of nitrile oxides with alkenes there are three possible mechanisms for the 
[3+2] cycloadditions; the first is a single step concerted process (Scheme 1.4). 
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The second is a stepwise, non-concerted, mechanism that involves a zwitteriornc 
intermediate (Scheme 1.5). 
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Scheme 1.6 
An important feature of the cycloaddition reaction between the 1,3-dipole and the alkene is 
that the configuration of the alkene is retained in the cycloadduct. This supports the 
concerted mechanism. However, if the mechanism involved a diradical or zwitterionic 
intermediate and the cyclisation were faster than the bond rotation the stereochemistry of the 
alkene would be retained. The concerted mechanism is also supported by the moderate 
activation energy and the large negative entropy of the reaction. However, some of the 
possible by-products of the cycloaddition reactions, such as oximes, can be explained by the 
existence of a diradical intermediate.4 
It is generally accepted, however, that the cycloaddition of a nitrile oxide to a dipolarophile 
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Figure 1.4 
The regioselectivity of the cycloaddition of a nitrile oxide to an asymmetrically substituted 
alkene is determined by the stability of the respective transition states for the formation of 
two isomers (Figure 1.4), which is in turn dictated by the degree of overlap of the frontier 
orbitals of the two components.3 This is set by the size of the coefficients such that the 
orbitals with the larger coefficients have the greater overlap. Therefore, the more stable 
arrangement is where orbitals with large coefficients are interacting and orbitals with small 
coefficients are interacting rather than those interactions of an orbital with a large coefficient 








L = large coeffecient 
S = small coeffecient 
Figure 1.5 
Also the smaller the energy difference between the HOMO and LUMO of the reactants the 
more stable the transition state.3 This may be illustrated by the HOMO and LUMO 
interactions for the reaction between the electrophilic nitrile oxide, fulminic acid, and ethene 
with electronically different substituents (Figure 1 	This diagram shows that altering the 
type of substituent on the dipolarophile may affect the stability of the transition state. 
Electron donating groups destabilise the frontier orbitals of the dipolarophile and result in an 
increase in energy, thus favouring the dipole-LUMO/dipolarophile-HOMO interaction over 
the dipole-HOMO/dipolarophile-LUMO interaction. Conjugating groups on the 
dipolarophile have a similar effect on this reaction. Electron withdrawing groups attached to 
the dipolarophile result in a lowering in the energy of the HOMO and the LUMO. This 
favours dipole-HOMO/dipolarophile-LUMO interactions. 
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Figure 1.6 
Figure 1.5 also illustrates the argument for the regioselectivity of the cycloaddition reaction 
between nitrile oxides and alkenes. It may be observed that the polarisation of the reactants 
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favours the 5-isomer in the most likely orbital arrangement of dipole-LUMO/dipolarophile-
HOMO interactions. 
Reaction of a monosubstituted alkene with a nitrile oxide usually gives 5-substituted 2-
isoxazolines (Scheme 1.7) in preference to the 4-substituted regioisomer. This is a result of 
the two effects discussed above. However, formation of the 4-substituted regioisomer is also 
limited by the large LUMO polarisation of the nitrile oxides.' Furthermore, steric effects 
result in the more electrophilic end of the dipole always bonding to the least substituted end 




1.3.5 	Limitations of Nitrile Oxide Cycloadditions 
One problem with the use of nitrile oxides in synthesis is their inherent reactivity and 
tendency to dimerise to give the corresponding 1 ,2,5-oxadiazole N-oxide (furoxan) (Scheme 
l.8).' 
R R R R 
N,0, N, 
Scheme 1.8 
Nitrile oxides have different half-lives; for example, aliphatic and acyl nitrile oxides are very 
reactive, while nitrile oxides containing aryl groups can have a half-life of several hours or 
days. As a result few nitrile oxides can be stored, and nearly all are produced in situ in the 
presence of excess dipolarophile for efficient cycloadduct formation.4 
1.3.6 	Synthetic Applications of Nitrile Oxide Chemistry 
There are a number of cycloaddition reactions that nitrile oxides may undergo, other than 
those with alkenes and alkynes, to give various 5-membered heterocycles (Scheme 1.9), this 
reaction has long been used in the production of five-membered heterocycles containing a 
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C=N—O group.3 When a nitrile oxide is generated in the presence of an imine the heterocycle 
is known as a 1,2,4-oxadiazoline (11), the reaction between a nitrile oxide and thiocarbonyl 
affords a 1,4,2-oxathiazoline (12) that can decompose, on heating, to give the corresponding 
carbonyl compound and an isothiocyanate (13). This is a convenient way of converting 
thiocarbonyls to carbonyl compounds. Nitrile oxides also react with carbonyl compounds to 
give I ,4,2-dioxazoles (14) in the presence of a Lewis acid. Nitriles are generally poor 
dipolarophiles for nitrile oxide cycloadditions, however, when they do react they result in 
1,2,4-oxadiazoles (15). Nitrile oxides have been known to cycloadd to other compounds 
containing unsaturated heteroatom bonds (e.g. R—C=P, R—N=N—R), but some of these 
cycloadducts are too unstable to be isolated. These reactions are discussed in greater detail in 
the literature.' 
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Scheme 1.9 
It has been known since 1894's that nitrile oxides react with alkenes to give 2-isoxazolines 
via 1,3-dipolar cycloaddition. Recently, however, these reactions have been directed toward 
the synthesis of a wider array of organic compounds. This broader use is due, in part, to the 
regio- and stereo-selective nature of 1,3-dipolar cycloadditions, as well as the mild nature of 
the reaction conditions. 
Introduction 
A major reason for using the nitrile oxide/isoxazoline approach is the stability of the 
isoxazoline ring when subjected to heat or when treated with acid, alkali or oxidising agents. 
An advantage of the stability of the isoxazoline moiety is that it allows the modification of 
substituents without affecting the ring system.1617 A further reason for employing this 
approach is the masked functionality contained within the isoxazoline ring (Scheme 1.10)418 
These functional groups can be released on reductive cleavage of the nitrogen-oxygen bond. 
A notable compound type accessible via the i soxazoline method is the 3-hydroxy ketone, 
thus providing an alternative to the aldol reaction (Scheme 1.11).16 
I ,3-diene 
I 
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1 ,3-diol 	 3-hydroxy ketone 	a,3-unsaturated 
I
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NH OH 	 N 	 NH2 OH 









There are a number of problems associated with the aldol approach: it is a reversible 
reaction, and there can be side reactions to give cross- or self-aldol condensation products. 
The reaction has poor selectivity and there is also the problem of selective enolate 
formation. '9 The cycloaddition method provides an alternative approach which overcomes 
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some of these obstacles. The advantages of the nitrile oxide/isoxazoline method include the 
ability to easily produce stable precursors of nitrile oxides for [3+2] cycloaddition to an 
alkene. These reactions are performed under milder conditions, compared to the variety 
observed for the aldol reaction and its derivatives. Furthermore, the isoxazoline acts as a 
masked 3-hydroxy ketone which can be released at any point in the synthetic sequence.2°  
Finally, these cycloaddition reactions can be regio- and stereo selective. '4 Overall, the aldol 
and nitrile oxide methods are complementary approaches as they produce different carbon-
carbon bonds within the product molecule (Scheme 1.11). 
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Scheme 1.11 
Within our group this chemistry has been applied to a number of sugar systems as a method 
for chain extension to give higher monosaccharides.'4"7 This work utilised a variety of 
sugar-derived nitrile oxides and sugar-derived alkenes, an example of which is shown in 
Scheme 1.12. The nonose derivative 16 was prepared by combination of D-glyceronitrile 
oxide 17 and D-galactose-derived alkene 18 and ring opening of the cycloadduct. 
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1.4 	Nitrone Chemistry 
1.4.1 	Generation of Nitrones 
As with nitrile oxides the synthesis of azomethine oxides (nitrones) (19) has been 
extensively researched and there are a number of possible pathways for their generation.3 
N,N-Disubstituted hydroxylamines (20) can be oxidised to corresponding nitrones using 
various oxidising agents such yellow mercuric oxide, "active" lead oxide, potassium 
ferricyanide, potassium permanganate, 1-butyl hydroperoxide and hydrogen peroxide .21  
Another method is the condensation of a hydroxylamine (21) with either an aldehyde or a 
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1.4.2 	Reactions and Reactivity of Nitrones 
There are varying reactivities over the nitrone family. Some are highly reactive, eg 23, such 
that they self react to give the corresponding dimer and/or trimer, while others are relatively 
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As with nitrile oxide chemistry, the reactivity of the nitrone analogues in 1,3-dipolar 
cycloadditions has been classified using the Sustmann model into three types with regard to 
the frontier molecular orbitals. Most nitrone cycloadditions are thought to involve Type II 
interactions. That is to say that they maybe both HOMO-dipole/LUMO-dipolarophile 
controlled and LUMO-dipole/HOMO-dipolarophile controlled.' 
Similar to the nitrile oxide case, the cycloaddition of a nitrone to a dipolarophile is thought to 
be a concerted asynchronous [4c + 27r] suprafacial process22 as the stereochemistry of the 
dipolarophile is retained in the resulting isoxazolidine cycloadduct3 and the thermodynamics 
of the reaction correspond to those of a concerted process.3 
1.4.3 	Selectivity 
The 1,3-dipolar cycloaddition between a nitrone and an alkene can give two pairs of 
regiomeric and d iastereomeric i soxazolidines (Scheme 1 .14) and can, depending upon the 
number of substituents on the alkene, generate two or three new stereocentres. For example 
reaction with monosubstituted a lkenes will result in two new s tereocentres while reaction 
with 1 ,2-disubstituted alkenes will produce three new stereocentres.22 
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The regiochemistry may be explained by the same reasoning as that given for the nitrile 
oxide cycloaddition in Section 1.3.5. The dominant regioisomers are those with the R3  
substituent in the 5-position of the isoxazolidine ring. This is due to the carbon of the nitrone 
and the unsubstituted carbon of the alkene having the largest atomic orbitals. Therefore, the 
interaction between these two atoms will provide the greatest overlap and hence the most 
stable transition state.3 However, it is notable that for very electron deficient dipolarophiles 
the cycloaddition is a Type I process and the 4-substituted product is produced. This is due to 
the lowering of the HOMO and LUMO levels of the dipolarophile, to favour the HOMO-
dipole/LUMO-dipolarophile interaction.3 
1.4.4 	Synthetic Applications of Nitrone/Isoxazolidine Chemistry 
Nitrones may undergo a variety of cycloaddition reactions these have been extensively 
reviewed.' The reactions involving alkenes and alkynes giving isoxazolidines (25) and 
isoxazolines (26) respectively are of greatest relevance to this work (Scheme 1.15). 
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Scheme 1.15 
The cycloaddition of nitrones to alkenes has long been a synthetic method for producing 5-
membered isoxazolidines.3 Isoxazolidines, like isoxazolines, have a number of synthetically 
useful masked functionalities that may be accessed by breaking the N-O bond, including 7- 
amino alcohols and -hydroxy ketones (Scheme 1.1 6)22  This chemistry allows an alternative 
to the nitrile oxide approach to these synthetically useful intermediates. 
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As with nitrile oxides the propensity for certain nitrones to dimerise limits the use of this 
chemistry to very reactive dipolarophiles with these labile nitrones.3  
1.5 	3-Deoxyulosonic Acids and Their Analogues 
3-Deoxyulosonic acids and their analogues have a variety of roles within Nature and are 
important in a number of biological systems. They are, therefore, important synthetic targets. 
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Four examples of ulosonic acids are shown below. 3-Deoxy-D-arabino-2-heptulosonic acid 
(DAH, 27), is important in the shikimate pathway (Scheme 1.17). This is a biosynthetic 
process in higher plants and bacteria that produces the three aromatic amino acids tyrosine, 
tryptophan and phenylalanine.'9'23'24  Inhibition of this pathway offers potential for the design 
of herbicidal, fungicidal and bactericidal compounds .2' There are a number of potential 
enzymes that may be targeted for inhibition through the synthesis of analogues of 
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intermediate metabolites found in the pathway.25 The specific enzyme that is targeted by the 
DAH analogues is the 7-phospho-3-deoxy-D-arabino-heptulosonate phosphate lyase (3-
dehydroquinate synthase), which catalyses the ring closure of DAHP to form the first alicylic 
in the pathway.25 3-Deoxy-D-manno-2-octulosonic acid (KDO, 28) is an eight-carbon 
ulosonic acid that is required for the replication of all Gram-negative bacteria. The 
importance of this saccharide is due to the core sugars of Gram-negative bacteria being 
linked to lipid A by KDO. The absence of this linker causes the structural and functional 
integrity of the outer membrane to be compromised. Therefore the incorporation of KDO 
into lipid A (Scheme 1.18) it is critical to the cell replication.26 As with the Shikimate 
pathway, there are several possible enzymes in this pathway that are potential targets for 
inhibition. For example, CMP-KDO synthase, which links the KDO with cytidine-5-
monophosphate to give a-cytidine-5'-monophosphate-KDO is a possible target for 
inhibition.26 
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N-Acetyl-5-amino-3 ,5-dideoxy-D-glycero-D-galacto-2-nonulosonic 	acid 	(N-acetyl- 
neuraminic acid, N eu5Ac or NANA, 29)1 s a nine-carbon sugar, which is a member of a 
group of compounds known as sialic acids. It is found in the nerve tissue and the cellular 
membrane of a number of mammals and bacteria, at the terminal positions of glycolipids, 
glycoproteins and oligosaccarides.27'28 This acid is significant in biological molecular 
recognition processes such as differentiation phenomena and cell adhesion. The 5-deamino 
analogue, 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN, 30) is found in the eggs 
of rainbow trout and is thought to be involved in their activation by protection against the 
action of sialidase.29 
In Nature, the synthesis of higher ulosonic acids is thought to proceed via a stereoselective 
aldol condensation of the aldose with phosphoenol pyruvate (PEP) catalysed by the 
appropriate aldolase enzyme. A number of derivatives of the above compounds have been 
produced,'9 with a view to inhibiting critical steps in the biosynthetic pathways. This allows 
access to potential anti-bacterial drugs for use in chemotherapy from the KDO derived 
compounds and possible herbicides and anti-microbial agents to be obtained from the DAH 
analogues. 19 The major advantage of these compounds is that they provide a non-toxic means 
of inhibition of these pathways. This is due to neither the shikimate pathway nor the KDO 
pathway being vital for the survival of animal cells, while both are required by prokaryote 
and plant 	There are a number of published methods to synthesise the above 
compounds and their analogues. These include a tetrazole containing analogue of DAH that 
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was produced from D-mannose.3 ' Neu5Ac has been previously synthesised by the chain 
extension of l-deoxy-1-nitrohexose by the of addition tert-butyl 2-(bromomethyl)acrylate.32 
There have been many syntheses published for KDO analogues, both chemical and 






A logical extension of the exoglycal work is to explore the potential of iminosugars as 
dipolarophiles for cycloaddition reactions. Iminosugars are saccharides in which the ring 
oxygen has been replaced with a secondary amine. 
1.6.2 	Iminosugars and Their Mimics 
The range of biological activity associated with iminosugars has been extensively reviewed 35 
and they have been explored as potential biomedical agents, pesticides and ecological agents. 
Iminosugars are known to inhibit glycosidase enzymes and can influence the glycosylation 
or catabolism of glycoproteins as well as inhibiting the recognition of specific 
carbohydrates.36 This is due to their structural similarity to monosaccharides involved in 
glycoprotein processing.35 Several studies have been carried out to identify the requirements 
for inhibition of glycosidases by basic sugar analogues. It was found that the following were 
necessary for successful inhibitors: 1) position of the basic (cationic) centre, 2) basicity, 3) 
geometry and charge distribution at the anomeric position, 4) hydroxylation pattern, ring size 
and flexibility as determinants of specificity, 5) interactions with the aglycon binding site 
and 6) hydrogen-bonding formation with the catalytic acid.35 
Several plants contain iminosugars that are toxic to a number of important insectoid pests, 
e.g. Locusta migratoria and Schistocera gregaria. It is thought that this is due to the 
glycosidase inhibitory properties of the iminosugars. Iminosugars have also been proposed 
as potential nematicides.35 
Iminosugars have also been proposed as potential plant growth inhibitors eg 
Castanospermine inhibits root elongation in dicotyledons. 35 
It is hoped to synthesise sugar mimics analogous to nojirimycin (31) and 1 -deoxynojirimycin 
(32), which inhibit the human lysosomial trimming a-glucosidases and a-mannosidases. 
These enzymes are involved in the biosynthesis of the N-linked oligosaccharidic component 
of the membrane glycoproteins.37'38 This inhibition stops the formation of the envelope 
19 
Introduction 
glycoprotein of HIV and the maturation of the oligosaccharide subunits of tumour cell 
glycoproteins, which are associated with possible malignancy.37 
HOH2C H 	HOH2C H 
N 3-NI 
HO" 	OH 	HO') 
HO OH 	 HO OH 
31 	 32 
The reason for the importance of azasugars in glycosidase processes is that the hydrolysis of 
the glycosidic bond involves an intermediate oxonium ion, 17,31  which may be mimicked by 
replacing the oxygen with a basic nitrogen. This will allow the protonated azasugar to 
occupy the enzymatic active site, but not allow the continuation of the biological process. 
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1.7 	Nitrile Sulfide Chemistry 
1.7.1 	Foreword 
The existence of nitrile sulfides was first confirmed by Franz in 1970.40  He observed that 
upon thermolysis of phenyl oxathiazolone (33) three decomposition products were 
generated, benzonitrile, sulfur and carbon dioxide.4 ' It was thought that this decomposition 
would proceed via an intermediate nitrile sulfide, and this was confirmed by heating the 
oxathiazolone in the presence of dimethyl acetylenedicarboxylate (DMAD), which trapped 
the nitrile sulfide to give the isothiazole diester (34) (Scheme 1.19).42 
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Scheme 1.19 
1.7.2 	Generation of Nitrile Sulfides 
There are a number of methods for production of nitrile sulfides employing both thermolytic 
and photolytic techniques. The latter does not generate the nitrile sulfides in synthetically 
usable yields43 and, as a result, has been used principally for matrix isolation and 
spectroscopic investigations.42 Consequently photolysis will not be discussed here, though it 
has been extensively reviewed.4244 Here we shall only be concerned with generation of 
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The most used route to nitrile sulfides is the cycloreversion of 5-membered heterocycles that 
contain the C=N-S unit.42 A common method (Schemes 1 .20) is the decarboxylation o f a 
1,3,4-oxathiazol-2-one (35). This stable precursor may be synthesised from the 
corresponding carboxamide by heating with chtorocarbonylsulfenyl chloride,45 or with 
perchioromethyl mercaptan followed by formic acid4 or triethytamine.46 
A major advantage of this method is that oxathiazolones may be synthesised with a variety 
of substituents in the 5-position including phenols,4749 esters,4751 nitriles,43'52 alkenes,5354 
sugars,5556 as well as simple alkyl and aryl groups.42 However, nucleophilic substituents 
cannot be present as these would react with the oxathiazolone moiety. 57-59  The oxathiazolone 
is then heated between 110-160°C in an inert solvent, such as xylene or toluene, to generate 
the corresponding nitrile sulfide via thermal decarboxylation.42 
1.7.3 	Reactions of Nitrile Sulfides 
Nitrite sulfides cannot generally be isolated, other than by matrix isolation techniques.42 
However, nitrite sulfides can react with a variety of functional groups yielding a plethora of 
new 5-membered heterocycles with variable substituents on the ring (Scheme 1.21). When 
an oxathiazolone is heated in an inert solvent in the absence of a dipolarophile the nitrile 
sulfide produced decomposes to the corresponding nitrite and sulfur. The reaction between 
nitrile sulfides and alkynes gives isothiazoles (36), that with alkenes results in 2-
isothiazolines (37), whereas nitriles produce 1 ,2,4-thiadiazoles (38), as does the reaction with 
imines (39), carbonyl compounds give 1,3,4-oxathiazoles (40) and finally the reaction 
between nitrite sulfides and a phosphaatkyne yields a 1,2,4-thiazaphasphole (41 ).42,44  Nitrile 
sulfides can also react with thiocarbonyl compounds to give 1 ,4,2-dithiazotes (42) in modest 
to good yields.6° However, the reaction fails with dithio esters and tertiary thioamides; it only 
works when the substituents of the thiocarbonyl compound are diaryl, aryl alkyl and dialkyl 
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As with nitrile oxides and nitrones, the reactivity of nitrile sulfide reactions may be 
rationalised using FMO theory. The HOMO and LUMO energy levels of nitrile sulfides are 
comparable to those of nitrile ylides; those of the former being only slightly lower in energy 
than those of the latter. This is due to the greater e lectronegativity of the s ulfur.42'43 As a 
result electron-poor acetylenic esters react with nitrile sulfides in HOMO dipole-controlled 
Sustmann Type II reactions.4243 Therefore, the rate of reaction increases as the electron 
deficiency of the dipolarophile increases, due to the lowering in energy of the dipolarophile 
LUMO. This gives the following reactivity profile for such esters with nitrile sulfides; 
DMAD>ethyl propiolate> ethyl phenyl propiolate > ethyl but-2-ynoate.43  
1.7.5 	Mechanism of Nitrile Sulfide Formation and Cycloadditions 
The proposed mechanism of the nitrile sulfide generation, from the oxathiazolone, is 
accepted as following a decomposition pathway where the oxathiazolone loses carbon 
dioxide to give the corresponding nitrile sulfide.43 Once produced the nitrile sulfide can 
undergo further decomposition to the nitrile through the loss of sulfur or it can react with a 
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dipolarophile to give a heterocyclic cycloadduct. The formation of both these products are 
first order and equal to that for the consumption of the oxathiazolone,43 thus indicating that 
no adduct is formed between the o xathiazolone and the dipolarophile prior to the loss o f 
carbon dioxide.43  
	
1.7.6 	Selectivity 
The regioselectivity of nitrile sulfide cycloadditions has been rationalised using CNDO/2 
calculations;42 these suggest that in the LUMO the largest orbital coefficient is affiliated to 
the carbon, while in the HOMO it is associated with the sulfur. The result of this is that 4-
substituted products are formed from dipole-HOMO controlled reactions and the 5- 
substituted heterocycles will predominate in dipole-LUMO controlled reactions.42 It has also 
been suggested that the high temperature at which nitrile sulfide cycloaddition reactions are 
carried out reduces the regioselectivity of the product. 12,41 
1.7.7 	Limitations of Nitrile Sulfide Chemistry 
The major drawback of nitrile sulfide chemistry is the tendency for the nitrile sulfide to 
decompose to the corresponding nitrile and sulfur before it can react with the 
dipolarophile.42'44 Initially the nitrile sulfide decomposition reaction was thought to be 
unimolecular, however, it was observed that isolated nitrile sulfides were stable on an inert 
matrix and as soon as this support was consumed then the dipole would decompose. 
Furthermore, nitrile sulfide trapping reactions were found to be dilution dependent such that 
a reaction would give improved yields o f the intended c ycloadduct rather than the nitrile 
decomposition product, only when the nitrile sulfide was present at a low concentration. 
These findings implied a higher order reaction and the following mechanism was proposed 
(Scheme 1 .22).42.44 
2 R—C=N—S 	 - RCN +RCNS 	RCN +S 	 S8 
+- 
R—CEN--S +5(x=2-7) 	 RCN +S +1  
Scheme 1.22 
There have been a number of suggested approaches to combat this problem. The first way to 
lessen the decomposition is to ensure that the concentration of the nitrile sulfide is kept low. 
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This may be achieved either by adding the nitrile sulfide precursor portionwise,54 or by 
having a large excess of the dipolarophile present.42 It has also been noted that electron 
withdrawing groups on a nitrile sulfide reduce the rate of decomposition of the 1,3-dipole.43  
However, electron withdrawing groups have been reported to inhibit the cycloaddition 
reaction which is favoured by electron donating groups on the nitrile sulfide .44 
1.7.8 	Synthetic Applications of Oxathiazolone Chemistry 
The initial interest in nitrile sulfide chemistry, with a view to biological applications, came in 
the early 1980's with the synthesis of o-(1,2,4-thiadiazoyl) benzoates as potential herbicides 
and plant growth inhibitors.52 A variety of nitrile sulfide derived compounds have been 
synthesised and some have been found to have significant biological activity. Of particular 
interest are sugar derived heterocycles, as these C-nucleoside analogues have potential anti-
tumour and anti-viral properties.55 The enhanced biological stability of C-nucleosides is due 
to their resistance to hydrolysis of the glycoside linkage which is important with regard to 
anti-tumour activity.55 
Oxathiazolones have b een used in metal c omplex chemistry. A number o f o xathiazolones 
have been used to insert sulfur into a manganese cluster by reaction between [Mn(CO)5]- and 
a 5-substituted oxathiazolone (35), where R = phenyl, methyl or 3,5-nitrophenyl, to give the 
cluster [Mn3(CO)9Qt3-S)2J 63 There are also examples of oxathiazolone reaction products 
being used as ligands for transition metals. An example of this is a cobalt centred complex 
that was produced by the thermolysis of phenyl oxathiazolone 33 in the presence of 
[Co(Cp)(CO)2] to give 1 ,2,5,3-cobaltadithiazole (43)64 
Nitrile sulfides have also been exploited in the synthesis of potential non-steroidal anti-
inflammatory drugs, eg 1 ,2,4-thiadiazole (44) with 2,6-di-tert-butyiphenol substituent 
(Scheme 1.23) in the 3-position.65 
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Scheme 1.23 
In the case of 5-tosyl 1 ,2,4-thiadiazoles the labile tosyl group in the 5-position can be 
displaced by a large number of nucleophiles that allowed access to a variety of 
derivatives66'67 of differing biological activities as potential inhibitors of both 
cyclooxygenase (CO) and 5-lipoxygenase (5-LO) activity as measured in rat basophilic 
leukaemia (RBL-1) cells.66 
Furanosyl nitrile sulfide chemistry has been previously explored by Buffel et al.55' 56 He 
prepared a number of compounds from the oxathiazolone (45). The nitrile sulfide was 
trapped by DMAD to give the dimethyl 3-(2',3',5'-tri-O-benzoyl--D-ribofuranosyl)-4,5-
isothiazoledicarboxylate (46), which was then reacted further to produce compounds such as 
4-amino-3 - -D-ribofuranosyl-5 -isothiazolecarboxamide 	(47), 	3 --D-ribofuranosyl- 
isothiazolo[4,5-dJpyrimidine-7(6H)-one (48) and 4-amino-3--D-ribofuranosylisothiazole-5-
carboxylic acid (49). 
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However, none of these compounds was found to have any biological activity despite the 
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Results and Discussion 
	
2. 	Results and Discussion 
There are three related topics explored in this work; the first involves the development of the 
synthetic method for producing higher monosaccharides by the chain extension of various 
lower homologues, the second is to examine the potential of sugar-derived enamines as 
synthetic building blocks for higher monosaccharide analogues, and the final theme explores 
the synthesis of C-glycosides based on nitrile sulfide chemistry. 
2.1 	Introduction 
Higher monosaccharides are of synthetic interest as they are less abundant in Nature than 
lower homologues and are involved in a number of biosynthetic pathways. They are possible 
targets for herbicidal, antifungal, antimicrobial and antibacterial agents. Examples of such 
higher sugars are the tunicamycins (52)67  and the herbicidins (53)68  Also of interest are DAH 
(27) and KDO (28) as discussed in Section 1.5. C-Glycosides are of synthetic value as they 
are resistant to hydrolysis of the glycoside linkage found in O-glycosides. These compounds 
have potential as glycosidase inhibitors, a number of which have been found in Nature.6971  
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Results and Discussion 
2.2 	Synthetic Strategy 
A number of approaches to higher monosaccharides are explored in this thesis. The first was 
based on previous work within the group. Young and McGhie employed nitrile oxide 
cycloaddition chemistry in the synthesis of 7-deoxynonoses, 7-deoxydecoses and 6-
deoxyundecoses. 4"6 It was hoped to develop this methodology in order to apply it to the 
production of deoxyheptoses and deoxyoctoses. It was proposed to carry out chain extension 
by the [3+2] cycloaddition of a nitrile oxide at both the non-reducing terminus of an o-
unsaturated hexofuranose (Scheme 2.1) and at the reducing terminus of a series of 1-
methylene hexopyranoses and heptopyranoses (exoglycals, Scheme 2.2) resulting in 5-
substituted isoxazolines, from which the higher monosaccharides could be produced by 
reductive ring cleavage. 
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It was also proposed to expand the work discussed above to the chain extension of sugar- 
based enamines using nitrile oxide cycloaddition chemistry to give higher iminosugars 
(Scheme 2.3). 
O—N 
Higher Iminosaccharide 	 > 	R
cj__~ 	 N 
0 N 	X 
(Y 
Scheme 2.3 
Isoxazolines are stable to a variety of conditions allowing for the modification of the groups 
in the 3- and 5-positions without interference to the ring. This will allow access to an 
increased variety of isoxazolines. Reductive cleavage of the ring can yield a variety of 
functionalities, including -hydroxy ketones and '-amino alcohols (Scheme 2.4).' 
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The nitrile oxides chosen for study were bromonitrile oxide (54), carbethoxyformonitrile 
oxide (55), benzonitrile oxide (56) and a xylose-derived nitrile oxide (57). These were 
generated either by dehydrohalogenation of the corresponding halogenated oximes or 
dehydration of the nitromethylxylose. 
Br—=—N-0 Et02CN-0 Ph 




_NO AcO",( 	c 
56 	 OAc 
57 
The dipolarophiles used were based on a series of sugars; 58, 59 and 60 were derived from 
D-glucose, 61 was prepared from D-mannose, 62 and 63 were synthesised from D-xylose, 
while 64 and 65 were based on L-arabinose and D-galactose, respectively. These were 
prepared using a variety of methods that will be discussed in greater detail later. 
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The final area of work is the synthesis of a number of sulphur-containing C-glycosides. This 
area stems from past work within the group using alkyl and aryl oxathiazolones as precursors 
for the 1,3-dipolar cycloaddition of nitrile sulfides to various of dipolarophiles. 
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In the synthesis of the nitrile sulfide-based C-glycosides it was hoped to take chemistry 
previously used in the group for alkyl and aryl nitrile sulfides and apply it to saccharides. It 
was intended to prepare these compounds by trapping pyranosyl nitrile sulfides, eg with 
ethyl cyanoformate or dimethyl acetylenedicarboxylate. It was proposed to generate the 
nitrile sulfides by thermal decarboxylation of 5-pyranosyl-1,3,4-oxathiazol-2-ones, and to 
prepare the latter by treatment of the corresponding carboxamide with 
chlorocarbonylsulfenyl chloride (Scheme 2.5). The nitrile sulfides used were based on two 
sugars, D-xylose and D-glucose. 
2.3 	Synthesis of Nitrile Oxide Precursors 
2.3.1 	Synthesis of Dibromoformaldoxime (66) 
00 OH H_H II OH 	 i) NaHCO3 Br\  N 0 	 ,N—OH 
H2N-0H.HCI H 	OH 	
ii) Br2 	Br 
66 
Scheme 2.6 
Dibromoformaldoxime was prepared using the method of Vyas et al,71 as described by Boyd 
(Scheme 2.6).72  Treatment of aqueous glyoxylic acid with hydroxylamine hydrochloride 
followed by addition of sodium bicarbonate and bromine afforded the product as a solid that 
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was recrystallised from hexane to leave white crystals (29%, overall). It was subsequently 
found that this compound decomposes within two months of production, resulting in the 
reduced yields of subsequent reactions. It was therefore prepared shortly before use. 
	
2.3.2 	Synthesis of Ethyl Chiorooximidoacetate (67) 
___ NO ___ 
+ 	Et02C\  P+ 
HONO EtO2C\_ + 	NO C-'--NEN 
EtO2C—CH2NH2 	 ,C—NEN 
H 	 - 
CI 	0 
Hshift 	 I 
Et02C 	 _________ EtO2C\ 
/C =N—OH 	 CPC—N=0 cv' 	Tautomerism 	H 
67 
Scheme 2.7 
This compound was produced employing the approach of Skinner,73 by reacting glycine 
ethyl ester hydrochloride with hydrochloric acid and sodium nitrite while ensuring that the 
temperature of the reaction did not exceed —20°C. The product was isolated as a white 
crystalline solid (39%). The proposed mechanism for the reaction is shown in Scheme 2.7. 
2.3.3 	Synthesis of Benzohydroximoyl Chloride (68) 
Cl 
H) C) 	CI 	 Hshift 	CI 
N—O—H H--NO 	 - =N—OH 
Ph 	 Ph 	Tautomerism Ph" 
Scheme 2.8 
	 68 
The title compound was produced using the method of Chiang,74 which involved chlorine 
being bubbled through a solution of a-benzaldoxime in DCM at —10°C. This resulted in a 
yellow solution, which yielded a white solid that was recrystallised from pentane (69%). The 
suggested mechanism for the reaction is shown in Scheme 2.8. 
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2.3.4 	Synthesis of 
(3,4,5_tri-O-acetyI-3-D-xylopyranosyInitromethafle) (70) 
CH2NO2 	 CHNO2 
	
O OH 	 CHOH CH 
1 '1" (i) 	 OH 	(II) 	 OH 
HO""OH 	 HO 	 HO 
OH 	 OH 	 OH 
CH20H CH20H 
1°JN02 	(lu) .[::NO2 
HO" 	"OH AcO" 
r 
OAc 
OH 	 OAc 
69 70 
(i) NaOMe, CH3NO2, MeOH; (ii) H20, reflux; (iii) Ac20, TfOH 
Scheme 2.9 
The first stage of the synthesis of the title compound was to add nitromethane to the sugar at 
the anomeric position employing the Fischer-Sowden reaction.75 The product was then 
heated to achieve dehydration and ring closure to form 69. Protection of the hydroxyl groups 
was 	achieved 	with 	acetic 	anhydride 	to 	give 	3,4,5-tri-O-acetyl-3-D- 
xylopyranosylnitromethane (70) as a white crystalline solid (37% from D-xylose) (Scheme 
2.9). The 1 H NMR spectrum showed that the 3-anomer had been formed. The observed 
coupling between 2-H and 3-H was 10.1 Hz, which is consistent with a trans-diaxial 
arrangement for these protons. If the a-anomer had been produced then the axial-equatorial 
arrangement of these protons would be expected to give J2,3 -'3 Hz. Of the four possible 
structures (Figure 2.1) the 3 5C2  form is favoured, as this is the arrangement where all the 
substituents are in the more stable equatorial positions. 
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Figure 2.1 
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i) SnCI4, NEt3, HSPh, THE; I) C12, CHCI3  
Scheme 2.10 
The title compound was prepared in a two step process (Scheme 2.10) from the acetylated 
nitromethyl x ylose 70 via the pyranosyl o xime 71. The first step followed the method of 
Baker et al,76 which used the reduction procedure developed by Bartra et al.77 The protected 
nitromethyl xylose was reacted with tin(IV) chloride, triethylamine and thiophenol to give 
the xylose oxime as an oil in a 65% yield. The oxime was then converted quantitatively to 
the hydroximoyl chloride 72 by chlorination using the same method as that employed for the 
benzohydroximoyl chloride (Section 2.3.3). 14 
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2.4 	Synthesis of Hex-5-enofuranosides 
2.4.1 	Synthetic Targets 
The targets for this work were a series of ulosonic acid analogues and it was hoped that the 
application of nitrile oxide/isoxazoline chemistry to sugar dipolarophiles would allow access 
to such derivatives. There are two potential pathways to these higher monosaccharide 
analogues 73 (Scheme 2.11). In pathway (a) the sugar ring will be deprotected prior to 
hydrolytic ring cleavage of the isoxazoline, while in route (b) the isoxazoline ring opening 
will occur first. The two sugar alkenes selected for initial study were based on D-glucose 58 
and D-mannose 61. The synthesis of these alkenes is discussed below. 
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2.4.2 	Synthesis of 3-O-Benzoyl-5,6-dideoxy-1 ,2-O-isopropylidene-a-D-xy/o-hex-5- 
enofuranose (58) 
This alkene was synthesised in four steps from diacetone-D-glucose (1,2:5,6-di-0-
isopropylidene-D-glucose, 74)78  In the first step (Scheme 2.12) the free hydroxyl group in 
the 3-position was converted into the benzoate ester 75 by treatment with benzoyl chloride in 
pyridine. The crude product was taken on to the next stage without purification. 
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74 	 75 
Scheme 2.12 
The second step required the selective removal of the isopropylidene group in the 5,6-
positions while leaving intact the other acetal at the 1,2-positions (Scheme 2.13). This was 
achieved by mild acid hydrolysis. The difference in reactivity between the two sites can be 
attributed to the steric hindrance afforded by the fused ring system that limits attack at the 
1,2-positions.78 The hydrolysis was carried out using glacial acetic acid in water (40°C) and 
afforded the crude product 76 as a brown oil, which was taken on to the next step without 
further purification. 
'*_0 	 HO o 1 o 	d13CO2F1 HO 	0 
)O 	H20 	 "lO 
BzO'O 	 BzO'O 
75 Scheme 2.13 	 76 
In the third stage (Scheme 2.14) the 5,6-diol was reacted with methanesulphonyl chloride in 
pyridine. The resulting dimesylate 77 was recrystallised from ethanol to give white crystals 
(28% overall from diacetone-D-glucose, 74). The structure of the product was confirmed by 
comparison of the 'H NMR data with previous work in the group .71 
HO 	 MsO 
HO j... 0 	MeS02CI MsO 	0 
- ( IO 'O 
)c pyridine 	 )-&, )c 
BzO 
, 0 	 BzO 0 
76 	 77 
Scheme 2.14 
The final step (Scheme 2.15) required the elimination of the two mesylate groups at the 5-
and 6-positions of compound 77 to give the desired alkene 58. This was achieved using a 
modified Tipson-Cohen procedure8° involving reaction of the dimesylate with a freshly 
prepared ZnICu couple in the presence of sodium iodide in DMF. The mechanism proposed 
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for this reaction is shown in Scheme 2.16.80  The product was isolated as a crystalline solid in 
77% yield (22% from diacetone D-glucose) and was identified by its melting point and using 
'H and '3C NMR spectroscopy. 
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Scheme 2.15 
Ms6) OMs Nal I 	OMs Zn I- -Zn OMs 
— CHR 	 C'HR
-ZnI 
- COMs 
-MsO 	C' H2C=CHR 	H2C HR  
Scheme 2.16 
2.4.3 Synthesis of Methyl 5,6-Dideoxy-2,3-0-isopropylidene-a-D-lyxo-hex-5-
enofuranoside (61) 
This alkene was produced in a four step process from D-mannose as previously reported.8 ' 
The first step required the protection of the sugar in the furanose form 78 (Scheme 2.17) 
which was achieved by heating the starting material in the presence of 2,2-
dimethoxypropane, methanol and c onc. H Cl. The crude product was taken on to the n ext 
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In the second step the isopropylidene group at the 5,6-position (Scheme 2.18) was selectively 
removed by mild acid hydrolysis. The hydrolysis was carried out using glacial acetic acid in 
water and afforded the crude product 79 as a brown oil, which was taken on to the next step 
without further purification. The 5,6-diol was then reacted with methanesuiphonyl chloride 
in pyridine to give the dimesylate 80 (Scheme 2.18) that was recrystallised from ethanol to 
yield white crystals (31% overall from D-mannose). The product was identified by its 














The Tipson-Cohen procedure described above for 58 was also used to convert dimesylate 80 
into the target alkene 61. This gave the desired product (Scheme 2.19) as an oil that 
solidified when left overnight in a freezer (77%, 23% from D-mannose). The title compound 
was identified by comparing the 'H and '3C NMR spectra with the literature. 12 
OMs 
Zn-Cu couple M,"OMe 
Nal 
ox0 	 °x° 
80 	 61 
Scheme 2.19 
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Scheme 2.20 
The cycloaddition reactions were all carried out under the conditions developed by 
Huisgen,'2 '3 which involves the in situ generation of the nitrile oxide by 
dehydrohalogenation of the corresponding hydroximoyl halide in the presence of the alkene 
(1:1.2). The generation of the nitrile oxide is controlled by slow addition of triethylamine to 
the reaction mixture over several days (by syringe pump), thus inhibiting furoxan formation. 
A further step that can be employed to limit furoxan formation is to ensure that the alkene is 
present in a large excess relative to the nitrile oxide (Scheme 2.20). 


















The cycloaddition reaction was carried out as described above (Scheme 2.21). The 
dibromoformaldoxime and the alkene 58 were dissolved in sodium-dried ether to which 
triethylamine in ether was added over three days. On completion of base addition the mixture 
was left to stir overnight. The work up gave an oil that contained the isoxazoline 
cycloadduct, which was present as a mixture of diastereomers, together with some unreacted 
alkene. The presence of the disastereomers were shown by a figure-of-eight arrangement of 
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product spots on the tic plate and this was confirmed by the 'H (Appendix 4a) and '3C NMR 
spectra which showed two sets of peaks attributable to the isoxazoiine rings. 
The crude mixture was subjected to dry flash chromatography and yielded, in order of 
elution, the unreacted alkene (58%) and a mixture of the two isoxazoline diastereomers 81a 
and 81b in 67% yield (based on consumed alkene). The isomer ratio was determined to be 
87:13 by comparison of their 'H NMR spectra. In the proton NMR the most suitable protons 
for determining this were those at the anomeric position as they had the greatest chemical 
shift of the sugar protons; the signals for the two isomers are also well separated (z n = 0.08 
ppm) and not obscured by any other signals. 





Figure 2.2: 'H NMR of the anomeric proton 
The two diastereomers could not be separated by dry flash chromatography and the major 
isomer 81a (3 0%) was therefore isolated by recrystallisation from ethanol. Products 81a and 
81b were assigned as having erythro and threo relationships (Scheme 2.22), respectively. 
This designation is based on the relative stereochemistry at C-4 and C-5. The major isomer 
was assigned 5R4S stereochemistry by correlation with examples of sugar isoxazoiines with 
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eleven carbons in the backbone as reported in the literature,' which showed that the major 
5R4S isomer (erythro) had the lower chemical shift for the anomeric H atom than the 5S4S 
minor isomer (threo) (Table 2. 1, Figure 2.2).' The cycloadduct 81a was characterised by 'H 




Table 2.1: Chemical Shifts of Cycloadduct 






81 5.97 6.05 Br 
82 5.96 6.02 CO2Et 
83 5.99 6.09 Ph 
2.5.2 	Synthesis of 5-(3-O-Benzoyl-1 ,2-O-isopropylidene-a-D-xylo-fu ranos-4-yl)-3- 
carbethoxy-2-isoxazoline (82) 
	
N—O 	 N—O 
0 EtO2CCnNO EtO2C'°
~0'10 
O 	+ EtO2C' )1O 
BzO 	0 	
Bz  BzO 	'0 
58 	 82a 	 82b 
Scheme 2.23 
The cycloaddition to give the title compound was carried out in the same manner as the 
previous reaction with the nitrile oxide being generated in situ by the slow addition of the 
base to the reaction mixture containing alkene 58 and ethyl chlorooximidoacetate (Scheme 
2.23). From the reaction mixture was isolated an oil that contained unreacted alkene and the 
desired cycloadduct 82 as a mixture of diastereomers. 
The oil was then subjected to dry flash chromatography to give, in order of elution, the 
unreacted alkene (4 1%), followed by a mixture of the isoxazoline diastereomers (67%, based 
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on consumed alkene). The isomer ratio was found to be 87:13 from the proton NMR 
spectrum (Appendix 4b). The isomers of this particular cycloadduct were not separable by 
chromatography and as a result the major (5R) adduct 82a (Table 2.1) was isolated by 
recrystallisation of the crude product from ethanol to give white crystals. The cycloadduct 
was characterised by its 'H and '3C NMR spectra and the mass was confirmed using FAB 
mass spectrometry. 
2.5.3 	Synthesis of 5-(3-O-Benzoyl-1 ,2-O-isopropylidene-c-D-xy10-furanos-4-y1)-3- 
phenyl-2-isoxazoline (83) 
N—a 	 N—a + - 
PhCEN-0 	 '0 + 	 0 '0 
BzO "0 	
Ph 
BzO '0 	 BzO 
58 	 83a 	 83b 
Scheme 2.24 
The cycloaddition was carried out by the standard method already described (Scheme 2.24). 
However, the base was added to the reaction mixture containing benzohydroximoyl chloride 
and alkene 58 over two days rather than over three days. The reaction produced an oil that 
contained the unreacted alkene and a mixture of the two isoxazoline diastereomers. 
Dry flash chromatography of the crude product afforded the unreacted alkene (22%) and the 
two product diastereomers 83 (69%, based on consumed alkene), the isomer ratio of which 
was determined to be 83:16 from the proton NMR spectrum of the product mixture 
(Appendix 4c). As with the two cases above, the diastereomers could not be separated by 
column chromatography, but the major (5R) isomer 83a (Table 2.1) was isolated by 
recrystallisation from ethanol. This compound was characterised by its melting point, 'H and 
'3C NMR and the mass was confirmed using FAB mass spectrometry. 
2.5.4 	Synthesis of 3-Bromo-5-(1 -O-methyl-2,3-O-isopropylidene-a-D-lyxo-furanos- 
4-yl)-2-isoxazoline (84) 
This reaction was carried out in an identical manner (Scheme 2.25) to the previous 
cycloadditions by addition of triethylamine in ether to a mixture of alkene 61 and 
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dibromoformaldoxime in sodium-dried ether. This resulted in the production of an oil 










The unreacted alkene (79%) was removed using dry flash chromatography to leave the 
inseparable diastereomers (92%, based on consumed alkene) as an oil. The compound was 
characterised from proton and carbon NMR and the isomer ratio was determined to be 79:21 
from the 'H NMR spectrum (Appendix 4d). It was not possible to isolate the major isomer 
by crystallisation from the crude mixture of isoxazolines. 
2.5.5 	Selectivity of Nitrile Oxide Cycloaddition Reactions 
Nitrile oxide cycloadditions to cyclic chiral allyl ethers results in it-facial selectivity; this is 
due to the faces of the alkene not being identical causing a degree of diastereoselectivity in 
the reactions. The selectivity is affected by electronic and steric factors imparted by the 
alkene substituents .4  The it-facial selectivity may be explained by the "inside-alkoxy" effect. 
This proposal by Houk et a!83 examines the transition state of the reaction between 1,3-
dipoles and cyclic and acyclic chiral allyl ethers and chiral allyl alcohols by considering the 
relative positions of the substituents in the transition state. 
+ + 
'n'de 
H, outside HI jS 
anti L 
Figure 2.3 
As can be seen from Figure 2.3 there are three possible positions for the substituents to take 
up in the transition state of the reaction between a nitrile oxide and a monosubstituted 
alkene .7' The inside position is generally favoured by the medium sized substituents, the 
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outside position is preferred by the smallest group and, finally, the largest group favours the 
anti position.4  Looking, more specifically, at chiral cyclic allylic ethers there are six possible 
staggered transition structures for the cycloaddition of a nitrile oxide to a chiral allyl ether 
(Figure 2.4). Theoretical calculations by Houk et a183 of the relative energies of the transition 
states places them in ascending order of energy A<A'<B<B'<C'<C. The major erythro 
adduct results from transition states A, B and C and the minor threo adduct results from A', 
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Figure 2.4 
There are several reasons for the selectivity of these reactions. The alkoxy group prefers the 
inside-position as this allows the slight rotation of the alkoxy and a lkyl groups to am ore 
relaxed conformation, this would not be possible in the outside-position due to the 
interaction between the lone pairs of the alkoxy oxygen and those of the nitrile oxide 
oxygen. The alkoxy group also shuns the anti-position as this would have a destabilising 
effect on the transition state because of the electron withdrawal from an already electron 
deficient transition state. This electron withdrawal is attributed to secondary bonding 
interactions where the *orbital of the carbon-oxygen bond interacts with the it-orbital of 
the alkene. This overlap is at its maximum when the alkoxy group takes up the anti-position 
and at a minimum when the group adopts the inside-position. The alkyl group prefers the 
anti-position as this stabilises the transition state through electron donation from the CT-
orbital of the carbon-carbon bond to the overlapping it-orbital of the alkene. The two other 
positions are unfavoured due to the lack of rotation that would be achievable by the group in 
either position to more relaxed conformation. The hydrogen takes up the outside position by 
default to allow the alkoxy and alkyl groups to satisfy their electronic and steric 
requirements.84'85  
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The difference in selectivity observed for the major and minor diastereomers of isoxazoline 
84 (79:21) versus isoxazolines 81, 82 and 83 (87-84:13-16) may be explained by the 
experimental error rather than by the "inside-alkoxy" effect. They can also be rationalised by 
the conclusions of De Micheli and co-workers. 78 They reported that for some nitrile oxide 
cycloadditions to D-xylo-hex-5-enofuranosides the erythro:threo ratio was larger than could 
be rationalised by Houk's "inside-alkoxy" effect. They concluded that some other interaction 
must have been affecting the stability of the transition states. It was surmised that the 
homoallylic oxygen in the 3-position was important in destabilising A and A' (Figure 2.5). 
The lone pair of this oxygen may exert a through space interaction in these transition states 
withdrawing electron-density from the system. However, in the next lowest energy transition 
state, B, the h omoallylic o xygen i s orientated in such a way that it cannot destabilise the 
double bond (Figure 2.5). B affords the erythro diastereomer thus explaining the increased 
levels of this product over the threo. 
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Figure 2.5 
This interaction has been further demonstrated by previous work in the group,86 where the 
configuration of the 3-position was inverted to explore the difference in diastereoselectivity 
of the cycloaddition reaction. It was found that the reaction between benzonitrile oxide and 
3 -O-benzyl-5 ,6-dideoxy- 1 ,2-O-isopropylidene-a-D-xylo-hex-5-enofuranose (85) was found 
to be highly stereoselective (73-93% d.e.), while the cycloaddition of benzonitrile oxide to 3-
O-benzyl-5 ,6-dideoxy- 1 ,2-O-isopropylidene-a-D-ribo-hex-5 -enofuranose (86) gave a 
considerably lower selectivity (16% d.e.). These findings support De Micheli's conclusions 
and add further weight to the "inside-alkoxy" effect rationalisation. 
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This may explain (Figure 2.5) the lower selectivity observed for isoxazoline 84 as the 
importance of transition state B is dependent upon the ability of the group in the 3-position 
to rotate to the most stable configuration, in the case of this isoxazoline the oxygen is locked 
in position as a 2,3-0-isopropylidine group. This results in transition state B being of limited 
importance in this cycloaddition, therefore less of the erythro product was generated. While 
the transition states that yield isoxazolines 81, 82 and 83 are all capable of allowing rotation 
at this position, consequently B is again an important transition state for generating the 
erythro product in the cycloaddition process. 
2.6 	Reactions of Cycloadducts 
2.6.1 	Reduction of the Ester Groups of 5-(3-O-Benzoyl-1,2-O-isopropylidene-a-D- 
xylo-furanos-4-yI)-3-carbethoxy-2-isoxazoline (82) 
Previous work in the group found that ring cleavage of 3-carbethoxy-2-isoxazolines was 
slow. This was a attributed to interaction, by resonance, of the carbonyl of the ester with the 
isoxazoline ring (Scheme 2.26), as a result the isoxazoline ring is not readily cleaved. The 
carbethoxy group was therefore to be converted to the alcohol prior to ring opening. It was 
hoped that this would provide a route to ulosonic acid analogues. Scheme 2.27 illustrates two 
potential routes to ulosonic acid analogues using this approach, for pathway (a) the sugar 
ring is deprotected and the resulting aldehyde is reduced to the alcohol to afford isoxazoline 
The isoxazoline will then be hydrolytically cleaved to yield the ulosonic acid analogue 
In pathway (b) the opposite method is taken whereby the isoxazoline will be cleaved to 
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The approach employed for the reduction of the ester group at the 3-position of the 
isoxazoline ring used sodium borohydnde (4 eq.) as the reducing agent. This was dissolved 
in dry ethanol and slowly added to a stirred solution of isoxazoline 82 in dry ethanol at room 
temperature. On consumption of the starting material the reaction mixture afforded an 
apparently pure (tic) white solid in low yield, after purification by dry flash chromatography. 
Examination of the product by proton NMR spectroscopy (Appendix 4e), however, indicated 
the presence of two compounds in a ca. 1:1 ratio. On the basis of the NMR spectrum the two 
compounds were assigned structures 90 (11%) and 91(8%). There were signals for two OH 
groups and an aromatic group; this suggests that there is one compound where the 
isoxazoline ester has been reduced to the alcohol and has also been d eprotected at the 3-
position by the removal of the benzoate to leave a second alcohol group (90). The 
isoxazoline ester of the second compound has been reduced to the alcohol but the benzoate 
has been left intact (91) (Scheme 2.28). Therefore, it was decided to alter the conditions to 
completely remove the benzoyl group in the 3-position in an effort to produce, solely, 
isoxazoline 90. 
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Scheme 2.28 
In an effort to obtain only alcohol 90 it was decided to increase the quantity of sodium 
borohydride to 20 eq.88 As before, tic indicated that the starting material had been consumed 
and a single compound had been produced. However, proton NMR (Appendix 4±) and the 
mass spectrum showed the white solid to be a mixture of 90 and 91. This experiment 
afforded deprotected alcohol 90 as the major product in a ca. 13:1 ratio with alcohol 91. This 
method had a much-improved yield, however, a mixture of alcohols was still obtained and it 
was not possible to separate the two alcohols or to isolate either as single diastereomers. 
2.6.2 	Substitution Reactions 
In order to increase the range of available isoxazolines it was intended to substitute the 
bromine atom in the 3-position of isoxazolines 81 and 84 with a series of nucleophiles. This 
would allow access to a number of substituted isoxazolines using one common nitrile oxide 
precursor. Furthermore, this approach would afford isoxazolines for which there is no 
reasonable precursor readily available. To test the basis of this chemistry it was decided to 
carry out model reactions using methoxide as the nucleophile employing a modified 
approach from Nishi et al.89 It was hoped that this would allow easy access to an array of 
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A solution of the 3-bromoisoxazoline 81 (R:S 87:13) in a lithium methoxide/methanol 
solution was heated at reflux until no starting material remained (tic) and from the reaction 
mixture was isolated an oil in 66% yield (Scheme 2.30). The product was identified as the 
title compound and assigned as being the SR-isomer by comparison with the proton NMR 
spectrum of the starting material; the former had peaks at 3.88 ppm and 3.05 ppm that 
corresponded to the 3-methoxy group and a hydroxyl group respectively. In contrast to the 
starting material, which was a mixture of isomers 81a and 81b, the product proved to be a 
single isomer. None of the minor isomer was isolated. 
2.6.2.2 Synthesis of 3-Methoxy-5-(methyl-2,3-O-isopropylidene-a-D-lyxo-furanosyl-4-
yl)-2-isoxazoline (93) 
Cycloadduct 86 (R:S 79:21) was refluxed in lithium methoxide/methanol solution, until no 
starting material remained (tic), to give the substitution product as a mixture of isomers in a 
78% yield (Scheme 2.31). The isomeric products were separated by column 
chromatography. This gave the major 5R-isomer 93a as an oil (63% isolated yield) and the 
minor 5S-isomer 93b as an oil (15% isolated yield). The evidence for the incidence of both 
cycloadducts was found in the proton NMR spectra of the starting material and the products. 
The former showed one singlet at 3.30 ppm corresponding to the 1-methoxy group attached 
to the sugar ring, while both product spectra contained peaks attributable to the I -methoxy 
group and the 3-methoxy group of the isoxazoline ring at 3.88 ppm and 3.35 ppm, 
respectively, for the major isomer, and 3.84 ppm and 3.33 ppm for the minor isomer. 
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Scheme 2.31 
These reactions indicate that cycloadducts 81 and 84 easily undergo nucleophilic substitution 
reactions and suggest that a number of substituted isoxazolines should be easily accessible 
via this route. This is of particular value for products where the nitrile oxide precursors may 
not be readily available, eg RO—C=N—O. However, further work will be required to 
determine what substitution reactions are possible. 
2.6.3 	Ring Opening Reactions 
2.6.3.1 Attempted Ring Opening of 5-(3-O-Benzoyl-1 ,2-O-isopropylidene-a-D-xylo-
furanosy-4-yl)-3-carbethoxy-2-isoxazOlifle (82) 
As previous work with 3-carbethoxy isoxazolines had shown that they were slow to cleave 
with catalysts such as Raney Ni and PdIC it was decided to use MO(CO)6 as the catalyst. 
This reaction used a method previously reported by Baraldi et al.90 Isoxazoline 82 was 
dissolved in acetonitrile in the presence of MO(CO)6 and the resulting mixture was refluxed 
for 1 h. On work up no ring opening products were observed either by the tic or in 1 H NMR 
spectrum and the starting material was recovered quantitatively. 
The failure of this reaction was attributed to the stabilising effect of the carbonyl in the ester 
group resonating with the imine group of the isoxazoline (Scheme 2.27). 
2.6.3.2 Attempted Ring Opening of 5(3O-Benzoyl-1,2-O-isoproPYIidefle-a-D-XY1O-
furanosy-4-yl)-3-phenyl-2-isoxazOlifle (83) 
Isoxazoline 83 was stirred in a solution of methanol and water under a hydrogen atmosphere 
in the presence of Raney nickel" for 48 h after which time tic showed that most of the 
starting material had been consumed. The reaction mixture was subjected to column 
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chromatography; this resulted in a low yielding unidentifiable product and recovered starting 
material (6%). 
2.7 	Conclusions 
It has b een shown that isoxazolines may be produced by the 1,3-dipolar cycloaddition o f 
bromoformonitrile oxide, ethoxycarbonylnitrile oxide and benzonitrile oxide with sugar-
derived alkenes. The reactions of the three chosen nitrile oxides with 3-O-benzoyl-5,6-
dideoxy-1 ,2-O-isopropylidene-a-D-xylo-hex-5-enofuranose (58) gave isoxazolines in similar 
yields (67-69%). it-Facial selectivity for the newly formed stereocentre at the 5-position, 
with isomer ratios in the range of 87-84:13-16 (R:5). It was not possible to separate the 
diastereomers by column chromatography. However, small quantities of the major R-isomer 
were isolated by recry stall isation. 
The final cycloaddition attempted was that of bromoformonitrile oxide and methyl 5,6-
dideoxy-2,3-0-isopropylidene-a-D-lyxo-hex-5-enofuranoside (61), which gave cycloadduct 
84 in a high yield (92%), but with reduced selectivity (79:21). This cycloadduct also presents 
problems for separation as it was not possible to isolate the diastereomers by column 
chromatography and, to date, has proved difficult to recrystallise. 
The reductions of the carbethoxy group in 5-(3-O-benzoyl-1,2-O-isopropylidene-(X-D-xylo-
furanos-4-yl)-3-carbethoxy-2-isoxazoline (82) gave an inseparable mixture of alcohols. The 
substitution reactions carried out on 5-(3-O-benzoyl-1,2-O-isopropylidene-a-D-xylo-
furanosy-4-yl)-3-bromo-2-isoxazoline (81) and 3 -bromo-5-(methyl- 1 ,2-O-isopropylidene-(x-
D-lyxo-furanosyl-4-yl)-2-isoxazoline (84) were more successful. The former gave the (5R) 5-
(1 ,2-O-isopropylidene-a-D-xylo-furanosy-4-yl)-3-methoxy-2-isoxazoline (92) in 66% yield, 
while the latter gave 3 -methoxy-5-(methyl- 1 ,2-O-isopropylidene-(x-D-lyxo-furanosyl-4-yl)-
2-isoxazoline (93) as an inseparable mixture of the R and S isomers 64% and 15%, 
respectively. These substitution reactions provide scope for the generation of 
diastereomerically pure novel sugar isoxazolines for which there are no easily available 
nitrile oxide precursors. 
The ring opening reaction attempted on 5-(3-O-benzoyl- 1 ,2-O-isopropylidene-a-D-xylo-
furanosy-4-yl)-3-phenyl-2-isoxazoline (83) resulted in a small amount of unidentifiable 
product and recovered isoxazoline (6%). That attempted with 5-(3-0-benzoyl-1 ,2-O- 
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isopropylidene-(t-D-xylo-furanosy-4-yl)-3-carbethoxy-2-isoxazoline (82) resulted in the 
quantitative return of starting material. 
Due to the problems discussed in this section an alternative approach to higher 
monosaccharides was explored, based on exoglycals. 
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2.8 	Synthesis of 1-Methylene Sugars (Exoglycals) 
1 -Methylene sugars (exoglycals) were selected as d ipolarophiles as it was c onsidered that 
they could provide an alternative route to ulosonic acid analogues, as illustrated in Scheme 
2.32. Cycloaddition of a nitrile oxide to an exoglycal would be expected to be regiospecific 
affording spiroisoxazolines, which could yield ulosonic acid-like hemiketals by the ring-
opening/ring-closure sequence shown below. Spiro-isoxazolines are also of biological 
interest in their own right. For example, bromotyrosine derived marine metabolites have 
been reported. Two examples of such metabolites are aerothionin (94) and psammaplysin-A 
(95) that contain the spirocyclohexadiene- and spiriooxepin-isoxazoline systems, 
respectively.9 ' 
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2.8.1 	Routes to Exoglycals 
The synthesis and uses of exoglycals have been recently reviewed by Taillefumier.92 There 
are two potential approaches to exoglycal synthesis, the first constructs the carbon skeleton 
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which undergoes an elimination reaction to give the double bond and the second method has 
the unsaturation included in the carbon-carbon bond formation process.93  
x 
RO 	1 




Exoglycals can be generated with or without substituents in the 1-position of 96, the 
synthesis of both will be outlined. First, the production of the unsubstituted exoglycals will 
be discussed. The elimination of the bromide and an acyl group from a pyranosyl bromide 
97,94 using Fischer-Zach conditions (Scheme 2.33) is one approach to the exoglycal 98, 
which required treatment with copper activated zinc in acetic acid. However, the endo-glycal 
99 is also produced under these conditions and, as yet, there is no method available to 
control the regiochemistry of this reaction.94 
Zn/HOAc 	0 







Scheme 2.33 R = Bz, Ac 
Exoglycals can also be produced by the olefination of a sugar lactone (Scheme 2.34) using 
either the Tebbe (route a)95 or Petasis (route b)96 reagents. Both these approaches produce the 
methylidenetitanocene (Cp2Ti=CH2) reactive species which undergoes a [2+2] 
cycloadditionlcycloreversion with the carbonyl group of the saccharide to afford the 
methylene group. 
0 	0 	a) Cp2Cl2, AIMe3 
RO5 	




Results and Discussion 
A novel approach to exoglycals was recently reported by T6th.97 Pyranosyl nitriles were 
converted to 2,6-anhydroaldose tosyl hydrazones 100 that gave the desired exoglycal 101 
when subjected to aprotic Bamford-Stevens conditions (Scheme 2.35). 
NaH 
0 	N 	Raney Nickel 	O-=N—NHTs 	1,4-dioxane









100 	 101 
Scheme 2.35 R = Ac, Bz 
The routes into 1-substituted exoglycals 102 are usually more complex than those for I -exo-
methylene sugars. The Ramberg-Backlund rearrangement has recently been identified as a 
novel route to functionalised exoglycals. This method exploits the known stability of alkyl 
and aryl thioglycosides, which are easily prepared and can be readily activated to give the 
sulphonium species.93 In this example (Scheme 2.36) the Ramberg-Backlund conditions are 
applied to a thioglycoside S,S-dioxide 103 (glycosyl sulphone) to synthesise a carbon-carbon 
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Scheme 2.36 R = Ac, Bz 
Another possible route to the desired exoglycals is to employ the Wittig reaction; however 
only functionalised exoglycals may be produced by this route as a stabilised ylide is 
required.98 '°° Two possible sets of conditions (Scheme 2.37) were used to carry out this 
reaction, the first required the heating of the lactone and the stabilised phosphorane in 
toluene for 24 h at 1400C.boo  A disadvantage of this route is that the reaction must be carried 
out in a sealed tube. The second technique used microwave radiation to achieve reaction by 
placing the reactants in a microwave oven at 90°C for ito 2 min to give the product. 101  
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5o 	Ph3P=CHR 
a) toluene, reflux 
OR b) microwave rad 
Scheme 2.37 R = CO2Me, CO2Et, CN 
A variety of exoglycals have been produced by the addition of nucleophiles to sugar lactones 
to give pyranoketoses that are subsequently dehydrated using trifluoroacetic anhydride and 
pyridine (Scheme 2.38).b02 
..-OBn 	 OBn 	 OBn 
BnO °\ 	R-CH2M 	
(CF3CO)20 BnO
9 
M = Li or Mx R 	pyridine 	iBnO 
BnO 
OBn 	 BflOOH 	 OBn 
R = H, C2H5, CO2Et, CH=CH2, PO(OMe)2, S03Et, C6H5 
Scheme 2.38 
The allylation of a sugar 1,1 -dihalide using two equivalents of allyltributyltin gives the allyl 
pyranosyl chloride 105 via a radical mechanism. This intermediate then affords the exocyclic 
diene 106 by a base catalysed 1,2-elimination reaction.'°3 This is known as the Keck reaction 
(Scheme 2.39). 
C6H6, irradiate 	'-.._-O 	 DBU 	RO - 
RO
CI nBU3SnCH2CH=CH2 RO 
	
CH3CN 
Br 	 Cl 	 H 
105 	 106 
Scheme 2.39 R = Ac 
A number of modified Petasis reagents have been used to produce functionalised alkenes in 
acyclic systems (Scheme 2.40).b04  It is possible that these may, in the future, be applied to 
cyclic systems and sugar lactones in particular. 
Cp ,—Ar 
Ti 	 Ar 0 	Cp"
 
"—Ar 
R1 R2 	 R1 R2 
Scheme 2.40 
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2.9 	Synthesis of Exoglycals 
Two approaches were considered for the preparation of the target 1-methylene sugars: the 
route used by Tóth et at?7 proceeding via tosyl hydrazones as intermediates (Scheme 2.35), 
and that involving Petasis olefination of sugar lactones (Scheme 2.34). 
2.9.1 	Synthesis of 2,6-Anhydro-3,4,5-tri-O-acetyl-1-deoxy-D-xylo-hex-1-enitol (62) 
o 	 0N 	 0 _N—NHTs 
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The acetylated nitromethyl xylose 70 was first converted into the nitrile 107 (84%) by 
treatment with phosphorous trichioride in pyridine following the method of Köil (Scheme 
2.41 ). 105 
2,6-Anyhdro-3,4,5-tri-O-acetyl-3-D-xylose tosyihydrazone (108) was then prepared from the 
protected xylose nitrile, produced in the above step, utilising a method modified by Tóth et 
at?8 from those of Albrecht et all 06  and Dettinger et al.'°7 Raney nickel was added to a stirred 
solution of pyridine, water and acetic acid, to which sodium hypophosphite, tosyl hydrazine 
and the xylose nitrile were added. The reaction mixture was allowed to stir until no starting 
material remained (tic). The hydrazone was isolated from the reaction mixture as a white 
solid (86%). 
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The target exoglycal 62 was produced from the xylose hydrazone 108 in a 51% yield [36% 
overall from 2,6-anhydro-3 ,4,5-tri-O-acetyl- 1 -deoxy- 1 -nitro-D-gulo-heptitol (70)] using 
aprotic Bamford-Stevens conditions as employed by T6th.97 The hydrazone was dissolved in 
dry 1 ,4-dioxane and added dropwise to a refluxing suspension of NaH in dry I ,4-dioxane. 
Heating was maintained until the reaction was complete (-4 h, tic) to give the product as a 
colourless oil, which was characterised by 'H and '3C NMR spectroscopy (Table 2.2) and 
mass spectrometry. The reaction was presumed to involve formation of diazo compound 109 
and carbene 110 as intermediates (Scheme 2.42). Evidence for the formation of the exoglycal 
was observed in the NMR spectra that were compared to those of the analogous compounds 
produced by Tóth et al.97108 The 'H NMR spectrum showed a pair of doublets of doublets at 
4.71 ppm and 4.97 ppm that correspond to the exocyclic alkene protons ia-H and lb-H, with 
the expected geminal and allylic couplings to 3-H [ 3J/Hz la-lb 1.5, la-3 0.8, la-3 0.5]. 
Furthermore, the peak attributable to 3-H exhibited one major coupling in the product rather 
than the triplet seen in the tosylate. This is consistent with the 3-H only being coupled to one 
ring proton (4-H) in the product while in the tosylate it was interacting with two protons (2-
H and 4-H). In the carbon spectrum a CH2 peak was observed at 99.4 ppm, which was 
assigned C-1 and the quaternary C-2 peak was at 154.0 ppm. The 'H NMR spectrum also 
shows that the pyranose ring of the exoglycal is distorted away from the ideal chair 
conformation. The observed couplings of 7.7 Hz and 7.6 Hz, respectively, for H-3/H-4 and 
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H-4/H-5 are significantly lower than those found for the tosyl hydrazone precursor 108 (9.7 
and 9.5 Hz) which are more typical of an ideal chair. 
Table 2.2: NMR data for 62 
Proton 611/ppm Coupling J/Hz Carbon öc/ppm 
la 4.97 la,lb 1.5 1 99.4 
lb 4.71 1a,3 0.8 2 154.0 
3 5.62 lb,3 0.5 3,4,5 69.2, 69.2, 72.6 
4 5.35 3,4 7.7 6 67.4 
5 5.30 4,5 7.6 
6a 4.42 5,6a 4.7 
6b 3.80 5,6b 8.2 
6a,6b 11.2 
Although the above approach was successful in the example described, it was found to be 
difficult to reproduce with a degree of consistency and the yields obtained were lower than 
those originally quoted by Tóth et al for similar compounds. 97  Work subsequently published 
by Tóth et al'°8 also indicated that this approach was not satisfactory for all sugar 
hydrazones. They reported that on incomplete deprotonation of the hydrazone the carbene 
could insert into the nitrogen-hydrogen bond of the remaining hydrazone to give compound 
111. In view of these problems and the inability to successfully scale up the reaction it was 
decided to explore the alternative lactone olefination route to the 1-methylenated sugars. 
RO o—N—N O fl
OR Ts 
111 
2.9.2 	Lactone Olefination Approach 
In this section the alternative method employed for the generation of exoglycals will be 
discussed. This approach utilised a series of generic reactions and the procedures will 
therefore be fully discussed only in the case of 2,6-anhydro-3,4,5,7-tetra-0-benzyl-1-deoxy-
D-gluco-hept-1-enitol (59) as a representative example. 
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Scheme 2.43 
The D-glucose based compound 59 (Scheme 2.43) had the advantage that methyl a-D-
glucopyranoside was commercially available as the starting material. In the first step of the 
synthesis the remaining hydroxyl groups were protected as their benzyl ethers. This was 
achieved using a standard sugar protection strategy'09 where a solution of the methyl 
glycoside in DMF was slowly added to a suspension of NaH in DMF. Benzyl bromide was 
added to the reaction mixture, which was stirred overnight and extracted to give the 
tetrabenzyl derivative 112 as a crude oil. The oil was purified by chromatography to give the 
product in 87% yield. It is noteworthy that the crude oil may b e carried forward without 
adversely affecting the quality of the product of the next stage. 
The tetrabenzyl compound 112 from the above step was dissolved in glacial acetic 
acid/sulphuric acid and stirred at 90°C overnight. The reaction mixture was extracted with 
DCM and the resulting solid recrystallised to give the lactol 113 as a white crystalline solid 
(3 5%) that was taken onto the next step. 109  To achieve oxidation of the lactol 113 to lactone 
114 an approach via an activated sulfoxonium intermediate was employed involving 
treatment of the lactone with DMSO/acetic anhydride for 24 h at room 
Extraction into DCM gave an oily residue that was subjected to column chromatography to 
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give the lactone as a colourless oil (76%), which was taken onto the next stage without 
further purification. 
In the final step dimethyl titanocene (115) was added to a solution of lactone 114 in toluene 
and the mixture was stirred in the dark for 24 h at 70°C. On cooling the residue was purified 
by column chromatography and crystallisation to give the title compound as a white 
crystalline solid in a 61% yield (14% overall from methyl a-D-glucopyranoside). The title 
compound was identified by comparison of the 'H and '3C NMR spectra with those in the 
literature." The presence of the benzyl protecting groups meant that it was not possible to 
observe the 'H NMR peaks attributable to the methylene group as they were obscured by the 
benzyl CH2 signals. However, in the '3C NMR spectrum it was possible to observe the 
characteristic C-i and C-2 peaks at 94.1 ppm and 155.7 ppm, respectively. The coupling 
constant of 7.1 Hz between axial protons 3-H and 4-H indicated that, as expected, the 
pyranose ring is distorted from the ideal chair conformation. 
2.9.2.2 Synthesis of 2,6-Anhydro-3,4,5,7-tetra-O-benzyl-1 -deoxy-D-galacto-hept-1 - 
enitol (65) 
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i) AcCI, MeOH; ii) NaH, BnBr, DMF; iii) AcOH, 1-12SO4, 90°C; 
iv) Ac20, DMSO; v) Cp2TiMe2, toluene, 70°C 
Scheme 2.44 
a/3-Methyl galactopyranoside (116) (Scheme 2.44) was produced using the method reported 
by Bennett et al. 112  D-Galactose was dissolved in methanolic HC1 (prepared by dissolving 
AcC1 in methanol) and the reaction mixture heated at reflux for 7 h, cooled and stored 
overnight at 0°C. The resulting crystals were filtered, washed with cold methanol and taken 
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on to the next step without further purification. The conditions for the benzylation were 
identical to those employed for the glucose derivative 112 and afforded methyl 2,3,4,6-tetra-
0-benzyl-D-galactopyranoside (117) as a brown oil (78% over 2 steps). This compound was 
identified by NMR before being taken on to the next stage. 
Employing a reaction sequence similar to that used for the glucose analogues 59, 2,3,4,6-
tetra-0-benzyl-D-galactopyranose (118) was prepared from the methyl D-galactoside (117) 
as a white crystalline solid (44%). Lactol 118 was then oxidised to the lactone 119 (97%). 
Petasis olefination of lactone 119 afforded 2,6-anhydro-3,4,5,7-tetra-O-benzyl-1-deoxy-D-
galacto-hept-1-enitol (65) as a white crystalline solid (40%; 13% overall from D-galactose) 
using the standard conditions discussed previously. As with glucose analogue 59, it was not 
possible to observe the methylene peaks in the proton NMR spectrum, however the 
characteristic peaks at 94.1 ppm for C-i and 155.6 ppm for C-2 were observed in the '3C 
NMR spectrum, these were in good agreement with those found in the literature.' 


































I) AcCI, MeOH; ii) NaH, BnBr, DMF; iii) AcOH, H2SO4, 90°C; 
iv) Ac20, DMSO; v) Cp2TiMe2, toluene, 70°C 
Scheme 2.45 
Methyl L-arabinopyranoside (120) (Scheme 2.45) was produced using the literature method 
by Bennett et al.' 2 The preparation of this compound was identical to that of the galactose 
analogue 116, and yielded the intended product as a white crystalline solid that was taken on 
to the next step without further purification. Employing the same method as for the glucose 
analogue 112, methyl 2,3,4-tri-O-benzyl-L-arabinopyranoside (121) was produced in both 
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anomeric forms as an oil in a 68% yield over the two steps. The deprotection at the anomeric 
position was carried out employing sulphuric acid and glacial acetic acid, as before, to give 
2,3,4-tri-O-benzyl-L-arabinopyranose (122) as a brown oil in a 52% yield. The oxidation of 
the above lactol to 2,3,4-tri-O-benzyl-L-arabino-1,5-lactone (123) used DMSO and acetic 
anhydride as previously discussed. This resulted in the title compound being produced as a 
colourless oil in a 96% yield. 
Olefination, employing the Petasis reagent 115, gave the desired 1-methylene sugar, 2,6-
anhydro-3,4,5-tri-O-benzyl-1-deoxy-L-arabino-hex-1-enitol (64), as an oil in a 36% yield 
(12% overall from L-arabinose). The characteristic exoglycal peaks were seen in the carbon 
NMR spectrum at 97.8 ppm and 155.6 ppm for C-i and C-2, respectively. 
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Scheme 2.46 
Methyl D-xylopyranoside (124) (Scheme 2.46) was produced in the same manner as the L-
arabinose analogue 120. There was, however, one major difference as on cooling no crystals 
were formed, therefore, the reaction mixture was neutralised and filtered according to the 
method of Yoo et a1113 to give the title compound as an oil that was taken on to the next stage 
without further purification. 
The reaction conditions used for the next stage paralleled those employed for the glucose 
analogue 59. The oil from the previous step gave methyl 2,3,4-tri-O-benzyl-D-
xylopyranoside (125) as a brown oil (52% over 2 steps). Duplicating the deprotection 
63 
Results and Discussion 
method employed above, 2,3,4-tri-O-benzyl-D-xylopyranose (126) was produced in a 59% 
yield as a white crystalline solid. 2,3,4-Tri-O-benzyl-D-xylo-1,5-lactone (127) was 
synthesised as an oil (78%) from the solid produced in the previous step, using the standard 
conditions discussed previously. 
2,6-Anhydro-3 ,4,5-tri-O-benzyl- 1 -deoxy-D-xylo-hex- 1 -enitol (63) was prepared from 
lactone 127 using the conditions described earlier for analogue 59. H owever, in this c ase 
there were problems of isolating the exoglycal from the titanocene by-products. As a result 
an accurate yield was not calculable, however it was possible to see the characteristic peaks 
attributable to an exoglycal in the '3C NMR spectrum at 86.4 ppm for C-i and 159.2 ppm for 
C-2. Therefore, the exoglycal was used for the subsequent cycloaddition reactions without 
purification. 
The procedures described above for the exoglycal synthesis proved to be reliable and three 
of the four targets were produced on a multigram scale in reasonable yields (12-14% overall 
from their respective methyl glycoside). The fourth was synthesised, though not isolated due 
to problems of separation from the titanocene by-products; however this was not a hindrance 
as the crude mixture could be taken on to the next stage, as discussed later in Section 2.10.8. 
The main reason for employing these 1-methylene sugars was to use them as easily 
accessible building blocks for higher monosaccharides. In the course of this work it was 
concluded that the stability of exoglycals was greater then had previously been suggested.93  
They have a shelf-life of at least two months at 4°C and do not decompose when purified on 
a silica column. Furthermore, they may be produced on a gram scale. 
2.10 	Cycloaddition Reactions of Exoglycals 
Cycloadditions of nitrite oxides to the exoglycals could yield four possible isoxazolines 
128a-128d (Scheme 2.47); i.e. a pair of diastereomers 128a and 128b in which the oxygen of 
the nitrite oxide is linked to the more substituted ring carbon of the exoglycal, and their 
regioisomers 128c and 128d. Formation of 128c and 128d was not expected as 
cycloadditions of nitrite oxides to 1,1-disubstituted alkenes have been reported to afford 
exclusively 3,5-disubstituted isoxazolines.3 The regioselectivity of these reactions has been 
attributed to both steric and electronic effects.' 
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Scheme 2.47 
Initial experiments were carried out with peracetylated D-xylose-derived exoglycal 62 using 
benzonitrile oxide 56 and carbethoxyformonitrile oxide 55 as representative nitrile oxides. 
The majority of the experiments employed the dehydrohalogentation of the appropriate 
hydroximoyl halide as used previously (Scheme 2.48), which was modelled on the method of 
Huisgen.'2"3 However, there were two modifications made to the technique; the first was to 
have the dipole in excess rather than the dipolarophile (1:1 to 1.4:1). The reason for this 
change was the longer synthetic sequence required for the exoglycals relative to the nitrile 
oxide precursors, as a result it was preferable to use excess hydroximoyl halide to ensure the 
maximum yield oft he c ycloadducts. The second modification was in the work up where, 
rather than employing a series o f extractions to remove the t riethylamine h ydrohalide by-
product, this compound was removed by filtration. The Mukaiyama method involved 
dehydration of pyranosyl nitromethanes that was also used for the production of the nitrile 
oxide in a single experiment.5 
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The cycloaddition (Scheme 2.49) was carried out by the overnight addition of triethylamine 
in sodium-dried ether to a solution of exoglycal 62 (1 eq) and benzohydroximoyl chloride 68 
(1 e q) in dry ether. Work up a fforded an oil that yielded on c hromatography, in order of 
elution, unreacted alkene (32%) and the isoxazoline cycloadduct 129 (46%, 76% based on 
consumed alkene). The recovered exoglycal was sufficiently pure to allow for it to be 
recycled in future cycloadditions. The product was characterised by 'H and '3C NMR (Table 
2.3), mass spectrometry and CHN analysis. Only one isomer was produced as the tic plate 
showed a single spot and the NMR spectra indicated the presence of a single compound. The 
NMR spectra confirmed the presence of the spiroisoxazoline; in the proton spectrum there 
was a characteristic signal at 3.44 ppm corresponding to the two protons at the 4-position of 
the isoxazoline ring. This signal appeared as a singlet, but it is noteworthy that the 4-H 
signals for some of the spiroisoxazolines described later gave an AB pattern. In the carbon 
spectrum there were characteristic peaks at 43.4 ppm (C-4), 107.2 ppm (C-5) and 157.8 ppm 
(C-3). The NMR spectra were assigned by comparison with those of the exoglycal precursor 
and with the reported data of the glucose and galactose based spiroisoxazolines prepared by 
RajanBabu et al' 4 and Colinas et al.' 5 The coupling constants H8ax/H9ax 9.6 Hz and H-
9ax/H10ax 10.1 Hz for the sugar ring protons ofthis cycloadduct indicate that the ring is 
closer to an ideal chair than the exoglycal 62. 
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Table 2.3: NMR data for 129 
Proton au/ppm Coupling J/Hz Carbon 5C/ppm 
4a, 4b 3.44 4a,4b nd 3 157.8 
7a 3.99 7a,7b 11.2 4 43.4 
7b 4.08 7a,8 6.4 5 107.2 
8 5.20 7b,8 10.5 7 60.3 
9 5.68 8,9 9.6 8, 9, 10 69.0, 69.5, 71.2 
10 5.48 9,10 10.1 
The a bove data were consistent with e ither the u.-anomer 1 29a or the f3-anomer 1 29b. In 
order to distinguish between the isomers an nOe experiment was carried out on the product 
129 where the compound was irradiated at 8 3.44 ppm, the frequency of the 4-H protons. 
This resulted in not only an 11% signal enhancement between ö 7.66-7.69 ppm for the 
aromatic region of the 3-phenyl substituent but also a 13% enhancement at 5 5.48 ppm, the 
peak corresponding to 10-H of the pyranose ring (Figure 2.6). It was concluded, therefore, 
that the cx-anomer 129a had been produced. If the -anomer had been formed then the 
interactions expected would have been at ö 4.08 ppm and ö 5.68 ppm for 9-H and 7b-H 
respectively. Finally an x-ray crystal structure of this isoxazoline was obtained and it 
confirmed that the a-anomer had been produced. The details of this crystal structure will be 
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The method was identical to that above although the reactant ratio was altered to 1:1.1 
exoglycal to nitrile oxide precursor 67 (Scheme 2 .50). The o ii produced was subjected to 
column chromatography to give, in order of elution, recovered exoglycal (48%), an oil that 
was identified as a single anomer of the title compound (45%, 94% based on consumed 
alkene), and diethoxycarbonyl furoxan 131a (23%), which was identified from its 'H NMR 
spectrum. It was concluded that it was the a-anomer that was present by comparison of the 





131a R = CO2Et 
131b R = Br 
Due to the problems previously discussed with regard to the synthesis of acetylated 
exoglycal 62 an alternative approach was investigated and the following details the 
cycloaddition reactions of exoglycals produced via the lactone olefination approach. 
2.10.3 	Synthesis of (5R,7S,8R,9S,1OR)-8,9,1 0-Tris(benzyloxy)-7-benzyloxymethyl-3- 
carbethoxy-1,6-dioxa-2-azaspiro [4.5] dec-2-ene (132) 
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The procedure was identical to those previously described with the triethylamine being 
added overnight and the nitrile oxide precursor:exoglycal ratio was 1.2:1 (Scheme 2.51). On 
purification, by column chromatography, the reaction mixture yielded an oil containing 
solely the title compound as a single isomer (72%, based on consumed alkene), which was 
identified by comparison of the NMR (Table 2.4) data with those of isoxazoline 130. The 
presence of only the a-anomer in the reaction mixture was confirmed by the tic showing a 
single spot and there was no evidence of any diastereomeric peaks in either the 'H or 13C 
NMR spectra. As with the xylose-derived examples (129, 130) the conformation of the 
pyranose ring was closer to an ideal chair than the precursor 59; this can be observed in the 
coupling constants of axial protons 8-H, 9-H and 10-H (H-8/H-9 9.2 Hz, 11-9/1-1-10 9.7 Hz). 
The NMR data compared favourably to that reported in the literature. 125 
Table 2.4: NMR data for 132 
Proton oH/ppm Coupling J/Hz Carbon Oc/ppm 
4a 3,15 4a,4b 18.4 3 159.5 
4b 3.24 7,8 10.2 4 40.9 
7 4.26 7,11a 1.8 5 110.3 
8 4.00 7,1 lb 2.7 7 72.2 
9 4.30 8,9 9.2 8 76.8 
10 3.94 9,10 9.7 9 83.0 
lla 3.77 lla,llb 11.3 10 77.7 
lib 3.87 11 67.3 
2.10.4 	Synthesis of (5R,7S,8R,9S,1OR)-8,9,10-Tris(benzyloxy)-7-benzyloxymethyl-3- 
phenyl-1 ,6-dioxa-2-azaspiro 14.51 dec-2-ene (133) 
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The procedure (Scheme 2.52) was identical to those previously described other than the 
volume of solvent being increased and the time taken for the addition of the triethylamine 
was extended to 72 h, this was due to the increase in scale and a wish to limit the 
concentration of nitrile oxide present in the reaction mixture to inhibit the formation of the 
furoxan. The exoglycal and the nitrile oxide precursor were in a 1:1.1 ratio. The work up 
gave some recovered alkene (9%) and the single a-anomer of the title compound as a white 
crystalline solid (86%, 94% based on consumed alkene), which was characterised by 'H and 
'3C NMR spectroscopy (Table 2.5), mass spectrometry and CHN analysis. This single 
anomer was identified as having the a-configuration from the x-ray crystal structure 
obtained (see Section 2.10.9). The x-ray crystal structure and the proton NMR of this 
cycloadduct showed that, unlike the exoglycal 59, the pyranose ring of compound 133 
adopted a predominately chair conformation (f/Hz 8-9 9.2, 9-10 9.7), 
Table 2.5: NMR data for 133 
Proton8H/PPM Coupling f/Hz Carbon sc/ppm 
4 x 2 3.05 7,8 10.1 3 157.0 
7 4.07 7,11a 1.9 4 42.4 
8 3.83 7,1 lb 2.9 5 108.3 
9 4.14 8,9 9.2 7 71.8 
10 3.74 9,10 9.7 8 77.0 
1 la 3.58 1 la,1 lb 10.9 9 83.4 
llb 3.76 10 77.8 
11 67.4 
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Figure 2.7: 	COSY 	Spectrum 	of 	(5R,75,8R,9S, 1 OR)-8,9, 1 O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl- 1 ,6-dioxa-2-azaspiro[4. 5]dec-2-ene (133) 
Figure 2.8: 	Expanded COSY Spectrum Showing the Interactions of the Sugar Ring 
Protons of (5R,7S,8R,9S, 1 OR)-8,9, I O-Tris(benzyloxy)-7-benzyloxymethyl-3-
phenyl-1 ,6-dioxa-2-azaspiro[4.5]dec-2-ene (133) 
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It was possible to fully characterise the proton and carbon spectra of the above 
spiroisoxazoline through the use of COSY (Figures 2.7 & 2.8) and HSQC (Figure 2.9) 
experiments. The COSY spectrum clearly shows two isolated areas of interaction. The large 
complex region between 4.34-4.95 ppm shows extensive coupling between the CH, groups 
of the benzyl protection. The other zone between 3.50-4.03 ppm corresponds to the coupling 
between the protons of the sugar ring. Although analysis of this region is complicated by the 
overlap of the signals for 10-H and llb-H a full assignment can be made by reference to the 
HSQC spectrum. In the COSY spectrum the red line indicates the 91-1/10H interaction while 
the blue lines illustrate the remaining coupling in the sugar ring. Having assigned the proton 
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Figure 2.9: 	HSQC 	Spectrum 	of 	(5R,7S,8R,9S,1OR)-8,9,10-Tris(benzyloxy)-7- 
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2.10.5 	Synthesis of (5R,7S,8R,9S,1OR)-8,9,10-Tris(benzyloxy)-7-benzyloxymethyl-3- 
bromo-1 ,6-dioxa-2-azaspiro [4.5] dec-2-ene (134) 











The procedure (Scheme 2.53) was as previously discussed with the ratio of nitrile oxide 
precursor to exoglycal being 1.2:1 and the addition of the triethyl amine taking 18 h. 
Chromatography of the reaction mixture gave, in order of elution, the title compound as an 
oil in the a-anomeric form(51%, based on consumed alkene) and the furoxan 131b as a 
white solid (31%). It was concluded that the compound had been produced as the a-anomer 
by comparison of the proton and carbon NMR spectra with those of isoxazoline 133. 
2.10.6 	Synthesis of (5R,7S,8S,9S,1 OR)-8,9,1 0-Tris(benzyloxy)-7-benzyloxymethyl-3- 
phenyl-1 ,6-dioxa-2-azaspiro [4.5] dec-2-ene (135) 










This reaction (Scheme 2.54) was carried out using the experimental conditions previously 
outlined with the triethylamine added to the reaction mixture over 72 h and the exoglycal to 
nitrile oxide precursor was 1:1.4. On work up only the title compound was isolated as a 
white solid (82%, based on consumed alkene), which was characterised by 'H and '3C NMR, 
mass spectrometry and CHN analysis. It was determined that the isoxazoline was in the a-
anomeric form by comparing the NMR spectra with those of isoxazoline 133 and those of 
(5R,7S,8S,9S, 1 OR)-8,9, 1 0-Tris(benzyloxy)-7-benzyloxymethyl-3 -carbethoxy- 1 ,6-dioxa-2-
azaspiro[4.5]dec-2-ene as reported in the literature. 125 
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This compound was prepared by cycloaddition of benzonitrile oxide (1.3 eq.) and L-
arabinose derived exoglycal 64 (1 eq.). The reaction conditions (Scheme 2.55) were as 
previously discussed, with the triethylamine slowly added to the reaction flask over 72 h. 
Work up gave the desired product as a white solid (50%, based on consumed alkene), which 
was characterised by 'H and '3C NMR, mass spectrometry and CHN analysis. Comparison 
of the spectra with those of isoxazoline 133 confirmed that it was the a-anomer that had 
been synthesised. No other products were isolated nor was any starting material recovered. 
The 'H NMR data for 136 also allowed the preferred conformation for the pyranose ring to 
be established. The observed couplings for 10-H/9-H (10.0 Hz) and 9-H18-H (3.0 Hz) are 
consistent with the 8C5 conformation 136a rather than 5 C8 136b. The coupling constants also 
suggest that the sugar ring is a near ideal chair. 
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2.10.8 	Synthesis of (5R,8R,9S,1 OR)-8,9,1 0-Tris(benzyloxy)-3-phenyl-1,6-dioxa-2- 
azaspiro [4.5]dec-2-ene (137) 
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Scheme 2.56 
In Section 2.9.2.4 it was noted that the exoglycal 63 could not be isolated from the titanocene 
by-products, an issue that has been noted by Petasis97 with regard to the olefination of some 
compounds using dimethyl titanocene. As a result of the inability to separate exoglycal 63 
from the titanocene by-products it was decided to carry the compound through to the next 
stage of the reaction without further purification. Triethylamine in sodium-dried ether was 
added to a mixture of benzohydroximoyl chloride 68 and the crude product from the 
olefination step in dry ether (Scheme 2.56). Following column chromatography the title 
compound was yielded as an oil (14% over two steps from lactone 127). This figure was 
comparable to that of 18% from lactone 123 obtained overall for the analogous L-arabinose 
136. This suggests that the inability to purify the reaction mixture at the exoglycal stage had 
only a marginal effect on the cycloaddition reaction. The product was characterised by 'H 
and '3C NMR spectroscopy and mass spectrometry, furthermore comparison of this 
compound's NMR spectra with those of isoxazoline 133 confirmed that it had been 
synthesised as the single a-anomer. 
2.10.9 	Structures of the Spiroisoxazolines 
Cycloadducts 129 and 133 were isolated from the reactions between benzonitrile oxide and 
exoglycals 62 and 59, respectively, as crystalline solids suitable for x-ray analysis. The 
crystal structures (Figure 2.10 & 2.11) established that the new asymmetric centre, C-5, had 
the R-configuration in both cases, thus confirming the conclusions of the n0e experiments 
described earlier. 
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2.10.9.1 (5R,8R,9S,1OR)-8,9,1 0-Tris(acetoxy)-3-phenyl- 1,6-dioxa-2-azaspirol4.5] dec-2-
ene (129) 
Figure 2.10: 	Crystal Structure of (5R,8R,9S, 1 OR)-8,9, 1 0-Tris(acetoxy)-3-phenyl- 1,6- 
dioxa-2-azaspiro[4. 5]dec-2-ene (129) 
The Haasnoot parameterisation of the Karplus 	16 was employed to calculate the 
proton-proton coupling constants from the torsion angles taken from the crystal structure, 
and the results are compared with those found experimentally in solution in Table 2.6. This 
gave a satisfactory correlation for the data presented. This was unusual as previous 
work"83'87"17 involving sugar isoxazolines indicated that the Haasnoot parameterisation does 
not always result in good correlation due to the parameters having been determined for a 
cyclohexane ring with no substituents. Furthermore, the lack of correlation has been 
attributed in previous cases to the molecule adopting different conformations in the solution 
and solid phases.82 This difference in observed and calculated coupling has also been 
reported for different solvents.' 8 In the present case the better correlation may be attributed 
to the rigidity imparted by the Spiro linkage to the isoxazoline. 
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Table 2.6: Calculated/Observed Coupling Constants for 129 
Protons Oobs/° a J0I/H2" Jobs/Hz 
10,9 -161.68 9.4 10.1 
9,8 +161.25 9.4 9.7 
8,7a +130.67(eq) 5.4 6.4 
8,7b -173.14(ax) 10.1 11.2 
a. H-C-C-H Torsion Angle (0) from x-ray data; b. J01. = 7.76cos'0-1 .lcosO+1 .4 
The Cremer and Pople puckering parameters '19 (Table 2.7) allow for discussion of the degree 
to which the isoxazoline and pyranose rings are distorted with respect to their ideal 
conformations. In this case the pyranose ring has 89% of the puckering of an ideal chair with 
Q = 0.546A and 0 = 990 compared with Q = 0.630A and 0 = 00 for an ideal chair. The low 
value of 0 indicates that the chair, as expected, is in the 8C5 orientation. 
Table 2.7: Cremer and Pople Puckering Parameters for 129 
Ring Q/A Of 
Pyranose C(5)-O(6)-C(7)-C(8)-C(9)-C(10) 0.546 9.9 341.1 
Isoxazoline 0(l)-N(2)-C(3)-C(4)-C(5) 0.228 142.4 
The isoxazoline ring was found to be near planar with a mean deviation from the plane of 
0.0936A (Table 2.8). The value of 142.4° indicates a mainly envelope conformation 
144). This is consistent with most literature isoxazolines, although some have been shown to 
have structures intermediate between twist (4 = 126) and envelope ( = l44).8 The plane of 
the phenyl substituent at C-3 on the isoxazoline ring is twisted with respect to the 
isoxazoline, as shown by the ca. 24° torsion angle out of plane of the isoxazoline. 
Table 2.8: Deviation from the Plane of Isoxazoline Ring for 129 
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2.10.9.2 (5R,7S,8R,9S,1OR)-8,9,1O-Tris(benzyloxy)-7-benzyloxymethyl-3-phenyl- 1,6-
dioxa-2-azaspiro[4.5] dec-2-ene (133) 
Figure 2.11: 	Crystal 	Structure 	of 	(5R,7S,8R,9S, I OR)-8,9,1 0-Tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl- 1,6-dioxa-2-azaspiro[4. 5]dec-2-ene (133) 
The proton-proton coupling constants were calculated from the measured torsion angles of 
the crystal structure (Figure 2.11) by employing the Haasnoot parameterisation of the 
Karplus equation.' 16  These values are compared with those found in the solution phase from 
the 1H NMR spectrum in Table 2.9. As with the example above the data presented gave a 
satisfactory correlation, albeit surprising due to the previous observations that the Haasnoot 
parameterisation does not always result in good correlation for sugar isoxazolines."83'87'117  
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Table 2.9: Calculated/Observed Coupling Constants for 133 
Protons Oobs/° a Jcalc/HZb Jobs/Hz 
10,9 -174.83 10.2 9.7 
9,8 +171.07 10.1 9.6 
8,7 -173.07 10.1 10.0 
7,11a -68.49 2.0 1.9 
7,1 lb +49.76 3.9 2.6 
a. H-C-C-H Torsion Angle (0) from x-ray data; b. Jcaic=7.76cos201.1cosO 4 
The Cremer and Pople puckering parameters (Table 2.10) show that in this case the pyranose 
ring has 91% of the puckering of an ideal chair with Q = 0.556A and 0 = 1.6° compared to Q 
= 0.630A and 0 = 0° for an ideal chair, and confirms that the chair is in the 8 C5 orientation. 
Table 2.10: Cremer and Pople puckering Parameters for 133 
Ring Q/A 810 
Pyranose 0(1 )-C(5)-C(7)-C(8)-C(9)-C( 10) 0.556 1.6 64.3 
Isoxazoline 0(l)-N(2)-C(3)-C(4)-C(5) 0.182 142.8 
The isoxazoline ring was found to be near planar with a mean deviation from the plane of 
0.0750A (Table 2.11), while the value of 142.80 indicates a mainly envelope conformation 
(E5, 4 = 144),fl8 which is comparable to spiroisoxazoline 129. As with the previous example, 
the phenyl ring on the isoxazoline was found not to be in the same plane as the isoxazoline 
ring, which was twisted out of alignment with a torsion angle of approximately 9°. 







Table 2.12 shows the bond lengths for the isoxazoline rings of compounds 129 and 133. It 
may be observed that, when compared, the lengths of both systems are broadly similar. Most 
79 
Results and Discussion 
of the bond lengths are also similar to those found for isoxazolines of other sugar 
Systems.  1,82,86 However, the carbon-oxygen bond 0(l)-C(5) of the isoxazoline ring was 
shorter than normal. 
Table 2.12: Isoxazoline Bond Lengths of 129 and 133 
Bond 129 Length/A Bond 133 Length/A 
0(l)-N(2) 1.436(3) 0(l)-N(2) 1.43 1(3) 
0(l )-C(5) 1.436(4) 0(l )-C(5) 1.444(4) 
N(2)-C(3) 1.287(4) N(2)-C(3) 1.281(4) 
C(3)-C(4) 1.497(4) C(3)-C(4) 1.495(4) 
C(3)-C(3 1) 1.481(4) C(3)-C(3 1) 1.464(4) 
C(4)-C(5) 1.511(4) C(4)-C(5) 1.506(3) 
Selected bond lengths of the two pyranose rings are shown in Table 2.13. As with the 
isoxazoline rings, the bond lengths show a degree of similarity between the two 
spiroisoxazolines. When compared to the bond lengths determined for the pyranose rings of 
other sugar-isoxazoline systems, they were generally found to correspond well, with the 
exception of C(5)-0(6).' 83'87"8 The variations for 0(1)-C(5) and C(5)-0(6) will be discussed 
later. 
Table 2.13: Selected Bond Lengths of Pyranose Rings of 129 and 133 
Bond 129 Length/A Bond 133 Length/A 
C(5)-0(6) 1.412(4) 0(6)-C(5) 1.416(4) 
C(5)-C(1 0) 1.533(4) C(5)-C(1 0) 1.514(4) 
0(6)-C(7) 1.431(4) 0(6)-C(7) 1.445(4) 
C(7)-C(8) 1.522(4) C(7)-C(8) 1.519(5) 
C(8)-C(9) 1.512(4) C(8)-C(9) 1.507(5) 
C(9)-C(10) 1.515(4) C(9)-C(10) 1.517(5) 
C(7)-C(71) 1.511(5) 
2.10.9.3 it-Facial Selectivity 
A noteworthy feature of this study into the cycloaddition of nitrile oxides to exoglycals is the 
high level of ic-facial selectivity, with only a single product being isolated. The reasons put 
forward by other researchers for the high selectivity in similar reactions was that the a-face 
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is less sterically hindered than the f3-face,'15 due to the steric bulk of the nitrile oxide' 16 
and/or the protecting groups on the sugar ring. 121,121  Another possible explanation would be 
the interactions between the electron lone pairs of the oxygen in the sugar ring and those of 
the nitrile oxide oxygen that would result from 3-face attack. The a-selectivity can also be 
rationalised in terms of the anomeric effect (Figure 2.12), where the a-anomer is stabilised 
by the secondary bonding from the lone p air of the sugar oxygen into the low lying a"-
orbital of the carbon-oxygen bond of the isoxazoline. In the f3-anomer this donation cannot 
take place. Furthermore the secondary bonding to the a*orbital  of the carbon-carbon bond 
in the 3-anomer would result in a decrease of stability as the CH2 group of the isoxazoline 
ring would be inductively electron donating. 
Figure 2.12 
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The carbon-oxygen bond lengths for isoxazolines have been quoted in the literature to be in 
the range of 1.446-1.489A,"8 while for compounds 129 and 133 this bond length was shorter 
in both cases, 1.436A and 1.444A, respectively. This is surprising as one might expect this 
bond to be longer in the spiroisoxazoline due to the secondary bonding interaction between 
the axial lone pair of 0(6) and the cT*orbita1  of bond 0(1)-C(5), thus weakening and 
lengthening this bond. However, it has been observed that the corresponding bond in 
glycosides 138 and 139 are also shorter than those of other carbon-oxygen bonds. In 
addition, both isoxazolines exhibited a shorter C(5)-0(6) bond length than that of 0(1)-C(5). 
These observations suggest that there may be some secondary orbital interactions present in 
spiroisoxazolines 129 and 133. Furthermore, when the bond lengths of the two 
spiroisoxazolines were compared to methyl 2,3,4,-tri-O-acetyl-a-D-xylopyranoside 138122 
(Table 2.14) it was observed that the length of the glycosidic carbon-oxygen bond was much 
shorter (1.401A) than the analogous bonds in either of the 129 of 133 at 1.436A and 1.444A, 
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respectively. Also the lengths of the bonds C(1)-0(6) (1.409A) and C(5)-0(6) (1.426A) in 
138 were both shorter than the corresponding bonds in either 129 or 133. In the case of 
trehalose octaacetate ethyl acetate solvate 139123  (Table 2.1.4) it was observed that the 
carbon-oxygen glycosidic bond was considerably shorter than the equivalent bond in the two 
spiroisoxazolines, while bonds C(1)-0(6) (1.415A) and C(5)-0(6) (1.438A) were of 
comparable length to the analogous bonds in the isoxazolines. These observations imply that 
the secondary bonding interactions are present in both isoxazolines, 129 and 133, as well as 
common O-glycosides. 
Table 2.14: Specific Bond Lengths of a-O-Glycosides/A 
129 133 138 139 
a 1.436 1.444 1.401 1.416 
b 1.412 1.416 1.409 1.415 
c 1.431 1.445 1.426 1.438 
During the course of the present work Gallos and co-workers '20"2 ' reported the cycloaddition 
of nitrile oxides to pent-4-enofuranosides 140 and hex-5-enopyranosides 141 (Scheme 2.58). 
They found that only a single diastereomer 142 was isolated on cycloaddition of a number of 
nitrile oxides with pent-4-enofuranoside 140. In contrast to this and the work presented in 
this thesis, c ycloadditions involving hex-5-enopyranoside 141 afforded two diastereomers, 
the major product 143a and a small quantity of 143b (Scheme 2.57). 
The reported explanation for this difference in selectivity was that one face of the furanoside 
alkene double bond is more hindered than the other; this was attributed to the adjacent 
isopropylidine group blocking the bottom face. The result of which is that the nitrile oxide 
attacks the top face of the alkene to give only one diastereomer. However, cycloadditions to 
the pyranoside were not as highly selective as it has only the more remote methoxy group in 
an axial position while the remaining substituents are equatorial. 
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Scheme 2.57 
2.10.10 Synthesis of (5R,7S,8R,9S,1OR)-8,9,1 0-Tris(benzyloxy)-7-benzyloxymethyl-3-
(3',4',5'-tri-O-acety1--D-xy10-pyranos-2'-y1)-1 ,6-dioxa-2-azaspiro 14.51 dec-2-
ene (144) 
Having carried out a number of cycloaddition reactions of non-carbohydrate nitrile oxides to 
exoglycals the synthesis of a 1,1 -isoxazoline linked D-xylose/D-glucose compound 144 was 
attempted by combination of D-xylose derived nitrile oxide 57 and exoglycal 59. Similar 
work has been carried out by this group where D-xylose derived nitrile oxide 57 underwent 
cycloaddition to hex-5-enofuranose 58. 124a  Two methods were used to generate the nitrile 
oxide: dehydrochiorination of hydroximoyl chloride 72, and dehydration of the 
pyranosylnitromethane 70. 124b 
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2.10.10.1 The Dehydrohalogenation Approach to the D-Xylose Nitrile Oxide (57) 
This reaction (Scheme 2.58) was carried out using the conditions previously described. 
Hydroximoyl halide 72 (1.2 eq.) and 2,6-anhydro-3 ,4,5,7-tetra-O-benzyl- 1 -deoxy-D-gluco-
hept- 1 -enitol (59) (1 eq.) were dissolved in dry ether and the a ddition o f triethylamine i n 
ether was carried out o vernight. This resulted in the title compound being produced as a 
white solid (45%, 72% based on consumed aikene); also isolated from the reaction mixture 
were unreacted aikene (37%) and the dixylopyranosyl furoxan 145 (15%) that was identified 
by comparison with an authentic sample (Section 2.10.10.3). The product was characterised 
by proton and carbon NMR spectroscopy (Table 2.15) and mass spectrometry. It was 
possible to conclude that only one anomer was present in the reaction mixture as the tic gave 
a single spot and there was no evidence of any diastereomeric peaks in either the 'H or I 3C 
NMR spectra. 
84 
Results and Discussion 
2.10.10.2 The Dehydration Approach to The D-Xylose Nitrile Oxide (57) 
This cycloaddition (Scheme 2.58) was undertaken using the Baker et a1124a  modification of 
the conditions reported by Mukaiyama.5 The exoglycal 59 (1 eq.) and the pyranosyl 
nitromethyl compound 70 (1 eq.) were dissolved in dry toluene, and the reaction mixture was 
heated at 109°C for eight days in the presence of a catalytic amount of triethylamine and 
tolylene 2,4-diisocyanate. Work up and column chromatography gave the title compound as 
a white solid (43%, 55% based on consumed alkene), along with recovered exoglycal (24%) 






Table 2.15: NMR data for 144 
Proton eu/ppm Coupling JIHz Carbon 6c/ppm 
4a 2.77 4a,4b 17.7 3 156.1 
4b 2.90 7,8 9.4 4 41.1 
7 3.88 7,11a 1.8 5 108.7 
8 3.72 7,11b nd 7 68.7 
9 3.97 8,9 9.2 8 77.4 
10 3.57 9,10 9.7 9 83.7 
ha 3.47 hla,llb 11.0 10 78.3 
llb 3.68 2',3' 9.9 11 68.1 
2' 4.39 3',4' 9.5 2' 72.9 
3' 4.97 41 ,5' 9.4  68.7 
 5.15 5',6a' 10.6 4' 72.5 
5' 4.92 5',6b' 5.6 5' 74.1 
6a' 3.29 6a',6b' 11.3 6' 66.7 
6b' 4.17 
It was possible to fully assign the NMR spectra of this compound by employing COSY 
(Figure 2.13) and HSQC (Figure 2.14) experiments. The former shows a series of well-
defined interactions, and from these all the protons were identified within the two sugar ring 
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systems. The signals attributable to the glucose ring are clustered between 3.6 ppm and 4.1 
ppm, while those signals resulting from the xylose ring are more widely spread over three 
distinct regions between 4.2-4.3 ppm, 5.0-5.3 ppm and a single signal at 3.4 ppm. The red 
lines indicate the interactions within the glucose unit and the blue lines illustrate the 
couplings between the protons of the xylose ring. The AB pattern of the isoxazoline protons 
may be clearly observed at -2.7-3.0 ppm. It is also possible to observe the coupling between 
the CH2's of the benzyl protecting groups between 4.50-4.78 ppm. The HSQC allowed for 
the identification of all the signals in the carbon spectrum in particular the isolation of the 





5.0 	 4,5 	 40 3S 	 3.0 
Figure 2.13: 	COSY 	Spectrum of (5R,7S,8R,9S, 1 OR)-8,9, 1 0-Tris(benzyloxy)-7- 
benzyloxymethyl-3-(3 ' ,4' ,5 '-tri-O-acetyl- 3-D-xylo-pyranos-2'-yl)- 1,6-
dioxa-2-azaspiro[4.5]dec-2-ene (144) 
It was not possible to state absolutely which anomer had been produced though it was 
probable, by comparison with the NMR spectra of spiroisoxazoline 133, that the a-anomer 
was produced. The '3C NMR spectrum of 133 gave signals for C-4 and C-S at 42.4 ppm and 
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108.3 ppm, respectively that were similar to those values observed for disaccharide 144. The 
'H NMR indicated that the pyranose ring of the spiroisoxazoline was less distorted than 
exoglycal 59, this was observable from the coupling constants of protons 8-H, 9-H and 10-H 
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Figure 2.14: 	HSQC 	Spectrum 	of 	(5R,7S,8R,9S,1OR)-8,9,10-Tris(benzyloxy)-7- 
benzyloxymethyl-3-(3 ',4' ,5 '-tri-O-acety14-D-xylo-pyranos-2 '-yl)-1 ,6-
dioxa-2-azaspiro[4.5]dec-2-ene (144) 
The reason for examining both methods to the C-disaccharide was to identify the most 
efficient approach for the production of this compound. When comparing the two reactions it 
was useful to examine the yields with respect to the amount of alkene consumed. In the case 
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while with the Mukaiyama method the yield was at best moderate as more alkene was 
consumed by the Mukaiyama reaction, while producing less disaccharide. 
In conclusion, it has been shown that there are two potential approaches for the regio- and 
stereo-specific synthesis of novel C-disaccharides. Furthermore, it may be observed that the 
hydroximoyl halide was superior with regard to the efficient synthesis of C -disaccharides 
from exoglycals as it may be considered to be less destructive to the thermally unstable 
exoglycals. 
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This furoxan (Scheme 2.59) was prepared to allow for the identification of the by-product 
from the synthesis of the C-disaccharide produced above. The Mukaiyama dehydration 
method was employed where nitromethyl xylose 70 (1 eq.) was heated in toluene (80°C) for 
eight days in the presence of tolylene 2,4-diisocyanate (3 eq.) and a catalytic amount of 
triethylamine. This afforded the furoxan as a white crystalline solid (67%), which was 
identified by comparison of its 'H and '3C NMR spectra with those in the literature. 124b  
In conclusion, it was possible to synthesise a series of spiroisoxazolines in moderate to good 
yields. Although a number of intermediates were required of the Petasis olefination route it 
was considered to be a more efficient route to the 1-methylene sugars in a multigram scale. 
The lack of reproducibility of the carbene method along with the low scale of the reaction 
made it prohibitively time consuming. It has also been conclusively proven that exoglycals 
are excellent dipolarophiles for a variety of nitrile oxides. 
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In an effort to expand the scope of 1,3-dipolar cycloaddition to exoglycal dipolarophiles it 
was decided to explore the cycloaddition reaction of nitrone dipoles. This approach may 
provide a complementary route to -hydroxy ketones and y-amino alcohols (Scheme 1.1 6)22 
N,a-diphenylnitrone was chosen as a readily available representative example for this study. 
A solution of exoglycal 59 (1 eq.) and Na-diphenylnitrone (2 eq.) in sodium-dried toluene 
was heated overnight, at reflux (Scheme 2.60). Concentration and column chromatography 
afforded an o il that contained the title compound as two inseparable d iastereomers (56%, 
based on consumed alkene). The moderate yield was probably due to the heating of the 
reaction mixture causing the degradation of the exoglycal prior to cycloaddition. The title 
compound was characterised by proton and carbon NMR spectroscopy (Table 2.16) and 
mass spectrometry. The '3C NMR spectrum provided evidence for the presence of a pair of 
diastereomers as there were two peaks assigned to C-4 at 48.0 ppm and 53.3 ppm. There was 
also an indication of other carbons exhibiting two diastereomers but it was not possible to 
fully assign the spectrum and identify them. There are eight possible products from the 
above cycloaddition reaction. However, four of these may be discounted as it has long been 
accepted that the cycloaddition of a nitrone to a 1,1-disubstituted alkene is regiospecific 
yielding only 5,5-disubstituted isoxazolidines.3 The four remaining isoxazolidines, 146a-d, 
are due to the formation of two new asymmetric centres at the 3- and 5-positions o f the 
heterocyclic ring (Figure 2.15). C ompounds 1 46a and 1 46b would b e produced by attack 
from the a-face, while f3-face selectivity would afford 146c and 146b. As in the nitrile oxide 
work, the anomeric effect is likely to promote attack of the nitrone from the a-face of the 
exoglycal. Therefore, it is probable that in this case the oxygen of the nitrone would attack 
the alkene at the most substituted terminus to afford the a-anomer. However, the possibility 
of the 3-anomer cannot be eliminated. Indeed, other researchers have suggested that the 
ME 
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cycloaddition of a nitrone to an exoglycal can result in attack from both the a- and the P-
faces of the methylene unit to afford two anomers of the 5,5-disubstituted isoxazolidine in 
the 3R conformation. 115 On the basis of the nitrile oxide cycloadditions discussed previously 
it was presumed than the nitrone had attacked from the a-face to yield the a-anomers, 
146a/146b. From the carbon spectrum it was possible to estimate that the diastereomeric 
ratio was 1:3. 
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146c 	 146d 
Figure 2.15 
Table 2.16: NMR data for 146 
Proton 611/ppm Carbon öc/ppm 
3 4.59 3 70.0 
4a 1.86 4 (2 diastereomers) 48.0, 53.3 
4b 1.87 9 84.3 
7 4.13-4.24 7, 8, 9, 10 
(2 diastereomers) 
70.0, 72.0, 73.6, 74.3, 75.8, 78.2 
8, 10, 11 a, 
1 lb 
3.66-3.90 CH2Ph, 11 
(2 diastereomers) 
68.0, 68.3, 70.6, 72.4, 73.2, 73.6, 
74.9, 75.3, 75.5 
9 4.31-4.40 5 104.4 
In conclusion, this cycloaddition afforded two diastereomeric isoxazolidines from a possible 
eight, in moderate yield. The regio-chemistry of the cycloadduct was as expected, as was the 
stereochemistry at the anomeric position. The lack of stereoselectivity at the 3-position was 
not unexpected by comparison with the literature.3 This reaction potentially provides an 
alternative route into the y-amino alcohol and the P -hydroxy ketone. However, the lower 
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yield suggests that the nitrile oxide route is better suited to the synthesis of higher 
monosaccharides, therefore, it was not pursued further. 
2.11 	Reactions of Cycloadducts 
Having produced a number of spirioisoxazolines in the previous section it was decided to 
attempt further reactions on the pathway to ulosonic acid analogues, as discussed earlier 
(Scheme 2.32). 
2.11.1 	Synthesis of (5R,7S,8R,9S,1 OR)-8,9,1 0-Tris(benzyloxy)-7-benzyloxymethyl-3- 
hydroxymethyl-1 ,6-dioxa-2-azaspiro [4.5] dec-2-ene (147) 
The carbethoxy group of isoxazoline 132 was to be reduced to the corresponding primary 
alcohol 147 as it was thought that the isoxazoline ring would be stabilised to reductive 
hydrolytic ring cleavage by resonance with the carbonyl of the ester 132 in a similar fashion 
to isoxazoline 82. Therefore, it was decided to reduce the ester 132 to the alcohol 147 prior 
to deprotection and ring opening to -hydroxy ketone 148. It was hoped that this would 
result in an easily accessible route from ester substituted spiroisoxazolines to ulosonic acid 
analogues 149 (Scheme 2.61) via open-chain J3-hydroxy ketone 150. 
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The method selected was b ased on that r eported by D e A mici e t a 1 for 3 -ethoxycarbonyl 
isoxazolines.88 A solution of isoxazoline 132 in ethanol had 10 eq. of sodium borohydride 
added portionwise (Scheme 2.62). The reaction mixture was stirred at room temperature and 
the title compound 147 was isolated by extraction and crystallisation as a white solid (8 1%). 
This compound was identified by proton and carbon NMR spectroscopy and by mass 
spectrometry. The 'H NMR spectrum shows that the ethyl group in the starting material is no 
longer present. A signal was observed at 4.40 ppm; this singlet was assigned to the CH2 of 
the hydroxymethyl substituent at the 3-position of the isoxazoline. Further evidence for 
structure 147 is provided by a peak in the 13C spectrum at 57.8 ppm, attributable to the 
CH20H group. Furthermore there was no indication of the c arbonyl, C H2 peak or methyl 
peak due to the carbethoxy group of the starting material. 
31CO2Et 










A single product was isolated, in contrast to the reduction of the 5-(3-O-benzoyl-1,2-O-
isopropylidene-a-D-xylo-furanos-4-yl)-3 -carbethoxy-2-isoxazoline (82) where two products 
were formed; this was attributed to the presence of the benzoyl ester protecting group found 
in cycloadduct 82. 
2.11.2 	Ring Opening Reactions 
A series of reductive ring openings were attempted using a variety of conditions and 
catalysts. The test reactions were carried out employing (5R,7S,8R,9S,1OR)-8,9,10-
tris(benzyloxy)-7-benzyloxymethyl-3 -phenyl- 1 ,6-dioxa-2-azaspiro[4.5]dec-2-ene (133) in 
order to find the best set of conditions for this manipulation. It was hoped that this would 
allow access to a variety of ulosonic acid analogues (Scheme 2.63). 
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2.11.2.1 Attempted Hydrogenolysis of (5R,7S,8R,9S,1 OR)-8,9,1 O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl-1,6-dioxa-2-azaspiro [4.51 dec-2-ene 	(133) 	with 
Palladium/Charcoal 
Isoxazoline 133 and boric acid were dissolved in a solution of methanol, water and THF, to 
which was added the Pd/C catalyst. The reaction mixture was degassed and left to stir under 
a hydrogen atmosphere for 48 h. Filtration and concentration yielded a white solid that was 
identified as the starting isoxazoline 133 (72%), there was no indication that any product had 
been generated. 
2.11.2.2 Attempted Hydrogenolysis of (5R,7S,8R,9S,1OR)-8,9,1 O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl-1 ,6-dioxa-2-azaspiro f4.5J dec-2-ene 	(133) 	with 
Raney Nickel: Method 1 
A solution of isoxazoline 133 in water/methanol was left to stir under a hydrogen 
atmosphere in the presence of the Raney nickel catalyst for 24 h. Work up yielded the 
starting material as a white solid (44%), with no evidence of product. 
2.11.2.3 Attempted Hydrogenolysis of (5R,7S,8R,9S,1OR)-8,9,1 O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl-1 ,6-dioxa-2-azaspiro [4.5] dec-2-ene 	(133) 	with 
Raney Nickel: Method 2 
Isoxazoline 133 was prepared as above, but rather than using a hydrogen filled balloon the 
hydrogenolysis was carried out at high pressure. The Parr high pressure hydrogenator and 
Parr 4840 controller unit were used to keep the reaction vessel at 40 bar for 5 h. Work up of 
the reaction mixture afforded a white solid that was identified as the starting material, 
isoxazoline 133 (94%). No ring-opened product could be detected in the reaction mixture. 
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2.11.2.4 Hydrogenolysis 	of 	(5R,7S,8R,9S, I OR)-8,9,1 O-Tris(benzyloxy)-7- 























Isoxazoline 133 was prepared as before, then palladium hydroxide on carbon (Peariman's 
catalyst) was added and the mixture stirred under an atmosphere of hydrogen for 24 h 
(Scheme 2.63). Work up yielded only baseline (tic) material as an oil, which gave a positive 
test with ninhydrin. This was shown to be l-(2'-amino-2'-phenylethyl)-2,3,4,6-tetra-O-
benzyl-1,5-dehydro-D-glucopyranose (149) (95% total yield) by 'H and '3C NMR 
spectroscopy (Table 2.17) and mass spectrometry. No evidence was observed for 3-hydroxy 
ketone 148. 
Five possible structures were considered for 149: four cyclic hemiketals 149a-d and the 
open-chain form 149e (Scheme 2.65). The '3C NMR provided evidence to support the 
presence of at least three of the compounds; 149a, 149b and 149e. Signals for the two cyclic 
forms were observed for only two of the carbons. The first was the Cl-[NH2 group (C-2') 
adjacent to the phenyl substituent with peaks at 52.3 and 52.5 ppm. The second was the 
anomeric quaternary carbon (C-l) with peaks at 98.0 and 98.3 ppm. The evidence for an 
open chain form 149e was a small quaternary peak at 197.7 ppm, this is the typical 
frequency for a ketone group. The low intensity of the peak indicated that the open-chain 
form was a minor component of the equilibrium (Scheme 2.64). This is consistent with the 
compound being more thermodynamically stable in the ring closed chair hemiketal form. 
From the carbon NMR it was possible to estimate the ratio of hemiketals 149a and 149b to 
be —1:1. The 91 MHz '3C NMR spectrum showed other peaks that may be attributable to 
hemiketals 149c and 149d 50.5, 51.2 ppm for C-2' and 97.7 and 100.7 ppm for C-i. 
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Table 2.17: '3C NMR data for 149 
Carbon sc/ppm 
(2 diastereomers) 34.1,35.3 b 
(4 diastereomers) 50.5, 51.2, 52.3, 525b 
6 688a,b 
C1-I2Ph 73.2, 74.7, 75.3, 756b 
1 (4 diastereomers) 97.7, 98.0, 98.3, 100.7 
2, 3,4, 5 70.6, 77.1, 78.4, 83.7a) 
Ph CH 125.4, 125.8, 1261a,b 
Bn CH 12721290a,b 
1 open chain form 1977b 
a: observed at 63 MHz; b: observed at 91 MHz. 
It was presumed that the cyclic hemiketals 149a-d if formed would adopt the 4C1 
conformation. The 1 C4 structures, as shown in Figure 2.16, are not likely as these would have 
all the benzyloxy groups in axial positions and so would be unfavoured relative to the 4C1 
conformations where they are all in the more stable equatorial arrangement. 
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Figure 2.16 
The formation of y-amino alcohol 149 rather than the target 3-hydroxy ketone 148 suggests 
that hydrogenation (Scheme 2.65, path a) of the intermediate imine 150 occurs more readily 
than hydrolysis (Scheme 2.65, path b) under the conditions used. As the water was added to 
the above reaction to hydrolyse the intermediate imine,'4'2° the reaction was repeated without 
water to establish whether the reaction would proceed under anhydrous conditions. As the 
reaction gave the y-amino alcohol even in the presence of water it was assumed that the 
removal of the water would have no effect on the reaction. However, this was not the case as 
the yield of the reaction was significantly lower without the water, 66% opposed to 95%. 
The reason for this apparent drop in yield is not known; perhaps the water somehow aided 
the removal of the product from the catalyst. 
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Results and Discussion 
Having found that Pearlman's catalyst successfully cleaved the isoxazoline ring, this was the 
catalyst of choice for the remaining ring opening reactions. 
2.11.2.5 Attempted Reductive Ring Opening of (5R,7S,8R,9S,1OR)-8,9,1O-
Tris(benzyloxy)-7-benzyloxymethyl-3-carbethoxy-1 ,6-dioxa-2- 
azaspiro [4.5] dec-2-ene (132) with Pearlman's catalyst 
It was thought that palladium hydroxide might be reactive enough to reductively cleave an 
ester stabilised isoxazoline ring to afford the 3-hydroxy ketone. To this end isoxazoline 132 
was prepared for reaction as previously discussed and was stirred, with Pearlman's catalyst, 
under an atmosphere of hydrogen for 18 h. However, the work up returned only the starting 
isoxazoline (46%). 
2.11.2.6 Hydrogenolysis 	of 	(5R,7S,8R,9S,1 OR)-8,9,1O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-hydroxymethyl.-1 ,6-dioxa-2-azaspiro[4.5] dec-2-ene (147) 
Using Pearlman's Catalyst 
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Isoxazoline 147 was stirred under a hydrogen atmosphere in the presence of Pearlman's 
catalyst for 24 h (Scheme 2.66). Employing the same work up as before, the reaction mixture 
gave an oil (89%) on the baseline (tic) that gave a positive test with ninhydrin. On the basis 
of its NMR spectra and mass spectrometry this was attributed to an inseparable mixture of I - 
(2' -oxo-2 ' -hydroxymethylethyl)-2 ,3 ,4,6-tetra-O-benzyl-D-glucopyranose (151) and 1 -(2'-
amino-2 ' -hydroxymethylethyl)-2,3 ,4,6-tetra-O-benzyl-D-glucopyranose (152) (Scheme 
2.67). 
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Scheme 2.67 
The 63 and 91 MHz '3C NMR spectra (Table 2.18) showed distinctive diastereomeric peaks 
for two hemiketal forms of the 7-amino alcohol. The principal evidence for these 
diastereomers were two peaks at 50.2 and 50.3 ppm, which were assigned to C-2'. From the 
carbon NMR spectrum it was estimated that these diastereomers were present in an 
approximate 1:1 ratio. There was also a small quaternary peak at 210.3 ppm, which is the 
typical frequency for a 3-hydroxy ketone in an open chain sugar" 7 which was assigned as 
151. The NMR evidence is consistent with only two hemiketal forms being present, it is 
probable that these have structures 152a and 152b. 
Table 2.18: '3C NMR data for 152 
Carbon 6c/ppm 
(2 diastereomers) 29.6, 30.6 
(2 diastereomers) 50.2, 50.3 
 68.4 
8 69.5 
CH2Ph 73.2, 74.7, 75.1, 75.5 
2, 3, 4, 5 71.0, 78.0, 81.4, 82.9 
1 97.6 
2' 3-hydroxy ketone 210.3 
Results and Discussion 
2.12 	Conclusions 
Two routes for the synthesis of exoglycals were examined; the first was from acetylated 
nitromethyl xylose 70 via pyranosyl tosylhydrazone 108 using aprotic Bamford-Stevens 
conditions, the s econd employed o lefination o f a pyranosyl 1 actone employing the P etasis 
methodology. The former method proved to be unreproducible, however the latter route 
provided a consistent and reliable approach to pure exoglycals on a gram scale. 
Three nitrile oxides were selected to examine the c ycloaddition reaction and to ultimately 
determine its feasibility as a synthetic approach to higer monosaccharides. The three nitrile 
oxides chosen were bromonitrile oxide, benzonitrile oxide and carbethoxynitrile oxide. 
The results of the cycloaddition reactions are summarised in Table 2.19, which illustrates the 
satisfactory to good yields of the cycloaddition reactions (50-94%). These reactions proved 
to be a highly stereo- and regio-selective, as in all cases only the a-anomer of the 
spiroisoxazoline was observed. 
Table 2.19: Summary of Cycloaddition Reactions to 1-Methylene Sugars 










62 68 1:1 129,76 32 n/a 
62 67 1.1:1 130,94 48 23 
59 67 1.2:1 132,72 n/a n/a 
59 68 1.1:1 133,94 9 n/a 
59 66 1.2:1 134,51 n/a 31 
59 72 1.2:1 144,72 37 15 
59 70 1:1 144d55 24 fl/de 
65 68 1.4:1 135,82 n/a n/a 
64 68 1.3:1 136, 50 n/a n/a 
63 68 n/dr 137,14g n/a n/a 
a. based on the recovered exoglycal; b. based on the consumption of nitrile oxide precursor; 
c. dehydrohalogenation method; d. dehydration method; e. furoxan contaminated by base 
line material; f. crude sample of exoglycal used; g. calculated over two steps from lactone 
127. 
Results and Discussion 
In a further illustration of the versatility of this reaction a cycloaddition was carried out to 
link two pyranosyl systems via an isoxazoline bridge. This was achieved using xylosenitrile 
oxide 57 generated from either hydroximoyl chloride 72 or pyranosylnitromethane 70. The 
nitrile oxide cycloadded to exoglycal 59 to afford spiroisoxazoline 144 in moderate to good 
yields (55-72%). 
Pilot ring opening reactions with spiroisoxazolines 133 and 147 resulted in a mixture of 7-
amino alcohols in the case of the former, while the hydrogenolysis of the latter afforded the 
targeted 3-hydroxy ketone as well as the 7-amino alcohols. 
2.13 	Future Work 
R2 
RO 
























OH OH 0 0 
The cycloadditions discussed above proceed in good yield and high selectivity. Thus far the 
ring hydrolytic ring cleavage reactions have afforded the y-amino alcohols rather than the 
target f3-hydroxy ketones. Therefore, it is required to optimise the hydrogenolysis reaction to 
afford only the target f3-hydroxy ketones. To this end there are a number of catalysts, other 
than those employed in this body of work, that could be employed for the hydrolytic 
reductive cleavage of an isoxazoline ring to afford the 3-hydroxy ketone and the 7-amino 
alcohol. These include Sm12,126 TiC13127 and ozone. 128 The ring opened products must next be 
deprotected to give access to the potentially biologically active compounds 152 (Scheme 
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2.68). Once produced the ulosonic acid analogues will be tested against the target biological 
systems to identify any with inhibitory properties. 
In an effort to expand the range of ulosonic acid analogues a number of approaches may be 
explored. Alternative nitrile oxides could be employed to afford isoxazolines with different 
substituents in the 3-position. The substituents of these cycloadducts could then be modified 
to yield a series of novel isoxazolines. With respect to a specific family of cycloadducts the 
3-bromoisoxazolines could undergo a number of substitution reactions to provide access to a 
number of novel compounds. There is also the possibility that these bromo-cycloadducts 
could undergo coupling reactions utilising Suzuki conditions or mixed organocuprates. 
These could, potentially, allow access to a series of spiroisoxazolines for which there are no 
nitrile oxide precursors available. This work has the potential to be applied to other sugars 
that will ultimately allow access to a variety of possible drugs, pesticides and herbicides. 
R 	 R 
R 1 	 R1  





R 1 	 R1  
10 
Scheme 2.69 
There may also be a future in the cycloaddition of nitrile oxides to 1-substituted exoglycals 
for the production of cycloadducts with three functional groups around the heterocyclic ring. 
One potential drawback is that the functionality in the 1-position would result in selectivity 
issues, both regio- and stereo- in the cycloaddition step. However, recent work by Colinas et 
a1115 has shown that the a-anomer diastereomeric pair is favoured (Scheme 2.69). Therefore, 
it is felt that this may be worthy of future exploration as it may provide an easy route to a 
101 
Results and Discussion 
wide range of 4-functionalised 5-membered heterocycles of synthetic value. An alternative 
route to 4-substituted isoxazolines is to deprotonate the heterocycle with a base then react the 
resulting anion with an electrophile as described by Jager eta! (Scheme 2.70)129 
E 0 
R base 	 R E 	 R 
0—N 	 0—N 	 0—N 
Scheme 2.70 
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2.14 	Iminosugars 
It was next intended to apply the chain elongation work from the exoglycals, discussed 
previously, to enamines that may lead to iminosugars. To this end two model systems were 
identified for a feasibility study. These were chosen to simulate the two structural forms of 
the intended sugar compounds. N-Benzyl-2-methylenepyrrolidine (153) was selected to 
represent a sugar in the furanosyl form and the pyranosyl analogue was to be based on N-
benzyl-2-methylenepiperidine (154), which may be produced from N-benzyl-2-piperidone 
(155). Enamines are known to be highly reactive towards nitrile oxides forming 5-amino-
substituted isoxazolines.'3° The previous work in the area has also shown that the initial 
product can decompose on treatment with acid to give the isoxazole through the loss of the 
amine (Scheme 2.71). Generally, this is believed to be a useful method to produce 5-
substituted isoxazoles.3 Having proved the principle of the reaction pathway it was then 
intended to apply this work to a sugar system. For example, enamine 156 might afford 
iminosugar 157 in a 5-step reaction sequence via spiroisoxazoline 158 as illustrated in 
Scheme 2.72. Furthermore, exposing isoxazoline 158 to acid might also be expected to 
afford aminotetrosyl substituted isoxazole 159. 
(Ph 	Ph 
Cr 0,  
153 	154 
Ar 	R2 
Ar__NtO + 	 Ji1<NR2 	
H 	Ar-R2 + NHR2 
NR2 	 N—O 	 N—O 
Scheme 2.71 
As stated previously it was decided to examine the potential of this approach by testing the 
reactions on two model systems. It was found by Petasis et a!96 that dimethyl titanocene 
(115) will react with 1 actams albeit at a 1 esser rate than their 1 actone a nalogues, although 
some difficulty was encountered in the isolation of the enamine products from the titanocene 
by-products by precipitation, distillation or chromatography. However, it was anticipated 
that, if this problem did arise in the present work, the enamine could be taken on in a 
reaction without purification. 
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R 	N 	 H2, H2O 	R__ 
1 10 Pd/Car I Is'' 
HO 	OH RaNi HO (OH 
OH 	 OH 
158 	 157 
Scheme 2.72 
2.14.1 	Feasibility Study Employing Model Systems 
It was decided that the two model enamines, N-benzyl-2-methylenepyrrolidine (153) and N-
benzyl-2-methylenepiperidine (154), should be reacted with benzonitrile oxide, generated by 
the dehydrochiorination of benzohydroximoyl chloride (68). 
2.14.1.1 Synthesis of N-Benzyl-2-methylenepyrrolidine (153) & 6-Benzyl-3-phenyl-1-
oxa-2,6-diazaspiro F4.41 non-2-ene (159) 
Ph 	 Bn 







The synthesis ofthe 5 -membered cyclic enamine 153 has been previously carried out by 
Petasis, although the product could not be purified .96  N-Benzyl-2-pyrrolidinone (1 eq.) was 
therefore dissolved in dry toluene with the Petasis reagent (2 eq.) and heated overnight 
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(Scheme 2.73). Concentration of the reaction mixture gave a dark brown-red gum. As found 
by Petasis the product could not be isolated in pure form. Evidence for the presence of the 
target enamine 153 in the product was a peak attributable to the methylene group in the 'H 
NMR spectrum at 4.39 ppm; furthermore peaks could tentatively be ascribed to the 
remaining protons of enamine 153. This crude mixture was taken on to the next step without 
purification. 
The crude enamine was dissolved in sodium-dried ether with excess benzohydroximoyl 
chloride (68) (1.1 eq. per equivalent of lactam), the solution was cooled and triethylamine 
dissolved in dry ether added. The work up was identical to that employed for the exoglycal 
cycloadditions in Section 2.10 and yielded 6-benzyl-3 -phenyl- 1 -oxa-2,6-diazaspiro[4.4]non-
2-ene (159) as an impure brown gum (24% from the lactam), which was identified from its 
'H and '3C NMR spectra and by mass spectrometry. Despite the impurities observed in the 
proton NMR spectrum it was possible to identify an AB pattern of a pair of doublets at 3.52 
ppm and 3.65 ppm, which were assigned to the CH2 of the isoxazoline. The major product 
was identified from the '3C NMR spectrum, with typical quaternary peaks for 
spiroisoxazolines at 107.4 ppm and 155.7 ppm for C-S and C-3, respectively. The 
characteristic CH2  peak (C-4) was identified at 40.0 ppm; this value was comparable to those 
of other spiroisoxazolines produced earlier. It is assumed that the p yrrolidine ring of this 
cycloadduct will adopt an E5  conformation with the oxygen of the isoxazoline in the pseudo-
axial position in order to allow for secondary bonding interactions between the lone pair of 
the nitrogen and the cN*orbital of the C—O bond of the isoxazoline ring. 
2.14.1.2 Synthesis of N-Benzyl-2-piperidone (155), N-Benzyl-2-methylenepiperidifle 
(154) & 6-Benzyl-3-phenyl-1-oxa-2,6-diaZaSPirO [4.5] dec-2-ene (160) 
H 	




155 	 154 
Scheme 2.74 
Using a literature method,'3' 6-valerolactam in THF was added to a suspension of sodium 
hydride in THF (Scheme 2.74). Once the evolution of hydrogen gas had ceased, benzyl 
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chloride was added to the reaction mixture, which was stirred until no starting material 
remained. Extraction leads to the title compound 155 as an oil (63%) that was identified by 
comparison of its NMR with those in the literature. 131 
The methods employed for the conversion of 155 to enamine 154 and isoxazoline 160 were 
identical to those utilised for the 5-membered analogue (Scheme 2.75). Piperidone 155 and 
Cp2TiMe2 (115) were dissolved in dry toluene and heated for 24 h. Work up gave a crude 
brown gum that when examined using 'H NMR spectroscopy displayed the peaks required 





154 	 160 
Scheme 2.75 
The crude enamine was dissolved with excess benzohydroximoyl chloride (68) in dry ether, 
and triethylamine in dry ether was added to the reaction mixture over 48 h. The reaction was 
allowed to stir for a further 10 h and on work up the title compound was produced as impure 
brown crystals (23% from lactam 155). The product was identified from the proton and 
carbon NMR spectra and by mass spectrometry. Although the product was not pure, it was 
possible to assign peaks in both NMR spectra to compound 160. The most characteristic 
feature of the 'H NMR spectrum was an AB pattern as a pair of doublets at 3.23 ppm and 
3.33 ppm, which were assigned to the CH2 group of the isoxazoline ring. 
2.14.1.3 Conclusions 
The two N-benzyl-enamines 153 and 154 were produced, from the corresponding lactams, as 
a gum and a brown solid, respectively, both of which contained titanocene by-products. 
Cycloaddition reactions were successfully carried out between benzonitrile oxide and 
enamines 153 and 154. In both cases impure cycloadducts were produced. 
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The yields of the crude cycloadducts for the two olefinationlcycloaddition processes above 
(159 24%, 160 23%) were marginally better than two of the pyranose analogues, L-arabinose 
136 and D-xylose 137, over two steps. However, they were somewhat poorer than those of 
the D-glucose 133 and D-galactose 135 analogues. This suggests that the model reactions are 
proceeding as expected, also it would appear that the lactams are not as unreactive to the 
Petasis reagent as previously thought. However, the reaction could be improved considerably 
by purification at the enamine stage. 
The model experiments showed sufficient promise that similar olefination and cycloaddition 
processes might be possible on the analogous sugar systems, in both furanosyl and pyranosyl 
analogues. However, due to time constraints only the latter was explored and will be 
discussed below. 
2.14.2 	Routes to Pyranosyl Lactams 
A number of methods for producing sugar lactams can be found in the literature, many of 
which are long and arduous processes. One of the most effective of these preparations is that 
employed by Overkleeft et al (Scheme 2.76) '36  which is similar to that of Hoos et al.132 In the 
former method, reaction of lactone 161 with methanolic ammonia afforded hydroxy amide 
162, and the hydroxyl group was then oxidised to the ketone. Keto amide 163 was then 
converted into lactam 164 by successive treatment with methanolic ammonia and then 
sodium cyanoborohydride/formic acid. The Hoos approach differed from that of Overkleeft 
at two stages of the reaction pathway. Firstly, in the cyclisation step where the ring closure 
was catalysed by acetic acid rather than with ammonia-saturated methanol. Secondly, formic 




OBn 	 OBn 	 OBn 
I) 	 OH ii) 	 i-iv 	 NH 
BnO_— 	 BnO M12 	BnO_--NH2 	BnO_— 
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I) NH3, MeOH; ii) DMSO, Ac20; iii) NH3, MeOH; iv) NaCNBH3, HCO2H. 
Scheme 2.76 
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Raj anikanth reported that the glucose derived lactam 165 could be prepared by simply 
heating the lactone 114 with benzylamine in the presence of 4A molecular sieves and a 
catalytic amount of amberlite JR 120H (Scheme 2.77)112 However, other workers have 
failed to reproduce these results; when Fleet et al. re-examined this method they only 
isolated acyclic amide 166.' 
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Fleet and co-workers also synthesised mannose based lactam 167 from L-gulonolactone 168 
(Scheme 2.78).'14  The nitrogen of the ring was introduced by the reduction of azido lactone 
169, which was produced by the selective deprotection of the hydroxyl groups in the 5,6-
position and tosylation of the 5-position followed by a nucleophilic substitution employing 
sodium azide. 
OH 	 Me2ButSlO N3 
I)  
HO 	OH 	
O\O(O ii) , 	 v) 
ox0 







I) acetone, 2,2-dimethoxypropane, TsOH; ii) AcOH, H20 (7:1); iii) imidazole, 1BuMe2S1CI, 
DMF; iv) a. (F3CS02)20, pyridine, DCM; b. NaN3 DMF; v) H2, Pd/C, MeOH 
Scheme 2.78 
A lactam analogue 170 of L-fucose has been produced by Schedler et al from the 
aminosugar D-galactosamine 171 (Scheme 2.79) by hydrolysis and thioacetalisation of 
glycoside 172. This was followed by the desulfuration, deprotection and cyclisation of 
compound 173 with Raney nickel. 135 
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i) CbzCl, H2O; ii) BnOH, CH3COCI; iii) Pt, 02, H20-EtOH; 
iv) 1:4 TFA:H20, 90°C; v) EtSH, HCI; vi) Raney Ni, EtOH 
Scheme 2.79 
Finally, Pistia-Brueggeman synthesised 5-amino-D-gluconic acid lactams 174 and 175 from 
methyl -D-glucoside (176) (Scheme 2.80). This was a chieved b y the oximation of k eto-
ester 177 with hydroxylamine to afford 178. Reduction of the oxime yielded lactam 174 by 
the spontaneous cyclisation of the 5-amine-5-deoxy intermediate. Alternatively, oxime 178 
could be converted to lactam 175 by treatment with hydrazine. 116 
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2.14.3 	Feasibility Study Employing a Monosaccharide System 
Following the success of the two model systems it was decided to apply this chemistry to a 
monosaccharide framework. A glucose-derived iminosugar was selected as the target as 
there was a relatively straightforward route from lactone 114 to the corresponding protected 
lactam 178 (Scheme 2.81).36 
2.14.3.1 Synthesis 	of 	(5R,7S,8R,9S,1 OR)-N-Boc-8,9,1 O-tris(benzyloxy)-7- 
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i) NH3 MeOH; ii) DMSO, Ac20; iii) NH3, MeOH; iv) NaCNBH3, HCO2H; 
v) DMAP, Boc20, MeCN; vi) Cp2TIMe2; vii) PhCICNOH, NEt3 
Scheme 2.81 
Employing the method described by Overkleeft et al (Scheme 2.8 1),36  lactone 114 was 
dissolved in ammonia/methanol solution and left to stir. Concentration and crystallisation of 
the residue from ethyl acetate and petroleum ether gave 2,3,4,6-tetra-0-benzyl-D-
gluconamide (179) as a white solid (86%) that was taken on to the next step. 
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Using a modified method from that used by Overkleeft et al,36  gluconamide 179 was 
dissolved in acetic anhydride and DMSO and the reaction mixture left to stir for 24 h. Work 
up yielded 	 gluconamide (180) as an oil that was 
directly taken on to the next stage without further purification. 
The 5-oxo-D-gluconamide 180 was dissolved in a solution of a mmonia/methanol and the 
mixture left to stir for 2 h. Column chromatography yielded a mixture of the two lactams, 
2,3 	 and L-idono-lactam 
(181a & 
181b). From the mixture 181a was isolated by column chromatography as a white solid 
(31% over 2 steps) leaving 181b (35% over 2 steps) as an oil. Both products were identified 
by comparison of their NMR spectra with those in the literature.36 
The mixture of hydroxylactams 181a & 181b was used in the next stage as both afforded the 
same lactam 182 on dehydration (Scheme 2.82). Hydroxylactams 181a & 181b were 
dissolved in a mixture of acetonitrile and formic acid, to which sodium cyanoborohydride 
was added. The reaction mixture was refluxed for 2 h, after which it was quenched with 
hydrochloric acid (0.1 M) and extracted into ethyl acetate. C olumn chromatography gave 
(182) as a white solid (72%). 
OBn 











The proposed mechanism for the formation of lactam 182 is shown in Scheme 2.82. The acid 
catalysed dehydration of the two lactams gave the same final product as both reactions 
proceed through the same intermediate acyliminium ion 183. The hydride ion then attacks 
intermediate 183 from the a-face to result in the desired lactam. The lone pair of the nitrogen 
in lactam 182 is presumed to be axial to the ring as this allows the most potent overlap 
between the nitrogen lone pair and the 7T-orbital of the carbonyl (Figure 2.17)36 
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Figure 2.17 
Some problems were encountered in the attempted protection of the 1 actam n itrogen. The 
initial technique required the iminosugar to be stirred with potassium hydroxide and benzyl 
chloride. This resulted in a mixture of the target compound 184 and a by-product, (5S,6R)-N-
benzyl-3 ,4-bis(benzyloxy)-6-benzyloxymethyl- 1,2,5 ,6-tetrahydropyridin-2-one (185), as 
reported in the literature. 132  Both were formed in poor yields 14% and 8%, respectively, and 
an alternative route was therefore sought. It was attempted to improve this method by 
adapting that employed for the model system, where the iminosugar was refluxed with 
benzyl b romide and sodium hydride. This gave only the b y-product 185 and none o f the 
target 184 was detected. A third approach was to stir the imino sugar with benzyloxycarbonyl 
succinimide and triethylamine, however this returned the starting material and the CbzOSuc 















Ultimately, the protection strategy a dopted u tilised a B oc protecting group. The protected 
lactam 178 was produced by stirring lactam 182 in acetonitrile for five and a half hours in 
the presence of DMAP and Boc anhydride. Column chromatography yielded the target 
compound 178 as a colourless oil (46%), which was identified by comparison of its proton 
and carbon NMR data with those in the literature. 137 
The protected lactam 178, produced above, was dissolved in toluene and heated in the 
presence of dimethyl titanocene (115) for 24 h (Scheme 2.83). The resulting oil was 
subjected to column chromatography to give, in order of elution, the target enamine 60 (8%) 
and unreacted lactam 178. Due to the impurities present it was difficult to positively identify 
enamine 60 as the mass spectrum was inconclusive and it was not possible to observe the 
methylene protons due to the benzyl protecting strategy. The Boc protecting group was 
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present at 1.49 ppm and visually the spectrum looked very similar to that of glucose 
analogue 59 with a doublet at 3.89 ppm, a multiplet between 3.60-3.72 ppm for the 
remaining sugar protons and a second multiplet between 4.41-4.82 ppm that contained the 
methylene protons as well as the CH2 protons from the protecting groups. It was thought that 
there were two reasons for the poor yield of this reaction. The first was the fact that lactams 
have been found, by Petasis,96 to be less reactive to dimethyl titanocene reagent than other 
carbonyl compounds. Therefore, less of the target enamine was produced, this also explains 
the recovery of some starting material from the reaction mixture. It is also possible that the 
enamine is thermally unstable. Work involving the analogous glucose exoglycal (Section 
2.9.2.1) suggested that this type of compound was thermally unstable; as a result it is 
possible that the enamine is even less stable and decomposes during the reaction. 
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Scheme 2.83 
The above reaction was repeated on a larger scale; however, it was found not to be possible 
to isolate the enamine from the titanocene by-products. This was probably due to the ratio of 
dimethyl titanocene:lactam being increased from 2:1 to 3:1 in an effort to increase the yield 
of the reaction. 
The final step of the reaction sequence was carried out using the crude enamine. The 
procedure used was identical to that employed for the pyranose analogues, where 
benzohydroximoyl chloride (68) and the crude enamine 60 were dissolved in sodium-dried 
ether and triethylamine in sodium-dried ether was added over 72 h. The work up yielded an 
oil. C olumn c hromatography gave, in order of e lution, an unidentified s ide p roduct and a 
single isomer of the desired isoxazoline 187 as a white solid (35 mg, 3% over two steps), 
which was identified by 'H NMR spectroscopy (Table 2.20) and mass spectrometry. The 
proton spectrum from a 360 MHz instrument gave a well resolved spectrum, from which the 
couplings were all determined. This spectrum indicated the presence of a single anomer, the 
NMR was also visually very similar to the analogous glucose derived spiroisoxazoline, the 
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corresponding pyranose analogue 133. However, if it were assumed that the crude enamine 
reaction proceeded in the same yield as the test reaction it would be possible to estimate the 
yield for the cycloaddition reaction as being approximately 45%. Analysis by tic indicated 
that a single anomer was present, the identity of which was determined by a NOESY 
experiment. The sample was irradiated at 3.12 ppm, the signal of the isoxazoline CH2 group, 
and this resulted in an interaction at frequency of 3.75 ppm which corresponded with that of 
proton 10, as with the analogous oxygen containing compound in Section 2.10.3, this 
confirmed that the a-anomer had been synthesised. 
OBn 	 OBn 
BnON
06  
BOC 3 Ph 	BnO 8 BnO 
1 	2 
187 
Table 2.20: 'H NMR data for 187 
Proton 	 5H/PPM 	 Coupling 	 f/Hz 
4 	 3.12 	 7-8 	 9.8 
7 	 4.08 	 7-ha 	 1.89 
8 	 3.84 	 7-lib 	 2.9 
9 	 4.15 	 8-9 	 9.5 
10 	 3.75 	 9-10 	 9.7 
ha 	 3.60 	 lIa-hib 	 10.9 
The limiting feature of this route was at the olefination stage, the enamine was a minor 
product the major product being an unidentified oil, which was not isolable from the 
enamine by crystallisation or chromatography. Further work is required to fully understand 
the processes present in this system. 
2.15 	Conclusions 
The 	enamine N-Boc-2,6-anhydro-3 ,4,5,7-tetra-O-benzyl- 1 -deoxy-6 -aza-D-gluco-hept- I - 
enitol (60) was synthesised in a poor yield (8%) as a white crystalline solid using the 
olefination approach employing the Petasis reagent. This low yield was attributed to the low 
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concluded that this is not the best method to this enamine. A more advantageous route would 
be to adapt the method proposed by Tatibouet et al. 138 
Benzonitrile oxide was cycloadded to N-Boc-2,6-anhydro-3 ,4,5 ,7-tetra-O-benzyl- I -deoxy-6-
aza-D-gluco-hept-1-enitol (60) to give a white solid identified as (5R,7S,8R,9S,IOR)-N-Boc-
8,9,1 O-tris(benzyloxy)-7-benzyloxymethyl-3-phenyl- 1 -oxa-2,6-diazaspiro[4. 5]dec-2-ene 
(187) as the a-anomer (3%, over two steps). 
Although the above pyranosyl system was not very successful the work presented shows the 
potential for the cycloaddition of nitrile oxides to sugar enamines when considering the 
estimated yield of the cycloaddition step (45%) which could be optimised to give a useful 
approach to higher monosaccharides. A more reliable method for the production oft hose 
dipolarophiles is required. 
2.16 	Future Work 
Due to the problems discussed above with regard to the olefination of lactams it is felt that 
an alternative route to synthesise sugar derived enamines would be advantageous. To the 
best of this researcher's knowledge only one sugar-based enamine has been synthesised to 
date. Tatibouet et al. 138  produced an enamine (188) from D-arabinofuranose in 8 steps with 
moderate to good yields (Scheme 2.84). 
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OH 	1) p-nitrober,zoic acid 
BnO Ph3PCH3Br, PhLi 	BnO 	 Ph3P, DIAD, toluene c( + -
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2) (CH2NH2)2, EtOH 	 2) DBU, toluene 
BnO 	OBn 	3) BnOCOCI, pyridine, BnO OBn 	70% 	
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The immediate future for the azasugar work would be to obtain a stock of the enamine as 
produced by Tatibouët et al, 138  react it with benzonitrile oxide and carry out some pilot 
reductive ring opening reactions employing palladium hydroxide as the catalyst. A further 
aim would be to extend this work to other sugar systems or vary the nitrile oxides to allow 
access to a number of biologically active compounds 189 (Scheme 2.85) as discussed earlier. 
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There has been some research into the potential of thiasugars as glycosidase inhibitors. '39 A 
D-arabinofuranose based heteroglycal 190 was synthesised by Tatibouët et al"' in moderate 
to good yields over 7 steps (Scheme 2.86). It was felt that we could expand on this work by 
exploring the possibility of applying nitrile oxide cycloaddition chemistry to this thiaglycal 
that would give access to a wide variety of spiroisoxazolines 191 for further reaction. This is 
the only heteroglycal of its kind reported in the literature. 
° 	
+ - OH 	1) p-nitrobenzoic acid 
BnOc'(0F1 Ph3PCH3Br, PhL1 	BnO 	 Ph3P, DIAD, toluene 
toluene 	 2) MeOH, MeONa 
BnO OBn 	90% BnO OBn 	 70-75% 
BnO"ç'0 = 	DIAD, Ph3P 	BnO 	 LiAIH4, Et2O BnOçrzzr 
Zn(SCSN Me2)2 




NIS, CH2Cl2 	BnO( 	RXC=N—OH 
BnO flj 
DBU, toluene 	 NEt3 
50%, 3 steps BnO OBn 	 BnO 	OBn 
190 	 191 
Scheme 2.86 
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Only one other thiasugar has been synthesised with an unsaturated bond directly attached exo 
to the ring. 4-Cyanophenyl 6-deoxy-1,5-dithio-3-D-xylo-hex-5-enopyranoside 192 was 
synthesised from the 6-iodo-glycoside 193 by dehydroiodonation with silver fluoride in 




AcO\"'IOAc 	pyridine 	Ac 
OAc 	 OAc 
193 	 192 
Scheme 2.87 
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2.17 	Nitrile Sulfide Chemistry 
Having explored applications of nitrile oxide chemistry in carbohydrate synthesis, it was 
decided to investigate the potential of nitrile sulfides for the preparation of pyranosyl-
substituted heterocycles incorporating the C=N—S unit. Compared to other nitrilium 
betaines (nitrile oxides, nitrile ylides and nitrile imides)3 nitrile sulfides have received 
relatively little coverage in the literature. 42,44  However, a variety of cycloadditions with 
double- and triple-bonded dipolarophiles have been reported (Scheme 2.88). These include 
alkenes, alkynes, nitriles, imines, carbonyl compounds, phosphaalkynes and thiocarbonyl 
compounds. 
R.y 	 R y 
II X R—CEN—S XEEY 
N-.5' 	 N-. ,' 
Scheme 2.88 
A wide variety of substituents have been incorporated in the nitrile sulphide, including alkyl, 
aryl, heterocycles, phenols, esters and amides. There are few examples, however, of more 
complex nitrile sulfides such as carbohydrates. Rare examples are the furanosylnitrile 
sulfides reported by Buffel et al. as discussed in Section 1.7.8.5556  They showed that a 
number of target compounds (46, 47, 48, 49) could be synthesised from a ribose based nitrile 
sulfide 45. It was intended to apply Buffel's work to pyranose systems, rather than the 
furanose analogues employed previously. 
The interest in this area comes from the enhanced biological stability of C-nucleosides which 
is due to their resistance to hydrolysis of the glycoside linkage, this is important with regard 
to anti-tumour activity.55 
As discussed in section 1.7.8 pyrazofuran (50) is a good target for analogues as it has a range 
of anti-viral and anti-tumour activity and several analogues have already been produced.55 
Formycin A (51a) restricts the de novo purine synthesis, 140  has antineoplastic activity and as 
well as antifungal, antibacterial and antiviral activity.55 While formycin B (Sib) inhibits the 
purine nucleoside phosphorylase in human erythrocytes, 141  the growth of mouse sarcoma 180 
cell and the influenza Al virus.55 
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Another ribose based anti-tumour agent is 2-(-D-ribofuranosy1)thiazo1e-4-carboxamide 
(194).56 This is an analogue of synthetic nucleoside ribovarin that was synthesised from 
nitrile 195 via thioamide 196 (Scheme 2.89).142 
S 	 SO 
HO..(1)_.N 	I) 	HO..Oy..ANH2 ii) 
_
, iii) 	HO_.çO))N 	NH2 
HO' 'OH 	
HO' 'OH 	 Hd 'OH 
195 	 196 	 194 
I) H2S, 4-dimethylaminopyridine; ii) BrCH2C00O2C2H5, AcCN; iii) NH2, MeOH 
Scheme 2.89 
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Scheme 2.90 	 202 
The most widely used method for the generation of nitrile sulfides is the thermal 
decarboxylation of the 5-substituted 1,3,4-oxathiazolones, which are usually prepared by 
reaction of chiorocarbonylsulfenyl chloride with the corresponding carboxamide. For the 
present research a route to pyranosyloxathiazolone 199 was therefore required. It was 
proposed that this could be achieved by hydrolysis of nitrile 198 to amide 197 and its 
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subsequent reaction with C1COSC1 (Scheme 2.90). The pyranosylnitrile sulfide 200 would 
then be generated by thermal decarboxylation of oxathiazolone 199 (Scheme 2.90) and 
trapped by reactions with ethyl cyanoformate and dimethyl acetylenedicarboxylate to afford 
novel C-glycosides 201 and 202. 
To demonstrate the feasibility of this chemistry three pyranosylnitrile sulfide precursors 203, 
204 and 205 were selected for the initial study, these were based on D-xylose and D-glucose. 
For 203 and 205 the nitrile sulphide would be attached to the anomeric position, whereas for 




































C-(2,3,4-Tri-O-acetyl-3-D-xylo-pyranosyl)formamide (206) was prepared from the xylose 
nitrile 107 described in Section 2.9.1. Following the method employed by BeMillar et al. ,141 
titanium tetrachloride and water were added to a cooled suspension of the nitrile in glacial 
acetic acid (Scheme 2.91) and the reaction mixture allowed to stir for 72 h. Following 
extraction into chloroform and crystallisation, the product was obtained as a white solid 
(67%). The title oxathiazolone 203 was prepared using a modified method from Franz and 
Black .40 The formamide 206 (1 eq.) from the previous step was dissolved in dry chloroform 
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with chlorocarbonylsulfenyl chloride (2.42 eq.) and the mixture was vigorously refluxed 
until the evolution of HC1 ceased (48 h). Removal of the solvent and excess C1COSC1, 
filtration and crystallisation yielded the title compound as a white solid (74%). The 13C NMR 
spectrum showed characteristic peaks for the quaternary carbons of the oxathiazolone at 
172.2 ppm and 155.4 ppm for C-2 and C-5, respectively (Table 2.21). The coupling 
constants (J 9-11 Hz) observed in the 1H NMR spectrum for the sugar protons are 
characteristic of the sugar ring adopting a chair confromation. 
Table 2.21: NMR data for 203 
Proton 611/ppm Coupling f/Hz Carbon 6c/ppm 
1' 4.25 l'-2' 9.3 1',2',3',4' 68.1, 69.1, 72.0, 74.5 
2' 5.16 2'-3' 9.2 5' 66.8 
3' 5.22 3'-4' 9.2 2 172.2 
4' 5.00 4'-5a' 10.7 5 155.4 
 3.36 4'-5b' 5.5 
 4.20 5a'-5b' 11.4 
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C-( 1,2,3 ,4-Tetra-O-acetyl-a-D-gluco-pentopyranos-5-yl)formamide (207) was produced by 
acetylation of commercially available glucuronamide (Scheme 2.92). Acetic anhydride was 
added to a solution of glucuronamide in pyridine and left to stir overnight. Concentration and 
crystallisation afforded the product 207 as white crystals (92%). The method employed for 
the conversion of amide 207 into oxathiazolone 204 was similar to that used in the synthesis 
of oxathiazolone 203 (Scheme 2.92). The formamide 207 was dissolved in dry toluene, 
chlorocarbonylsulfenyl chloride was added and the reaction mixture was heated at reflux for 
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6 h until the reaction was complete (tic). Removal of the solvent and excess C1COSC1 and 
crystallisation from ethanol gave the title compound as white crystals (82%). As with 
oxathiazolone 203 the '3C NMR spectrum showed characteristic peaks at 170.3 ppm for C- 2 
and 155.4 ppm for C-5 of the oxathiazolone ring. The structure of the oxathiazolone ring was 
confirmed by x-ray crystal structure (Figure 2.18). 
Figure 2.18: 	Crystal Structure of 5-( 1 ',2 ' ,3 ',4 '-Tetra-O-acetyl-a-D-gluco-pentopyranos- 
5'-yl)-1,3,4-oxathiazol-2-one (204); from a crystal produced by Mr M. 
Tackett. 
The Haasnoot parameterisation of the Karplus equation' 16  was employed to calculate the 
proton-proton coupling constants from the torsion angles taken from the crystal structure and 
compared to those found in the solution phase (Table 2.22). This gave a satisfactory 
correlation for the data presented, despite the substituents of the sugar ring as discussed for 
spiroisoxazolines 129 and 133 in Section 2.10.9. 
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Table 2.22: Calculated/Observed Coupling Constants 
Protons 0b/° a Jcaic/HZb Jobs/Hz 
1',2' +54.94 3.3 3.6 
2',3' -174.15 10.2 10.3 
3',4' +170.84 10.1 9.9 
4',5' -169.04 10.0 10.1 
a. H-C-C-H Torsion Angle (0) from x-ray data; b. Jca ic 7.76C0S201.1C050+1.4 
The Cremer and Pople puckering parameters" give an indication of the shape of the 
oxathiazolone and pyranose rings (Table 2.23). In this case the pyranose ring has 91% of the 
puckering of an ideal chair with Q = 0.577A and 0 = 4.4° compared to Q = 0.630A and 0 = 
00 for an ideal chair. This value of 0 indicated that the chair was in the 4C, conformation. 
Table 2.23: Cremer and Pople Puckering Parameters 
Ring Q/A 0/0 
Pyranose C( I ')-C(2')-C(3 ')-C(4')-C(5 ')-0(6') 0.577 4.4 55.4 
Oxathiazolone 0(l)-C(2)-S(3)-N(4)-C(5) 0.051 308.0 
The oxathiazolone ring was found to be near planer with a mean deviation from plane of 
0.0203A (Table 2.24), while the 4 value of 308.0° indicates a mainly twist conformation. 







Table 2.25 shows the bond lengths and angles for the oxathiazolone ring, these were found to 
correspond favourably to the values for other, non-carbohydrate, oxathiazolones.'44 
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Table 2.25: Bond Lengths and Angles of Oxathiazolone Ring in 204 
Bond LengthlA Atoms Angle/' 
0(l)-C(2) 1.383(3) 0(l)-C(5)-N(4) 120.6(23) 
C(2)-0(21) 1.188(3) C(5)-0(1)-C(2) 110.3(12) 
C(2)-S(3) 1.753(3) 0(l)-C(2)-0(2 1) 122.8(21) 
S(3)-N(4) 1.689(2) 0(l)-C(2)-S(3) 107.1(29) 
N(4)-C(5) 1.262(3) 0(21 )-C(2)-S(3) 130.1(8) 
C(5)-O( I) 1.366(3) C(2)-S(3)-N(4) 93.2(12) 
C(5')-C(5) 1.495(3) C(5)-N(4)-S(3) 108.6(26) 
2.17.1.3 Synthesis 	of 	5-(2 ',3 ',4',6'-Tetra-O-acetyl--D-g1ucopyranosyI)-1,3,4- 
oxathiazol-2-one (205) 
It was necessary to prepare the glucose nitrile 208 to allow the synthesis of oxathiazolone 
205. To this end glucopyranosylnitromethane 209 was prepared from D-glucose and the 
nitromethyl compound converted into nitrile 208. 
H(NO2 
 
AcO(° 'NO2°  
D-GIc 	
O H 	 AcO" 	Ac 
OH 	 OAc 
209 
(I) NaOMe, CH3NO2, MeOH, (ii) H20, reflux, (iii) Ac20, TfOH 
Scheme 2.93 
The method used to produce 2,3,4,6-tetra-0-acetyl-f3-D-glucopyranosyl nitromethane (209) 
(Scheme 2.93) was similar to that employed for the xylose analogue 70. Sodium methoxide 
solution was slowly added to a solution of D-glucose in methanol and nitromethane, the 
reaction mixture was left to stir, under nitrogen, overnight. The resulting solid was passed 
through an ion-exchange column, concentrated and carried on to the next stage without 
further purification. 
The oil produced in the previous step was dissolved in water and heated at reflux overnight. 
The reaction mixture was filtered, extracted and concentrated to give the title compound as 
orange-brown crystals that were taken on to the next stage without further purification. 
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Triflic acid was added to a cold suspension of the crystals produced above in acetic 
anhydride, the reaction mixture was left to stir overnight. Ice-water was added and the 
reaction mixture u nderwent a series o f extraction and heating steps that resulted in an oil 
which was crystallised to give glucopyranosyl nitromethane 209 as a white crystalline solid 
(13% over three steps). 


















2,3,4,6-Tetra-0-acetyl--D-glucopyranosylnitrile (208) was prepared from acetylated 
nitromethyl glucose 209 (Scheme 2.94) using the same conditions employed for the xylose 
analogue 107, as described in Section 2.9.1. This yielded the desired compound as a white 
crystalline solid (59%). The 3C NMR showed a characteristic peak at 114.0 ppm for the 
quaternary C-i of the nitrile functionality. Formamide 210 was produced using the same 
method as that employed for xylose formamide 206 in Section 2.17.1.1. This afforded C-
(2,3,4,6-tetra-0-acetyl-J3-D-glucopyranosyl)formamide (210) as fine white crystals (46%). 
The product was differentiated from nitrile 209 by the change in the C-1 frequency from 114 












The method used for the final stage (Scheme 2.95) was similar to those used in the previous 
oxathiazolone syntheses. The formamide 210 (1 eq.) produced in the above step was 
dissolved in dry toluene with chiorocarbonylsulfenyl chloride (4.5 eq.). The reaction mixture 
was heated at reflux for 4 h and work up yielded the title compound 205 as a white solid 
(75%). The '3C NMR spectrum showed characteristic peaks for the quaternary carbons of the 
oxathiazolone at 170.0 ppm and 156.1 ppm for C-2 and C-5, respectively. 
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2.17.2 	Reactions of Pyranosyl Oxathiazolones 
Due to the competing reactions of c ycloaddition and fragmentation for n itrile sulfides, as 
discussed in Section 1.7.7, it was decided to examine the decomposition time for the 
thermolysis of oxathiazolones prior to attempting any trapping reactions. 
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AcO""OAc 	 OAc 
OAc 
203 	 107 
Scheme 2.96 
The title compound 203 was dissolved in xylene and heated at reflux until all the starting 
material had been consumed (36h). Due to the similar tic Rf values of nitrile 107 and 
oxathiazolone 203 this reaction was monitored by 1 H NMR spectroscopy. Once the reaction 
was complete the solvent was removed to leave nitrile 107 as a white solid (100%) (Scheme 
2.96), which was identified by comparison with an authentic sample, as prepared in section 
2.9.1. This reaction established the maximum heating time for the nitrile sulfide generation 
and trapping reactions. 
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Results and Discussion 
The title compound was dissolved in mesytilene and heated at reflux for 72 h. Work up 
yielded the expected decomposition product in the form of a white solid that was identified 
as nitrile 211 (100%) (Scheme 2.97). This decomposition reaction indicates the time taken 
for the oxathiazolone to degrade to the nitrile and, therefore, the maximum heating time 
required for the thermal trapping reaction. 
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With a view to obtaining a pure sample of nitrile 211, the parent amide 207 was refluxed in 
thionyl chloride to afford the title compound (74%) as a white solid (Scheme 2.98) that was 
identified by 'H and '3C NMR spectroscopy and mass spectrometry. This reaction was 
carried out as literature data for this nitrile was not available to allow identification of the 
decomposition product prepared above. 
2.17.2.3 Attempted Reaction of 5-(2',3 ',4'-Tri-O-acetyl--D-xy10-pyranosyl)- 1,3,4-
oxathiazol-2-one (203) and Ethyl Cyanoformate (ECF) 
Xylopyranosyl oxathiazolone 203 (100 mg) and ECF (9 eq.) were dissolved in xylene and 
heated at reflux for 72 h, under nitrogen. Work up yielded the starting oxathiazolone and the 
corresponding nitrile 107 as an unseparable mixture (38 mg) in a 1:1 ratio as identified from 
the 'H NMR spectrum. Although none of the nitrile sulfide had been trapped, formation of 
the nitrile indicated that the nitrile sulfide had been generated.4 ' 
2.17.2.4 Attempted Reaction of 5-(2',3',4'-Tri-O-acetyl-3-D-xy10-pyranosyl)-1 ,3,4-
oxathiazol-2-one (203) and Dimethyl Acetylenedicarboxylate (DMAD) 
The method employed was similar to that used above. Oxathiazolone 203 (100 mg) and ECF 
(9 eq.) were dissolved in xylene and the reaction mixture was refluxed for 48 h. This reaction 
yielded only nitrile 107 (100%). There was no indication of the desired cycloadduct being 
present. 
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Due to the lack of success in trapping the nitrile sulfide from oxathiazolone 203 using 
normal thermal methods it was decided to explore the use of microwave radiation. It was 
anticipated that this would allow shorter reaction times and it was hoped that the avoidance 
of prolonged thermolysis at elevated temperatures would give cleaner reaction mixtures. 
Oxathiazolone 203 (100 mg) and ECF (17 eq.) were dissolved in mesitylene, the ramp time 
of the reaction was 10 min and the reaction mixture was irradiated for 5 min at 130°C 
(Scheme 2.99). Concentration of the reaction mixture and dry flash column chromatography 
gave the starting material 203 (48%), the nitrile 107 (8%), the amide 206 (7%) and a trace 
amount of the title compound. The quantity of the product was not sufficient to allow 
isolation and characterisation; however, the mass spectrum of the crude mixture contained a 
peak that was attributable to the product (M+1 417). A surprising feature of this reaction 
was the formation of the amide as well as the usual nitrile decomposition product. This was 
probably due to the nitrile reacting with atmospheric water as these reactions were not 
carried out under a nitrogen atmosphere. 
As there was a quantity of the oxathiazolone remaining after a 5 min irradiation it was 
decided to double the exposure time to 10 min in order to ensure the consumption of the 
starting material and perhaps allow the isolation of characterisable amount of the 
cycloadduct. As before oxthiazolone 203 (100 mg) and ECF (17 eq.) were dissolved in 
mesitylene and irradiated in the microwave reactor. When worked up it was found that all 
oxathiazolone 203 had been consumed, however the reaction mixture yielded only a trace 
amount of the product as well as nitrile (23%) and amide (32%) decomposition products that 
were isolated by filtration through a thin silica pad. 
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2.17.2.6 Synthesis of Ethyl 3-(1 ',2 ',3',4 '-Tetra-O-acetyl-a-D-gluco-pentopyranos-S'-












This experiment was carried out in collaboration with Mr M. Tackett.'45  
Oxathiazolone 204 (500 mg) and ethyl cyanoformate (17 eq.) were dissolved in mesitylene 
and the reaction mixture was heated at reflux for 24 h (Scheme 2.100). Concentration and 
column chromatography yielded nitrile 211 and the product 213 as a white solid. Preparative 
tic resulted in the isolation of the title compound as a white solid (1%). The title compound 
was identified by the mass spectrum and by the proton NMR spectrum (Table 2.26). The 
latter exhibited a major change in the chemical shift of 5-H, in oxathiazolone 204 the signal 
for this proton was at 4,75 ppm while in the product it had been shifted to 5.37 ppm. As well 
as the sugar ring protons the NMR also showed signals attributable to the CH2 and CH3 of 
the ester group at 4.53 ppm and 1.46 ppm, respectively. 
Table 2,26: 'H NMR data for 213 
Proton /ppm Coupling JIHz 
CH3CH2CO2 1.46 CH3-CH2 7.1 
CH3 jjCO2 4.53 1'-2' 3.8 
1' 6.49 2'-3' 10.4 
2 5.29 3'-4' 9.7 
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2.17.2.7 Synthesis of Ethyl 3-(1 ',2 ',3 ',4'-Tetra-O-acetyl-ct-D-gluco-pentopyranos-5'-
yl)-1,2,4-thiadiazole-5-carboxylate (213): Method 2 
Oxathiazolone 204 (105 mg) and ECF (17 eq.) were dissolved in mesitylene and the reaction 
mixture irradiated in the microwave for 15 min at 130°C (Scheme 2.99). Work up gave a 
mixture (47 mg) of the starting material, the title compound and amide 207. However, it was 
not possible to isolate the thiadiazole 213 from the starting material. The 'H NMR spectrum 
showed that a small amount of the cycloadduct was present in the mixture, which was 
confirmed by FAB mass spectrometry. 
2.17.2.8 Attempted Reaction of 5-(l',2',3',4 I-Tetra- 0-acetyl-a-D-glueo-pentopyranos- 1' ' , '- etra-O-acetyl-a- c
5'-yl)-1 ,3,4-oxathiazol-2-one (204) and Dimethyl Acetylenedicarboxylate 
This experiment was carried out in collaboration with Mr M. Tackett. 
Oxathiazolone 201 (500 mg) and DMAD (15 eq.) were dissolved in mesitylene and heated at 
reflux for 24 h. Work up resulted in the recovery of the starting material (61%) and the 
nitrile decomposition product 211(25%). 
2.17.2.9 Attempted Reaction of 5-(2 ',3',4',6'-Tetra-O-acetyl-3-D-glucopyranosyl)-
1,3,4-oxathiazol-2-one (205) and Ethyl Cyanoformate 
Oxathiazolone 205 (148 mg) and ECF (17 eq.) were dissolved in mesitylene and the reaction 
mixture irradiated in a microwave for 15 min at 130°C. Work up yielded and inseparable 
mixture (84 mg) of the oxathiazolone 205, amide 210 and the nitrile 208. The 'H NMR 
spectrum indicated that the oxathiazolone and the nitrile were present in approximately 1: 
ratio. 
2.18 	Conclusion 
The work presented here has extended that of B uffel et al55' 56 to pyranosyl sugars. Three 
novel nitrile sulfide precursors were synthesised 5-(2',3',4'-tri-O-acetyl-3-D- 
xylopyranosyl)- 1,3 ,4-oxathiazol-2-one 	(203), 	5-( 1' ,2' ,3 ',4' -tetra-O-acetyl-a-D-gluco- 
pentopyranos-5 -yl)- 1,3 ,4-oxathiazol-2-one (204) and 5-(2 ' ,3 ',4' ,6 '-tetra-O-acetyl-fl-D- 
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glucopyranosyl)-1,3,4-oxathiazol-2-one (205). These were produced in good overall yields 
from their respective amides (233, 74%; 204, 82%; 205, 75%) as crystalline solids. 
A variety of conditions were employed in experiments designed to generate and trap the 
nitrile sulfides. These experiments achieved mixed success. When heated in a microwave 
reactor for 10 min the xylopyranosyl oxathiazolone 203 gave traces of (-1%) of the 
cycloadduct ethyl 3-(2 ' ,3 ',4 '-tri-O-acetyl-f3-D-xylo-furanosyl)- 1 ,2,4-thiadiazol-5-carboxylate 
(211), the major by-products being nitrile 107 and amide 206. When oxathiazolone 203 was 
heated in refluxing xylene with ECF only the nitrile 107 was obtained. Heating the 
glucuronamide-derived oxathiazolone 204 in mesitylene with the dipolarophile resulted in a 
ethyl 	3 -(1' ,2 ' ,3 ',4 ' -tetra-O-acetyl-a-D-gluco-pentopyranos-5 '-yl)- I ,2,4-thiadiazol-5- 
carboxylate (213) in a poor yield (1%). When a similar reaction was carried out in a 
microwave reactor the oxathiazolone was recovered, although a small amount of cycloadduct 
213 was identified in the 'H NMR spectrum of the crude mixture. Heating glucopyranosyl 
oxathiazolone 205 in a microwave reactor produced a mixture of the oxathiazolone 205 and 
nitrile 208. There was no evidence, in this case, to suggest that a cycloaddition had taken 
place. 
The production ofnitriles 107 and 211 on heating of o xathiazolones 203 and 204, in the 
absence of dipolarophile, is consistent with nitrile sulphide formation on thermolysis rather 
than the oxathiazolone decomposing via another route. The very low yields of cycloadducts 
indicates that the decomposition rate of pyranosylnitrile sulfides is greater than the rate of 
trapping by the dipolarophiles employed for this purpose. 
The route described is a useful approach to sugar derived oxathiazolones. However, so far 
attempts to trap the nitrile sulfides in useful yields have not been successful, even with 
reactive dipolarophiles. Furthermore, problems have been encountered in separating 
cycloadducts from the oxathiazolone and the nitrile by product. 
2.19 	Alternative Routes to Nitrile Sulfides 
There are a number of alternative precursors to nitrile sulfides, these will be discussed 
below. The first (Scheme 2.101) is to use 1,4,2-diathiazol-5-ones (214)146147  and 5-thiones 
(215). 146a,148  The former fragments more slowly than oxathiazolones and affords isothiazoles 
(216) in good yields when heated in the presence of DMAD.'47 In contrast thione 214 reacts 
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directly with DMAD to afford dithiolethione (217), and no nitrile sulfide-derived products 
are observed. 148  The access to these precursors is, however, less straight forward than to the 
oxathiazolones and the forcing conditions required to produce the nitrile sulfides would 
make the diathiazolone approach restrictive. 
215 	 214 
ci3csci RyS ______________ 	 a) Hgfl(OAc)2146b R. 15 
RCSNH2 
OR b) KMn04I46a 
DMAD 	 OR c) PhCNOI46b 
CO 	
heat 
-SCO A-- (75-200h) 
2Me 	 1600C 
S=<sXCO2Me R / 
— "1I—CO2Me 	 R—N + —S 
COMe 	
N-s
217 	 216 
Scheme 2.101 
Other potential routes are from 1,3,4-oxathiazoles (218)149150  and 4,5-dihydro-1,2,4-
thiadiazoles (219), 15  ' both decompose slowly at high temperatures to give nitrile sulphide-
derived products. However, there are few synthetic routes to these compounds short of 
reacting the target nitrile sulfide with the relevant unsaturated system (Scheme 2.l02),42  thus 
negating this as a useful synthetic technique. Furthermore, the conditions required to 
generate the nitrile sulphides are highly forcing and the reported yields are low. 
1R2R0 	 HCAr=NPh 
R0 	





N 5 Ar 
218 	160°C 	 160°C 	219 
Scheme 2.102 
It has also been attempted to produce nitrile sulfides by the thermolysis of a number of 1,2,5-
thiadiazoles (220), however this resulted in decomposition directly to the corresponding 
nitrile and sulphur.60 
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Finally (Scheme 2.103), nitrile sulfides have also been generated by the thermolysis of 
(alkylimino) sulphur difluorides (22 1)12,112  and N-thioacyldiphenylsulphinirnides (222).' 53 
These were found to be of limited synthetic use. 
_____ 	 ______ 	 + - 
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Scheme 2.103 
2.20 	Future Work 
It may be possible to improve the generation and trapping of nitrile sulfides by exploring 
other solvents used in conjunction with the microwave conditions. For example, subsequent 
work in the group showed that lower boiling solvents will allow for easier work up of 
reactions, but allows the reaction to proceed at a temperature higher than that of the solvent's 
boiling point. 114  More polar solvents, e.g. 1,2-dichloroethane may improve the heating of the 
reaction mixture. The sugar based oxathiazolones may also have potential as water-soluble 
oxathiazolone fungicides. This would require the protection strategy to be altered from an 
ester group to an ether group to allow the deprotection of the sugar ring without the 
degradation of the oxathiazolone moiety through nucleophilic attack. There is also the 
possibility of using oxathiazolone reaction products as ligands in transition metal 






Melting points were measured on a Gallenkamp capillary tube apparatus and are 
uncorrected. 
All 'H and '3C NMR were recorded on Bruker AX250 and WP200SY instruments by Mr J. 
R. A. Millar and Mr W. Kerr. Chemical Shifts (5) in all spectra are measured in parts per 
million using tetramethylsilane (S = 0.0) as a reference signal. 
FAB mass spectra and exact mass measurements were recorded on a Kratos MS50TC 
instrument using either glycerol or thioglycerol as matrix by Mr A. Taylor and Mr H. 
M'Kenzie. 
The x-ray structural analysis was carried out by Dr A. Dawson, Dr A. Parkin and Dr S. 
Parsons. 
Infrared spectra were recorded on a Jasco FTIIR-460 Plus using sodium chloride plates. 
The microwave experiments were carried out using CEM Explorer microwave system 
controlled by Discover software. 
3.1.2 	chromatography 
Analytical tic was carried out on Polygram plastic-backed plates coated with silica gel (0.2 
mm) with fluorescent indicator UV254  and Merck aluminium backed plates with Kieselgel 
GF254 (0.2 mm). 
Dry flash chromatography was performed using sinters of 30mm diameter filled with Fluka 
Kiesegel GF254  silica and eluted under a vacuum supplied by a water pump. 
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3.1.3 	Solvents and Reagents 
All reagents were standard laboratory grade and were used as supplied, unless specifically 
stated in the text. 
Dry ether, toluene and benzene were Analar grade dried over sodium wire. 
Dry chloroform was obtained by distillation over calcium chloride and stored over 4A 
molecular sieves. 
Dry pyridine was Analar grade distilled from and stored over potassium hydroxide. 
Dry THF was freshly distilled from calcium hydride. 
Acetic anhydride was purified by fractional distillation and stored over 4A molecular sieves. 
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3.2 	Synthesis of Nitrite Oxide Precursors 
3.2.1 	Dibromoformaldoxime (66)7172 
Lab. Book Ref. KG 5 
Molecular Formula CHBr2NO 




Hydroxylamine hydrochloride (7.44 g, 0.11 mol) was added to a stirred solution of glyoxylic 
acid (15.55 g, 50% w/w acid/water, 0.11 mol) and the resulting solution stirred for 24 hours 
at room temperature. Sodium carbonate (18.38 g, 0.17 mol) was cautiously added to the 
resulting suspension, this was followed by dichtoromethane (100 ml). The resulting biphasic 
system was cooled to -.6°C using an ice bath. Bromine (23.39 g, 0.15 mol) in 
dichioromethane (50 ml) was added, with vigorous stirring. The addition was carried out at a 
rate such that the temperature never exceeded 10°C. The reaction mixture was stirred for 
three hours, after which the organic phase was separated from the aqueous; this was washed 
with dichioromethane (3 x 50 ml). The combined organic layers were dried (MgSO4) and the 
solvent was removed in vacuo. The residue was recrystallised from n-hexane to yield a white 
crystalline solid (21.32 g, 29%); mp 69-70°C (lit.18 70-710C). 
3.2.2 	Ethyl Chtorooximidoacetate (67) 
73 
Lab. Book Ref. KG 7 
Molecular Formula C4H6C1NO3 




Glycine ethyl ester hydrochloride (30.13 g, 0.22 mol) was dissolved in distilled water (90 
ml) and the solution was cooled, using a dry ice/acetone bath, to —20°C. Hydrochloric acid 
(18 ml, 37% w/w, 0.6 mol) was next added; followed, in a dropwise fashion, by a solution of 
sodium nitrite (14.52 g, 0.17 mol) in water (25 ml), at such at rate that the temperature of the 
reaction mixture did not exceed —20°C. The additions of HC1 and NaNO2 were repeated and 
the cooled suspension was stirred for 90 mills. The resulting solid was filtered off, washed 
with petroleum ether (40-60, 3 x 10 ml) and dried to afford the product (12.83 g, 39%) as 
white crystalline solid; mp 74-75°C 
(lit.  115 79-800C). 
136 
Experimental Procedures 
3.2.3 	Benzohydroximoyl Chloride (68) 74 
Lab. Book Ref, KG 10 
	
Ph 
Molecular Formula C71-16C1NO3 	 CI 	
—OH 
Formula Weight 155.5 
A solution of a-benzaldoxime (2.0 g, 0.12 mol) in dry chloroform (50 ml) was cooled to - 
10°C (dry ice/acetone bath). Chlorine gas was passed through the solution until the colour 
changed from Oxford blue to sunset yellow having passed through emerald green. The 
excess chlorine was removed by displacement with nitrogen gas. The solution was 
evaporated to dryness and the resulting white solid was recrystallised from pentane to yield 
the product as white prisms (1.77 g, 69%); mp 49-50°C (lit.74 5051aC).a 




Lab. Book Ref. KG 66 	 NO2 
Molecularl r Formula C6H11N06 	 HO" 	"OH 
Formula Weight 193 	 OH 
Sodium methoxide (2.68 g sodium in 88 ml methanol) was added, over 10 mm, to a stirred 
suspension of xylose (9.12 g, 0.06 mol), nitromethane (45 ml, 50.7 g, 0.83 mol) and dry 
methanol (35 ml). This mixture was stirred overnight to give a brown solid, which was 
filtered off and dried by suction, washed with ice-cold methanol and again dried by suction. 
The solid was quickly dissolved in ice-cold water and passed down a column of amberlite JR 
120 (plus) resin (-300 g). 
To prepare the column water was passed through the column until the colour was lost. Then 
1M HC1 (100 ml) was added, after which more water was added until pH 4 was obtained. 
Once the solution prepared above had been passed through, the column was washed with 




water (100 ml) and the combined elutants were reduced in vacuo until only water distilled 
over. 
The resulting mixture was refluxed overnight. Activated charcoal (5 g) was added and the 
solution was refluxed for a further 2 h, the reaction mixture was hot-filtered through a celite 
pad and the yellow solution was evaporated in vacuo to give a yellow oil that was carried on 
to the next step without further purification. 
3.2.4.2 2,6-Anhydro-3,4,5-tri-O-acetyl-1-deoxy-1-nitro-D-gulo-hepitOl (3,4,5-tri-0-
acetyl-3-D-xylopyranosylnitromethane) (70) 75 
Lab. Book Ref. KG 69 	 NO2 
Molecular Formula C12H17N09 	 AcO" rOAC 
Formula Weight 319 	 OAc 
A suspension of 2,6-anhydro- 1 -deoxy- 1 -nitromethylxylose 69 in a cetic anhydride (20 ml) 
was cooled to 0°C (ice bath) and stirred under a nitrogen atmosphere. Trifluoromethane 
sulphonic acid (0.1 ml) was added and the sugar slowly dissolved. The solution was stirred 
overnight while warming to room temperature, this was followed by addition of ice-water 
(100 ml). After stirring, the mixture was extracted with chloroform (2 x 100 ml); the 
organics were washed with water and dried (MgSO4). The solvent was removed in vacuo and 
the oil obtained co-evaporated with toluene (5 x 75 ml). The crude oil was dissolved in 
chloroform (100 ml) and stirred with activated charcoal (2 g) for 30 mm. The solution was 
filtered through a celite pad and the solvent was removed to give the crude acetylated 
nitromethyl xylose. This was further co-evaporated with toluene and recrystallised from 
ethanol to give the title compound as a white solid (10.70 g, 37%); mp 163-164°C (lit.156 
164-165°C); 5H  (250 MHz, CDC13) 2.30, 2.33 (9H, 3 x s, CH3), 3.61 (1H, dd, 6a-H), 4.40 
(1H, dd, 6b-H), 4.44 (1H, ddd, 2-H), 4.67 (1H, dd, lb-H), 4.76 (1H, dd, la-H), 5.15 (1H, dd, 
3-H), 5.26 (1H, dd, 5-H), 5.52 (1H, t, 4-H); J(x-y)/Hz la-lb 13.4, la-2 8.9, lb-2 3.0, 2-3 
10. 1, 3-4 9.3, 4-5 9.4, 5-6a 5.7, 5-6b 10.6, 6a-6b 11.4; 8c (63 MHz, CDC13) 21.0, 21.0, 21.2 
(3 x COCH3), 67.1 (C-6), 69.0, 69.9, 73.5, 75.4 (C-2, C-3, C-4, C-5), 76.4 (C- 1), 170.2, 




hexitol (7 1)77  
Lab. Book Ref. KG 143 
Molecular Formula C121-117N08 	 AcO""OAc 
Formula Weight 303 	 OAc 
The Baker et a176 modified method from Bartra et al,77  was employed to reduce the 
acetylated nitromethyl xylose 70 to the oxime. 
Tin (IV) chloride (454 mg, 0.21 mol, 1.5 eq) was dissolved, under nitrogen, in dry THF (6 
ml) and was cooled to 0°C. Triethylamine (1.09 ml, 7.76 mmol, 5 eq) and thiophenol (0.73 
ml, 7.07 mmol, 4.5 eq) were then added to give a yellow mixture. The acetylated nitromethyl 
xylose 70 (501 mg, 1.57 mmol, 1 eq) dissolved in dry THF (6 ml) was added dropwise to the 
reaction mixture, which was left to stir overnight while allowing to warm to room 
temperature. The solvent was removed in vacuo to give a yellow solid that was co-
evaporated with hexane (3 x 50 ml). The solid was purified using column chromatography 
(silica, 0-+100% ether in hexane; gradient elution) to give the title compound as a white 
crystalline solid (309 mg, 65%); mp 130°C (lit.76 135-137°C; lit.  ' 57 160-1630C); Rf 0.50 
(Et20); 5H  (250 MHz, CDC13) 1.87, 1.93, 1.93 (91-1, 3 x s, CH3), 3.25 (11-1, t, 6a-H), 3.88 (11-1, 
dd, 2-H), 4.04 (11-1, dd, 6b-H), 4.70 (11-1, broad s, OH), 4.90 (11-1, ddd, 5-H), 4.94 (11-1, t, 3-
H), 5.15 (11-1, t, 4-H), 7.19 (11-1, d, 1-H); J(x-y)/Hz 1-2 6.7, 2-3 9.8, 3-4 9.5, 4-5 9.4, 5-6a 
10.9, 5-6b 5.6, 6a-6b 11.3; 6c(63  MHz, CDC13) 20.7,20.8(3 x CH3), 66.7 (C-6), 69.0, 69.9, 
72.8 (C-3, C-4, C-5), 76.2 (C-2), 146.8 (C-i), 170.0, 170.1, 170.6 (3 x COCH3); m/z(FAB) 
Found: M+l 304.1026. C12H18N08 requires M+1 304.1032. 
3.2.4.4 2,6-Anyhydro-3,4,5-tri-O-acetyl-1-chloro-1-deoxy-1-hydroxyimino-D-glycero-
-D-xy10-hexitol (72) 14 
Lab. Book Ref. KG 220 	 0 Cl 
	
N-OH 
Molecular Formula C121-116C1N08 	
AcO" 	Ac 
Formula Weight 337.5 	
OAc 
A solution of the above oxime 71 (234 mg, 0.77 mmol) in dry chloroform (25 ml) was 
cooled to -78°C (dry ice/acetone bath). Dry chlorine gas was slowly bubbled through the 
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solution until the solution became a green colour having first passed through blue. The 
reaction mixture was allowed to warm overnight with stirring during which time the colour 
faded. The solvent was removed in vacuo to give an oil that was triturated from ether to give 
the title compound as a white solid (260 mg, 100 %); mp 140-141°C; 6H  (250 MHz, CDC13) 
2.18, 2.23, 2.24 (9H, 3 x s, CH3), 3.60 (1H, t, 6a-H), 4.36-4.49 (2H, in, 2-H, 6b-H), 5.21-5.31 
(1H, in, 5-H), 5.36-5.54 (2H, in, 3-H, 4-H), 9.40 (1H, broad s, OH); J(x-y)IHz 2-3 nd, 3-4 
nd, 4-5 nd, 5-6a 10.8, 5-6b nd, 6a-6b 10.8; 8c  (63 MHz, CDC13) 20.4 x 2, 20.5 (3 x CH3), 
66.5 (C-6), 68.5, 68.9, 73.2, 78.8 (C-2, C-3, C-4, C-5), 136.2 (C-i), 169.3, 169.9, 170.5 (3 x 
COCH3); m/z(FAB) Found: M+l 338.0643. C12H17N08C1 requires M+1 338.0644. 
3.3 	Synthesis of Hex-5-enofuranosides 
3.3.1 	Synthesis of 3-O-Benzoyl-5,6-dideoxy-1 ,2-O-isopropylidene-a-D-xylo-hex-5- 
enofuranose (58) 
The title compound was synthesised in four steps from commercially available diacetone-D-
glucose, as previously reported.78 
3.3.1.1 3-0-Benzoyl-1 ,2 : 5,6-di-O-isopropylidene-a-D-glucofuranose (75) 
Lab. Book Ref. KG 1 
) 
Molecular Formula C19H24O7 	
O 	O
- "o 
Formula Weight 336 	
BzOO 
Diacetone-D-glucose (20.57 g, 79.0 mmol) was dissolved in chloroform (50 ml) under 
nitrogen, and pyridine (80 ml) was added. Then, using an ice bath, the solution was cooled to 
0°C and benzoyl chloride (16 ml, 138 mmol) added in a dropwise fashion. The solution was 
then stirred overnight. The resulting green solution was, poured slowly into water (250 ml), 
the aqueous layer separated and extracted with chloroform (2 x 50 ml). The combined 
organic layers were washed with saturated aq. NaHCO3 (3 x 75 ml) and water (2 x 75 ml). 
The combined organic layers were then dried (MgSO4) and the solvent was removed in 




3.3.1.2 3-0-Benzoyl-1,2-0-isopropylidene-a-D-glucofuranose (76) 
Lab. Book Ref. KG 2 	 HO 
HO 1 0 
Molecular Formula C161-12007 )"O 
Formula Weight 324 	 BzO'O 
The benzoylated-D-glucose 75 produced in the previous step was stirred overnight at 40°C 
with glacial a cetic a cid (100 ml) and water (60 ml). The resulting solution was added to 
chloroform/water (1:1, 400 ml), and the aqueous layer extracted with chloroform (2 x 100 
ml). The combined organic layers were then washed with H20 (200 ml) before being dried 
(MgSO4). The organic layers were co-evaporated with toluene to give an oil, which was 
carried forward to the next stage. 
3.3.1.3 3-O-Benzoyl-1 ,2-O-isopropylidene-5,6-bis-O-methanesulphonyl-a-D-
glucofuranose (77) 
Lab. Book Ref. KG 3 	 MsO 
MsO, O 0 
Molecular Formula C18H2401 1S2 	
' Formula Weight 480 	 BzO " 
The oil produced in the above step was dissolved, under nitrogen, in 100 ml dry chloroform, 
to which pyridine (50 ml) was added. The solution was cooled (salt-ice bath), and 
methanesulphonyl chloride (22.05 g, 0.19 mol) was added dropwise to the reaction mixture, 
which was then allowed to return to room temperature, and stirred overnight. The resulting 
suspension was poured into chloroform/water (1:1, 300 ml) and the aqueous phase extracted 
with chloroform (2 x 100 ml). The combined organic layers were next washed with 1M 
H2SO4 (3 x 100 ml), sat. NaHCO3 (2 x 100 ml) and water (2 x 100 ml). The solution was 
dried (MgSO4) and the solvent removed in vacuo to yield an oil that gave crystals on the 
addition of ethanol. The product was recrystallised from ethanol (10.61 g, 28% from 74); mp 
168-169°C (lit.79 168-1690C). 
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3.3.1.4 3-O-Benzoyl-5,6-dideoxy-1 ,2-O-isopropylidene-a-D-xylo-hex-5-enofuranose 
(58)80 
Lab. Book Ref. KG 4 	 10 
Molecular Formula C16H,905  
BzO 	0 
Formula Weight 273 
Prior to production of the alkene a zinc/copper couple had to be prepared. This was achieved 
by thoroughly washing powdered zinc (3.44 g) with 1M HCl (4 x 15 ml), water (2 x 15 ml), 
CuSO4 (3 x 15 ml), water (2 x 15 ml), ethanol (2 x 15 ml) and DMF (3 x 15 ml). 
The freshly prepared Zn/Cu couple was added to a stirred solution of 3-O-benzoyl-5,6-
dideoxy- I ,2-O-isopropylidene-5 ,6-bis-O-methanesulphonyl-a-D-glucofuranose (77) (4.77 g, 
9.93 mmol), dry sodium iodide (7.50 g, 0.05 mol), DMF (20 ml) and DME (6 ml). The 
resulting mixture was then refluxed for 70 mins. The solution was allowed to cool, after 
which it was poured into water (200 ml) and toluene (150 ml) added. The mixture was then 
filtered through a celite pad and the pad was washed with toluene (2 x 100 ml). The 
washings were then used to extract the aqueous layer; the combined organics were next 
washed with water (2 x 100 ml), dried (MgSO4) and the solvent removed in vacuo. The 
resulting oil was recrystallised from petroleum ether (60-80) and washed with n-pentane to 
afford the product as a white solid (2.22 g, 77%); mp 70°C; [aID'8 —57.0 (c = 1.0, CHC13); 
(250 MHz, CDCI3) 1.32, 1.55 (6H, 2 x s, C(CH3)2), 4.68 (1H, dd, 2-H), 4.85 (1H, dd, 4-H), 
5.23-5.28 (2H, m, 6a-H, 6b-H), 5.44 (1H, d, 3-H), 5.80-5.94 (1H, dm, 5-H), 6.02 (1H, d, 1-
H), 7.25-8.02 (5H, m, Ph); J(x-y)/Hz 1-2 3.8, 2-3 3.0, 3-4 3.0, 4-5 6.4, 5-6a nd, 5-6b nd, 6a-
6b nd; 5c (63 MHz, CDCI3) 26.0, 26.5 (C(CH3)2) 77.7, 80.1 (C-3, C-4), 83.4 (C-2), 104.5 (C-
l), 111.9 (C(CH3)2), 119.5 (C-6), 128.3 (2 x CHPh), 129.17 (qCPh), 129.54(2 x CHPh), 
130.5 (C-5), 133.3 (CHPh), 165.1 (COPh); m/z(FAB) Found: M+1 291.1230. C16H1905 
requires M+1 291.1233. 
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3.3.2 	Synthesis of Methyl 5,6-Dideoxy-2,3-0-isopropylidene-cx-D-lyxo-hex-5-eno 
furanoside (61) 
The title compound was prepared using a literature procedure.8' 
3.3.2.1 Methyl 2,3: 5,6-di-O-isopropylidene-c-D-mannofuranoside (78) 
Lab. Book Ref. KG 70 
Molecular Formula C13H2206 
Formula Weight 274 
A solution of D-mannose (25 g, 0.14 mol),2,2-dimethoxypropane (85 ml), acetone (82.5 
ml), methanol (82.5 ml) and concentrated hydrochloric acid (2.5 ml) was heated at reflux for 
2 hr. The solution was cooled, water (250 ml) added and concentrated in vacuo to —250 ml 
below 30°C. The product was not isolated but taken directly on to the next stage. 
3.3.2.2 Methyl 2,3-0-isopropylidene-a-D-mannofuranoside (79) 
OH 
Lab. Book Ref, KG 71 	 HO,_,J,,n.,,\OMe 
Molecular formula C,0H,806 
Formula Weight 234 	 0 0 
To a stirred solution of furanoside 78, prepared above, methanol (250 ml) and concentrated 
hydrochloric acid (6.25 ml) were added and the resulting solution stirred for 200 mm. The 
solution was then neutralised by addition of sodium hydrogen carbonate solution (1M, 188 
ml), the methanol was removed in vacuo. The compound was isolated in chloroform by 
liquid-liquid extraction for 3 hr. The extract was dried (MgSO4) and then concentrated to 





Lab. Book Ref. KG 72 
Molecular Formula C12H22010S2 






Syrup 79 was dissolved in pyridine (125 ml) and methanesulphonyl chloride (37.5 ml) added 
while maintaining the stirred solution below 35'C. The solution was stirred at 20°C for 3 hr, 
and the excess methanesulphonyl chloride was decomposed by slow addition of water, while 
keeping the temperature below 50°C. More water (l500 ml) was added and the product was 
filtered off, washed with water and dried in vacuo over phosphorous pentoxide. The crude 
product was recrystallised from ethanol to yield white crystals (16.8g, 31% from D-
mannose) that were taken on to the next stage. 
3.3.2.4 Methyl 5,6-Dideoxy-2,3-0-isopropylidene-a-D-lyxo-hex-5-eno furanoside 
(61)80 
OMe 
Lab. Book Ref. KG 13 
Molecular Formula C10H1604 	 o o 
Formula Weight 200 
Methyl 	2,3-O-isopropylidene-5 ,6-di-O-methanesulphonyl-ct-D-lyxo-hex-5-enofuranoside 
(80) (5.03 g, 12.9 mmol) was dissolved in DMF (33 ml) and DME (9 ml) with dry sodium 
iodide (9.66 g, 0.06 mol). A freshly prepared Zn/Cu couple was added to the above mixture, 
which was refluxed for 70 min with stirring. The resulting solution was cooled and poured 
into water, with rapid stifling. Toluene (53 ml) was added and the mixture was filtered 
through a celite pad that was washed with toluene (2 x 83 ml). The filtrate was used to 
extract the aqueous layer of the reaction mixture; the combined organics were washed with 
water (2 x 50 ml) and evaporated in vacuo to give a yellow oil. The oil was purified by dry 
flash chromatography (hexane:ether 90:10) to give the pure alkene (1.98 g, 77%); 3 (250 
MHz, CDC13) 1.27, 1.43 (6H, 2 x s, C(CH3)2), 3.31 (lH, s, OMe), 4.35 (1H, dd, 44 3.6 45 
7.4, 4-H), 4.54 (1H, d, J,3 5.8, 2-H), 4.64 (1H, dd, J3,4 3.6 J2, 3 5.9, 3-H), 4.87 (lH, s, 1-H), 
5.96, 5.87-6.04 (1H, ddd, J45 7.3 J5,6a nd J5-6b nd, 5-H), 5.26-5.42 (2H, in, 6a-H, 6a-H); J(x-
y)/Hz 1-2 0, 2-3 5.9, 3-4 3.6, 4-5 7.4, 5-6a nd, 5-6b nd, 6a-6b nd; 6c (63 MHz, CDC13) 24.8, 
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25.9 (C(CH3)2) 54.6 (OMe), 81.0, 81.4 (C-2, C-3),85.2 (C-4),107.0 (C-i), 112.5 (C(CH3)2), 
119.0 (C-6), 132.2 (C-5); m/z(FAB) Found: M+i 201.1134. C10H1704 requires M+1 
201.1127. 
3.4 	Cycloaddition Reactions of Hex-5-enofuranosides 
3.4.1 	General Method for Cycloaddition of Nitrile Oxides to Hex-5- 
enofuranosides12"3  
The hex-5-enofuranoside (1.2 eq.) was dissolved in sodium-dried ether and the nitrile oxide 
precursor (1 eq.) added with stirring. The solution was cooled (ice bath) and triethylamine 
(1.2 eq.) in sodium-dried ether was added to the mixture over 48-72 h using a syringe pump. 
The solution was then stirred for a further ten hours, after which the triethylamine 
hydrochloride precipitate was dissolved by the addition of water. The aqueous layer was then 
extracted with ether, the combined organics were dried (MgSO4) and the solvent was 
removed in vacuo. The diasteromeric isoxazolines were separated from the unreacted alkene 
and the furoxan by dry flash column chromatography (silica, 0—>100% diethyl ether in 
hexane; gradient elution). 
3.4.2 	5-(3-O-Benzoyl- 1,2-O-isopropylidene-(x-D-xylo-furanos-4-yl)-3-bromo-2- 
isoxazoline (81) 
N—O 
Lab. Book Ref. KG 6 
Molecular Formula C17H18BrN06 	 Br   
Formula Weight 412 	 BzO 
Using the general method above; triethylamine (346 mg, 3.42 mmol) in sodium-dried ether 
(40 ml) was added, over 72 hours, to the stirred mixture of 3-O-benzoyl-5,6-dideoxy-1,2-O-
isopropylidene-a-D-xylo-hex-5-enofuranose (58) (1.04 g, 3.59 mmol) and 
dibromoformaldoxime (66) (608 mg, 3.00 mmol) in sodium-dried ether (50 ml). The solution 
was then stirred for a further ten hours, and poured into water (100 ml). The aqueous layer 
was extracted with ether (3 x 50 ml), the combined organics were dried (MgSO4) and the 
solvent removed in vacuo. 
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The diastereomeric cycloadducts were separated from the unreacted alkene using dry flash 
chromatography (silica, 0—> 100% ether in hexane; gradient elution). The column afforded, in 
order of elution, unreacted alkene (600 mg, 58%) and a pair of inseparable diastereomeric 
cycloadducts as a solid (421 mg, 67% based on consumed 58) in the ratio of 13:87 as 
determined by 'H NMR spectroscopy from the signal for the anomeric proton (1-H); mp 
116-118°C. 
The major isomer was isolated by recrystallisation of the crude mixture from ethanol (131 
mg, 30%); mp 130-137°C; [0,11) 21 —76.7 (c = 0.41, CHC13); Rf 0.68 (Et20); öu (250 MHz, 
CDC13) 1.30, 1.52 (6H, 2 x s, C(CH3)2), 3.26 (1H, dd, 6b-H), 3.42 (1H, dd, 6a-H), 4.45 (1H, 
dd, 4-H), 4.64 (IH, d, 2-H), 4.96 (1H, ddd, 5-H), 5,50 (1H, d, 3-H), 5.96 (1H, d, 1-H), 7.39-
8.02 (5H, in, Ph); J(x-y)/Hz 1-2 3.7, 2-3 -'0, 3-4 3.1, 4-5 6.9, 5-6a 7.4, 5-6b 10.6, 6a-6b, 
17.5; 8c (63 MHz, CDC13) 26.6, 27.2 (C(CH3)2), 44.5 (C-6), 76.7, 78.6, 79.4, 83.9 (C-2, C-3, 
C-4, C-5), 105.5 (C-I), 113.0 (C(CH3)2), 129.1, 130.1, 129.5 (5 x CHPh), 134.2 (qCPh), 
138.1 (C-7), 165.4 (PhCO); m/z(FAB) Found: Br 79  M+1 412.03870. C,7H,9NO6Br requires 
M+1 412.03957; Found Br" M+1 414.0377. C17H,9NO6Br requires M+1 414.0281; CaIc. 
For C17H18BrNO6: C, 59.26; H, 5.68; N, 3.46. Found: C, 59.22; H, 5.45; N, 2.86%; 
diagnostic signals for minor isomer 6  (250 MHz, CDC13) 4.69 (1H, d, 2-H), 6.27 (1H, d, 2-
H); J(x-y)/Hz 1-2 3.8; unidentified peak at 5.95, possible due to an unisolated isomer. 
3.4.3 	5-(3-O-Benzoyl-1 ,2-O-isopropylidene-a-D-xylo-furanos-4-yl)-3-carbethoxy-2- 
isoxazoline (82) 
Lab. Book Ref. KG 12 
Molecular Formula C20H23N08 





Using the general method above; triethylamine (482 mg, 4.77 mmol) in sodium-dried ether 
(40 ml) was added, over 72 hours, to the stirred mixture of 3-O-benzoyl-5,6-dideoxy-1,2-O-
isopropylidene-a-D-xylo-hex-5-enofuranose (58) (1.20 g, 4.15 mmol) (50 ml) and 
dibromoformaldoxime (67) (600 mg, 3.96 mmol) in sodium-dried ether. The solution was 
then stirred for a further ten hours, and poured into water (100 ml). The aqueous layer was 
extracted with ether (3 x 50 ml), the combined organics were dried (MgSO4) and the solvent 
removed in vacuo. 
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The diastereomeric cycloadducts were separated from the unreacted alkene using dry flash 
chromatography (silica, 0-> 100% ether in hexane; gradient elution). The column afforded, in 
order of elution, unreacted alkene (489 mg, 41%) and a pair of diastereomeric cycloadducts 
as a white solid (670 mg, 67%, based on consumed alkene) in a ratio of 13:87 (determined 
from H NMR spectroscopy from the signal for the anomeric proton [1-H]); mp 90°C. 
The major isomer was isolated by the recrystallisation of the crude mixture from ethanol; mp 
108-110°C; Rf 0.70 (Et20); ö(250 MHz, CDC13) 1.31 (3H, t, CH3CH2), 1.32, 1,55 (6H, 2 x 
s, C(CH3)2), 3.23 (1 H, dd, 6b-H), 3.43 (1H, dd, 6a-H), 4.29 (2H, q, CH3CH2), 4.45 (1H, dd, 
4-H), 4.64 (1H, d, 2-H), 5.07 (1H, ddd, 5-H), 5.50 (1H, d, 3-H), 5.96 (1H, d, 1-H), 7.39-8.01 
(5H, m, Ph); J(x-y)/Hz CH3CH2  7.1, 1-2 3.7, 2-3 nd, 3-4 3.1, 4-5 6.5. 5-6a 7.5, 5-6b 11.3, 6a-
6b 17.9; 6c  (63 MHz, CDC13) 13.8 (CH3CH2), 25.9, 26.5 (C(CH3)2), 36.0 (C-6), 76.2, 78.7, 
79.7, 83.2 (C-2, C-3, C-4, C-5), 104.8 (C-i), 112.4 (C(CH3)2), 128.4, 129.5, 133.53(5 x 
CHPh), 128.8 (qCPh), 151.7 (EtCO), 160.2 (C-7), 164.8 (PhCO); m/z(FAB) Found: M+1 
406.1498. C20H24N08  requires M+l 406.1502; diagnostic signals for minor isomer ö (250 
MHz, CDC13) 4.68 (1 H, d, 2-H), 6.02 (1H, d, 2-H); J(x-y)IHz 1-2 3.8; unidentified peak at 
5.95, possible due to an unisolated isomer. 
3.4.4 	5-(3-O-Benzoyl-1 ,2O-isopropy1idene-a-D-xyIo-furanos-4-y1)-3-pheflY1-2- 
isoxazoline (83) 
Lab. Book Ref. KG 14 
Molecular Formula C23H23N06 





Using the general method above; triethylamine (238 mg, 2.35 mmol) in sodium-dried ether 
(40 ml) was added, over 48 hours, to the stirred mixture of 3-O-benzoyl-5,6-dideoxy-1,2-O-
isopropylidene-a-D-xylo-hex-5-enofuranose (58) (611 mg, 2.11 mmol) (50 ml) and 
dibromoformaldoxime (68) (300 mg, 1.93 mmol) in sodium-dried ether. The solution was 
then stirred for a further ten hours, and poured into water (100 ml). The aqueous layer was 
extracted with ether (3 x 50 ml), the combined organics were dried (MgSO4) and the solvent 
removed in vacuo. 
The diastereomeric cycloadducts were separated from the unreacted alkene using dry flash 
chromatography (silica, 0-100% ether in hexane; gradient elution). The column yielded, in 
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order of elution, unreacted alkene (137 mg, 22%) and a pair of diastereomeric cycloadducts 
as a solid (458 mg, 69%, based on consumed alkene) in a ratio of 16:84 (determined from 'H 
NMR spectroscopy from the signal for the anomeric proton [1-H]); mp 137-138°C. 
The major isomer was isolated by repeated recrystallisation from ethanol; mp 133°C; Rf 0.61 
(Et20); 8H  (250 MHz, CDC13) 1.31, 1.52 (6H, 2 x s, C(CH3)2), 3.53 (1H, dd, 6b-H), 3.62 (1H, 
dd, 6a-H), 4.43 (1H, dd, 4-H), 4.70 (1H, d, 2-H), 5.09 (1H, ddd, 5-H), 5.60 (1H, d, 3-H), 5.99 
(1H, d, 1-H), 7.34-8.07 (5H, in, Ph); J(x-y)/Hz 1-2 3.7, 2-3 nd, 3-4 3.1, 4-5 8.1, 5-6a 7.2, 5-
6b 11.3, 6a-6b 17.0; 5c (63 MHz, CDC13) 26.0, 26.5 (C(CH3)2), 38.2 (C-6), 76.2, 76.9, 79.3, 
83.4 (C-2, C-3, C-4, C-5), 104.8 (C-i), 112.3 (C(CH3)2), 126.7, 128.4, 130.1 (5 x CHPh, Bz), 
128.9 (qCPh, Bz), 128.6, 129.2 (5 x CHPh, Ph), 133.4 (qCPh, Ph), 156.5 (C-7), 164.9 
(PhCO); m/z(FAB) Found: M+1 410.1601. C23H23N06 requires M+1 410.1604; diagnostic 
signals for minor isomer ö  (250 MHz, CDC13) 3.24 (1H, dd, 6a-H), 3.39 (iH, dd, 6b-H), 
4.74 (1H, d, 2-H), 4.56 (lh, dd, 4-H), 6.09 (IH, d, 2-H); J(x-y)/Hz 1-2 3.9, 2-3 nd, 3-4 3.7,4-




Lab. Book Ref. KG 45 	 Br 0 SMe 
Molecular Formula C11 H,6BrNO5 
Formula Weight 322 	
0  
Using the general method above; triethylamine (360 mg, 3.56 mmol) in sodium-dried ether 
(40 ml) was added, over 72 hours, to the stirred mixture of methyl 5,6-dideoxy-2,3-0-
isopropylidene-a-D-lyxo-hex-5-enofuranoside (61) (963 mg, 4.81 mmol) and 
dibromoformaldoxime (66) (605 mg, 2.98 mmol) in sodium-dried ether (50 ml). The solution 
was then stirred for a further ten hours, and poured into water (100 ml). The aqueous layer 
was extracted with ether (3 x 50 ml), the combined organics were dried (MgSO4) and the 
solvent removed in vacuo. 
The diastereomeric cycloadducts were separated from the unreacted alkene using dry flash 
chromatography (silica, 0 —>100% ether in hexane; gradient e lution). The column gave, in 
order of elution, unreacted alkene (764 mg, 79%) and a pair of diastereomeric cycloadducts 
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(296 mg, 92%, based on consumed alkene) as an oil in a ratio of 21:79 (determined by 'H 
NMR spectroscopy from the signal for the anomeric proton [1-H]); [a]D2 ' +8.52 (c = 2.18, 
CHC13); Rf 0.66 (Et20); 5H (250 MHz, CDC13) 1.27, 1.43 (6H, 2 x s, C(CH3)2), 3.23 (1H, dd, 
6b-H), 3.30 (3H, s, OMe), 3.35 (1H, dd, 6a-H), 4.11-4.13 (IH, dd, 4-H), 4.54 (1H, d, 2-H), 
4.73 (1H, dd, 3-H), 4.90 (1H, s, 1-H), 4.91-4.97 (1H, ddd, 5-H); J(x-y)/Hz 1-2 —0,2-3 5.9, 3-
4 3.7, 4-5 nd, 5-6a 8.4, 5-6b 10.7, 6a-6b 17.5; 8c  (63 MHz, CDC13) 24.0, 25.5 (C(CH3)2), 
43.3 (C-6) 54.7 (OMe), 78.8, 78.9, 79.2, 84.5 (C-2, C-3, C-4, C-5), 107.0 (C-I), 112.6 
(C(CH3)2), 137.9 (C-7); m/z(FAB) Found: M+1 322.0340. C12H,7BrNO5 requires M+1 
322.0290; Caic. For C,,H16BrNO5: C, 40.99; H, 4.97; N, 4.97. Found: C, 40.42; H, 4.02; N, 
4.38%. 
3.5 	Reactions of Cycloadducts 
3.5.1 	Reduction of Ester Groups of 5-(3-O-Benzoyl-1 ,2-O-isopropylidene-a-D-xylo- 
furanos-4-yl)-3-carbethoxy-2-isoxazoline (82)8788 
N—O 
Lab. Book Ref. KG 365 	 I 	0 HO 
90 Molecular Formula C,,H,7N06 
HO '0 Formula Weight 259 
91 Molecular Formula C,8H2,N07 	
HO ,It,_ BI- 
Formula Weight 363 	
zO  
Sodium borohydride (38 mg, 1.0 mmol) was added portionwise to a solution of the ester 
isoxazoline 82 (99 mg, 0.24 mmol) in ethanol (6 ml) and DCM (2 ml). The reaction mixture 
was stirred at room temperature until the disappearance of the starting material (3-4 h). The 
solution was poured into water (25 ml) and then extracted with dichloromethane (4 x 20 ml). 
The combined extracts were dried (MgSO4) and the solvent was removed in vacuo, this gave 
the two alcohols 90 and 91 as an inseparable white solid (14 mg). 
A twenty-fold excess of sodium borohydride (392 mg, 10.0 mmol) was added portionwise to 
a solution of the ester isoxazoline 82 (210 mg, 0. 519 mmol) in ethanol (35 ml). The reaction 
mixture was stirred at room temperature until the disappearance of the starting material (3-4 
h). The solution was poured into water (25 ml) and then extracted with dichloromethane (4 x 
20 ml). The combined extracts were dried (MgSO4) and the solvent was removed in vacuo, 
this gave the two alcohols 90 and 91 as a white solid (112 mg). The mass spectrum indicates 
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that the major product is alcohol 90 that has been deprotected in the 3-position; 90 8H (250 
MHz, CDC13) 1.31, 1.53 (6H, 2 x s, C(CH3)2, 3.15-3.53 (2H, m, 6a-H, 6b-H), 4.13 (1 H, d, 4-
H), 4.37-4.43 (2H, m, 8a-H, 8b-H), 4.65 (1H, d, 2-H), 4.72-5.01 (1H, m, 5-H), 5.52 (1H, d, 
3-H), 5.97 (1H, d, 1-H), 6.10 (IH, broad s, 8-OH), 7.00 (1H, broad s, 8-OF!); J(x-y)/Hz 1-2 
3.71, 2-3 nd, 3-4 nd, 4-5 nd, 5-6a nd, 5-6b nd, 6a-6b nd, 8a-8b nd; m/z (FAB) 260 and 364; 
diagnostic peaks for 91 8H(2SO  MHz, CDC13) 3.75-3.80 (2H, m, 6a-H, 6b-H), 4.07 (IH, d, 4-
H), 7.41-8.03 (5 x CHPh). 
3.5.2 	Substitution Reactions" 
3.5.2.1 5-(1 ,2-O-isopropylidene-a-D-xylo-furanos-4-yI)-3-methoxy-2-isoxazoline (92) 
Lab. Book Ref. KG 56-1 	 N0 
Molecular Formula C12H17N06 	 MeO ?°")'O 
Formula Weight 259 	
HO 	"10-17  
Isoxazoline 81 (R:S 87:13) (150 mg, 0.36 mmol) was dissolved in lithium 
methoxide/methanol solution (31 mg lithium dissolved in 15 ml dry methanol). The reaction 
mixture was heated at reflux until no starting material remained and was then allowed to stir 
for a further 30 mm. The mixture was poured into ice-cold water (50 ml) and the product 
was extracted into ether (3 x 50 ml). The combined organics were dried (MgSO4) and the 
solvent was removed in vacuo to leave the title compound as an oil containing only the R-
isomer (63 mg, 66%, total; 72%, based on R-isomer content of starting material); [aID2' - 
73.6 (c = 0.63, CHC13); Rf 0.42 (Et20); 5H  (250 MHz, CDC13) 1,34, 1.52 (6H, 2 x s, 
C(CH3)2), 3.05 (IF!, d, OH), 3.09 (1H, dd, 6b-H), 3.18 (IH, dd, 6a-H), 3.88 (31-1, s, CH3), 
4.23 (1H, dd, 4-H), 4.39 (1H, dd, 3-H), 4.57 (1H, d, 2-H), 4.91 (1H, ddd, 5-H), 5.96 (1H, d, 
1-H); J(x-y)/Hz 1-2 3.6, 2-3 nd, 3-4 2.8, 3-OH 4.2, 4-5 11.1, 5-6a 9.8, 5-6b 7.7, 6a-6b 16.7; 
5c (63 MHz, CDC13) 26.6, 27.2 (C(CH3)2), 36.6 (C-6), 57.9 (OCH3), 74.8, 78.5, 81.4, 85.8 
(C-2, C-3, C-4, C-5), 105.6 (c-i), 112.3 (C(CH3)2), 168.8 (C-7); m/z(FAB) Found: M+l 





N—O 	 N—O 
Lab. Book Ref. KG 59-1, 59-2 MeO 	 0Me MeO 	 0Me 
Molecular Formula C12H19N06 	
\ \  
Formula Weight 273 	 0 x0 
Isoxazoline 84 (R:S 79:21) (152 mg, 0.47 mmol) was dissolved in lithium 
methoxide/methanol solution (23 mg lithium dissolved in 10 ml dry methanol). The reaction 
mixture was heated at reflux until no starting material remained and was then allowed to stir 
for a further 30 mm. The mixture was poured into ice-cold water (50 ml) and the product 
was extracted into ether (3 x 50 ml). The combined organics were dried (MgSO4) and the 
solvent was removed in vacuo to leave the title compound as an oil containing a mixture of 
the two isomers isomer (101 mg, 78%). The two isomers were partially separated using 
column chromatography (silica, 0 -> 100% ether in h exane; gradient elution); 93a (82 mg, 
63%, total; 80%, based on R -isomer content in starting material); [am21 +28.6 (c = 0.52, 
CHC13); Rf  0.54 (Et20); 8H(2SO  MHz, CDC13) 1.32, 1.46 (6H, 2 x s, C(CH3)2), 3.04 (1H, dd, 
6b-H), 3.15 (1H, dd, 6a-H), 3.35 (3H, s, C-1-OCH3), 3.88 (3H, s, C-7-OCH3), 4.13 (1H, dd, 
4-H), 4.58 (IH, d, 2-H), 4.78 (1H, dd, 3-H), 4.90 (1H, s, I-H), 4.94 (IH, ddd, 5-H); J(x- 
y)/Hz 1-2 	2-3 5.9, 3-4 3.7, 4-5 5.5, 5-6a 8.1, 5-6b 10.1. 6a-6b 16.7; 8c(63  MHz,  CDC13) 
24.8, 26.2 (C(CH3)2), 35.2 (C-6), 55.2 (C-1-OCH3), 57.7 (C-7-OCH3), 79.2, 79.6, 79.7, 85.2 
(C-2, C-3, C-4, C-5), 107.6 (C-l), 113.1 (C(CH3)2), 168.5 (C-7); 93b (19 mg, 15%, total; 
70%, S-isomer); [aID 2' +65.3 (c = 0.92, CHC13); Rf  0.47 (Et20); 8H (250 MHz, CDC13) 1.26, 
1.41 (6H, 2 x s, C(CH3)2), 2.76 (1H, dd, 6b-H), 3.15 (IH, dd, 6a-H), 3.3 (3H, s, C-1-OCH3), 
3.84 (3H, s, C-7-OCH3), 4.08 (lH, dd, 4-H), 4.54 (1H, d, 2-H), 4.68 (1H, dd, 3-H), 4.83 (1H, 
ddd, 5-H), 4.95 (1H, s, 1-H); J(x-y)/Hz 1-2 —0, 2-3 5.9, 3-4 3.8, 4-5 8.5, 5-6a 10.0, 5-6b 8.7, 
6a-6b 16.6; öc (63 MHz, CDC13) 24.6, 25.8 (C(CH3)2), 35.1 (C-6), 54.7 (C-1-0CH3), 57.2 
(C-7-OCH3), 79.6, 80.4, 81.0, 84.7 (C-2, C-3, C-4, C-5), 107.4 (C- 1), 112.8 (C(CH3)2), 167.5 
(C-7); m/z(FAB) Found: M+1 274.1291. C12H20N06 requires M+i 457.1281. 
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3.5.3 	Ring Opening Reactions 
3.5.3.1 Attempted Ring Opening of 5-(3-O-Benzoyl-1,2-O-isopropylidene-a-D-xylo-
furanos-4-yl)-3-carbethoxy-2-isoxazoline (82) 0 
Lab Book Ref. KG 101 
Molybdenum hexacarbonyl (30 mg, 0.11 mmol) was added to a solution of isoxazoline 82 
(101 mg, 0.25 mmol) in acetonitrile (15 ml) containing 5 drops of water. The resulting 
suspension was heated to reflux with stirring, after 1 h an additional portion of MO(CO)6  (15 
mg, 0.06 mmol) was added and heating continued for 3 h. Column chromatography yielded 
the starting material quantitatively and no product was observed. 
3.5.3.2 Attempted Ring Opening of 5-(3-O-Benzoyl-1 ,2-O-isopropylidene-a-D-xylo-
furanos-4-yl)-3-phenyl-2-isoxazoline (83)17 
Lab Book Ref KG 100 
Isoxazoline 83 (100 mg, 0.25 mmol) and boric acid (15 mg, 6 eq.) were dissolved in 
methanol:water (6 ml, 5:1), to this six spatula tips of Raney nickel catalyst were added. The 
reaction mixture was degassed three times and was left to stir under an atmosphere of 
hydrogen for 24 h. The mixture was filtered through a celite pad and the solvent removed in 
vacuo. The resulting oil was co-evaporated with methanol to remove the residual boric acid, 
this yielded a white solid (6 mg, 6%) that was identified as the staring material and an 
unidentified brown oil (4 mg). 
3.6 	Synthesis of Exoglycals 
3.6.1 	Synthesis of 2,6-Anhydro-3,4,5-tri-O-acetal-1-deoxy-D-xylo-hex-1-enitol (62) 97 
3.6.1.1 	2,6-Anhydro-3,4,5-tri-O-acetyl--D-xylopyranosylnjtriIe (107)105 
0 
Lab. Book Ref. KG 55 	
N 
Molecular Formula C12H15N07 	 AcO"*( 	c 
Formula Weight 285 	 OAc 
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Acetylated nitromethyl xylose 70 (150 mg, 0.47 mmol) was dissolved in pyridine (3 ml) and 
cooled in an ice bath. To this Pc13 (1.1 eq, 0.05 ml, 0.52 mmol) was added and the mixture 
was stirred overnight at room temperature. Ice-cold 1M HC1 (20 ml) was added to the 
solution and was stirred for 20 mm. The product was extracted into chloroform (3 x 10 ml); 
the combined organics were washed with sat. NaHCO3 (2 x 10 ml) and water (10 ml). The 
organic layer was dried (MgSO4) and the solvent was removed in vacuo, to give the title 
compound as a white solid (113 mg, 84%); mp 128-129°C (lit. °5 131-1320C); [a]D18 —36.7 (c 
= 0.90, CHC13); Rf 0.54 (Et20); 6H  (250 MHz, CDC13) 2.03, 2.06, 2.07 (9H, 3 x s, CH3), 3.56 
(111, dd, 6b-H), 4.18 (111, dd, 6a-H), 4.46 (1H, d, 2-H), 4.83-4.90 (IH, in, 5-H), 5.04-5.07 
(2H, in, 3-H, 4-H); J(x-y)/Hz 2-3 6.9, 3-4 nd, 4-5 nd, 5-6a 4.0, 5-6b 6.8, 6a-6b 12.4; 5c (63 
MHz, CDC13) 20.3, 20.5 (COCH3), 65.1 (C-6), 65.3, 66.8, 67.6, 68.7 (C-2, C-3, C-4, C-5), 
114.3 (C-i), 168.8, 169.2, 169.4 (3 x COCH3). m/z(FAB) Found: M+1 286.0921. 
C12H16N07 requires M+i 286.0927. 
3.6.1.2 	2,6-Anydro-3,4,5-tri-O-acetyl-f-D-xylose tosylhydrazone (108)", 108 
Lab. Book Ref. KG 67 C r 
o_N—N 
Molecular Formula C19H24N209S Ts 
Formula Weight 456 	 AcO"  
OAc 
Raney nickel (1.5 g, from an aqueous suspension, Sigma) was added, at room temperature, to 
a vigorously stirred solution of pyridine (5.7 ml), acetic acid (3.4 ml) and water (3.4 ml). 
Then sodium hypophosphate (740 mg, 8.40 mmol), tosylhydrazine (320 mg, 1.70 mmol) and 
the acetylated xylose nitrile 107 (303 mg, 1.06 mmol) were added to the mixture that was 
left to stir overnight. The insoluble materials were filtered through a celite pad, which was 
washed with DCM (10 ml). The organic layer of the filtrate was separated, washed 
sequentially with water (3 ml), 10% HC1 (2 x 3 ml), cold saturated sodium hydrogen 
carbonate (2 x 3 ml), water (3 ml) and then dried (MgSO4). The solution was concentrated 
and the traces of pyridine were removed by repeated co-evaporations with toluene. The 
residue was purified by column chromatography (silica, 0—*100% ether in hexane; gradient 
elution), to give the title compound as a white solid (416 mg, 86%); Rf 0.33 (Et20); 8H  (250 
MHz, CDC13) 1.71, 2.00, 2.38 (9H, 3 x s, COCH3), 2.00 (CH3), 3.27 (1H, t, 6b-H), 3.86 (IH, 
dd, 2-H), 4.07 (1H, dd, 6a-H), 4.87 (1H, t, 3-H), 4.87-4.99 (1H, in, 5-H), 5.21 (1H, t, 4-H), 
6.94 (lH, d, 1-H), 7.27-7.79 (4H, m, Ph), 8.90 (1H, s, NH); J(x-y)/Hz 1-2 6.4, 2-3 9.7, 3-4 
9.6, 4-5 9.5, 5-6a 5.6, 5-6b 10.9, 6a-6b 11.1 öc  (63 MHz, CDC13) 20.4, 20.5, 21.4 (3 x 
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COCH3), 20.5 (CH3), 65.7 (C-6), 68.8, 69.5, 72.4 (C-3, C-4, C-5), 78.0 (C-2), 127.8, 129.5, 
135.1 (5 x CHPh), 144.0 (C-i), 144.1 (qCPh), 169.8, 170.0, 170.5 (3 x COCH3); m/z(FAB) 
Found: M+i 457.1286. C19H25N209S requires M+1 457.1281. 
3.6.1.3 3,4,5-Tri-O-acetyl-2,6-anhydro-1-deoxy-D-xylo-hex-1 -enitol (62) 108 
Lab. Book Ref. KG 116 	
0 
Molecular Formula C12H1607 	 AcO" 	"OAc 
Formula Weight 272 	 OAc 
Sodium hydride (76 mg, 3.2 mmol) was added to dry 1,4-dioxane (10 ml). The stirred 
suspension was heated at reflux and had 2,6-anhydro-3,4,5-0-acetyl-f3-D-xylose 
tosylhydrazone (108) (125 mg, 0.27 mmol) in dry 1,4-dioxane (25 ml) added in a dropwise 
fashion. When the reaction was complete (tic) the mixture was cooled and the insoluble 
materials were filtered off. The solvent was removed in vacuo and the residue was purified 
by column chromatography (silica, 0->100% ether in hexane; gradient elution) to give the 
title compound as a white solid (161 mg, 5 1%); Rf 0.64 (Et20); oH (250 MHz, CDC13) 2.29, 
2.34 (9H, 3 x s, COCH3), 3.80 (1 H, dd, 6b-H), 4.42 (1H, dd, 6a-H), 4.71 (1H, dd, la-H), 4.97 
(lH, dd, lb-H), 5.30 (1H, ddd, 5-H), 5.35 (1H, t, 4-H), 5.62 (1H, d, 3-H); J(x-y)/Hz la-lb 
1.5, la-3 0.8, lb-3 0.5, 3-4 7.7, 4-5 7.6, 5-6a 4.7, 5-6b 8.2. 6a-6b 11.2; 8c (63 MHz, CDC13) 
21.2 (3 x COCH3), 67.4 (C-6), 69.2, 72.6 (C-3, C-4, C-5), 99.4 (C-i), 154.0 (C-2), 169.7, 
170.2 (3 x COCH3); m/z(FAB) Found: M+l 273.0970. C12H1707 requires M+l 273.0974. 
3.6.2 	Synthesis of 2,6-Anhydro-3,4,5,7-tetra-O-benzyl-1-deoxy-D-gluco-hept-1 - 
enitol (59) 
3.6.2.1 	Methyl 2,3,4,6-tetra-0-benzyl-cx-D-glucopyranoside (112)158 
Lab. Book Ref. KG 169 	 BnO 	
\\0Me  
Cod." OBn Molecular Formula C35H3806 	 BnO"  
Formula Weight 554 	 OBn 
To a cooled suspension (5°C) of NaH (60% w/w, 12.36 g, 0.3 mol) in anhydrous DMF (80 
ml) was added a solution of methyl a-D-glucopyranoside (10 g, 0.05 mol) in DMF (lOOmI) 
from a dropping funnel over 30 mm. and the mixture stirred for 1 h while warming to room 
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temperature. After recooling to 5°C, benzyl bromide (37 ml, 0.31 mmol) was added in three 
portions via a syringe and the reaction stirred for 20 h. After cautiously quenching the excess 
Na}-I with methanol (60 ml) the reaction mixture was partitioned between toluene (200 ml) 
and water (200 ml) and the aqueous phase was further extracted with toluene (2 x 100 ml). 
The organic parts were washed with water (150 ml), brine (150 ml), dried (MgSO4) and the 
solvent was removed in vacuo. Addition of triethylamine (20 ml) to the crude oil followed 
by stirring for one hour at room temperature converted excess benzyl bromide into benzyl 
triethylammonium bromide, which was removed b y addition o f ether (200 ml) and water 
(150 ml). The organic phase was washed with brine (150 ml), dried (MgSO4) and the solvent 
was removed in vacuo to leave a pale yellow oil, which was taken through to the next stage 
without further purification. However, if purification was required then this would be 
achieved by column chromatography (silica, 19:1 -* 1:1 ethyl acetate in petroleum ether, 
gradient elution) to give the title compound as a colourless oil (27.14 g, 87%); [a]D'8 +19.7 
(c = 1.0, CHC13) Pit- 109 +18.7 (c = 1.5, CHC13)]; Rf 0.69 (petroleum ether:ethyl acetate, 1:1); 
81, (250 MHz, CDC13) 3.39 (3H, s, OMe), 3.60 (1H, d, 2-H), 3.62-3.74 (4H, m, 4-H, 5-H, 6a-
H, 6b-H), 4.00 (1H, t, 3-H), 4.64 (1H, d, 1-H), 4.46-5.28 (8H, m, CH2Ph), 7.30-7.39 (20H, 
m, Ph); J(x-y)IHz 1-2 3.6, 2-3 9.1, 3-4 9.1, 4-5 nd, 5-6a nd, 5-6b nd, 6a-6b nd; 6c(63  MHz, 
CDCI3) 55.0 (OMe) 68.3 (C-6), 69.3, 77.5, 79.7, 82.0 (C-2, C-3, C-4, C-5), 73.2, 73.3, 75.0, 
75.6(4 x CH2Ph), 98.1 (C-i), 127.4-128.3 (20 x CHPh), 137.8, 138.0, 138.1, 138.6(4 x 
qCPh). 
3.6.2.2 2,3,4,6-Tetra-0-benzyl-a-D-glucopyranose (113)159 
Lab. Book Ref. KG 174 
Molecular Formula C34H3606 	 BnO 	J 	i' OH 
Formula Weight 540 	 BnO""OBn 
OBn 
To a solution of the glycoside 112 (8.07 g, 14.6 mmol) in glacial acetic acid (lOOml) was 
added 2M aq. sulphuric acid (50 ml, 100 mmol) and the mixture stirred at 90°C for 18 h. 
After cooling to room temperature, the acetic acid was removed in vacuo and DCM (100 ml) 
added and the organic layer was washed with saturated aq. sodium bicarbonate (50 ml) and 
brine (50 ml). The solvent was removed under reduced pressure to give the crude product as 
a white solid that was recrystallised from methanol to afford the title compound as fine 
colourless needles (2.79 g, 35%); mp 150°C (lit."0 151-152°C); [a]D'8 +20.8 (c = 0.96, 
CHC13) Pit- 110 +22 (c = 1, CHC13)]; Rf 0.51 (petroleum ether:ethyl acetate, 1:1); o (250 
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MHz, CDC13) 3.86-4.00 (5H, m, 2-H, 4-H, 5-H, 6a-H, 6b-H), 4.31 (1H, t, 3-H), 5.02-5.29 
(8H, m, CH2Ph), 5.53 (1H, d, 1-H), 7.54-7.64 (20H, m, Ph); J(x-y)/Hz 1-2 3.5, 2-3 9.3, 3-4 
9.3, 4-5 nd, 5-6a nd, 5-6b nd, 6a-6b nd; 5C(63  MHz, CDC13) 67.9 (P C-6), 69.5, 77.1, 79.3, 
81.1 (a C-2, a C-3, a C-4, a C-5), 72.5, 72.8, 74.3, 75.1 (4 x a & 3 CH2Ph), 73.9, 77. 1, 
82.4, 83.9 (3 C-2, P C-3, 3 C-4, P C-5), 90.6 (a C-i), 96.8 (0 C-i), 127.0-127.8 (20 x 
CHPh), i37.1-138.0 (4 x qCPh). 
3.6.2.3 	2,3,4,6-Tetra-0-benzyl-D-glucono-1 ,5-lactone (1 14)36 
Lab. Book Ref. KG 176 	 BnO0 0 
Molecular Formula C34H3406 	
B"OBn 
Formula Weight 538 	 OBn 
A solution of the lactol 113 (3.00 g, 5.6 mmol) in a mixture of acetic anhydride (10 ml) and 
dimethyl sulphoxide (15 ml) was stirred at room temperature for 24 h, quenched with water 
(70 ml), stirred for a further 15 mm. and extracted with DCM (3 x 30 ml). The organic phase 
was washed with saturated aq. NaHCO3 (30 ml), dried (MgSO4) and purified by column 
chromatography (elution with light petroleum:ethyl acetate, 1:1) to give the title compound 
as a yellow oil (2.27 g, 76%); [aID '8 +40.2 (c = 0.82, CHC13) [lit." +79 (c = 1, CHC13)]; Rf  
0.67 (petroleum ether:ethyl acetate, 1:1); 6  (250 MHz, CDC13) 3.78-3.91 (2H, m, 6a-H, 6b-
H), 4.05-4.15 (2H, m, 3-H, 4H), 4.24-4.32 (1H, m, 2-H), 4.59-4.92 (8H, m, 5-H & CH2Ph), 
5.16 (1H, d, CH2Ph), 7.37-7.59 (20H, m, Ph); J(x-y)/Hz 2-3 nd, 3-4 nd, 4-5 nd, 5-6a nd, 5-6b 
nd, 6a-6b nd; 8c(63  MHz, CDC13) 68.1 (C-6), 73.4, 73.6, 73.8 (4 x CH2Ph), 75.9, 77.2, 78.0, 
80.8 (C-2, C-3, C-4, C-5), 127.7, 127.8, 127.9, 128.3 (20 x CHPh), 136.8, 137.4, 137.4 (4 x 
qCPh), 169.2 (C-i); m/z(FAB) Found: M+i 539.2425. C34H3506 requires M+1 539.2434. 
3.6.2.4 2,6-Anhydro-3,4,5,7-tetra-O-benzyl-1-deoxy-D-gluco-hept-1-enitol (59)95(1 
Lab. Book Ref. KG 195 	
BnO0 
Molecular Formula C35H3605 	
BnO" 	"OBn 
Formula Weight 536 	 OBn 
A solution containing the lactone 114 (2.0 g, 3.8 mmol) and dimethyl titanocene (115) (2 eq, 
1.52 g, 7.3 mmol) in toluene (50 ml) was stirred at 70°C in the dark for 24 h. After cooling, 
the solvent was removed in vacuo and the residue was chromatographed (silica, 9:1—*4:1, 
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ethyl acetate in hexane with 1% NEW to give a yellow solid. Recrystallisation from hexane 
gave the title compound as fine, white needles (1.22 g, 61%); mp 65°C (lit.95d  65-680C); 
[a]018 +48.7 (c = 0.78, CHC13) [lit.95 '+58.4 (c = 1.5, DCM)]; Rf 0.20 (petroleum ether:ethyl 
acetate, 4:1); 8H  (250 MHz, CDC13) 3.94-4.08 (5H, m, 4-H, 5-H, 6-H, 7a-H, 7b-H), 4.26 (1H, 
broad, 3-H), 4.80-5.20 (10H, m, CH2Ph, la-H, 1-H), 7.56-7.67 (20H, m, Ph); J(x-y)/Hz 3-4 
7.1, 4-5 nd, 5-6, nd, 6-7a nd, 6-7b nd, 7a-7b nd; 8c(63  MHz, CDC13) 68.0 (C-7), 72.1, 72.8, 
73.8, 73.82 (4 x CH2Ph), 76.9, 77.9, 78.3, 84.0 (C-3, C-4, C-5, C-6), 94.1 (C-i), 127.0, 
127.1, 127.2, 127.7, 127.8 (20 x CHPh), 137.2, 137.3, 137.4, 137.7 (4 x qCPh), 155.7 (C-2); 
m/z(FAB) Found: M+i 537.2631. C35H3705 requires M+l 537.2641. 
3.6.3 	Synthesis of 2,6-Anhydro-3,4,5,7-tetra-O-benzyl-1-deoxy-D-galacto-hept-1- 
enitol (65) 
3.6.3.1 	Methyl 2,3,4,6-tetra-0-benzyl-D-galactopyranoside (117)' 12,160 
Lab. Book Ref. KG 246 	 BnO 	
0 OMe 
Molecular Formula C35H3806 	
BnO 	
TOBn 
Formula Weight 554 	 OBn 
D-Galactose (6.00 g, 33.3 mmol) was dissolved in a 1% solution of hydrogen chloride in dry 
methanol [formed by the careful addition of acetyl chloride (0.68 ml) to dry methanol (40 
ml)]. The solution was heated, under nitrogen, at reflux for 7 h then cooled rapidly in a 
water-bath and stored at 0 °C overnight. The crystals produced were then filtered, washed 
rapidly with cold methanol (3 x 50 ml) and dried in vacuo. The combined filtrate and 
washings were refluxed for 3.5 h, and the methanol was removed in vacuo till -13 ml 
remained and the residue was treated as above to afford a second crop of crystals that were 
taken on to the next stage. 
The solid produced above was dissolved in DMF (100 ml), this was added to sodium hydride 
(12.39 g, 309 mmol) in DMF (80 ml). The mixture was cooled and benzyl bromide (37 ml, 
312 mmol) was added. Work up was identical to that for the glucose analogue 112 and 
resulted in the title compound as a brown oil (14.37 g, 78% over two steps); [a]D18 +11.2 (c 
0.98, CHCI3); Rf 0.67 (petroleum ether:ethyl acetate, 1:1); 6(250 MHz, CDC13) 3.40 (3H, s, 
OMe), 3.60-3.76 (5H, m, 2-H, 4-H, 5-H, 6a-H, 6b-H), 4.12 (1H, t, 3-H), 4.46-4.87 (9H, m, 1-
H, CH2Ph), 7.27-7.36 (20H, m, Ph); J(x-y)/Hz 1-2 nd, 2-3 9.2, 3-4 9.2, 4-5 nd, 5-6a nd, 5-6b 
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nd, 6a-6b nd; 6c(63 MHz, CDC13) 54.47 (a OMe), 56.41 (13 OMe), 59.69 (a 6C), 67.76 (13 
6C), 69.34, 74.13, 76.94, 77.15, 79.12, 81.43, 81.61, 93.94, (a & f3 CH, 2C, 3C, 4C, 5C), 
68.19, 72.78, 74.06, 74.14, 74.33, 75.07 (4 x a & 13 CH2Ph), 97.51 (a 1C), 104.01 (f3 1C), 
126.90-127.75 (20 x CHPh), 137.21-138.10 (4 x qCPh). 
3.6.3.2 	2,3,4,6-Tetra-0-benzyl-D-galactopyranose (118) 160a 
Lab. Book Ref, KG 255 
	 BnO 	
0 OH 
Molecular FormulaC34H3606 	 B'OBn 
Formula Weight 540 	
OBn 
Employing an identical method to that used for the glucose analogue 113, the title compound 
was produced by dissolving methyl 2,3,4,6-tetra-0-benzyl-a-D-galactopyranoside (117) 
(7.98 g, 14.4 mmol) in glacial acetic acid (100 ml) and 2M sulphuric acid (50 ml). The 
reaction mixture was then heated overnight at 90°C to yield on work up the desired product 
as a white solid (3.39 g, 44%); mp 147-148°C; [a]D18 +17.3 (c = 1.04, CHCI3) Pit-' 60b +13.1 
(c = 1.6 CHC13)]; Rf 0.53 (major) 0,68 (minor) (petroleum ether:ethyl acetate, 1:1); 5H  (250 
MHz, CDC13) 3.35-3.64 (5H, m, 2-H, 3-H, 5-H, 6a-H, 6b-H), 4.00 (1H, t, 4-H), 4.41-4.96 
(9H, m, CH2Ph, 1-H), 7.23-7.32 (20H, m, Ph); J(x-y)/Hz 1-2 nd, 2-3 nd, 3-4 9.1, 4-5 9.1, 5-
6a nd, 5-6b nd, 6a-6b nd; 8c (63 MHz, CDC13) 67.9 (a C-6), 68.2 (13 C-6), 72.4, 72.7, 74.0, 
74.3, 75.0 (4 x (x & 13 CH2Ph), 69.4, 73.8, 77.1, 79.3, 81.0, 82.4, 83.9 (a & 13  C-2, C-3, C-4, 
C-5), 90.5 (a C-i), 96.8 (PC-1), 126.9-127.8 (20 x CHPh), 137.0-138.0 (4 x qCPh). 
3.6.3.3 2,3,4,6-Tetra-0-benzyl-D-galacto-1 ,5-lactone (119)36 
Lab. Book Ref. KG 258 	 BnO0 0 
Molecular Formula C34H3406 	
B'OBn 
Formula Weight 538 	 OBn 
The title compound was produced using the same oxidation method to that employed for the 
glucose analogue 114; 2,3,4,6-tetra-0-benzyl-a-D-galactopyranose (118) (3.00 g, 5.6 mmol) 
was dissolved in a mixture of acetic anhydride (10 ml) and DMSO (15 ml) this was stirred 
overnight to afford the product as a yellow oil on work up (2.90 g, 97%); [a]D'8 +47.0 (c = 
1.68, CHC13) [lit.  160c +75.2 (CHC13)]; Rf 0.72 (petroleum ether:ethyl acetate, 1:1); oH (250 
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MHz, CDC13) 3.82-3.85, 4.05-4.11 (5H, 2 x m, 3-H, 4-H, 5-H, 6a-H, 6b-H), 4.27 (1H, d, J2,3  
6.7, 2-H), 4.57-4,76 (8H, m, CH2Ph), 7.34-7.52 (20H, m, Ph); J(x-y)IHz 2-3 6.7, 3-4 nd, 4-5 
nd, 5-6a nd, 5-6b nd, 6a-6b nd; ö (63 MHz, CDC13) 67.9 (6C), 72.6, 73.0, 73.4, 73.6 (4 x 
CH2Ph), 75.5, 76.7, 78.0, 80.7 (C-2, C-3, C-4, C-5), 127.7-128.3 (20 x CHPh), 136.7-138.4 
(4 x qCPh), 169.2 (1C). Vj,,ax (film) 3088, 3063, 3032, 2981, 2913, 2870, 1755 and 1241 cm 
3.6.3.4 2,6-Anhydro-3,4,5,7-tetra-O-benzyl-1-deoxy-D-galacto-hept-1 -enitol (65)161 
Lab. Book Ref, KG 264 	 BnO0 
Molecular formula C35H3605 	 BnO 	"OBn 
Formula Weight 536 	 OBn 
The title compound was produced using the same olefination method as that employed for 
the glucose analogue 59; 2,3,4,6-tetra-0-benzyl-D-galacto-1,5-lactone (119) (2.02 g, 3.8 
mmol,) was refluxed in toluene (50 ml) with dimethyl titanocene (115) (1.6 g, 7.7 mmol) to 
give the title compound as a brown oil (802 mg, 40%); [aID'8 +50.0 (c = 0.44, CHC13); Rf  
0.39 (petroleum ether:ethyl acetate, 4:1); 5H (250 MHz, CDC13) 3.96-4.02 (5H, m, 4-H, 5-H, 
6-H, 7a-H, 7b-H), 4.21 (1H, d, .134 7.1, 3-H), 4.74-5.15 (1 OH, m, CH2Ph, la-H, lb-H), 7.51-
7.61 (20H, m, Ph); J(x-y)/Hz 3-4 7.1, 4-5 nd, 5-6 nd, 6-7a nd, 6-7b nd, 7a-7b nd; 6c  (63 
MHz, CDC13) 68.0 (C-7), 72.1, 72.9, 73.8 x 2 (4 x CH2Ph), 76.8, 77.9, 78.2, 84.0 (C-3, C-4, 
C-5, C-6), 94.1 (C-I), 127.0-127.8 (20 x CHPh), 137.2, 137.3, 137.6, 137.6 (4 x qCPh), 
155.6 (C-2); m/z(FAB) Found: M+1 537.2654. C35H3705 requires M+1 537.2641. 
3.6.4 	Synthesis of 2,6-Anhydro-3,4,5-tri-O-benzyl-1-deoxy-L-arabino-hex-1-enitol 
(64) 
3.6.4.1 	Methyl 2,3,4-tri-0-benzyl-L-arabinopyranoside (121)' 12,162 
Lab. Book Ref. KG 243 
o OMe 
Molecular Formula C27H3005 	
[ 	( 
Formula Weight 434 	 BnO'("OBn 
OBn 
L-arabinose (5.00 g, 33.3 mmol) was dissolved in a 1% solution of hydrogen chloride in dry 
methanol [formed by the careful addition of acetyl chloride (0.68 ml) to dry methanol (40 
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ml)]. The solution was heated at reflux for 7 h under nitrogen, then cooled rapidly in a water-
bath and stored at 0°C overnight. The crystals produced were then filtered, washed rapidly 
with cold methanol (3 x 50 ml) and dried in vacuo. The combined filtrate and washings were 
boiled under reflux for 3.5 h, and the methanol was removed in vacuo till -13 ml remained 
and the residue was treated as above to give a second crop of crystals that were taken on to 
the next stage without further purification. 
The title compound was prepared using the same benzylation method as that employed for 
the glucose analogue 112; methyl L-arabinopyranoside (120) (7.71 g, 47 mmol) was 
dissolved in 100 ml DMF, to which was added sodium hydride (12.16 g, 0.30 mol) in DMF 
(80 ml). This mixture was cooled and benzyl bromide (37 ml, 312 mmol) was added, work 
up afforded the title compound as a brown oil (19.92 g, 68% over two steps); [a]D'8 +41.5 (c 
= 2.00, CHCI3); Rf 0.57 (petroleum ether:ethyl acetate, 1:1); 5H  (250 MHz, CDC13) 3.60 (3H, 
s, OMe), 3.83-3.97 (3H, in, 2-H, 3-H, 4-H), 4.10 (1H, dd, 5a-H), 4.24 (IH, dd, 5Hb), 4.84-
5.03 (9H, m, i-H, CH2Ph), 7.52-7.58 (15H, in, Ph); J(x-y)/Hz 1-2 nd, 2-3 nd, 3-4 nd, 4-5a 
3.4, 4-5b 2.1, 5a-5b 10.2; 6c(63 MHz, CDC13) 55.3 (OMe), 60.0 (C-5), 71.6, 72.6, 73.5 (3 x 
CH2Ph), 73.9, 76.2, 77.1 (C-2, C-3, C-4), 99.2 (C-I), 127.3-128.2 (15 x CHPh), 138.2, 
138.5, 138.6 (3 x qCPh). 
3.6.4.2 2,3,4-Tri-O-benzyl-L-arabinopyranose (122)163 
Lab. Book Reff, KG 248 
	
O OH 
Molecular Formula C26H2805 	
BnO 	1110 B 
Formula Weight 420 	 OBn 
Duplicating the method used for the glucose analogue 113, the title compound was produced 
by dissolving methyl 2,3,4-tri-O-benzyl-L-arabinopyranoside (121) (6.27 g, 14.4 mmol) in 
glacial acetic acid (100 ml) and 2M sulphuric acid (50 ml). The reaction mixture was then 
heated overnight at 90°C to yield, on work up, the desired product as a white solid (6.07 g, 
52%) mp 65°C (lit.95d  69-700C); [a]n' 8 +34.6 (c = 0.78, CHC13) [lit.  161 +36.6 (c = 1.83 
CHC13)]; Rf 0.51 (petroleum ether:EtOAc, 1:1); 8H  (250 MHz, CDC13) 3.93-4.30 (5H, m, 2-
H, 3-H, 4-H, 5a-H, 5b-H), 4.82-5.10 (7H, in, 1-H, CH2Ph), 7.58-7.66 (15H, m, Ph); J(x-
y)/Hz 1-2 nd, 2-3, nd, 3-4 nd, 4-5a nd, 4-5b nd, 5a-5b nd; ö (63 MHz, CDC13)  58.4 (c C-5), 
60.7 (f3 C-5), 71.4, 72.5, 73.4 (3 x a & fI CH2Ph), 71.9, 75.4, 77.4 (a & f3 C-2, C-3, C-4), 
91.9 (a C-i), 93.8 (f3 C-i), 127.5-128.3 (15 x CHPh), 137.3-138.2 (3 x qCPh). 
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3.6.4.3 	2,3,4-Tri-O-benzyl-L-arabino-1 ,5-lactone (123)164 
Lab. Book Ref. KG 253 
Molecular Formula C26H2605 
	 BnO 	"OBn 
Formula Weight 418 
	 OBn 
The title compound was produced using the same oxidation method as that employed for the 
glucose analogue 114; 2,3,4-tri-O-benzyl-L-arabinopyranose (122) (2.34 g, 5.6 mmol) was 
dissolved in a mixture of acetic anhydride (10 ml) and DMSO (15 ml) this was stirred 
overnight. Work up gave the product as a yellow oil (2.24 g, 96%); [a]n18 +38.7 (c = 1.06, 
CHCI3); Rf 0.68 (petroleum ether:ethyl acetate, 1:1); oH (250 MHz, CDC13) 4.14-4.44 (5H, 
m, 2-H, 3-H, 4-H, 5a-H, 5b-H), 4.89-5.07 (6H, m, CH2Ph), 7.61-7.69 (15H, m, Ph); J(x-
y)/Hz 2-3 nd, 3-4 nd, 4-5a nd, 4-5b nd, 5a-5b nd; 8c (63 MHz, CDC13) 59.8 (C-5), 70.9, 76.2, 
76.9 (C-2, C-3, C-4), 71.3, 72.0, 74.3 (3 x CH2Ph), 127.0-127.9 (15 x CHPh), 136.6, 137.0, 
137.7 (3 x qCPh), 170.6 (C-i); Vinax (film) 3088, 3063, 3031, 3007, 2981, 2873, 1741 and 
1242 cm'. 
3.6.4.4 2,6-Anhydro-3,4,5-tri-O-benzyl-1-deoxy-L-arabino-hex- 1-enitol (64) 
Lab. Book Ref. KG 267 	 0 
Molecular Formula C27H2804 	
BnO 	"OBn 
Formula Weight 416 	 OBn 
The title compound was produced using the same olefination method as was employed for 
the glucose analogue 59; 2,3,4-tri-O-benzyl-L-arabino-1,5-lactone (123) (1.62 g, 3.9 mmol) 
was refluxed in toluene (50 ml) with dimethyl titanocene (115) (1.6 g, 7.7 mmoi) to yield the 
title compound as a brown oil (0.58 g, 35%); [a]018 +2.9 (c = 0.68, CHC13); Rf 0.41 
(petroleum ether:ethyi acetate, 4:1); °H  (250 MHz, CDC13) 3.99-4.07, 4.25-4.27 (4H, 2 x m, 
4-H, 5-H, 6a-H, 6b-H), 4.33 (1H, d, 3-H), 4.70-5.00 (8H, m, CH2Ph, la-H, lb-H), 7.48-7.59 
(I 5H, m, Ph); J(x-y)/Hz 3-4 6.0, 4-5 nd, 5-6a nd, 5-6b nd, 6a-6b nd; 8c (63 MHz, CDC13) 
66.7 (C-6), 71.2, 71.4, 72.3 (3 x CH2Ph), 72.4, 76.1, 76.7 (C-3, C-4, C-5), 97.8 (C-i), 127.5-
128.2 (15 x CHPh), 137.9, 138.0, 138.3 (3 x qCPh), 155.6 (C-2); m/z(FAB) Found: M+1 
417.2072. C27H2904 requires M+i 417.2066. 
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3.6.5 	Synthesis of 2,6-Anhydro-3,4,5-tri-O-benzyl-1-deoxy-D-xylo-hex-1-enitol (63) 
3.6.5.1 	Methyl 2,3,4-tri-O-benzyl-D-xylopyranoside (125)' 12,165 
0 Lab. Book Ref. KG 244 	 OMe 
Molecular Formula C27H3005 	 BnO" 
Formula Weight 434 	 OBn 
D-xylose (10.01 g, 66.6 mmol) was dissolved in a 1% solution of hydrogen chloride in dry 
methanol [formed by the careful addition of acetyl chloride (0.68 ml) to dry methanol (40 
ml)]. The solution was heated at reflux for 7 h under nitrogen, then cooled rapidly in a water-
bath and stored at 0°C overnight. The reaction mixture was neutralised using silver nitrate 
and filtered through a celite pad. The filtrate was evaporated to dryness to give a crude 
mixture of the methylated sugar as a sticky oil that was taken on to the next stage without 
further purification. 
The title compound was prepared using the same method for the benzylation of a 
monomethylated sugar employed for the glucose analogue 112; methyl D-xylopyranoside 
(124) (9.036 g, 55 mmol) was dissolved in 100 ml DMF, to which was added sodium 
hydride (12.20 g, 305 mmol) in DMF (80 ml). This mixture was cooled and benzyl bromide 
(37 ml, 312 mmol) was added, work up resulted in the title compound as a brown oil (15.01 
g, 52% over two steps); [aID'8 +12.5 (c = 3.36, CHC13) [lit.  161 +8 (c = 1 CHC13)]; R1  0.71 
(petroleum ether:ethyl acetate, 1:1); 8H  (250 MHz, CDC13) 3.56 (3H, s, OMe), 3.84-3.93 (3H, 
m, 2-H, 3-H, 4-H), 4.13-4.20 (2H, m, 5a-H, 5b-H), 4.60-4.79 (7H, m, I-H, CH2Ph), 7.31-
7.50 (15H, m Ph); J(x-y)/Hz 2-3 nd, 3-4 nd, 4-5a nd, 4-5b nd, 5a-5b nd; 6 (63 MHz, CDC13) 
55.1 (aOMe), 55.5 (f3 OMe), 69.2 (aC-5), 69.6 (3 C-5), 71.8, 72.0, 72.4, 73.3, (a & 
CH2Ph), 75.7, 79.93, 81.3, 83.7, 86.7 (a & P C-2, C-3, C-4), 100.3 ((x C-i), 108.0 (P C-i), 
127.4-128.2 (15 x PhCH), 137.4-138.1 (3 x PhC). 
3.6.5.2 2,3,4-Tri-O-benzyl-D-xylopyranose (126)166 
Lab. Book Ref. KG 249 
	
O OH 
Molecular Formula C26H2805 	
BnO" 	"OBn 
Formula Weight 420 	 OBn 
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Employing an identical method to that used for the glucose analogue 113, the title compound 
was produced by dissolving methyl 2,3,4-tri-O-benzyl-a-D-xylopyranoside (125) (6.27 g, 
14.4 mmol) in glacial acetic acid (100 ml) and 2M sulphuric acid (50 ml). The reaction 
mixture was then heated overnight at 90°C to give the desired product, on work up, as a 
white solid (3.58 g, 59%); mp 143-145°C; MD 18 +19.2 (c = 0.94, CHC13) [lit.  163a +18.5 (c = 1 
CHC13)]; Rf 0.63 (petroleum ether:ethyl acetate, 1:1); 8H  (250 MHz, CDC13) 3.42-3.54 (5H, 
m, 2-H, 4-H, 5a-H, 5b-H), 3.9 (1H, t, 3-H), 4.34-4.85 (7H, m, 1-H, CH2Ph), 7.13-7.21 (15H, 
m, Ph); J(x-y)/Hz 1-2 nd, 2-3 9.2, 3-4 9.2, 4-5a nd, 4-5b nd, 5a-5b nd; öc (63 MHz, CDC13) 
67.9 (a C-5), 68.2 (3 C-5), 69.5, 75.0, 77.1, 79.3, 81.1, 82.4 (a & P C-2, C-3, C-4), 72.5, 
72.8, 73.9, 74.03, 74.3 (3 x a & 3 CH2Ph), 90.5 (a C-I), 96.8 (J3 C-i), 126.9-127.8 (15 x 
CHPh), 137.1-138.0 (3 x qCPh). 
3.6.5.3 	2,3,4-Tri-O-benzyl-D-xylo-1 ,5-lactone (127)167 
Lab. Book Ref. KG 254 
Molecular Formula C26H2605 	
BnO" 	"OBn 
Formula Weight 418 	 OBn 
The title compound was produced using an identical oxidation method to that employed for 
the glucose analogue 114; 2,3,4-tri-O-benzyl-a-D-xylopyranose (126) (2.30 g, 5.5 mmol) 
was dissolved in a mixture of acetic anhydride (10 ml) and DMSO (15 ml) that was stirred 
overnight to give, on work up, the product as a yellow oil (1.81 g, 78%); [aID +56.3 (c = 
1.42, CHC13); Rf 0.79 (petroleum ether:ethyl acetate, 1:1); ö,, (250 MHz, CDC13) 3.98-4.02, 
4.19-4.24, 4.39-4.42 (4H, 3 x m, 2-H, 4-H, 5a-H, 5b-H), 4.63 (1H, t, 3-H), 4.76-5.00 (5H, m, 
CH2Ph), 5.27 (1H, t, CH2Ph), 7.58-7.64 (lSH, m, Ph); J(x-y)/Hz 2-3 7.2, 3-4 7.2, 4-5a nd, 4-
5b nd, 5a-5b nd; 8c (63 MHz, CDC13) 60.2 (C-S), 68.0, 72.5, 73.5 (3 x CH2Ph), 75.8, 79.2, 
80.7, (C-2, C-3, C-4), 127.3-128.3 (15 x PhCH), 136.7-137.3 (3 x PhC), 169.2 (C-i); Vmax 
(film) 3088, 3063, 3031, 2916, 2869, 1754 and 1216 cm 1 . 
3.6.5.4 2,6-Anhydro-3,4,5-tri-O-benzyl-1-deoxy-D-xylo-hex-1 -enitol (63) 
Lab. Book Ref. KG 259 
Molecular Formula C27H2804 	 BnO" 	"OBn 
Formula Weight 416 	 OBn 
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The title compound was produced using the same olefination method as that employed for 
the glucose analogue 59; 2,3,4-tri-O-benzyl-D-xylo-1,5-lactone (127) (0.48 g, 1.2 mmol) was 
refluxed in toluene (50 ml) with dimethyl titanocene (115) (0.48 g, 2.30 mmol). Work up 
afforded the title compound as an impure brown oil; Rf 0.49 (petroleum ether:ethyl acetate, 
4:1); 6H (25O MHz, CDC13); 3.96-3.98 & 4.17-4.24 (5H, 2 x in, 3-H, 4-H, 5-H, 6a-H, 6b-H), 
4.37 (lH, broad s, la-H), 4.47 (IH, broad s, lb-H), 4.65-4.86 (8H, in, CH2Ph), 7.45-7.57 
(15H, in, Ph); J(x-y)/Hz 3-4 nd, 4-5 nd, 5-6a nd, 5-6b nd, 6a-6b nd; 8c  (63 MHz, CDCI3) 
66.2 (C-6), 69.9, 71.9, 73.3 (3 x CH2Ph), 79.9, 80.9, 81.8 (C-3, C-4, C-5), 86.4 (C-l), 125.8-
128.8 (15 x CHPh), 137.4-138.1 (3 x qCPh), 159.2 (C-2). 
3.6.6 	Dicyclopentadienyl-dimethyltitanium (Dimethyl Titanocene) (115)168 
Lab. Book Ref. KG 193 
Molecular Formula C,2H 0.1 Me ,6Ti 
Formula Weight 208 	
Me 
In the absence of light a solution ofmethyllithium (30 ml, 48 mmol, 1.6M in ether) was 
carefully added to a cold (10°C) solution of titanocene dichloride (5.04 g, 20.2 mmol) in dry 
ether (100 ml), under nitrogen. After completion of the addition, the mixture was allowed to 
warm to room temperature, stirred for a further 10 mm, and then cooled to 0-5°C, and at this 
temperature ice/water (15 ml) was added dropwise to decompose the excess methyllithium. 
The aqueous phase was extracted with ether (2 x 50 ml), the combined organic layers were 
dried (MgSO4) and the solvent was in vacuo in the dark at 20°C to yield the title complex as 
orange needles (4.06 g, 97%), dec.p. 93-96°C (lit.  166 93-960C). 
3.7 	Cycloaddition Reactions of Exoglycals 
3.7.1 	General Method for Cycloaddition of Nitrile Oxides to Exoglycals'2"3 
The e xoglycal (1 eq.) was dissolved in sodium-dried ether and the n itrile oxide precursor 
(1.1 eq.) was added with stirring. The solution was cooled (ice bath) and triethylamine (1.2 
eq.) in sodium-dried ether was added to the mixture over -16-48 h using a syringe pump. 
The solution was then stirred for a further sixteen hours, after which the triethylamine 
hydrochloride precipitate was removed by filtration to leave the reaction mixture containing 
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the desired product plus unreacted alkene and the furoxan. The product was purified by 
chromatography (silica, 0—* 100% ethyl acetate in petroleum ether; gradient elution). 




Lab. Book Ref. KG 127 	 7OfN 
Molecular Formula C19H21N08 	 I I 01 
Formula Weight 391 	
Ac0 0Ac 
Oft 
Using the general method described above; triethylamine (230 mg, 2.3 mmol) in sodium-
dried ether (50 ml) was added to a solution of 2,6-anhydro-3,4,5-tri-O-acetyl-1-deoxy-D-
xylo-hex-1-enitol (62) (127 mg, 0.53 mmol) and benzohydroximoyl chloride (68) (83 mg, 
0.53 mmol) in sodium-dried ether (50 ml). The mixture afforded, in order of elution, 
unreacted alkene (40 mg, 32%) and the title compound that was isolated as a white solid (95 
mg, 76%, based on consumed 62); mp 127-130°C; MD 19 +32.8 (c = 0.58, CHC13); Rf 0.51 
(Et20); 81-1 (250 MHz, CDC13) 2.17, 2.18 (9H, s, CH3), 3.44 (2H, s, 4-H), 3.99 (1H, dd, 7a-H), 
4.08 (lH, t, 7b-H), 5.20 (lH, ddd, 8-H), 5.48 (1H, d, 10-H), 5.68 (1H, t, 9-H), 7.50-7.78 (5H, 
m, Ph); J(x-y)/Hz 7a-7b 11.2, 7a-8 6.4, 7b-8 10.5, 8-9 9.6, 9-10 10.1; 6c(63  MHz, CDC13) 
20.7, 20.8 (CH3), 43.4 (C-4), 60.3 (C-7), 69.0, 69.5, 71.2 (C-8, C-9, C-b), 107.2 (C-5), 
126.9, 128.9, 130.9 (5 x CHPh), 128.5 (qCPh), 157.8 (C-3), 169.8, 170.1, 170.4 (COCH3); 
m/z(FAB) Found: M+1 392.1347. C19H22N08 requires M+1 392.1345; CaIc. For 
C19H21N08: C, 58.31; H, 5.37; N, 3.58. Found: C, 58.28; H, 5.37; N, 3.41%. 
3.7.3 	(5R,8R,9S,1 OR)-8,9,1 O-Tris(acetoxy)-3-carbethoxy-1,6-dioxa-2- 
azaspiro[4.5]dec-2-ene (130) 
Lab. Book Ref. KG 133 	 6 4 
CO2Et 
\2 
Molecular Formula C16H21N010 	 7 
0 
Formula Weight 387 AcO"8 10"OAc 
OAc 
Using the general method described above; triethylamine (238 mg, 2.35 mmol) in sodium-
dried ether (50 ml) was added to a solution of 2,6-anhydro-3,4,5-tri-O-acetyl-1-deoxy-D-
xylo-hex-1-enitol (62) (161 mg, 0.59 mmol) and ethyl chlorooximidoacetate (67) (102 mg, 
0.67 mmol) in sodium-dried ether (50 ml). Column chromatography gave, in order of 
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elution, recovered a ikene (77 mg, 48%), the title compound, produced as an oil (106 mg, 
94%, based on consumed 62) and diethoxycarbonyl furoxan (35 mg, 23%); [a]D 8 +40.3 (c = 
0.72, CHC13); Rf 0.41 (Et20); 8jj 	MHz, CDC13)  1.30 (3H, t, CH2CH3), 1.98, 1.99, 2.00 
(9H, 3 x s, COCH3), 3.10 (2H, 2 x s, 4-H), 3.81 (1H, s, 7b-H), 3.84 (1H, s, 7a-H), 4.29 (2H, 
q, CH2CH3), 5.00 (1H, d, 8-H), 5.23 (lH, d, 10-H), 5.45 (lH, t, 9-H); J(x-y)/Hz CH3CH2 7.1, 
7a-7b nd, 7a-8 nd, 7a-8 nd, 8-9 9.6, 9-10 9.0; 5c(63  MHz, CDC13) 14.1 (CH2CH3), 20.7 x 2 
(COCH3), 42.0 (C-4), 60.6 (C-7), 62.6 (CH2CH3), 68.6, 69.3, 70.9 (C-8, C-9, C-b), 108.0 
(C-5), 152.7 (CO2CH2CH3), 159.7 (C-3), 169.8, 169.9, 170.0 (COCH3); m/z(FAB) Found: 
M+1 388.1242. C16H22N010 requires M+l 388.1244. 
3.7.4 	(5R,7S,8R,9S,1 OR)-8,9,1 O-Trs(benzyloxy)-7-benzyloxymethyl-3-carbethoxy- 
1 ,6-dioxa-2-azaspiro [4.5] dec-2-ene (132) 
Lab. Book Ref. KG 205 
Molecular Formula C39H41N08 








Using the general method described above; triethylamine (108 mg, 1.07 mmol) in sodium-
dried ether (50 ml) was added to a solution of 2,6-anhydro-3,4,5,7-tetra-O-benzyl-1-deoxy-
D-gluco-hept-1-enitol (59) (198 mg, 0.37 mmol) and ethyl chloro-oximinoacetate (67) (70 
mg, 0.46 mmol) in sodium-dried ether (50 ml). This resulted in only the title compound 
beingproduced as an oil (l72 mg, 72%, based on consumed 59); [a]D"  +3.2 (c = 1.24, 
CHC13); Rf 0.63 (petroleum ether:ethyl acetate, 4:1); oH (250 MHz, CDC13) 1.55 (3H, t, 
CH2CH3), 3.15 (1H, d, 4a-H), 3.24 (IH, d, 4b-H), 3.77 (1H, dd, ha-H), 3.87 (1H, dd, lib-
H), 3.94 (1H, d, 10-H), 4.00 (lH, t, 8-H), 4.26 (1H, dt, 7-H), 4.30 (1H, t, 9-H), 4.51 (2H, q, 
CH2CH3), 4.66-5.19 (8H, m, CH2Ph), 7.41-7.55 (20H, m, Ph); J(x-y)/Hz CH3CH2 7.7, 4a-4b 
18.4, 7-8 10.2, 7-1 la 1.8, 7-bib 2.7, 8-9 9.2, 9-10 9.7, ila-lib 11.3; 6c (63 MHz, CDC13) 
13.4 (CH3), 40.9 (C-4), 61.5 (CH2CH3), 67.3 (C- 11), 72.2 (C-7), 72.8, 74.3, 74.4, 75.0 (4 x 
CH2Ph), 76.8 (C-8), 77.7 (C-b), 83.0 (C-9), 110.3 (C-5), 126.3-127.9 (20 x CHPh), 136.9, 
137.1, 137.4, 137.6 (4 x qCPh), 151.9 (CO2Et), 159.5 (C-3); m/z(FAB) Found: M+l 
652.2910. C39H42N08 requires M+i 652.2916. 
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3.7.5 	(5R,7S,8R,95,l OR)-8,9,1 O-Tris(benzyloxy)-7-benzyloxymethyl-3-pheflyl-1 ,6- 
dioxa-2-azaspiro[4.5]dec-2-ene (133) 
Lab. Book Ref. KG 204 	 11 70 	2 
BnO 
Molecular Formula C4241 1N06 
Formula Weight 655 	 Bno io"oBn  
OBn 
Using the general method described above; triethylamine (202 mg, 1.99 mmol) dissolved in 
sodium-dried ether (50 ml) was added to a solution of 2,6-anhydro-3,4,5,7-tetra-0-benzyl-1-
deoxy-D-gluco-hept-1-enitol (59) (401 mg, 0.75 mmol) and benzohydroximoyl chloride (68) 
(131 mg, 0.84 mmol) in sodium-dried ether (50 ml). Column chromatography gave 
unreacted exoglycal (35 mg, 9%) with the title compound being produced as a white solid 
that was recrystallised from ethyl acetate:petroleum ether to give a crystalline solid (422 mg, 
94%, based on consumed 59); mp 127-130°C; MD 18 -2.2 (c = 1.84, CHC13); Rf 0.22 
(petroleum ether:ethyl acetate, 4:1); 8H  (360 MHz, CDC13) 3.05 (2H, s, 4-H), 3.58 (1H, dd, 
ha-H), 3.74 (lH, d, 10-H), 3.76 (1H, dd, llb-H), 3.83 (1H, t, 8-H), 4.07 (1H, dt, 7-H), 4.14 
(1H, t, 9-H), 4.40-5.00 (8H, m, CH2Ph), 7.24-7.37 (25H, m, Ph); J(x-y)IHz 7-8 10.1, 7-ha 
1.9, 7-11b 2.9, 8-9 9.2, 9-10 9.7, lia-lIb 10.9; 8c(63  MHz, CDC13) 42.4(C-4), 67.4 (C-lI), 
71.8 (C-7), 72.8, 74.1, 74.3, 75.1 (4 x CH2Ph), 77.0 (C-8), 77.8 (C-b), 83.4 (C-9), 108.3 (C-
5), 126.0-129.6 (25 x CHPh), 137.1, 137.5, 137.7 (5 x qCPh), 157.0 (C-3); m/z(FAB) Found: 
M+l 656.301. C42H42N06 requires M+1 656.2989; Calc. For C42H41N06: C, 76.95; H, 
6.25; N, 2.14. Found: C, 75.26; H, 6.24; N, 2.00%. 
3.7.6 	(5R,7S,8R,9S,1OR)-8,9,1 O-Tris(benzyloxy)-7-benzyloxymethyl-3-brOmO-1 ,6- 
dioxa-2-azaspiro 14.51 dec-2-ene (134) 
Br 
Lab. Book Ref. KG 206 	 BnO  )5"/ 
Molecular Formula C36H36BrN0 "(
70 
9 01 
BnO 8 10 OBn 
Formula Weight 658 	 OBn 
Using the general method described above; triethylamine (109 mg, 1.08 mmol) in sodium-
dried ether (50 ml) was added to a solution of 2,6-anhydro-3,4,5,7-tetra-O-benzyl-1-deoxy-
D-gluco-hept-1-enitol (59) (201 mg, 0.38 mmol) and dibromoformaldoxime (66) (90 mg, 
0.44 mmol) in sodium-dried ether (50 ml). Column chromatography afforded, in order of 
elution the title compound being produced as an oil (164 mg, 66%, based on consumed 
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alkene) and the furoxan as a white solid (33 mg, 31%); [a]018 +174 (c = 1.38, CHC13); Rf  
0.45 (petroleum ether:ethyl acetate, 4:1); 6(250 MHz, CDC13) 2.75 (1H, d, 4a-H), 2.86 (1H, 
d, 4b-H), 3.48-3.75 (4H, m, 8-H, 10-H, ha-H, llb-H), 3.87-4.02 (2H, m, 7-H, 9-H), 4.38-
4.88 (8H, m, CH2Ph), 7.05-7.26 (20H, m, Ph); J(x-y)/Hz 4a-4b 17.8, 7-8 nd, 7-1 la nd, 7-1 lb 
nd, 8-9 nd, 9-10 nd, ila-lib nd; 5c(63  MHz, CDC13) 48.2 (C-4), 67.2 (C-1 1), 72.0 (C-7), 
73.8, 74.1, 74.3, 75.1 (4 x CH2Ph), 77.8 (C-8), 82.9 (C-b), 84.0 (C-9), 108.9 (C-5), 127.0-
128.0 (20 x CHPh), 136.9-137.7 (4 x qCPh), 155.6 (C-3); m/z(FAB) Found: Br 79  M+1 
658.18042. C36H37NO6Br requires M+1 658.1802; Found: Br" M+1 660.17706 
C36H37NO6Br requires M+1 660.1785. 
3.7.7 	(5R,7S,8S,9S,1 OR)-8,9,1O-Tris(benzyloxy)-7-benzyloxymethyl-3-phenyl-1 ,6- 
dioxa-2-azaspiro[4.5]dec-2-ene (135) 
Lab. Book Ref. KG 265
6 
Molecular Formula C42H41N06 	
BnO 





Using the general method described above; triethylamine (460 mg, 4.56 mmol) in sodium-
dried ether (50 ml) was added to a solution of 2,6-anhydro-3,4,5,7-tetra-0-benzyl-1-deoxy-
D-galacto-hept-1-enitol (65) (578 mg, 1.08 mmol) and benzohydroximoyl chloride (68) (240 
mg, 1.54 mmol) in sodium-dried ether (50 ml). This resulted in the title compound being 
produced as a white solid (579 mg, 82%, based on consumed alkene); mp 136°C; [aID18  —3.5 
(c = 1. 14, CHC13); Rf 0.33 (petroleum ether:ethyl acetate, 4:1); 6  (250 MHz, CDC13) 3.39 
(2H, s,4-H), 3.99 (1H, dd, lla-H), 4.07-4.20 (3H, m, 8-H, 10-H, llb-H), 4.43-4.47 (2H, m, 
7-H, 9-H), 4.73-5.34 (8H, m, CH2Ph), 7.57-7.71 (20H, m, Ph); J(x-y)/Hz 7-8 nd, 7-ha 1.9, 
7-11b nd, 8-9 nd, 9-10 nd, lla-llb 10.9; 5c(63 MHz, CDC13) 42.9 (C-4),67.9 (C-li), 72.4 
(C-7), 73.4, 74.7, 74.8, 75.6 (4 x CH2Ph), 77.6 (C-8), 78.3 (C-b), 83.9 (C-9), 108.8 (C-5), 
126.6-130.2 (20 x CHPh), 137.7-138.2 (4 x qCPh), 157.6 (C-3); m/z(FAB) Found: M+1 
656.3012. C42H42N06 requires M+l 656.3025; Calc. For C42H41N06: C, 76.92; H, 6.30; N, 
2.14. Found: C, 75.99; H, 6.25; N, 2.01%. 
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3.7.8 	(5R,8S,9S,1OR)-8,9,1O-Tris(benzyloxy)-3-phenyl-1 ,6-dioxa-2-azaspiro[4.5] dee- 
2-ene (136) 
Ph 
Lab. Book Ref KG 272 7(0 
Molecular Formula C34H33N05 	 5 
Formula Weight 535 	 BnO 8 10"OBn 
OBn 
Using the general method described above; triethylamine (450 mg, 3.20 mmol) in sodium-
dried ether (50 ml) was added to a solution of 2 ,6-anhydro-3 ,4,5-tri-O-benzyl- 1 -deoxy-D-
arabino-hept- 1 -enitol (64) (497 mg, 1.19 mmol) and benzohydroximoyl chloride (68) (238 
mg, 1.53 mmol) in sodium-dried ether (50 ml). This resulted in the title compound being 
produced as a white solid (321 mg, 50%, based on consumed alkene); mp 108-109°C; [ai Dt 8 
+5.2 (c = 0.58, CHC13); Rf 0.35 (petroleum ether:ethyl acetate, 4:1); 6H  (250 MHz, CDC13) 
3.17 (1H, d, 4a-H), 3.32 (1H, d, 4b-H), 3.86 (lH, dd, 7a-H), 3.94 (1H, dm, 7b-H), 4.05 (1H, 
dm, 8-H), 4.17 (1H, dd, 9-H), 4.35 (IH d, 10-H), 4.77-4.87 (5H, m, CH2Ph), 5.15 (IH, d, 
CH2Ph), 7.31-7.47 (20H, m, 4 x Ph); J(x-y)IHz 4a-4b 17.3, 7a-7b 12.9, 7a-8 1.7, 7b-8 1.6, 8-
93.0,9-10 10.0; 8c(63  MHz, CDC13) 43.0 (C-4), 62.3 (C-7), 71.6, 72.1, 74.7 (3 x CH2Ph), 
73.3 (C-8), 75.2 (C-b), 79.7 (C-9), 109.7 (C-5), 126.5-130.1 (20 x CHPh), 138.0 (4 x 
qCPh), 157.5 (C-3). m/z(FAB) Found: M+1 536.2437. C34H34N05 requires M+l 536.2437; 
Cale. For C34H33N05: C, 76.24; H, 6.21; N, 2.62. Found: C, 77.09; H, 6.19; N, 2.53%. 
3.7.9 	(5R,8R,9S,1 OR)-8 ,9,1 O-Tris(benzyloxy)-3-phenyl-1 ,6-dioxa-2-azaspiro [4.5] dee- 
2-ene (137) 
Ph 
Lab. Book Ref. KG 364 	 7 0 
r5 
Molecular Formula C34H33N05 
BnO' 8 10 OBn 
Formula Weight 535 	 OBn 
Using the general method above: triethylamine (141 mg, 1.39 mmol) in sodium-dried ether 
(50 ml) was added to a solution of benzohydroximoyl chloride (68) (196 mg, 1.26 mmol) 
and the crude oil produced in section 3.6.5.4 that contained 2,6-anhydro-3,4,5-tri-O-benzyl-
1 -deoxy-D -xylo-hept- 1 -enitol (63) in sodium-dried ether (50 ml). This resulted in the title 
compound as an oil (88 mg, 14% over 2 steps); MD 18 +24.0 (c = 0.96, CHC13); R  0.28 
(petroleum ether:ethyl acetate, 4:1); 6H(2SO MHz, CDC13); 3.68 (2H, s, 4-H), 3.83-3.97 (2H, 
m, 7a-H, 7b-H), 4.30-4.32 (1H, m, 8-H), 4.59-4.61 (2H, m, 9-H, 10-H), 4.76-4.97 (6H, m, 
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CH2Ph), 7.40-7.65 (20H, m, Ph); J(x-y)/Hz 7a-7b nd, 7a-8 nd, 7b-8 nd, 8-9 nd, 9-10 nd; 8c  
(63 MHz, CDC13) 43.0 (C-4), 68.0 (C-7), 72.4, 73.6, 74.7 (3 x CH2Ph), 78.3, 77,4, 80.8 (C-8, 
C-9, C-b), 108.8 (C-5), 126.6-128.3 (20 x CHPh), 136.8, 137.3, 137.7 (4 x qCPh), 157.8 
(C-3); m/z(FAB) Found: M+1 536.2433. C34H34N05 requires M+1 536.2437. 
3.7.10 	(5R,7S,8R,9S,1 OR)-8,9,10-Tris(benzyloxy)-7-benzyloxymethyl-3-(3 ',4',5 '-Tn- 
O-acetyl-3-D-xy10-pyran-2'-yl)-1,6-dioxa-2-azaspiro[4.5] dec-2-ene (144) 
3.7.10.1 The Dehydrohalogenation Approach to the D-Xylose Nitrile Oxide (57) 
Lab. Book Ref. KG 230 
Molecular Formula C47H51N013 
Formula Weight 837 
OAc 
AcO—OAc 
6 4 1 J5 
BnO°" 	
6 
8 1 10 L'0 
BnO"("OBn 
OBn 
2 ,6-Anhydro-3 ,4,5 ,7-tetra-O-benzyl- 1 -deoxy-D-gluco-hept- I -enitol (59) (97 mg, 0.18 mmol) 
and hydroximoyl chloride 72 (73 mg, 0.22 mmol) were dissolved in sodium-dried ether (50 
ml), the solution was cooled and triethylamine (0.04 ml, 0.29 mmol) in sodium-dried ether 
(50 ml) was added over 24 h. The resulting suspension was filtered to remove the 
triethylamine hydrochloride salt and the solvent was removed in vacuo, to leave a crude 
white solid. Column chromatography yielded, in order of elution, unreacted exoglycal 59 (36 
mg, 37%), the title compound as a white solid (68 mg, 72%, based on consumed 59) and the 
xylose furoxan 145 (20 mg, 15%); 144; mp 94-98°C; [a]018 -18.5 (c = 1.46, CHC13); Rf 0.12 
(petroleum ether:ethyl acetate, 4:1); 8H(36O  MHz, CDC13) 1.84, 1.95, 1.97 (9H, s, CH3), 2.77 
(1H, d, 4a-H), 2.90 (1H, d, 4b-H), 3.29 (lH, t, 6a'-H), 3.47 (1H, dd, ha-H), 3.57 (1H, d, 10-
H), 3.68 (lH, m, I lb-H), 3.72 (1H, t, 8-H), 3.88 (lH, m, 7-H), 3.97 (lH, t, 9-H), 4.17 (1H, 
dd, 6b'-H), 4.39 (1H, d, 2-H), 4.50-4.78 (8H, m, CH2Ph), 4.92 (1H, m, 5'-H), 4.97 (111, t, 3'-
H), 5.15 (1H, t, 4'-H), 7.16-7.25 (20H, m, Ph); J(x-y)/Hz 4a-4b 17.7, 7-8 9.4, 7-ha 1.8, 7-
llb nd, 8-9 9.2, 9-10 9.7, ila-lib 11.0, 2'-3' 9.9, 3'-4' 9.5, 4'-5' 9.4, 5'-6a' 10.6, 5'-6b' 
5.6, 6a'-6b' 11.3, öc (63 MHz, CDC13) 20.2, 20.5, 20.5 (COCH3), 41.1 (C-4), 66.7 (C-6), 
68.1 (C-1 1), 68.7, 68.7 (C-3', C-7), 72.5 (C-4'), 72.9 (C-2'), 73.4, 74.7, 74.7, 75.5 (4 x 
CH2Ph), 74.1 (C-5'), 77.4 (C-8), 78.3 (C-b), 83.7 (C-9), 108.7 (C-5), 127.5-128.3 (20 x 
CHPh), 137.5, 137.9, 138.0, 138.2 (4 x qCPh), 156.1 (C-3), 169.0, 169.0, 169.7 (COCH3); 
m/z(FAB) Found: M++1 838.3426. C47H52N0 13requires M+i 838.3439. 
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3.7.10.2 	The Dehydration Approach to The D-Xylose Nitrile Oxide (57)5 
2,6-Anhydro-3 ,4,5 ,7-tetra-O-benzyl- 1 -deoxy-D-gluco-hept- 1 -enitol (59) (97 mg, 0.18 mmol) 
and 2,6-anhydro-3 ,4,5-tri-O-acetyl- 1 -deoxy- I --D-nitromethy1xy1ose (70) (58 mg, 0.18 
mmol) were dissolved in sodium-dried toluene (25 ml), under nitrogen. Triethylamine (0.1 
ml, catalytic) and tolylene 2,4-diisocyanate (0.5 ml, 3.5 mmol) were added to the reaction 
mixture, which was heated at 109°C for eight days, this resulted in a polymeric solid. The 
reaction was cooled to 0°C and diaminoethane (~! 3 eq., 0.1 ml) was slowly added with 
vigorous stirring. After I h the reaction mixture was filtered to remove the polymeric urea 
and the sinter was washed with chloroform (2 x 50 ml). The combined organics were 
evaporated to give a crude white solid. Column chromatography resulted, in order of elution, 
the recovered alkene 59 (23 mg, 24%), the title compound as a white solid 144 (64 mg, 55%, 
based on consumed 59) and the furoxan 145 as a crude mixture with some baseline material. 
3.7.10.3 3,4-Di-(2,3,4-tri-O-acetyl-f3-D-xy}opyranosyl)-1 ,2,5-oxadiazole 2-oxide (145) 124a 
Lab. Book Ref. KG 138 
Molecular Formula C24H30N2016 





To a stirred solution of 2,6-anhydro-3,4,5-tri-O-acetyl-1-deoxy-1-nitroxylose (70) (0.192 g, 
0.602 mmol) in dry toluene (25 ml), under nitrogen, was added triethylamine (0.1 ml, 
catalytic) and tolylene 2,4-diisocyanate (3 eq., 0.259 ml). The reaction mixture was heated at 
reflux for eight days (109°C), over which time a polymeric solid was formed. The reaction 
was cooled to 0°C and diaminoethane (~: 3 eq., 0.12 ml) was slowly added with vigorous 
stirring. After an hour the reaction mixture was filtered to remove the polymeric urea and the 
sinter was washed with chloroform (2 x 50 ml). The combined organics were evaporated to 
leave the title c ompound as a white s olid. This was recrystallised from e thanol:hexane to 
give pure furoxan (121 mg, 67 %); mp 190°C [aID'8 —95.9 (c = 0.44, CHC13); o (250 MHz, 
CDCI3) 1.87, 1.89, 1.98, 1.99, 2.00, 2.01 (18H, 6 x s, COCH3), 3.43 (2H, dd, 5'b & 5"b-H), 
4.27 (2H, dd, S'a & 5"a-H), 4.78 (2H, d, 1' & 1"-H), 4.99 (2H, ddd, 4' & 4"-H) 5.29 (2H, 
dd, 3' & 3"-H), 5.37 (2H, dd, 2' & 2"-H); J(x-y)/Hz 1'/1"-2'/2" 2.0, 2'12"-3'/3" 9.3, 3'/3"-
4'/4" 2.5, 4'/4"-5a'/5a" 5.4, 4'/4"-5b'/5b" 10.8, 5a'/5a"-5b'/5b" 7.7; & (63 MHz, CDC13) 
20.24, 20.48, 20.68 (COCH3), 66.98, 67.13 (5'C, 5"C), 68.50 (1'C, 1"C), 69.97, 70.44, 
71.78, 72.68 (VC, 1"C, 2'C, 2"C, 3'C, 3"C, 4'C, 4"C), 112.87 (3C), 153.92 (4C), 169.50, 
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169.69, 169.85, 170.05, 170.11 (COCH3); m/z (FAB) Found: M+1 603.1684. C24H30N2016 
requires M+1 603.1674. 
3.7.11 	(5R,7S,8R,9S,1 OR)-8,9,1 O-Tris(benzyloxy)-7-benzyloxymethyl-2,3-diphenyl- 
1,6-dioxa-2-azaspiro[4.5]decane (146)169 
Ph 
Lab. Book Ref. KG 371 	
° BnO 	i—Ph Molecular Formula C43H45N06 	 O 
Formula Weight 671 	 BnO' 8 10 'OBn 
OBn 
A mixture of 2,6-anhydro-3 ,4,5 ,7-tetra-O-benzyl- 1 -deoxy-D-gluco-hept- 1 -enitol (59) (496 
mg, 0.92 mmol, 1 eq) was refluxed for three days in dry toluene (10 ml) with Na-diphenyl 
nitrone (363 mg, 1.84 mmol, 2 eq.). The solvent was removed in vacuo and the cycloadduct 
was separated from the residue using dry flash chromatography (silica, 0—*100% ethyl 
acetate in petroleum ether; gradient elution) to give the title compound as two inseparable 
diastereomers as an oil (619 mg, 56%, based on consumed alkene); [U]D25 +42.0 (c = 1.62, 
CHC13); R1  0.61 (major) 0.56 (minor) (petroleum ether: ethyl acetate, 4:1); 8H  (250 MHz, 
CDCI3); 1. 87, 1.86 (1H, 2 x s,4-H, two diastereomers), 3.66-3.90 (4H, m, 10-H, 8-H, ha-H, 
llb-H), 4.13-4.24 (1H, m, 7-H), 4.31-4.40 (1H, m, 9-H), 4.59 (IH, s, 3-H), 4.64-5.05 (8H, 
m, CH2Ph), 7.16-7.68 (30H, m, Ph); J(x-y)/Hz 3-4a nd, 3-4b nd, 7-ha nd, 7-11b nd, 7-8 nd, 
8-9 nd, 9-10 nd, hla- llb nd; 8c (63 MHz, CDC13) 48.0, 53.3 (C-4, two diastereomers), 68.0, 
68.3, 70.6, 72.4, 73.2, 73.6, 74.9, 75.3, 75.5 (CHPh, C-il, two diastereomers), 70.0 (C-3), 
72.0, 73.6, 74.3, 75.8, 78.2 (C-7, C-8, C - b, two diastereomers), 84.3 (C-9), 104.4 (C-5), 
127,4-128.5 (30 x CHPh), 137.6, 137.8, 138.0, 138.1, 138.2 (5 x qCPh), 144.7, 149.7 
(qCNPh, two diastereomers); m/z (FAB) Found: M+1 734.3482 C48H48N06 requires M+1 
734.3489. 
3.8 	Reactions of Cycloadducts 
3.8.1 	Synthesis of (5R,7S,8R,9S,1OR)-8,9,1 0-Tris(benzyloxy)-7-benzyloxymethyl-3- 
hydroxymethyl-1,6_dioxa-2_azaspiro[4.5]dec_2ene (147)88 
Lab. Book Ref. KG 320 	 11 6 
4  3" 
BnO02 OH 
Molecular Formula C37H39N07 	




A ten-fold excess of sodium borohydride (297 mg, 7.85 mmol) was added portion-wise to a 
solution of the ester isoxazoline 132 (511 mg, 0.79 mmol) in ethanol (35 ml). The reaction 
mixture was stirred at room temperature until the disappearance of the starting material (3-4 
h). The solution was then poured into water (25 ml) and extracted with dichioromethane (4 x 
20 ml). The combined extracts were dried (MgSO4) and the solvent was removed in vacuo, 
this gave the desired alcohol as a white solid (386 mg, 81%); mp 87-90°C; [a] 21 +2.78 (c = 
0.36, CHC13); Rf 0.03 (petroleum ether:ethyl acetate, 4:1); oH (250 MHz, CDC13) 2.63 (1H, 
broad s, OH), 2.89 (1 H, d, 4a-H), 2.99 (1H, d, 4b-H), 3.71-3.89 (4H, m, 8-H, 10-H, ha-H, 
I lb-H) 4.16-4.25 (2H, m, 7-H, 9-H), 4.40 (2H, s, CH20H), 4.53-5.12 (8H, m, CH2Ph), 7.36-
7.47 (20H, m, Ph); J(x-y)/Hz 4a-4b 17.9, 7-8 nd, 7-1 la nd, 7-1 lb nd, 8-9 nd, 9-10 nd; 6c (63 
MHz, CDC13) 42.8 (C-4), 57.8 (CH20H), 67.9 (C- 11), 72.2 (C-7), 73.3, 74.7, 74.7, 75.5(4 x 
CH2Ph), 77.6, 78.3, 83.8 (C-8, C-9, C-b), 108.6 (C-5), 127.5-128.4 (20 x CHPh), 137.6, 
137.6, 138.0, 138.2 (4 x qCPh), 159.7 (C-3); m/z(FAB) Found: M+1 610.2805. C37H39N07 
requires M+l 610.2799. 
3.8.2 	Ring Opening Reactions 
3.8.2.1 General Procedure for the Hydrogenolysis of Isoxazolines'4 
A mixture of the isoxazoline (1 eq.), boric acid (6 eq.) and the relevant catalyst in 
methanol:water (5:1; —15 ml per 100 mg of isoxazoline) and THF. The reaction mixture was 
degassed, flushed several times with hydrogen, and stirred under hydrogen until the starting 
material was consumed. After filtration through a celite pad the mixture was concentrated in 
vacuo (-20°C). Several portions of methanol were added and removed in vacuo (to remove 
the remaining boric acid as trimethyl borate) to yield the product. 
Raney Nickel was prepared by repeated washing and decanting with water (x 20), after 
which the catalyst was stored under methanol in a freezer for 3-4 weeks prior to use. 
3.8.2.2 Attempted Hydrogenolysis of (5R,7S,8R,9S,1OR)-8,9,1 O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl-1,6-dioxa-2-azaspiro [4.5] dec-2-ene (133) 	with 
Palladium/Charcoal 
Lab Book Ref. KG 288 
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Isoxazoline 133 (103 mg, 0.16 mmol) and boric acid (60 mg, 6 eq.) were dissolved in 
methanol:water (6 ml, 5:1), to this PcIJC catalyst (100 mg) was added. The reaction mixture 
was degassed three times andleft to stirurider an atmosphere ofhydrogen for48 h. The 
mixture was filtered through a celite pad and the solvent removed in vacuo. The resulting 
solid was co-evaporated with methanol to remove the residual boric acid this afforded a 
white solid (74 mg, 72%) that was identified as the staring material. 
3.8.2.3 Attempted Hydrogenolysis of (SR,7S,8R,9S,1 OR)-8,9,1 O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl-1 ,6-dioxa-2-azaspiro [4.5] dec-2-ene 	(133) 	with 
Raney Nickel: Method 1 
Lab Book Ref, KG 301 
Isoxazoline 133 (54 mg, 0.08 mmol) and boric acid (31 mg, 6 eq.) were dissolved in 
methanol:water (6 ml, 5:1), to this six spatula tips of Raney nickel catalyst were added. The 
reaction mixture was degassed three times and was left to stir under an atmosphere of 
hydrogen for 24 h. The mixture was filtered through a celite pad and the solvent removed in 
vacuo. The resulting solid was co-evaporated with methanol to remove the residual boric 
acid this yielded a white solid (24 mg, 44%) that was identified as the staring material. 
3.8.2.4 Attempted Hydrogenolysis of (5R,7S,8R,9S,1 OR)-8,9,1 O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl-1,6-dioxa-2-azaspiro [4.5] dec-2-ene 	(133) 	with 
Raney Nickel: Method 2 
Lab Book Ref. KG 248 
Isoxazoline 133 (47 mg, 0.07 mmol) and boric acid (27 mg, 6 eq.) were dissolved in 
methanol:water (20 ml, 5 :1), to this six spatula tips of R aney nickel catalyst were a dded. 
Using a Parr high pressure hydrogenator the reaction mixture was degassed three times and 
was left to s tir under a 40 b ar atmosphere o f hydrogen for 5 h. The mixture was filtered 
through a celite pad and the solvent removed in vacuo. The resulting solid was co-evaporated 
with methanol to remove the residual boric acid this yielded a white solid (46 mg, 94%) that 
was identified as the starting material. 
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3.8.2.5 Hydrogenolysis 	of 	(5R,7S,8R,9S,1OR)-8,9,1 O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl-1,6-dioxa-2-azaspiro [4.51 dec-2-ene (133) Using 




Lab. Book Ref. KG 345 	 BnO 
I OH 
Molecular Formula C47H45N06 	 BnO" 	"OBn 
Formula Weight 659 	 OBn 
Isoxazoline 133 (147 mg, 0.22 mmol) and boric acid (83 mg, 6 eq.) were dissolved in 
methanol: water (22 ml, 5:1), to this the palladium hydroxide (Pearlman's) catalyst (100 mg) 
was added. The reaction mixture was degassed three times and was left to stir under an 
atmosphere of hydrogen for 24 h. The mixture was filtered through a celite pad and the 
solvent removed in vacua. The resulting solid was co-evaporated with methanol to remove 
the residual boric acid, this yielded an oil that was identified as 7-amino alcohol 149 (141 
mg, 95%); [0,]018 = +13.7 (c = 1.9, CHC13); 8 (250 MHz, CDC13) 3.24-4.07 (8H, in, 2'-H, 
la'-H, lb'-H, 2-H, 3-H, 4-H, 5-H, 6a-H, 6b-H), 4.41-4.55 (4H, in, CH2Ph), 4.73-4.84 (4H, 
in, CH2Ph), 7.08-7.27 (25H, in, Ph); J(x-y)/Hz 2'-la' nd, 2'-lb' nd, 2-3 nd, 3-4 nd, 4-5 nd, 
5-6a nd, 5-6b nd; 6 (63 MHz, CDC13) 34.1 (C-l') 50.5, 52.6 (C-2', 2 diastereomers), 68.8 
(C-6), 73.2, 74.7, 75.3, 75.6 (4 x CH2Ph), 70.6, 77.1, 78.4, 83.7 (C-2, C-3, C-4, C-5), 97.7, 
98.0, 98.3, 100.7 (C-3', 4 diastereomers), 125.4-129.0 (25 x CHPh), 138.1, 138.2, 138.3, 
138.5 (5 x qCPh); 6 (91 MHz, CDC13) 34.1, 35.3 (C-l' 2 diastereomers), 50.5, 51.2, 52.3, 
52.5 (C-2', 4-diastereomers), 97.7, 98.0, 98.3, 100.7 (C-i, 4 diastereomers), 197.7 (C-3, 
open chain); m/z(FAB) Found: M+1 660.3320. C42H46N06 requires M+1 660.3325. 
3.8.2.6 Hydrogenolysis 	of 	(5R,7S,8R,9S,1 OR)-8,9,1O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl-1,6-dioxa-2-azaspiro [4.5] dec-2-ene 	(133) 	Using 
Pearlman's Catalyst: Method 2 
Isoxazoline 133 (142 mg, 0.22 mmoi) and boric acid (84 mg, 6 eq.) were dissolved in 
methanol (22 ml), to this p alladium hydroxide (Pearlman's) catalyst (150 in g) was added. 
The reaction mixture was degassed three times and was left to stir under an atmosphere of 
hydrogen for 24 h. The mixture was filtered through a celite pad and the solvent removed in 
vacua. The resulting solid was co-evaporated with methanol to remove the residual boric 
acid this yielded an oil that was identified as the title compound in five structural forms 
=1:1:l:l:nd(95 mg, 66%). 
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3.8.2.7 Attempted Reductive Ring Opening of (5R,7S,8R,9S,1OR)-89,1O-
Tris(benzyloxy)-7-benzyloxymethyl-3-carbethoxy-1 ,6-dioxa-2- 
azaspiro [4.5] dec-2-ene (132) with Palladium Hydroxide 
Lab Book Ref. KG 347 
Isoxazoline 132 (88 mg, 0.14 mmol) and boric acid (50 mg, 6 eq.) were dissolved in 
methanol:water (6 ml, 5:1), to this Peariman's catalyst (60 mg) was added. The reaction 
mixture was degassed three times and was left to stir under an atmosphere of hydrogen for 
18 h. The mixture was filtered through a celite pad and the solvent removed in vacuo. The 
resulting solid was co-evaporated with methanol to remove the residual boric acid this 
yielded an oil (40 mg, 46%) that was identified as the staring material. 
3.8.2.8 Hydrogenolysis 	of 	(5R,7S,8R,9S,1 OR)-8,9,1 O-Tris(benzyloxy)-7- 
benzyloxymethyl-3-hydroxymethyl-1 ,6-dioxa-2-azaspiro[4.5] dec-2-ene (147) 
Using Peariman's Catalyst 
Lab. Book Ref. KG 354 	
6 	
1' 2 ' OH 
	
6 	
1' 2' ' OH 
Molecular Formula C37H43N07 BnO5 01 	2 	BnO0 
OH 4 OH 
Formula Weight 613 	 BnO" 	2"OBn 	BnO(2"OBn 
OBn 	 OBn 
Isoxazoline 147 (130 mg, 0.21 mmol) and boric acid (85 mg, 6 eq.) were dissolved in 
methanol:water (22 ml, 5:1), to this palladium hydroxide (Pearlman's) catalyst (150 mg) was 
added. The reaction mixture was degassed three times and was left to stir under an 
atmosphere of hydrogen for 24 h. The mixture was filtered through a celite pad and the 
solvent removed in vacuo. The resulting solid was co-evaporated with methanol to remove 
the residual boric acid, this yielded an oil that was identified as a mixture of 3-hydroxy 
ketone 151 and y-amino alcohol 152 (117 mg, 89%); [a]D'8 = +24.4 (c = 2.3, CHC13); 811 
(250 MHz, CDC13)  3.56-4.65 (10H, in, la'-H, lb'-H, 2'-H, 3a'-H, 3b'-H, 2-H, 3-H, 4-H, 5-
H, 6a-H, 6b-H), 4.76-5.28 (8H, in, CH2Ph), 7.46-7.69 (20H, m, Ph); J(x-y)/Hz la- la nd, la-2 
nd lb-2 nd, 2-3a nd, 2-3b nd, 5-6 nd, 6-7 nd, 7-8 nd, 8-9a nd, 8-9b nd; 6c  (63 MHz, CDC13) 
29.6, 30.6 (C-l'), 50.2, 50.3 (C-2', 2 diastereomers), 68.4 (C-3'), 69.5(C-8), 73.2, 74.7, 75.1, 
75.5 (CH2Ph), 78.0, 81.4, 82.9, 71.0(C-2, C-3, C-4, C-5), 97.6(C-l), 127.6-128.2 (20 x 
CHPh), 137.6, 137.8, 138.2 (4 x qCPh); 8c (91 MHz, CDC13) 210.3 (C-3, open chain); 




3.9.1 	Synthesis of 5-(N-Benzyl-2-pyrrolidine)-3-phenyl-2-isoxazoline (159) 
3.9.1.1 N-Benzyl-2-methylenepyrrolidine (153)96 
Lab. Book Ref. KG 299 
Molecular Formula C12H15N 
Formula Weight 173 
(Ph 
Cr 
N-Benzyl-2-pyrrolidone (499 mg, 2.85 mmol) was dissolved in sodium-dried toluene (50 ml) 
with the Petasis reagent (115) (1.19 g, 5.7 mmol), the reaction mixture was heated at 70°C 
for 24 h. The solvent was removed to afford the title compound as an oil, contaminated with 
titanocene by-products, which was taken on to the next stage without further purification; 
(200 MHz, CDC13) 2.15 (2H, m, 4a-H, 4b-H), 2.60 (2H, t, 3a-H, 3b-H), 3.40 (2H, t, 5a-H, 
5b-H), 4.39 (2H, 2 x s, la-H, lb-H), 4.60 (2H, s, CH2Ph), 7.40 (5H, m, Ph). 
3.9.1.2 6-Benzyl-3-phenyl-1-oxa-2,6-diazaspiro [4.4] non-2-ene (159) 
Lab. Book Ref. KG 299 	 ,Ph 
Molecular Formula C19H20N20 	
Ph 
Formula Weight 292  
N-Benzyl-2-methylenepyrrolidine (165) and benzohydroximoyl chloride (68) (0.49 g, 3.13 
mmol) were dissolved in sodium-dried ether (50 ml) and triethylamine (0.35 g, 3.45 mmol), 
in dry ether (50 ml) was added over 24 h using a syring pump. Removal of the solvent in 
vacuo yielded an oil that on column chromatography afforded the product as a brown gum 
(196 mg, 24% over two steps); R f 0.41 (ethyl acetate: petroleum ether, 1:4); MD 25 0 (c = 
1.82, CHC13); 6H  (250 MHz, CDC13) 1.98-2.25 (2H, m, 7a-H, 7b-H), 2.60-2.72 (2H, m, 8a-H, 
8b-H), 3.00-3.09 (1H, m, 9a-H), 3.21-3.26 (1H, m, 9b-H), 3.52 (1H, d, 4a-H), 3.65 (1H, d, 
4b-H), 3.79 (1H, d, CH2Ph), 4.57 (1H, d, CH2Ph), 7.43-7.91 (10H, m, Ph); J(x-y)IHz CH2 
14.0, 4a-4b 17.9, 7-7 nd, 7-8 nd, 8-8 nd, 8-9 nd, 9-9 nd; 5c(63  MHz, CDC13) 20.3 (C-8), 38.1 
(C-9), 40.0 (C-4), 50.6 (C-7, CH2Ph), 107.4, 108.3 (C-5), 126.1-129.6 (10 x CHPh), 139.0 (2 




3.9.2 	Synthesis of 5-(N-Benzyl-piperidine)-3-phenyl-2-isoxazoline (160) 
3.9.2.1 N-Benzyl-2-piperidone (155) 13 1 
Lab. Book Ref. KG 291 
Molecular Formula C12H15N0 
Formula Weight 189.70 
Sodium hydride dispersion in oil (60%, 2.10 g, 48.0 mmol) was washed with anhydrous 
hexane (3 x 10 ml) under nitrogen, resuspended in dry THF (50 ml), and cooled to 0°C. A 
solution of -valerolactam (4.66 g, 45.5 mmol) in dry THF (200 ml) was slowly added to the 
suspension. The mixture was stirred at 0°C for 30 mm, and at room temperature until 
cessation of hydrogen evolution. Benzyl chloride (95.2 ml, 45,4 mmol) was added dropwise 
under nitrogen, and the new mixture was refluxed until completion of the aikylation was 
observed by tic (48 h). The reaction was quenched with H20 (200 ml) the aqueous phase was 
extracted with Et20 (100 ml) and CH2C12 (100 ml). The combined organics were dried 
(MgSO4), and the remaining benzyl chloride and solvent were removed in vacuo to give the 
title compound (5.73 g, 63%) as a pale oil that was reacted without further purification. Rf  
0.14 (petroleum ether:ethyl acetate, 2:1); 5H (250 MHz, CDC13) 1.78-1.94 (4H, m, 4-H, 5-H), 
2.54-2.59 (2H, m, 6-H), 3.26-3.28 (2H, m, 3-H), 4.69 (2H, s, CH2Ph), 7.33-7.56 (5H, m, Ph); 
J(x-y)/Hz 3-3 nd, 3-4 nd, 4-4 nd, 4-5 nd, 5-5, nd 5-6 nd, 6-6 nd; 8c (63 MHz, CDC13) 21.2 
(C-5), 23.0 (C-4), 32.3 (C-3), 47.1 (C-6), 49.9 (CH2Ph), 127.1, 127.9, 128.4 (5 x CHPh), 
137.1 (qCPh), 169.7 (C-i); ,n/z (FAB) Found: M+l 190.12132 C 2H16NO requires M+1 
190. 1232. 
3.9.2.2 N-Benzyl-2-methylenepiperidine (154) 
Lab. Book Ref. KG 306A 
Molecular Formula C13H17N 




N-Benzyl-2-piperidone (155)(250 mg, 1.43 mmol) and the Petasis reagent (115)(0.59 g, 
2.85 mmol) were dissolved in sodium-dried toluene, the reaction mixture was heated for 24 h 
at 70°C. The solvent was removed in vacuo to yield the product as an oil, which was 
contaminated with titanocene by-products, but was taken on to the next stage without further 
178 
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purification; o (200 MHz, CDC13)  1.90 (4H, m, 4a-H, 4b-H, 5a-H, 5b-H), 3.10 (2H, m, 6a-
H, 6b-H), 3.30 (2H, m, 3a-H, 3b-H), 4.30 (2H, s, la-H, lb-H), 4.74 (2H, s, CH2Ph), 7.30 
(5H, m, Ph). 
3.9.2.3 6-Benzyl-3-phenyl-1-oxa-2,6-diazaspiro [4.5]dec-2-ene (160) 
Lab. Book Ref KG 306 	 Ph Ph 
4 31  
Molecular Formula C20H22N20 	 N 5[ N2 




The title compound was produced by the addition of triethylamine (0.24 ml, 1.60 mmol) to a 
solution of N-benzyl-2-methylenepiperidine (154) and benzohydroximoyl chloride (68) (244 
mg, 1.57 mmol) dissolved in dry ether, over 24 h. Concentration and column 
chromatography afforded the product as a brown solid (72 mg, 23% over two steps); mp 88-
9 1°C; Rf 0.41 (petroleum ether:ethyl acetate, 4:1); [aID25 0 (c = 0.94, CHC13); oH (250 MHz, 
CDC13) 1.96-2.02 (2H, m, 7a-H, 7b-H), 2.56-2.60 (4H, m, 9a-H, 9b-H, 8a-H, 8b-H), 3.23 
(1H, d, 4a-H), 3.33 (1H, d, 4b-H), 3.60 (1H, d, CH2Ph), 3.83 (1H, d, C142Ph), 4.45 (1H, d, 
CH2Ph), 7.25-7.32 (1 OH, m, Ph); J(x-y)/Hz 4a-4b 18.0, 6-6 nd, 6-7 nd, 7-7 nd, 7-8 nd, 8-8 
nd, 8-9 nd, 9-9 nd, 9-10 nd, 10-10 nd; 5C (63 MHz, CDC13) 38.1 (C-4), 43.8, 45.3, 45.3, 47.7 
(C-7, C-8, C-9, C-b), 53.4 (CH2Ph), 101.2 (C-5), 126.1-130.0 (10 x CHPh), 139.3, 140.0 (2 
x qCPh), 155.0 (C-3); m/z (FAB) Found: M+1 307.1818. C20H22N20 requires M+1 
307.1810. 
3.9.3 	Synthesis 	of 	(5R,7S,8R,9S,1 OR)-N-Boc-8,9,1 0-tris(benzyloxy)-7- 
benzyloxymethyl-3-phenyl-1-oxa-2,6-diazaspiro [4.5] dec-2-ene (186) 
3.9.3.1 2,3,4,6-Tetra-0-benzyl-D-glnconamide (179)36 
Lab. Book Ref, KG 342 	
ç_-OBn 
Bn O—-0H 
Molecular Formula C34H36N06 	 BnO_—--1--NH2 
Molecular Weight 555 	
BnO 0 
Gluconolactone 114 (2.00 g, 3.7 mmol) was dissolved in 50 ml of an 8N ammonia-solution 
in methanol. After stirring for 1.5 h, under nitrogen, the reaction mixture was concentrated in 
vacuo. Crystallisation of the yellow oil from ethyl acetate and petroleum ether 60-80 
179 
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afforded the title compound as white crystals (1.78 g, 86%); mp 75°C (Lit. 161  89-900C); Rf  
0.22 (petroleum ether:ethyl acetate, 1:1); 6H  (250 MHz, CDC13) 3.60 (1H, s, OH), 3.69-375 
(2H, m, 6aH, 6b-H), 3.80-3.82 (2H, m, 4H, 5-H), 4.13-4.20 (1H, m, 3-H), 4.62-4.69 (1H, m, 
2-H), 4.87-5.09 (8H, m, CH2Ph), 7.42-7.52 (20H, m, Ph); J(x-y)/Hz 2-3 nd, 3-4 nd, 4-5 nd, 
5-6a nd, 5-6b nd, 6a-6b nd; 5c (63 MHz, CDC13)  68.8 (C-6), 73.0, 73.3, 74.8, 75.5 (4 x 
CH2Ph), 77.7, 79.9, 81.5 (C-2, C-3, C-4), 90.9 (C-5), 127.4-128.2 (20 x CHPh), 137.6, 
138.3, 138.5 (4 x qCPh), 173.1 (C-I); m/z(FAB): Found M+l 556.2699. C34H38N06 
requires M+I 556.2699. 
3.9.3.2 2,3,4,6-Tetra-0-benzyl-5-dehydro-oxo-D-gluconamide (180)36 
Lab. Book Ref. KG 344 	 OBn 
Molecular Formula C34H35N06 	 Bnc — NH 
Molecular Weight 554 	
BnO 0 
A solution of 179 (1.93 g, 3.5 mmol) in dimethyl sulphoxide (12.5 ml) and acetic anhydride 
(7.5 ml) was stirred, under nitrogen, for 12 h. Water (50 ml) was added and the mixture was 
stirred for a further 15 mm, during which time a yellow oil was precipitated. The reaction 
mixture was extracted with DCM (3 x 30 ml) the combined organics were then washed with 
water (3 x 30 ml) and brine (2 x 30 ml). The organic layer was dried (MgSO4) and 
concentrated in vacuo. The title compound was carried forward to the next reaction without 
further purification; Rf 0.26 (petroleum ether:ethyl acetate, 1:1); o (250 MHz, CDC13) 3.67-
3.71 (2H, m, 6a-H, 6b-H), 3.90-3.96 (2H, m, 3H, 4-H), 4.10-4.13 (1H, m, 2-H), 4.44-5.01 
(8H, m, CH2Ph), 7.19-7.37 (20H, m, Ph); J(x-y)/Hz 2-3 nd, 3-4 nd, 6a-6b nd; öc (63 MHz, 
CDC13) 68.1 (C-6), 73.4, 73.6, 73.8, 73.8 (4 x CH2Ph), 77.4, 78.0, 80.8 (C-2, C-3, C-4), 
127.7-128.3 (20 x CHPh), 136.8, 137.3, 137.4(4 x qCPh), 169.2 (C-1,C-5). 
3.9.3.3 2,3,4,6-Tetra-0-benzyl-5-dehydro-5-hydroxy-D-glucono- and L-idonolactam 
(18 1)36 
OBn 
Lab. Book Ref. KG 357 	
BnO 	NH 
O Molecular Formula C34H36N06 	 Bn
HO 	0 
Molecular Weight 554 	 BnO  
180 
Experimental Procedures 
Compound 180 (267 mg, 0.48 mmol) was dissolved in 10 ml of a solution of ammonia in 
methanol (8N ammonia). The mixture was stirred for 2 h, after which it was concentrated in 
vacuo. The residue was purified by dry flash chromatography (petroleum ether:ethyl acetate, 
2:1). This yielded two products: a white solid identified as 181a (122 mg, 46%) and a yellow 
syrup 181b (139 mg, 52%); 181a mp 97°C (lit.36 99-1010C); Rf 0.14 (petroleum ether:ethyl 
acetate, 1:1); S (250 MHz, CDC13) 3.27 (1H, d, 6a-H), 3.34 (1H, d, 6b-H), 3.75 (1H, d, 4-
H), 4.01 (1H, d, 2-H), 4.23 (1H, dd, 3-H), 4.41-4.92, (7H, m, CH2Ph), 5.17 (t H, d, J2 11.2, 
CH2Ph), 6.29 (1H, broad s, NH), 7.19-7.33 (20H, m, Ph); J(x-y)/Hz 2-3 8.6, 3-4 9.6, 6a-6b 
9.6; 5c (63 MHz, CDC13) 72.3, 73.4, 74.6, 75.1 (4 x CH2Ph), 75.1 (C-6), 77.1, 79.2, 81.7 (C-
2, C-3, C-4), 127.6-128.4 (20 x CHPh), 136.8, 137.1, 137.6, 138.0 (4 x qCPh), 170.6 (C-l), 
171.32 (C-5); 181b Rf 0.06 (ethyl acetate:petroleum ether, 1:1); 5H (250 MHz, CDC13) 3.18 
(1H, broad s, OH), 3.60-3.68 (2H, m, 6a-H, 6b-H), 3.88-3.93 (2H, m, 3-H, 4-H), 4.25 (1H, d, 
2-H), 6.71 (1H, broad s, NH), 7.20-7.33 (20H, m, Ph); J(x-y)/Hz 1-2 nd, 2-3 3.4, 4-5 nd, 5-
6a nd, 5-6b nd, 6a-6b nd; 8c (63 MHz, CDC13) 70.9, 73.1, 73.5, 73.91 (CH2Ph), 75.03 (C-6), 
77.5, 79.4, 80.4 (C-2, C-3, C-4), 127.5-128.4 (20 x CHPh), 136.6-138.0 (4 x qCPh), 170.4 
(C-i), 173.9 (C-5). 
3.9.3.4 2,3,4,6-Tetra-0-benzyl-D-glucono-6-Iactam (182)36 
Lab. Book Ref. KG 361 	 _-OBn 
BnO --- NH 
Molecular Formula C34H35N05 	 BnO 
BnO 0 
Molecular Weight 537 
Compounds 181a & 181b (1.00 g, 1.8 mmol) were dissolved in 25 ml acetonitrile and 6.5 ml 
formic acid. To this mixture, sodium cyanoborohydride (360 mg) was added and the reaction 
mixture was refluxed for 2 h. The mixture was then cooled in ice and the reaction was 
quenched by adding aq. hydrochloric acid (0.1M). After stirring for 15 mill, the mixture was 
poured into a solution of ethyl acetate and saturated sodium bicarbonate solution (1:1, 100 
ml). The water layer was separated and extracted with ethyl acetate (2 x 50 ml), the 
combined organic layers were then washed with brine (50 ml), dried (MgSO4), the solvent 
was removed in vacuo and the resulting white solid was recrystallised from petroleum 
ether:ethyl acetate to give the title compound as white crystals (698 m g, 72%); mp 98°C 
(lit.36 100-102°C); Rf 0.43 (petroleum ether:ethyl acetate, 1:1); ö (250 MHz, CDC13) 3.27-
3.29 (1H, m, 6a-H), 3.54-3.60 (2H, m, 5-H, 6b-H), 3.67-3.71 (1H, m, 4-H), 3.90-3.99 (2H, 
m, 2-H, 3-H), 4.44-5.18 (8H, m, CH2Ph), 6.21 (1H, broad s, NH), 7.78-7.42 (20H, m, Ph); 
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J(x-y)/Hz 2-3 nd, 3-4 nd, 5-6a nd, 5-6b nd, 6a-6b nd; öc (63 MHz, CDC13) 69.7, 73.2, 75.6, 
74.5, 74.5 (C-6, 4 x CH2Ph), 78.0, 78.6, 80.8, 82.1 (C-2, C-3, C-4, C-5), 127.7-128.3 (20 x 
Ph), 137.1, 137.4, 137.6, 137.8 (4 x qCPh), 170.6 (C-i); m/z(FAB): Found M+1 538.2598. 
C34H36N05 requires M+1 538.2594. 
3.9.3.5 Attempted Synthesis of Pentabenzyl-D-nojirilactam (183) and (5S, 6R)-N-
Benzyl-3,5-bis(benzyloxy)-6- F(benzyloxy)methyll-1,2,5,6-tetrahydropyridin-2-
one (184)132 
Lab. Book Ref, KG 362 
Molecular Formula 183 C41H41N05 	 OBn 	 oBn  
Molecular Formula 184 C34H33N04 	BncTT1\1 Bfl BnO '  
Molecular Weight 183 627 	 BnO 0 	 BnO 
Molecular Weight 184 519 
The lactam 182 (105 mg, 0.20 mmol) was added to a stirred suspension of freshly pulverised 
potassium hydroxide (21.9 mg, 0.4 mmol) in dry DMSO (3.9 ml) at room temperature, 
treated with benzyl chloride (90 ml, 0.78 mmol) for 5 mm, and poured into a mixture of 
saturated sodium bicarbonate solution (2 ml) and diethyl ether (20 ml). The organic layer 
was separated, and the aqueous layer was extracted with ether (2 x 10 ml) and ethyl acetate 
(10 ml). The combined organics were dried (MgSO4) and the solvent was removed in vacuo. 
The resulting oil was purified by column chromatography (silica, 0—*100% ethyl acetate in 
petroleum ether, gradient elution) to yield a white solid (43 mg, 42%) that was identified as 
starting material, a colourless oil Rf 0.59 (hexane:ether, 1:2) (17 mg, 14%) this was thought 
to be the desired nojirilactam and a brown oil Rf 0.12 (hexane:ether, 1:2) (8 mg, 8%) this 
was thought to be the side product. 
3.9.3.6 Attempted Synthesis of N-Benzyloxycarbonyl-2,3,4,6-tetra-0-benzyl-D-
glucono-6-lactam (185)170 
To a stirred, ice-cold, solution of iminosugar 182 (577 mg, 1.07 mmol) in chloroform (25 
ml) were added sequentially, triethylamine (1 ml) and benzyloxycarbonyl succinimide (1.02 
g, 3.85 mmol). The reaction mixture was allowed to return to room temperature and stirred 
for 18 h. The solution was washed with brine, dried (MgSO4) and the solvent removed in 
vacuo to leave a white solid. This solid was purified (silica, 0-100% ethyl acetate in 
182 
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petroleum ether, gradient elution) to give the iminosugar 182 and CbzOSuc as an inseparable 
mixture. 
3.9.3.7 N-Boc-2,3,4,6-tetra-0-benzyl-D-glucono--lactam (178)137 
Boc 
Lab. Book Ref, KG 385 	 BnON 0 
Molecular Formula C39H43N07 	
BT'OBn Formula Weight 637 	 OBn 
A solution of lactam 182 (232 mg, 0.43 mmol) and DMAP (16 mg, 0.13 mmol) in 
acetonitrile (7 ml) was treated with Boc20 (200 mg, 0.92 mmol) and stirred for 5.5 h. The 
solvent was removed and the resulting oil was purified by column chromatography (silica, 
0->100% diethyl ether in hexane, gradient elution) to give the title compound as a yellow oil 
(164 mg, 46%); Rf 0.32 (petroleum ether:ethyl acetate, 4:1); Rf 0.63 (diethyl ether:hexane, 
2:1); MD 25 +13.8 (c = 0.8, CHC13); E, (250 MHz, CDC13) 1.65 (9H, s, CMe3), 3.63 (IH, dd, 
6a-H), 3.76 (lH, dd, 6b-H), 3.98-4.07 (2H, m, 3-H, 4-Fl), 4.33-5.23 (10H, m, CH2Ph, 2-H, 5-
H), 7.35-7.60 (20H, m, Ph); J(x-y)/Hz 2-3 nd, 3-4 nd, 4-5 nd, 5-6a 4.85, 5-6b 6.07, 6a-6b 
9.68; 8C(63  MHz, CDC13) 27.8 (C(CH3)3), 57.6 (C-5), 69.4 (C-6), 71.5, 73.1, 73.4, 73.9 (4 x 
CH2Ph), 76.0, 79.5, 81.7 (C-2, C-3, C-4), 83.5 (C(CH3)3), 127.5-128.3 (20 x CHPh), 137.4, 
137.8 (4 x qCPh), 151.9 (NCO2CMe3), 169.4 (C-i); m/z (FAB) 1298 (2 M + Na), 638 (M+ 




Lab. Book Ref. KG 388 	 I 
BnO
N  
Molecular Formula C40H43N06 	
B1"OBn Formula Weight 635 
OBn 
N-Boc-3,4,5,7-tetra-D-0-benzyl--glucolactam (178) (290 mg, 0.46 mmol, I eq.) was 
dissolved in sodium-dried ether (50 ml) with the Petasis reagent, (115) (2 eq.), the reaction 
mixture was heated at 70°C for 24 h. The solvent was removed in vacuo and the residue was 
purified by column chromatography to afford the title compound as a white solid (15 mg, 
8%); mp 63-64°C; Rf 0.45 (petroleum ether:ethyl acetate, 4:1); [a]D25 +40.0 (c = 0.3, CHC13); 
oH (250 MHz, CDC13) 1.49 (9H, s, CMe3), 3.60-3.72 (5H, m, 4-H, 5-H, 6-H, 7a-H, 7b-H), 
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3.89 (1H, d, 3-H), 4.41-4.82 (10H, in, CH2Ph, la-H, lb-H), 7.00-7.29 (20H, in, Ph); J(x-
y)/Hz la- lb nd, 3-4 7.22, 4-5 nd, 5-6 nd, 6-7a nd, 6-7b nd. 
3.9.3.9 (5R,7S,8R,9S,1OR)-N-Boc-8,9,1O-trs(benzyIoxy)-7-benzy1oxymethyI-3-pheny1-
1-oxa-2,6-diazaspiro [4.5] dec-2-ene (186) 
Ph 
Boc 	/ 
Lab. Book Ref. KG 392 	 BflO TN 
I 	I"o' Molecular Formula C47H50N207 	
BnO('"OBn 
Formula Weight 754 	 OBn 
Triethylamine (0.30 ml, 3.0 mmol) in sodium-dried ether (50 ml) was added to a mixture of 
N-Boc-2,6-anhydro-3 ,4,5 ,7-tetra-O-benzyl- 1 -deoxy-6-aza-D-gluco-hept- 1 -enitol (60) and 
benzohydroximoyl chloride (68) (222 mg, 1.43 mmol) in sodium-dried ether (50 ml). The 
reaction mixture was filtered and the solvent removed in vacuo and the residue was purified 
by column chromatography to yield, in order of elution, an unidentified oil (273 mg) and the 
product as a white solid (35 mg, 3% over two steps); Rf 0.14 (petroleum ether:ethyl acetate, 
4:1); [ct]D-7.1 (c = 0.7, CHC13); 	(360 MHz, CDC13) 1.31 (9H, s, CMe3), 3.12 (2H, s, 4-H), 
3.60 (1H, dd, I la-H), 3.75 (1H, d, 10-H), 3.79 (1H, dd, 1 lb-H), 3.84 (1H, t, 8-H), 4.08 (IH, 
dt, 7-H), 4.15 (lH, t, 9-H), 4.48-5.07 (8H, in, CH2Ph), 7.21-7.45 (25H, in, Ph); J(x-y)IHz 7-8 
9.8, 7-11a 1.9, 7-11b 2.9, 8-9 9.5, 9-10 9.7, lla-llb 10.9; m/z (FAB) Found: M+l 
755.3691. C47H51N207 requires M+l 755.3696, 654 (M+1 —Boc). 
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3.10 	Nitrile Sulfide Chemistry 
3.10.1 Synthesis of 5-(2',3' 
one (203) 
3.10.1.1 C_(2,3,4_Tri_O_acetyl_-D-xyIopyraflOSYl)fOrmamide (206)143 
Lab. Book Ref. KG 184 0 
NH2  
Molecular Formula C12H17N08  
Formula Weight 303 	
AcO" 	"OAc 
OAc 
2,3,4Tri-Oacetyl-p-D_xylopyranoSylnitrile (107) (1.71 g, 6.0 mmol, 1 eq.) was dissolved in 
glacial acetic acid (5 ml) under nitrogen and the solution was cooled in an ice bath. Titanium 
tetrachloride (0.13 ml, 0.75 mmol, 0.13 eq.) was added to the solution this was followed by 
water (0.11 ml, 1 eq.). After 30 min the ice bath was removed, and the mixture was stirred 
for 5 days at room temperature. The solution was poured into stirred ice-water (50 ml) and 
then extracted into chloroform (3 x 50 ml). The combined organics were washed with cold 
sat. NaHCO3  (3 x 50 ml) followed by water (50 ml) and dried (MgSO4). The solvent was 
removed in vacuo and the resulting solid was recrystallised from chloroform/diethyl ether, 
this afforded the product (722 mg, 67%); mp 175°C; Rf  0.03 (petroleum ether:EtOAc, 1:1); 
[a]u18  —38.0 (c = 1.00, CHC13); 8H(2SO MHz, CDC13) 2.13, 2.14, 2.16 (9H, 3 x s, CH3), 3.48 
(1H, dd, 6a-H), 3.93 (1H, d, 2-H), 4.30 (1H, dd, 6b-H), 5.08 (1H, ddd, 5-H), 5.22 (1H, t, 3-
H), 5.36 (1H, t, 4-H), 6.28 (IH, broad s, NH), 6.54 (1H, broad s, NH); J(x-y)/Hz 2-3 9.6, 3-4 
9.3, 4-5 9.2, 5-6a 10.3, 5-6b 5.5, 6a-6b 11.3; 5c (63 MHz, CDCI3) 21.0(3 x CH3), 66.5 (C-6), 
69.1, 69.7, 72.9, 76.9 (C-2, C-3, C-4, C-5), 170.2, 170.3, 170.4 (3 x COCH 3, C- 1); m/z(FAB) 
Found: M+1 304.1027. C12H18N08  requires M+l 304.1032; Calc. For C12H17N08: C, 
47.53; H, 5.65; N, 4.62. Found: C, 47.37; H, 5.60; N, 4.34%. 
3.10.1.2 5-(2',3',4 '-Tri-O-acetyl-3-D-xylopyranosyl)-1 ,3,4-oxathiazol-2-one (203)55 56 
N—S 
Lab. Book Ref. KG 208  0 
0 
Molecular formula C13H15N09S  




(206) (117 mg, 0.39 mmol, 1 eq.) was 
dissolved in dry chloroform (10 ml) under nitrogen in a flask fitted with an HC1 trap. 
Chiorocarbonylsulfenyl chloride (0.08 ml, 0.94 mmol, 2.42 eq.) was added and the mixture 
was refluxed vigorously until the reaction was complete by tic (48 h). The solvent was 
removed in vacuo and the resulting solution was co-evaporated with toluene (3 x 20 ml) to 
give a brown solid. The solid was dissolved in DCM (50 ml) and purified by filtration 
through a thin silica pad (5 mm) to give the desired product as a white crystalline solid (104 
mg, 74%); mp 134-137°C; Rf  0.49 (ethyl acetate: petroleum ether, 1:1); [a]D18 -41.7 (c = 
0.48, CHC13); 81  (250 MHz, CDC13) 1.95, 1.98, 1.99 (9H, 3 x s, CH3), 3.36 (1H, dd, 5a'-H), 
4.20 (111, dd, 5b'-H), 4.25 (1H, d, 1'-H), 5.00 (1H, ddd, 41-H), 5.16 (IH, t, 2'-H), 5.22 (1H, 
t, 3'-H); J(x-y)/Hz 1'-2' 9.3, 2'-3' 9.2, 3'-4' 9.2, 4'-5a' 10.7, 4'-5b' 5.5, 5a'-5b' 11.4; 5c(63  
MHz, CDC13) 20.3, 20.5 x 2 (3 x CH3), 66.8 (C-5'), 68.1, 69.1, 72.0, 74.5 (C-l', C-2', C-3', 
C-4'), 155.4 (C-5), 169.3, 169.5, 169.9 (3 x GOGH3), 172.2 (C-2); m/z(FAB) Found: M+1 
362.0546. C121116N09S requires M+i 362.0547; Cale. For C13H15N09S: C, 43.21; H, 4.18; 
N, 3.88. Found: C, 43.40; H, 4.20; N, 3.71%. 
3.10.2 	Synthesis of 5-(1 ',2',3' ,4'_TetraO_acety1-a-D_g1UCO-PentOPYra110SSYI)4 ,3,4- 
oxathiazol-2-one (204) 
3.10.2.1 C-(1 	 0rmamide (207)171 
0 
Lab. Book Ref. KG 333a
H2NV."OAc 
\OAC 
Molecular Formula C14H19NO10  
AcO" 
Formula Weight 361 	 OAc 
Acetic anhydride (20 ml) was added to a suspension of glucuronamide (2.00 g, 10.4 mmol) 
in pyridine (20 ml), and the reaction mixture left stirring overnight, under nitrogen, at room 
temperature. The mixture was concentrated in vacuo, azeotroped with toluene followed by 
diethyl ether. The product recrystallised from ethanol to give the title compound as small 
colourless crystals (3.424 g, 92%); mp 155-156°C; Rf  0.12 (petroleum ether:ethyl acetate, 
1:1); [U]D18 = +10.4 (c = 1.0, CHG13); 8H (250 MHz, CDC13) 2.40, 2.19, 2.19 (12H, 4 x s, 
GOGH3), 4.40 (1H, d, 5-H), 5.19 (111, dd, 2-H), 5.34 (1H, dd, 4-H), 5.64 (1H, t, 3-H), 6.02 
(1H, broad s, CONH2), 6.48 (1H, d, 1-H), 6.55 (1H, broad s, CONH2); J(x-y)IHz 1-2 3.6, 2-3 
10. 1, 3-4 9.6, 4-5 10.1; 6c (63 MHz, CDC13) 20.3, 20.5, 20.6 (4 x GOGH3), 68.8, 70.1 (C- 1, 
186 
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C-2, C-3, C-4), 88.1 (C-5), 168.7, 168.9, 169.6, 169.7 (4 x COCH3, CONH2); m/z(FAB) 
Found: M+1 362.1086. C14H20N010  requires M+1 362.1087. 




Lab. Book Ref. KG 333
01.  
0--k 
Molecular Formula Cl5Hl7N011S 	
10 5 
Formula Weight 419 	
AcO"4' 	"OAc 
OAc 
Chiorocarbonylsulfenyl chloride (0.1 ml, 1.2 mmol, 4.2 eq.) was added to a solution of 
amide 207 (100 mg, 0.28 mmol) in Na-dried toluene (3 ml), and the mixture heated at reflux 
for 6 h. The reaction mixture was concentrated, azeotroped with toluene and recrystallised 
twice from ethyl acetate to give the title compound as small colourless crystals (92 mg, 
82%); mp 212-214°C; Rf  0.82 (petroleum ether:ethyl acetate, 1:1); [a]D'8 = + 12.7 (c = 1.0, 
CHC13); 6H (250 MHz, CDC13) 2.03, 2.04, 2.07, 2.23 (12H, 4 x s, COCH3
), 4.75 (IH, d, 5'-
H), 5.16 (IH, dd, 2'-H), 5.30 (1H, t, 4'-H), 5.58 (1H, t, 3'-H), 6.42 (1H, d, l'-H); J(x-y)/Hz 
1'-2' 3.6, 2'-3' 10.3, 3'-4' 9.9, 4'-5' 10.1; 8c (63 MHz, CDC13) 20.8 (4 x COCH3), 68.9, 
69.1, 69.2, 69.6 (C-l', C-2', C-3', C-4'), 89.1 (C-5'), 155.4 (C-5), 168.8, 169.8, 169.9 (4 x 
COCH3), 170.3 (C-2) m/z(FAB) M+l Found 420.0600. C15H,8NO11S requires M+l 
420.0601. 
3.10.3 	Synthesis 	of 	5-(2',3' 	 ,3,4- 
oxathiazol-2-one (205) 
3.10.3.1 
(2,3,4,6_Tetra-O-acetyl-1-deOXY-l- /J_Dg1ucopyranosylnitrOmethanC) (209) 
' 14 
Lab. Book Ref. KG 337 	 AcO 	
0 	
NO2 
Molecular Formula C15H21N0,1 	 AcO" 	"OAc 
Formula Weight 391 	 OAc 
Sodium (2.55 g, 111 mmol, 1.3 eq.) was added portionwise to ice cold dry methanol (90 ml) 
and left stirring until homogeneous. The resultant solution was added dropwise over a period 
of 10 min to a solution of D-glucose (15.10 g, 83.8 mmol) in nitromethane (45 ml) and dry 
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methanol (30 ml), and the mixture left stirring overnight. The resultant solid was filtered off, 
washed with ice-cold methanol, and sucked dry. This was dissolved quickly in ice-cold water 
and passed down a column of amberlite JR 120 (plus) resin, for the preparation of the 
column see section 3.2.4.1. The resin was washed through with water (100 ml) and the 
combined eluents concentrated in vacuo until only -150 ml remained. The solution was 
taken onto the next stage without further purification. 
The solution produced above was heated at reflux overnight, then activated charcoal (3 g) 
added and the mixture was refluxed for a further 2 h. The reaction mixture was hot filtered 
through celite and concentrated in vacuo to -'30 ml, then transferred to a liquid-liquid 
extractor, and extracted over 3 days (water/ethyl acetate). The organic phase was 
concentrated to give the crude product as orange-brown crystals that were taken onto the 
next stage without further purification. 
Trifluoromethylsulfonic a cid (0.1 ml) was added to an ice-cold suspension of the crystals 
produced above in acetic anhydride (20 ml) under nitrogen. The mixture was allowed to 
warm to room temperature, and left stirring overnight. Ice-water (ca. 100 ml) was added to 
the reaction mixture, and this was stirred for a further hour, before extracting the product 
with chloroform. The organic extracts were washed with H20 (50 ml) and saturated aqueous 
NaCl (50 ml), then (MgSO4), filtered and the solvent removed in vacuo. The resultant dark 
brown oil was azeotroped with toluene, then dissolved in chloroform (50 ml) and activated 
charcoal (ca. 2 g) added. The mixture was heated to reflux for 30 min and hot-filtered 
through a celite pad. The solvent was removed in vacuo, and the product recrystallised from 
ethanol to the title compound as a white solid (4.86 g, 15% over three steps); mp 143-144°C 
(lit.'59 144-145°C); 6 (250 MHz, CDC13) 1.99, 2,01, 2.05, 2.07 (12H, 4 x s, COCH3), 3.74 
(1H, in, 6-H), 4.03 (1H, dd, 7a-H), 4.29 (2H, in, 2-H, 7b-H), 4.42 (IH, dd, la-H), 4.53 (1H, 
dd, lb-H), 4.93 (1H, t, 3-H), 5.07 (1H, t, 5-H), 5.26 (1H, t, 4-H); J(x-y)/Hz la-lb 13.6, la-2 
2.7, lb-2 10.0, 2-3 9.7, 3-4 9.6, 5-6 9.7, 6-7a 2.1, 6-7b nd, 7a-7b 12.5, 8c (63 MHz, CDC13) 
20.4, 20.5 (4 x COCH3), 61.4 (C-7), 67.7, 69.1, 73.4, 74.2, 75.7 (C-2, C-3, C-4, C-5, C-6), 
75.5 (C-i), 169.2, 169.5, 169.9, 170.4 (4 x COCH3); m/z(FAB) M+l Found 392.1189. 
C15H22N0,, requires M+1 392.1193. 
Experimental Procedures 
3.10.3.2 2,3,4,6-Tetra-0-acetyl-1-deOXY-1- fJ_D-gucopyranosylnitrile (208)105 
Lab. Book Ref. KG 334 	 0 	N AcO 
Molecular Formula C151119N09 
Formula Weight 357 	 OAc 
Phosphorous trichloride (0.4 ml, 4.58 mmol, 1.2 eq.) was added to an ice-cold solution of 
209(1.50 g, 3.84 mmol) in pyridine under nitrogen; the reaction mixture was allowed to 
warm to room temperature and left stifling for 72 h. The resultant dark-brown mixture was 
quenched with ice-cold aqueous HCl (1M, Ca. 150 ml) and left stifling for 1 h then extracted 
with chloroform (3 x 150 ml). The organic extracts were combined, washed with saturated 
aqueous NaHCO3 (100 ml), H20 (50 ml) and saturated aqueous NaCl (50 ml). The organic 
layers were then dried (MgSO4) and the solvent removed in vacuo to give an orange-brown 
oil. This was dissolved in DCM (ca. 100 ml), passed through a silica pad and concentrated in 
vacuo to give the title compound as a white solid (812 mg, 59%); mp 110-111°C 
(,it.  112 114- 
115°C); Rf  0.33 (petroleum ether:ethyl acetate, 1:1); 6H (250 MHz, CDC13) 2.03, 2.04, 2.11 
(12H, 4 x s, COCH3), 3.73 (1H, m, 6-H), 4.20 (2H, ddd, 7a-H, 7b-H), 4.33 (1H, d, 2-H), 
5.07-5.22 (2H, m, 3-H, 5-H), 5.32 (IH, t, 4-H); J(x-y)/Hz 2-3 10.1, 3-4 9.8, 4-5 9.8, 5-6 9.4, 
6-7a 4.8, 6-7b 2.3, 7a-7b 12.7; 8c (63 MHz, CDC13) 20.3 (4 x COCH3), 61.3 (7-C), 66.3, 
67.1, 68.8, 72.7, 76.7 (C-2. C-3, C-4, C-5, C-6), 114.0 (C-i), 168.6, 169.0, 169.9, 170.4(4 x 
COCH3); m/z(FAB) M+1 Found 358.1137. C,5H20N09  requires M+1 358.1138. 
3.10.3.3 C-(2,3,4,6-Tetra-O-acetyl-1-deOXY-1- fl-D-glucopyranosyl)formamide (210)' 
43 
Lab. Book Ref. KG 336 	 AcO 0 NH2  
Molecular Formula C15H21N0,0 	 AcO>'/OAC 
Formula Weight 375 	 OAc 
Titanium tetrachloride (0.05 ml, 0.45 mmol, 0.16 eq.) and water (0.06 ml, 3.3 mmol, 1.2 eq.) 
were added to an ice-cold solution of nitrile 208 (1.00 g, 2.80 mmol) in glacial acetic acid (5 
ml) and stifled at 0°C for -.30 mm. The reaction mixture was allowed to warm to room 
temperature and left stirring for 5 days. Then it was poured into stirred ice-water (50 ml) and 
the product extracted with chloroform (3 x 50 ml). The organic extracts were combined, 
washed with saturated NaHCO3  solution (50 ml) and saturated NaCl (50 ml). The organic 
layer was dried (MgSO4), filtered and concentrated in vacuo. The resulting solid was 
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recrystallised from chloroformlEt20 (1:5) to give the title compound as fine white crystals 
(478 mg, 46%); mp partially 112-114°C, totally 146-147°C (lit.105 partially 112-114°C, totally 
146-1470C); [a]D25  +103.1 (c = 0.98, CHC13); Rf  0.05 (petroleum ether:ethyl acetate, 1:1); 
(250 MHz, CDC13) 1.81, 1.85, 1.88, 1.93 (12H, 4 x s, COCH3), 3.57-3.59 (1H, m, 6-H), 3.69 
(1H, d, 2-H), 4.00 (2H, ddd, 7a-H, 7b-H), 5.10 (1H, t, 3-H), 5.28 (1H, t, 5-H), 5.42 (1H, t, 4-
H), 5.49 (1H, broad s, NH) 6.20 (1H, broad s, NH); J(x-y)/Hz 2-39.6, 3-4 9.7, 4-5 9.7, 5-6 
10.3, 6-7a 2.2, 6-7b 7.0, 7a-7b 13.0; 6c  (63 MHz, CDC13) 20.2, 20.4, 20.5 (4 x COCH3), 61.8 
(C-7), 66.4, 68.1, 73.6, 75.0, 75.9 (C-2, C-3, C-4, C-5, C-6), 169.1, 169.8, 170.4, 170.5 (C-1, 
4 x COCH3); m/z(FAB) M+1 Found 376.1243. C15H22N010  requires M+1 376.1244. 
3.10.3.4 	 ,3,4-oxathiazol-2-one (205) 
NS 
Lab. Book Ref. KG 373  o 	/O 
Molecular Formula C1H19NO11S 	
AcO 	 0 
Formula Weight 433 	 AcO" 	"OAc 
OAc 
Chlorocarbonylsulfenyl chloride (0.1ml, 1.2 mmol, 4.5 eq.) was added to a solution of 210 
(100 mg, 0.27 mmol) in Na-dried toluene (3 ml), and the mixture heated at reflux for 4 h. 
The reaction mixture was concentrated in vacuo, azeotroped with toluene, then passed 
through a silica pad [cyclohexane:ethyl acetate, 1:1 (50 ml)] and concentrated in vacuo to 
give the title compound as a white solid (88 mg, 75%); mp 112-113°C; [all) 
25 +1.8 (c = 1.64, 
CHC13); Rf  0.43 (petroleum ether:ethyl acetate, 1:1); ö (250 MHz, CDC13) 2.02, 2.03, 2.07, 
2.09 (12H, 4 x s, COCH3), 3.70-3.86 (1 H, m, 5'-H), 4.06-4.19 (2H, m, 6'a-H, 6b'-H), 4.48 
(lH, d, 1'-H), 5.17 (1H, t, 2'-H), 5.30 (1H, t, 4'-H), 5.52 (1H, t, 3'-H); J(x-y)/Hz 1'-2' 10.0, 
2'-3' 9.6, 3'-4' 9.6, 4'-5' 9.4, 5'-6a' nd, 5'-6b' nd, 6a'-6b' nd; 8c (63 MHz, CDC13) 20.3, 
20.4 (4 x COCH3), 61.5 (C-6'), 66.3, 67.9, 70.2, 72.8, 73.8 (C-l', C-2', C-3', C-4', C-5'), 
156.1 (C-5), 168.9, 169.3, 169.7 (4 x COCH3) 170.0 (C-2); m/z(FAB) M+1 Found 
434.0752. C16H20N01 1 S requires M+1 434.0757. 
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3.10.4 	Reactions of Oxathiazolones 
3.10.4.1 Decomposition 	of 
	
5-(2' 	 ,3,4- 
oxathiazol-2-one (203) 
Lab. Book Ref. KG 297 
Molecular Formula C12H15N07 




Oxathiazolone 203 (101 mg, 0.28 mmol) was dissolved in m-xylene (5 ml) and the solution 
was heated at reflux, in the absence of a dipolarophile, for 36 h. Once cooled the solvent was 
removed in vacuo and the resulting oil was co-evaporated with toluene to give the n itrile 
decomposition product 107 as a white solid (80 mg, 100%). 
3.10.4.2 Decomposition of 5-(1 
1,3,4_oxathiazol-2-Ofle (204) 
Lab. Book Ref. KG 335 	
NI0 OA 




Formula Weight 343 	 OAc 
Oxathiazolone 204 (50 mg, 0.14 mmol) was dissolved in mesitylene (5 ml) was heated at 
reflux under a nitrogen atmosphere for 12 h. The reaction mixture was concentrated in vacuo 
the residual solvent was removed by azeotroping with toluene. The resulting white solid was 
identified as1,2,3,4-tetra-0-acetyl-a-D-gluco-pyranos-5-ylnitrile (210) (40 mg, 97%); mp 
212-215°C; [c]025  +83.9 (c = 0.62, CHC13); Rf  0.65 (petroleum ether:ethyl acetate, 1:1); 5
H 
(250 MHz, CDC13) 2.28, 2.30, 2.37, 2.47 (12H, 4 x s, COCH3
), 4.98 (lH, d, 5-H), 5.35 (1H, 
dd, 2-H), 5.54-5.70 (2H, m, 3-H, 4-H), 6.62 (1H, d, 1-H); J(x-y)/Hz 1-2 3.7, 2-3 9.5, 3-4 nd, 
4-5 10.0; Sc (63 MHz, CDCI3) 20.2, 20.6 (4 x COCH3
), 61.0, 68.1, 68.5,68.6(C-1, C-2, C-3, 
C-4), 88.3 (C-5), 114.0 (C-6), 167.9, 168.6, 169.2, 169.8 (4 x COCH3); m/z(FAB) M+l 
Found 344.0979. C14H18N09  requires M+1 344.0982; Calc. For C14H17NO9
: C, 48.98; H, 
4.99; N, 4.08. Found: C, 48.97; H, 5.38; N, 3.68%. 
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3.10.4.3 1 ,2,3,4-tetra-O-acetyl-cz-D-gluco-pyranosylnitrile (210) 
Lab. Book Ref. KG 374 	 NE 	0 \0Ac 
Molecular Formula C14H17N09 	
A'"OAc 
Formula Weight 34 	 OAc 
A solution of amide 207 (220 mg, 0.61 mmol) in thionyl chloride (1.0 ml) was heated to 
reflux for 72 h, then passed through a silica pad (eluting with 1:1 cyclohexane:ethyl acetate 
(50 ml)) and concentrated in vacuo to give 1 ,2,3,4-tetra-O-acetyl-a-D-gluco-pyranosyl nitrile 
(210) as a white solid (155 mg, 74%). 173 
3.10.4.4 Attempted Cycloaddition of 5-(2',3',4'-Tri-O-acetyl-f-D-xylopyranosyl)-1 ,3,4-
oxathiazol-2-one (203) with Ethyl Cyanoformate (ECF) 
Lab. Book Ref. KG 341 
Oxathiazolone 203 (100 mg, 0.28 mmol) and ECF (250 mg, 2.52 mmol, 9eq.) were dissolved 
in m-xylene under nitrogen, the solution was heated at reflux for 72 h. The reaction mixture 
was cooled and the solvent was removed in vacuo, the resulting oil was co-evaporated with 
toluene to remove the residual ECF to give a white solid (38 mg). The tic showed only one 
spot for the starting material but the 'H NMR and mass spectrum indicated it was shown that 
a mixture of the starting material and the nitrile was present in a 1:1 ratio. 
3.10.4.5 Attempted Cycloaddition of 5-(2 ',3',4'-Tri-O-acetyl-3-D-xylo-pyranosyl)-
1,3,4-oxathiazol-2-one (203) with Dimethyl Acetylenedicarboxylate (DMAD) 
Lab. Book Ref. KG 298 
Oxathiazolone 203 (100 mg, 0.28 mmol) and DMAD (358 mg, 2.52 mmol, 9eq.) were 
dissolved in m-xylene under nitrogen, the solution was heated at reflux for 48 h. The reaction 
mixture was cooled and the solvent was removed in vacuo the resulting oil was co-
evaporated with toluene to remove the residual DMAD to give the nitrile decomposition 
product as a white solid (79 mg, 100%). 
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3.10.4.6 Ethyl 	3(2',3',4'-tri-O-acety1--D-xy10-furaflOSyl)-1 ,2,4-thiadazole-5- 
carboxylate (212) 
Lab. Book Ref. KG 345A 
	
OEt 
Molecular Formula C16H20N09S 	 AcO""OAc 
Formula Weight 402 
	
OAc 
Oxathiazolone 203 (100 mg, 0.28 mmol) and ECF (472 mg, 4.76mmol, l7eq.) were 
dissolved in mesitylene, the solution was irradiated with microwaves for 5 mm (225 W, 
130°C). The reaction mixture was cooled and the solvent was removed in vacuo, the 
resulting oil was co-evaporated with toluene to remove the residual ECF that yielded a white 
solid containing a mixture of compounds. The tic showed several spots and the mass 
spectrum indicated the presence of the cycloadduct, the starting material and the two 
decomposition products (nitrile 107 and amide 206). The reaction mixture was then 
subjected to preparative tic to yield the starting material (48 mg, 48%), the nitrile (7 mg, 8%) 
and the amide (6 mg, 7%), it was not possible to isolate the cycloadduct via this method. 
Oxathiazolone 203 (100 mg, 0.28 mmol) and ECF (472 mg, 4.76 mmol, l7eq.) were 
dissolved in mesitylene under nitrogen and irradiated with microwaves for 10 mm (225 W, 
130°C), in an effort to maximise the yield of the reaction. The reaction mixture was cooled 
and the solvent was removed in vacuo the resulting oil was co-evaporated with toluene to 
remove the residual ECF that afforded a white solid containing a mixture of compounds. The 
tic showed several spots and the mass spectrum indicated the presence of the cycloadduct, 
and two decomposition products (nitrile 107 and amide 206). The reaction mixture was then 
subjected to preparative tic to yield the nitrile 107 (18 mg, 23%) and the amide 206 (27 mg, 
32%), again it was not possible to isolate the cycloadduct by this method. 
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3.10.4.7 Ethyl 3-(1 ',2',3',4'-Tetra-O-acetyl-a-D-gluco-pyranos-5'-yJ)-1 ,2,4-thiadiazole-
5-carboxylate (213): Method 1 
This expt. was carried out in collaboration with Mr M. Tackkett 
O Lab. Book Ref. n/a 	 S 
EtO N 
Molecular Formula C18H22N2011 S  
Formula Weight 474 	 AcO" 	"OAc 
OAc 
A solution of oxathiazolone 204 (500 mg, 1.2 mmol) and ECF (2.0 ml, 20.2 mmol, 16.9 eq.) 
in mesitylene (30 ml) was heated at reflux under a nitrogen atmosphere for 24 h. Mass 
spectrometry and tic confirmed no starting material remained, so the reaction mixture was 
concentrated in vacuo and azeotroped with toluene to give a light yellow-brown solid. 
Purified by column chromatography (silica, 0—>100% ethyl acetate in cyclohexane, gradient 
elution) to give 212 mg of a mixed fraction containing cycloadduct 213 and the 
corresponding nitrile 210. Successive preparative tic (98:2 DCM:methanol) gave the title 
compound as a white solid (6 mg, IN; 6H (250 MHz, CDCI3) 1.46 (3H, t, CH3CH200C), 
1.92, 2.07, 2.08, 2.23 (12H, 4 x s, COCH3), 4.53 (2H, q, CH3CH2), 5.29 (1 H, dd, 2'-H), 5.37 
(lH, d, 5'-H), 5.52 (1H, t, 4'-H), 5.67 (IH, t, 3'-H), 6.49 (1H, d, l'-H); J(x-y)/Hz CH3CH2 
7.1, 1'-2' 3.8, 2'-3' 10.4, 3'-4' 9.7, 4'-5' 9.8; m/z(FAB) M+l Found 475.1034. 
C18H23N20 31 S requires M+1 475.1023. 
3.10.4.8 Ethyl 3-(1 ',2 ',3',4'-Tetra-O-acetyl-a-D-gluco-pyranos-5'-yl)-1 ,2,4-thiadiazole-
5-carboxylate (213): Method 2 
This expt. was carried out in collaboration with Mr M. Tackkett 
Lab. Book Ref. KG 393 	 EtO 	N 
Molecular Formula C18H22N2011S 	
AcO" 	"OAc 
Formula Weight 474 	 OAc 
Oxathiazolone 204 (105 mg, 0.25 mmol) and ECF (0.42 ml, 4.25 mmol, 17eq.) were 
dissolved in mesitylene and was irradiated with microwaves for 15 mill (225 W, 130°C), in 
an effort to maximise the yield o ft he reaction. The reaction mixture was cooled and the 
solvent was removed in vacuo, the resulting oil was co-evaporated with toluene to remove 
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the residual ECF that left a white solid (47 mg), which contained the starting material and a 
small quantity of the title compound. 
3.10.4.9 Attempted Reaction of 5-(1 ',2',3',4'-Tetra-O-acetyi-a-D-gluco-pentopyranos 
5'-yI)l ,3,4-oxathiazol-2-one (204) and DMAD 
Lab. Book Ref. n/a: This expt. was carried out in collaboration with Mr M. Tackkett 
A solution of 204 (500 mg, 1.2 mmol) and DMAD (2.2 ml, 17.9 mmol, 15 eq.) in mesitylene 
(30 ml) was heated at reflux under a nitrogen atmosphere for 24 h. It was indicated by tic 
that some starting material remained, and the mass spectrum showed no product peaks. After 
cooling, large crystals had formed in the reaction mixture; these were removed by filtration 
and washed with diethyl ether to give oxathiazoione 204 (306 mg, 61%). The filtrate was 
concentrated in vacuo, azeotroped with toluene, and purified by column chromatography 
(silica, 0—*100% ethyl acetate in cyclohexane, gradient elution) to give nitrile 210 (94 mg, 
23%), but no cycioadduct could be detected. 
3.10.4.10 Attempted Reaction of 5-(2',3 ',4',6'-Tetra-O-acetyi--D-giucopyranosyi)-
1,3,4-oxathiazol-2-one (205) and ECF 
Lab Book Ref, KG 380 
Oxathiazolone 205 (148 mg, 0.34 mmol) and ECF (0.57 ml, 5.78 mmol, 17 eq.) were 
dissolved in mesityiene under nitrogen and the solution was irradiated with microwaves for 
15 mm (225 W, 130°C), in an effort to maximise the yield of the reaction. The reaction 
mixture was cooled and the solvent was removed in vacuo the resulting oil was co-
evaporated with toluene to remove the residual ECF to give a white solid, which contained 
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Appendix 1: X-ray Crystal Data for 129 
Table 1. Crystal data and structure refinement for kg127a. 
Contact Alice Dawson c4ed.ac.uk 
A. CRYSTAL DATA 
Empirical formula C19 H21 N 08 
C19 H21 N 08 
Formula weight 391.37 
Wavelength 0.71073 A 
Temperature 150(2) 	K 
Crystal system Monoclinic 
Space group P2(1) 
Unit cell dimensions a 	= 9.0722(14) A 	alpha = 90 deg. 
b = 5.5871(8) A beta = 92.223(3) 	deg. 
c 	= 18.620(3) A 	gamma = 90 deg. 
Volume 943.1(2) 	A3 
Number of reflections for cell 2087 	(2.03 	< theta < 	26.24 	deg.) 
Z 2 
Density 	(calculated) 1.378 Mg/mA3 
Absorption coefficient 0.108 mm'-1 
F(000) 412 
DATA COLLECTION 
Crystal description 	 colourless Plate 
Crystal size 	 0.30 x 0.23 x 0.08 mm 
Theta range for data collection 	2.19 to 26.44 deg. 
Index ranges 	 -9<=h<=11, -6<=k<=6, -23<=l<=22 
Reflections collected 	 5432 
Independent reflections 	 2125 [R(int) = 0.03541 
Scan type 	 \w scans 
Absorption correction 	 Multiscan (Tmin= 0.8908, Tmax=1.0) 
SOLUTION AND REFINEMENT. 
Solution 	 direct (SHELXS-97 (Sheldrick, 1990)) 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
Hydrogen atom treatment 
Data / restraints / parameters 
Goodness-of-fit on F2 
Conventional R [F>4sigma(F)] 
Weighted R (F2 and all data) 
Full-matrix least-squares on F2 
SHELXL- 97 
ge om 
riding, Me gps riding rotating 
2125/1/256 
1.163 
Rl = 0.0486 	[1935 data] 
wR2 = 0.1001 
Absolute structure parameter 	0(10) 
Final maximum delta/sigma 	 0.000 
Weighting scheme 
calc 	 where P=(Fo2+2Fc2A)/3 
Largest diff. peak and hole 	0.210 and -0.189 e.A'-3 
Table 2. Atomic coordinates ( x l04) and equivalent isotropic 
displacement parameters (A2 x 10A3)  for kg127a. 	U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensor. 
x y z U(eq) 
C(5) 2671 (3) 65(6) 7057 (2) 23(1) 
C(4) 1348 (3) -1417(6) 6817 (2) 22(1) 
C(3) 450 (4) 444 (6) 6423 (2) 22(1) 
 -854(3) -48(6) 5942 (2) 24(1) 
 -1320(4) 1603 (7) 5422 (2) 29(1) 
 -2554(4) 1103(8) 4976(2) 38(1) 
 -3301(4) -1023(8) 5044 (2) 40(1) 
 -2841(4) -2683(8) 5562 (2) 42(1) 
 -1615(4) -2196(7) 6005(2) 33(1) 
N(2) 879(3) 2603 (6) 6551(l) 26(1) 
0(1) 2138 (2) 2487 (4) 7041(l) 26(1) 
C(10) 3327(3) -567(6) 7804 (2) 23(1) 
0(101) 2290(2) -24(5) 8338(1) 28(1) 
C(102) 1893 (4) -1865(8) 8773 (2) 33(1) 
0(103) 2254 (3) -3895(5) 8691(l) 45(1) 
C(104) 934 (4) -955(9) 9350(2) 49(1) 
C(9) 4754 (3) 734 (6) 7997 (2) 23(1) 
0(91) 5353 (2) -620(4) 8604(1) 27(1) 
C(92) 6122 (4) 505(7) 9141 (2) 28(1) 
0(93) 6383 (3) 2623(S) 9142(1) 36(1) 
C(94) 6577(4) -1241(8) 9713 (2) 39(1) 
C(8) 5805(3) 698(6) 7387(2) 23(1) 
0(81) 6924 (2) 2512 (4) 7505(1) 27(1) 
C(82) 8229(4) 1823(6) 7832(2) 26(1) 
0(83) 8540(3) -234(5) 7942(1) 35(1) 
C(84) 9127(4) 3951(7) 8047(2) 33(1) 
C(7) 5002(4) 1362 (7) 6682 (2) 29(1) 
0(6) 3774 (2) -205(4) 6549(1) 26(1) 
Table 3. Bond lengths [A] 	and angles [deg] 	for kg127a. 
C(5)-0(6) 1.412(4) 
C(5)-0(l) 1.436(4) 







C(31) -C(36) 1.392(5) 




















C(9) -0(91) 1.447(4) 
C(9)-C(8) 1.512(4) 







C(8) -0(81) 1.445(4) 
C(8)-C(7) 1.522(4) 
C(8) -H(8) 1.0000 
0(81) -C(82) 1.366(4) 
C(82)-0(83) 1.199(4) 











0(1) -C(S) -0(10) 110.7(3) 
C(4)-C(5)-C(10) 114.7(3) 
C(3)-C(4)-C(5) 100.1(3) 





N(2) -0(3) -0(31) 121.0(3) 
N(2)-C(3)-C(4) 113.9(3) 
0(31) -0(3) -C(2) 125.1(3) 
0(36) -0(31) -0(32) 119.5(3) 
0(36) -0(31) -C(3) 119.8(3) 
0(32) -0(31) -C(3) 120.8(3) 
0(31) -0(32) -C(33) 119.8(4) 
0(31) -0(32) -1-1(32) 120.1 
C(33)-C(32)-H(32) 120.1 
C(34)-C(33) -C(32) 120.3(4) 
0(34) -C(33) -H(33) 119.9 
C(32)-C(33)-H(33) 119.9 
C(33) -C(34) -C(35) 120.3(4) 
0(33) -C(34) -H(34) 119.8 
C(35)-C(34)-H(34) 119.8 
C(36) -C(35) -0(34) 119.6(4) 
0(36) -C(35) -H(35) 120.2 
C(34)-C(35)-H(35) 120.2 
0(35) -C(36) -0(31) 120.5(3) 
0(35) -C(36) -H(36) 119.7 
C(31)-C(36) -H(36) 119.7 
0(3) -N(2) -0(1) 107.6(3) 
N(2)-0(1)-C(5) 108.3(2) 
0(101) -0(10) -0(9) 108.2(3) 
0(101) -C(10) -0(5) 109.8(2) 
0(9) -C(10) -C(5) 113.8(3) 













0(91) -0(9) -0(8) 110.6(2) 
0(91)-C(9)-C(10) 103.1(3) 















0(81) -C(8) -C(7) 105.7(2) 
C(9)-C(8)-C(7) 110.5(3) 
0(81)-C(8)-H(8) 110.3 
C(S) -C(S) -H(S) 110.3 
C(7) -C(8) -H(S) 110.3 
C(82) -0(81) -C(8) 117.5(3) 
0(83) -C(82) -0(81) 122.8(3) 
0(83)-C(82)-C(84) 126.7(3) 






H(843) -C(84) -H(84C) 109.5 
0(6)-C(7)-C(8) 110.1(3) 
0(6)-C(7)-H(71) 109.6 
C(S) -C(7) -H(71) 109.6 
0(6)-C(7)-H(72) 109.6 
C(8)-C(7)-H(72) 109.6 
H(71) -C(7) -H(72) 108.2 
C(5)-0(6)-C(7) 112.7(2) 
Symmetry transformations used to generate equivalent atoms: 
Table 4. 	Anisotropic displacement parameters (A2 x l03) for kg127a. 
The anisotropic displacement factor exponent takes the form: 
-2 pi'2 [ h'2 a*2  Ull + . . . + 2 h k a* b* U12 ] 
Ull U22 U33 U23 U13 U12 
C(S) 22(2) 22(2) 25(2) -4(1) 3(1) -2(1) 
C(4) 22(2) 18(2) 25(2) 0(1) -4(1) -1(1) 
C(3) 23(2) 20 (2) 24 (2) -1(1) -1(1) 1(1) 
C(31) 22(2) 28 (2) 22 (2) -5(2) -1(1) 5(2) 
C(32) 29(2) 30 (2) 27(2) 4(2) 3(1) 5(2) 
C(33) 36 (2) 53(3) 23 (2) 4(2) -2(2) 17(2) 
C(34) 36 (2) 48 (3) 34 (2) -15(2) -10(2) 7(2) 
C(35) 35(2) 33 (2) 58 (2) -11(2) -14(2) 3(2) 
C(36) 29(2) 30(2) 39 (2) 1(2) -8(2) 2(2) 
N(2) 24(1) 31(2) 25(1) 2(1) -4(1) 1(1) 
0(1) 25(1) 22(1) 29(1) -2(1) -5(1) 0(1) 
C(10) 20 (2) 23 (2) 25(2) 1(1) -1(1) -1(1) 
0(101) 22(1) 33(1) 29(1) 4(1) 3(1) -3(1) 
C(102) 25(2) 48 (3) 25(2) 4(2) -9(1) -15(2) 
0(103) 59(2) 38 (2) 38 (2) 10(1) 1(1) -19(2) 
C(104) 36(2) 79(4) 33 (2) -1(2) 4(2) -9(2) 
C(9) 23 (2) 21(2) 24 (2) 4(1) -4(1) 1(1) 
0(91) 27(1) 30 (1) 24 (1) 2(1) -2(1) -3(1) 
C(92) 20(2) 42(2) 22 (2) -6(2) 2(1) -3(2) 
0(93) 39(2) 35(2) 34 (1) -6(1) -3(1) -8(1) 
C(94) 35 (2) 51 (3) 30 (2) 4(2) -6(2) -7(2) 
C(8) 18 (2) 23 (2) 27(2) 0(1) 1(1) -2(1) 
0(81) 23 (1) 25(1) 34(1) 3(1) -3(1) -2(1) 
C(82) 21(2) 29(2) 27(2) -1(2) 5(1) -2(2) 
0(83) 26(1) 28(2) 50(2) 1(1) -5(1) 1(1) 
C(84) 24(2) 34 (2) 40(2) -1(2) 1(2) -3(2) 
C(7) 26(2) 34 (2) 28(2) 2(2) 1(1) -4(2) 
0(6) 22(1) 33 (1) 23 (1) -6(1) 0(1) -3(1) 
Table 5. 	Hydrogen coordinates 	( x 104) 	and isotropic 
displacement parameters (A'2 	x 10'3) for kg127a. 
x y z U(eq) 
H(4A) 1626 -2743 6497 26 
H(4B) 826 -2071 7231 26 
H(32) -800 3065 5370 34 
H(33) -2881 2237 4624 45 
H(34) -4134 -1359 4736 47 
H(35) -3364 -4142 5612 51 
H(36) -1291 -3337 6355 39 
H(10) 3526 -2327 7818 27 
H(104A) 1431 -1208 9821 74 
H(1043) -6 -1821 9330 74 
H(104C) 751 758 9278 74 
H(9) 4546 2419 8144 27 
H(94A) 5813 -1329 10070 59 
H(94B) 7509 -720 9947 59 
H(94C) 6709 -2823 9497 59 
H(8) 6271 -916 7348 27 
H(84A) 10173 3510 8077 49 
H(84B) 8827 4525 8516 49 
H(84C) 8973 5220 7688 49 
H(71) 4650 3037 6706 35 
H(72) 5688 1241 6283 35 
Appendix 2: X-ray Crystal Data for 133 
Table 1. Crystal data and structure refinement for kmg204. 
Contact 	 Andy Parkin, a.parkin@ed.ac.uk 
A. CRYSTAL DATA 






Unit cell dimensions 
deg 
Volume 





B. DATA COLLECTION 
Crystal description 
Crystal size 













a = 23.355(4) A 	alpha = 90 deg. 
b = 5.8198(11) A beta = 112.270(2) 
c = 27.228(5) A 	gamma = 90 deg. 
3424.8(11) A3 
4966 (2.4 < theta < 28.9 deg.) 
4 
1.272 Mg/m3 
0.084 mm" -1 
1392 
Colourless lath 
1.42 x 0.39 x 0.13 mm 
1.62 to 23.50 deg. 
-26<=h<=26, -6<=k<=6, -30<=l<=30 
11049 
5062 [R(int) = 0.03441 
phi scans 
Semi-empirical from equivalents (Tmin= 
C. SOLUTION AND REFINEMENT. 
Solution 	 direct (sir92) 
Refinement type 	 Full-matrix least-squares on F2 
Program used for refinement 	SHELXL-97 
Hydrogen atom placement 	 geometric 
Hydrogen atom treatment 	 riding 
Data / restraints / parameters 	5062/1/443 
Goodness-of-fit on F2 	 1.074 
Conventional R [F>4sigma(F)] 	Ri = 0.0543 [4467 data] 
Weighted R (F2 and all data) 	wR2 = 0.1251 
Absolute structure parameter 	0.0(8) 
*Absolute structure determined from precursor of known hand.* 
Extinction coefficient 	 0 
Final maximum delta/sigma 	 0.000 
Weighting scheme 
calc 	 where P=(Fo2+2FcA2)/3 
Largest diff. peak and hole 	0.385 and -0.361 e.A-3 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic 
displacement parameters (A2 x l03) for kmg204. 	U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensor. 
x y z U(eq) 
0(1) -9689(1) -4672(4) -3255(1) 34(1) 
N(2) -10341(l) -4808(5) -3554(1) 31(1) 
C(3) -10580(1) -2834(5) -3544(1) 26(1) 
 -11243(l) -2417(6) -3820(1) 29(1) 
 -11629(1) -4097(6) -4143(1) 36(1) 
 -12257(2) -3697(7) -4398(1) 39(1) 
 -12505(1) -1640(7) -4327(1) 41(1) 
 -12125(1) 28(7) -4009(1) 39(1) 
 -11504(1) -368(6) -3755(1) 34(1) 
C(4) -10116(1) -1068(6) -3239(1) 34(1) 
C(S) -9556(1) -2538(6) -2962(1) 31(1) 
C(10) -8938(1) -1646(6) -2941(1) 31(1) 
0(101) -8970(1) -1301(4) -3468(1) 35(1) 
 -8828(2) 997(6) -3570(1) 40(1) 
 -8932(2) 1233 (6) -4148(1) 37(1) 
 -9166(2) 3253 (7) -4414(1) 46(1) 
 -9267(2) 3507(8) -4946(2) 51(1) 
 -9136(2) 1726 (8) -5212(2) 53(1) 
 -8892(2) -290(8) -4954(2) 57(1) 
C(108) -8788(2) -554(7) -4420(1) 45(1) 
C(9) -8416(1) -3288(6) -2645(1) 40(1) 
0(91) -7834(1) -2335(5) -2577(1) 46(1) 
 -7589(2) -2843(11) -2972(2) 84(2) 
 -6904(1) -2969(7) -2716(1) 40(1) 
 -6528(2) -1141(7) -2768(1) 57(1) 
 -5876(2) -1350(8) -2512(1) 56(1) 
 -564S(2) -3282(9) -2225(2) 59(1) 
 -6008(2) -4933(8) -2180(2) 62(1) 
 -6614(2) -4813(7) -2420(1) 49(1) 
C(8) -8422(2) -3781(6) -2104(1) 42(1) 
0(81) -7987(1) -5582(4) -1868(1) 66(1) 
 -7515(2) -4995(8) -1373(1) 51(1) 
 -6975(2) -6582(6) -1259(1) 39(1) 
 -6418(2) -5998(7) -860(1) 51(1) 
 -5904(2) -7335(8) -751(2) 60(1) 
 -5931(2) -9320(8) -1031(2) 55(1) 
 -6478(2) -9959(8) -1428(1) 52(1) 
 -7000(2) -8601(7) -1538(1) 46(1) 
C(7) -9057(2) -4575(7) -2142(1) 48(1) 
C(71) -9100(2) -4841(11) -1605(2) 93(2) 
0(72) -8878(2) -2887(10) -1294(1) 119 (2) 
 -9268(2) -1837(9) -1145(3) 124(3) 
 -8994(2) 136(9) -755(2) 68(1) 
 -8371(2) 688(8) -575(2) 67(1) 
 -8131(2) 2501 (9) -236(2) 71(1) 
 -8498(2) 3808(11) -61(2) 85(2) 
 -9127(2) 3249(13) -241(2) 93 (2) 
 -9362(2) 1460(11) -582(2) 80(2) 
0(6) -9523(1) -2933(4) -2439(1) 39(1) 




C(3) -C(31) 1.464(4) 
C(3)-C(4) 1.495(4) 
C(31) -C(36) 1.380(5) 
-C(32) 1.393(4) 






C(5)-C(10) 1.514 (4) 
C(10) -0(101) 1.421(4) 


















C(97) -C(98) 1.317(5) 
C(8) -0(81) 1.431(4) 










C(7) -C(71) 1.511(5) 
C(71)-0(72) 1.395(7) 
0(72) -C(73) 1.281(7) 
C(73)-C(74) 1.530(8) 






N(2) -0(1) -C(5) 108.8(2) 
C(3)-N(2)-0(1) 108.4(2) 
N(2) -C(3) -C(31) 121.5(3) 
N(2)-C(3)-C(4) 113.5(3) 
C(31)-C(3)-c(4) 125.0(3) 
C(36) -C(31) -C(32) 118.5(3) 
C(36) -C(31) -C(3) 120.6(3) 
-C(31) -C(3) 120.8(3) 
-C(32) -C(31) 120.5(3) 
C(34)-C(33)-C(32) 119.9(3) 
C(33)-C(34)-C(35) 119.8(3) 
C(36) -C(35) -C(34) 120.4(3) 
C(35)-C(36)-C(31) 121.0(3) 
C(3) -C(4) -C(S) 101.3(3) 
0(6)-C(5)-0(1) 109.5(2) 
0(6) -C(5) -C(4) 107.4(2) 
0(1)-C(5)-c(4) 104.3(2) 
0(6)-C(S) -C(lo) 109.3(2) 
0(1) -C(S) -C(10) 108.6(2) 
C(4)-C(5) -C(10) 117.4(3) 
0(101) -C(10) -C(5) 108.9(2) 
0(101) -C(10) -C(9) 110.5(2) 
C(5)-C(10) -C(9) 111.4(3) 
C(10) -0(101) -C(102) 113.6(2) 







C(l06) -C(l07) -C(l08) 120.2(4) 
C(107)-C(108)-C(103) 119.6(4) 
0(91) -c(9) -C(8) 108.1(3) 
0(91) -C(9) -C (10) 111.1(3) 
C(8)-C(9)-C(10) 109.7(3) 
C(9) -0(91) -C(92) 117.4(3) 











C(9) -C(8) -C(7) 111.1(3) 
C(82)-0(8l)-C(8) 114.3(3) 
0(81) -C(82) -C(83) 109.7(3) 
C(84)-C(83) -C(88) 118.0(4) 
C(84) -C(83) -C(82) 118.5(3) 
C(88)-C(83)-C(82) 123.5(3) 
C(85)-C(84)-C(83) 121.1(4) 
-C(85) -C(86) 120.5(4) 
-C(86) -C(87) 119.8(4) 
C(86)-C(87)-c(88) 119.6(4) 
C(87) -C(88) -C(83) 120.9(3) 
0(6) -C(7) -C(71) 107.3(4) 
0(6) -C(7) -C(8) 110.3(3) 
C(71) -C(7)-C(8) 112.7(3) 












Symmetry transformations used to generate equivalent atoms: 
Table 4. 	Anisotropic displacement parameters (A2 x 103) for kmg204. 
The anisotropic displacement factor exponent takes the form: 











N(2) 24 (1) 37 (2) 27(1) -3(1) 2(1) -2(1) 
C(3) 30 (2) 30 (2) 17(2) -2(1) 9(1) 1(1) 
C(31) 27(2) 40(2) 18 (2) 0(2) 7(1) -1(2) 
C(32) 34 (2) 41(2) 31 (2) -1(2) 8(1) -1(2) 
C(33) 33(2) 46(2) 36 (2) -6(2) 9(2) -3(2) 
C (34) 25(2) 60 (2) 34 (2) 4(2) 7(1) 6(2) 
C(35) 32 (2) 43 (2) 36 (2) -1(2) 6(2) 9(2) 
C(36) 33 (2) 37(2) 27(2) -5(2) 8(1) 0(2) 
C(4) 29(2) 35 (2) 36 (2) -10 (2) 10(1) -3(2) 
C (5) 33 (2) 33 (2) 24 (2) -6(2) 9(1) 1(2) 
C(10) 33 (2) 36(2) 24(2) -7(2) 10 (1) -2(2) 
0(101) 43 (1) 36(1) 27(1) -7(1) 15(1) -6(1) 
C(102) 48 (2) 36 (2) 39 (2) -9(2) 21 (2) -12 (2) 
C(103) 36 (2) 44 (2) 33 (2) -2(2) 17 (2) -10 (2) 
C(104) 39 (2) 48 (2) 52(2) -2(2) 16(2) -6(2) 
C(105) 37 (2) 65 (3) 48 (2) 13 (2) 12 (2) -5(2) 
C(106) 48 (2) 76 (3) 35 (2) 2(2) 13 (2) -28(2) 
C(107) 77 (3) 61(3) 43 (2) -16 (2) 35 (2) -25(2) 
C(108) 58 (2) 45 (2) 34 (2) -10(2) 20(2) -11(2) 
C(9) 31 (2) 45 (2) 36 (2) -12 (2) 4(2) 1(2) 
0(91) 26 (1) 72 (2) 38 (1) -23(1) 8(1) 2(1) 
C(92) 36 (2) 146 (5) 63 (3) -42(3) 14 (2) 6(3) 
C (93) 29(2) 61 (3) 29 (2) -16 (2) 9(1) 5(2) 
C(94) 102 (3) 44 (3) 24 (2) -2(2) 23 (2) 19 (2) 
C(95) 69 (3) 69(3) 42 (2) -21(2) 34 (2) -40(3) 
C(96) 41(2) 85 (4) 48 (2) -10 (3) 14 (2) 10(2) 
C(97) 67(3) 58 (3) 54 (3) -5(2) 15(2) 6(3) 
C(98) 61 (3) 51(2) 40(2) -8(2) 25(2) -12(2) 
C (8) 38 (2) 38 (2) 36 (2) 1(2) -2(2) -1(2) 
0(81) 60(2) 41(2) 54 (2) 1(1) -30(1) 1(1) 
C(82) 45(2) 56(3) 35 (2) -2(2) -3(2) 0(2) 
C(83) 42 (2) 39(2) 29(2) 6(2) 3(2) -4(2) 
C(84) 49 (2) 48 (3) 45 (2) 1(2) 4(2) -2(2) 
C(85) 43 (2) 55 (3) 60 (3) 2(2) -3(2) -2(2) 
C(86) 52 (2) 58 (3) 58 (3) 8(2) 25 (2) 7(2) 
C(87) 77 (3) 47(2) 39(2) 4(2) 28 (2) 7(2) 
C(88) 57(2) 45(2) 26(2) 2(2) 4(2) -10(2) 
C(7) 47(2) 52 (2) 30 (2) 7(2) -2(2) -14(2) 
C(71) 87(3) 136(5) 37 (2) 13 (3) 3(2) -74(4) 
0(72) 105 (3) 219 (5) 42 (2) -49(3) 37(2) -112(3) 
C(73) 37 (3) 40(3) 231(8) 28 (4) -21(4) 7(2) 
C(74) 41 (2) 73 (3) 76 (3) 36 (3) 6(2) 8(2) 
C(75) 54 (3) 62 (3) 70 (3) 16 (3) 8(2) 4(2) 
C(76) 62 (3) 83 (4) 52 (3) 9(3) 6(2) -13(3) 
C(77) 93 (4) 112(5) 41(3) 4(3) 14(3) 4(4) 
C(78) 79(4) 150(6) 48 (3) 27(4) 20(3) 19(4) 
C(79) 60(3) 121(5) 48 (3) 46 (3) 8(2) -4(3) 
0(6) 39(1) 52(2) 26(1) -5(1) 13 (1) -9(1) 
Table 5. 	Hydrogen coordinates 	( x 10'4) 	and isotropic 
displacement parameters (A2 x 103) for kmg204. 
x y z U(eq) 
-11459 	 -5527 	 -4189 	 44 
-12516 -4843 -4621 47 
1-1(34) -12937 -1370 -4496 49 
H(35) -12294 1462 -3965 47 
H(36) -11248 784 -3530 40 
H(4A) -10250 -253 -2982 41 
H(43) -10039 66 -3478 41 
H(10) -8854 -135 -2752 37 
H(102A) -8391 1354 -3349 48 
H(102B) -9095 2095 -3478 48 
 -9259 4489 -4229 56 
 -9426 4909 -5124 61 
 -9214 1878 -5579 64 
 -8795 -1506 -5141 68 
 -8619 -1946 -4241 54 
H(9) -8475 -4757 -2849 48 
H(92A) -7711 -1628 -3247 100 
H(92B) -7756 -4326 -3145 100 
H(94) -6708 189 -2970 68 
H(95) -5609 -173 -2541 68 
H(96) -5210 -3444 -2050 71 
H(97) -5828 -6244 -1971 74 
H(98) -6857 -6063 -2385 59 
H(8) -8299 -2370 -1878 51 
H(82A) -7678 -5118 -1087 61 
H(82B) -7382 -3388 -1384 61 
H(84) -6393 -4644 -658 61 
H(85) -5525 -6888 -479 72 
H(86) -5572 -10251 -950 66 
H(87) -6497 -11321 -1627 63 
H(88) -7379 -9059 -1807 55 
H(7) -9151 -6088 -2330 57 
H(71A) -9536 -5107 -1652 111 
H(71B) -8855 -6195 -1422 111 
H(73A) -9454 -2964 -978 148 
H(73B) -9604 -1220 -1463 148 
 -8104 -208 -688 80 
 -7702 2846 -122 85 
 -8334 5057 175 102 
 -9394 4128 -125 112 
H(79) -9792 1128 -701 96 
Appendix 3: X-ray Crystal Data for 204 
Table 1. Crystal data and structure refinement for mt025a. 
Contact 	 Alice Dawson, alice.dawson@ed.ac.uk 







Unit cell dimensions 
Volume 





ClS H17 Ni 011 Sl 





P 21 21 21 
a = 8.8149(7) A 	alpha = 90 deg. 
b = 12.787(1) A beta = 90 deg. 
c = 16.4257(13) A 	gamma = 90 deg. 
1851.4(3) A'3 
















0.14 x 0.23 x 0.24 mm 
Bruker SMART 
2.018 to 28.782 deg. 
-ll<=h<=ll, -17<=k<=17, -21<=l<=21 
16665 
4525 [R(int) = 0.031 
\f & \w scans (phi and omega scans) 
Semi-empirical from equivalents 
(Tmin= 0.859225, Tmax=1.0) 
C. SOLUTION AND REFINEMENT. 
Solution 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
Hydrogen atom treatment 
Data 
Parameters 
Goodness-of-fit on F2 
R 
Rw 
Absolute structure parameter 
Final maximum delta/sigma 
Weighting scheme 
Largest diff. peak and hole 
direct (Shelxs 












0.63 and -0.53 e.A-3 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic 
displacement parameters (A2 x 103) for publish. 	U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensor. 
x y z U(eq) 
0(6') 6701 (2) 4382(1) 3588(1) 22 
C(11 ) 7945 (3) 4749(2) 4045(1) 21 
0(111 ) 7579(2) 5666(1) 4487(1) 23 
C(12') 6732(3) 5527(2) 5179(2) 29 
C(13 1 ) 6525(4) 6543(3) 5601(2) 45 
0(131 ) 6265(2) 4693(2) 5385(1) 37 
C(21 ) 9240(3) 5025(2) 3471(2) 19 
0(211 ) 10486(2) 5473(1) 3901(1) 24 
C(221 ) 11447(3) 4785(2) 4259(2) 28 
C(231 ) 12710(3) 5350(3) 4673(2) 41 
0(231 ) 11276(2) 3861(2) 4233(1) 35 
C(3 1 ) 8733(2) 5843(2) 2857(1) 18 
0(311 ) 9894 (2) 5944(1) 2250(1) 20 
C(32') 10569(3) 6894 (2) 2163 (2) 21 
C(331 ) 11592(3) 6879(2) 1437(2) 34 
0(33') 10348 (2) 7619(1) 2601(l) 30 
C(4') 7300(3) 5491(2) 2423(1) 18 
0(411 ) 6773(2) 6392(1) 1979(1) 20 
C(42') 5953(3) 6230(2) 1286(1) 19 
C(43 1 ) 5686(3) 7240(2) 858 (2) 26 
0(43') 5537(2) 5384(1) 1070(1) 25 
C(5 1 ) 6094(3) 5137(2) 3035(1) 19 
C(5) 4806(3) 4596 (2) 2619(1) 20 
0(1) 5191 (2) 3695 (1) 2223 (1) 24 
C(2) 3963 (3) 3313 (2) 1791(2) 27 
0(21) 4050(3) 2582(1) 1347(1) 38 
S(3) 2404(1) 4104(1) 2033 (1) 32 
N(4) 3454 (2) 4921 (2) 2612(1) 24 
Table 3. 	Bond lengths [A] and angles [deg] for publish. 
0(6')-C(1') 1.409(3) 
0(6')-C(5') 1.429(3) 
C(1' ) -0(11') 1.417(3) 
C(l' ) -C(2) 1.522(3) 
C(1' ) -H(ll') 1.002 
0(11') -C(12') 1.372(3) 
) -C(13') 1.483(4) 
C(12') -0(13') 1.192(3) 
C(13')-H(131') 1.000 
C(13')-H(132') 0.999 
) -H(133' ) 1.004 
C(2' ) -0(21') 1.426(3) 
C(2')-C(3') 1.521(3) 
C(2') -H(21') 1.001 
0(21') -C(22' ) 1.355(3) 
C(22') -C(23') 1.491(4) 
C(22') -0(23') 1.193(3) 
C(23' ) -H(231' ) 1.001 
C(23')-H(232') 0.999 
C (23' ) -H (233' ) 1.002 





C(32') -0(33') 1.190(3) 
C(33' ) -H(331') 0.999 
C(33' ) -H(332' ) 1.001 
C(33' ) -H (333' ) 1.004 
-0(41') 1.441(3) 
C(4') -C(5') 1.532(3) 
C (4' ) -H (41' ) 1.000 
0(41') -C(42' ) 1.364(3) 
) -C(43' ) 1.488(3) 
C(42') -0(43') 1.196(3) 
) -H(431') 1.000 
C(43')-H(432') 0.999 
C (43' ) -H (433' ) 1.002 









0(6') -C(1') -0(11') 111.8(18) 
0(6') -C(1')-C(2') 109.3(3) 
0(11') -C(l') -C(2') 107.3 (33) 
0(6') -C(1') -H(11') 106.997 
0(11') -C(l') -H(1l') 109.396 
C(2') -C(1')-H(ll') 112.133 
C(1') -0(11') -C(12') 116.2 (27) 
0(11') -C(12') -C(13') 109.9(42) 
0(11') -C(12')-0(13') 122.6(44) 
C(13')-C(12')-0(13') 127.51(18) 
C(12' ) -C(13' ) -H(131') 109.763 
C(12')-C(13')-H(132') 109.614 
H(131' ) -C(13') -H(132') 109.551 
C(12' ) -C(13' ) -H(133' ) 109.478 
H(131')-C(13')-H(133') 109.170 
H(132')-C(13')--I-j(133') 109.249 
C(1') -C(2' ) -0(21') 111.3(5) 
C(1') -C(2') -C(3') 110.5(14) 
0(21')-C(2')-C(3') 106.1(33) 
C(1' ) -C(2') -H(21') 106.378 
0(21') -C(2' ) -H(21' ) 110.718 
C(3' ) -C(2') -H(21' ) 111.866 




C(22' ) -C(23') -H(231') 109.514 
C(22' ) -c (23' ) -H (232' ) 109.614 
H(231' ) -C(23' ) -H(232') 109.497 
C(22' ) -C(23') -H(233') 109.579 
) -C(23' ) -H(233') 109.209 
) -C(23') -H(233' ) 109.413 
C(2') -C(3') -0(31') 108.2(18) 
C(2')-C(3')-C(4') 110.6(30) 
0(31')-C(3')-C(4') 107.1(6) 
C (2' ) -C (3' ) -H (31' ) 108.819 
0(31') -C(3') -H(31') 112.141 
C(4') -C(3') -H(31') 109.947 




C(32' ) -C(33') -H(331') 109.785 
C(32' ) -C (33' ) -H (332' ) 109.647 
H(331') -C(33' ) -H(332') 109.515 
C(32')-C(33')-H(333') 109.531 
H(331')-C(33')-H(333') 109.247 
H(332' ) -C (33' ) -H (333' ) 109.098 
C(3')-C(4')-0(41') 105.6(31) 
C (3' ) -C(4' ) -C(5' ) 110.854 
0(41') -C(4') -C(5') 110.2 (15) 
C(3') -C(4') -H(41') 111.345 
0(41') -C(4') -H(41' ) 111.865 
C(5' ) -C(4') -H(41' ) 107.055 
C(4' ) -0(41') -C(42' ) 118.1(26) 
0(41') -C(42' ) -C(43' ) 110.2 (35) 
0(41') -C(42')-0(43') 123.2(35) 
C(43') -C(42')-0(43') 126.61(6) 
C(42' ) -C(43') -H(431') 109.586 
C(42' ) -C(43') -H(432' ) 109.595 
H(431' ) -C(43' ) -H(432') 109.575 
C(42' ) -C(43') -H(433') 109.309 
-C(43' ) -H(433') 109.353 
-C(43' ) -H(433') 109.408 
0(6')-C(5')-C(4') 111.0(11) 
0(6')-C(5')-C(5) 105.2(32) 
C(4' ) -C(5') -C(5) 111.3(5) 
0(6') -C(5' ) -H(51' ) 111.631 
C(4' ) -C(5' ) -H(51') 105.980 
C(S) -C(5') -H(51' ) 111.848 
C(5' ) -C(S) -0(1) 114.7(13) 
C(5')-C(5)-N(4) 124.7(37) 
0(1) -C(5) -N(4) 120.6(23) 
C(5) -0(1) -C(2) 110.3 (12) 
0(1)-C(2)-0(21) 122.8(21) 
0(1) -C(2) -5(3) 107.1(29) 
0(21)-C(2)-s(3) 130.1(8) 
C(2)-S(3)-N(4) 93.165(12) 
C(5) -N(4)-S(3) 108.6(26) 
Symmetry transformations used to generate equivalent atoms: 
Table 4. 	Anisotropic displacement parameters (A2 x 103) for publish. 
The anisotropic displacement factor exponent takes the form: 
-2 pi2 [ h2 a*2 Ull + . . . + 2 h k a* b* U12 I 
Ull U22 U33 U23 U13 U12 
0(6') 24(1) 20(1) 22(1) 4(1) -2(1) -3(1) 
C(l') 22(1) 22(1) 19(1) 3(1) -1(1) 1(1) 
0(111 ) 24(1) 28(1) 16(1) 1(1) 1(1) 2(1) 
 21(1) 49 (2) 16(1) 5(1) -3(1) 7(1) 
 56(2) 56(2) 22(1) -6(1) 8(1) 15(2) 
0(13') 28(1) 54(1) 27(1) 13(1) 4(1) -4(1) 
C(2') 18(1) 18(1) 22(1) -1(1) -2(1) 1(1) 
0(21') 21(1) 28(1) 22(1) 2(1) -3(1) 0(1) 
 21(1) 42 (2) 20(1) 5(1) 4(1) 8(1) 
 29 (2) 64(2) 31(1) 2(2) -10(1) 4(2) 
0(23') 33(1) 36(1) 36(1) 10(1) -1(1) 12(1) 
C(3') 17(1) 19(1) 17(1) -2(1) 2(1) -2(1) 
0(31') 20(1) 20(1) 20(1) 1(1) 3(1) -1(1) 
 19(1) 22(1) 23(1) 3(1) -4(1) 1(1) 
 33 (2) 32(1) 36 (2) 7(1) 10(1) -2(1) 
0(33') 32(1) 22(1) 36(1) -5(1) 4(1) -4(1) 
C(4' ) 19(1) 19(1) 18(1) 0(1) -2(1) 1(1) 
0(41') 24(1) 20(1) 18(1) 2(1) -3(1) 0(1) 
 14(1) 29(1) 16(1) 1(1) 3(1) 1(1) 
 28(1) 26(1) 23(1) 1(1) -3(1) 0(1) 
0(43') 28(1) 25(1) 22(1) 0(1) -4(1) -5(1) 
C(5') 21(1) 17(1) 19(1) -1(1) 0(1) -1(1) 
C(5) 24(1) 18(1) 19(1) 2(1) 1(1) -4(1) 
0(1) 27(1) 19(1) 26(1) -2(1) -3(1) -3(1) 
C(2) 38(2) 19(1) 23(1) 7(1) -4(1) -10(1) 
0(21) 61(2) 23(1) 32(1) -3(1) -7(1) -10(1) 
S(3) 23(1) 40(1) 32(1) -3(1) -4(1) -10(1) 
N(4) 21(1) 30(1) 22(1) -4(1) 0(1) -7(1) 
Table S. 	Hydrogen coordinates ( x 10A  4) and isotropic 
displacement parameters (A2 x 10A 3) for publish. 
x y z IJ(eq) 
H(111 ) 8229 4179 4435 26 
H(1311 ) 5903 6440 6104 54 
H(1321 ) 7536 6837 5751 54 
H(1331 ) 5988 7044 5229 54 
H(211 ) 9548 4357 3200 24 
H(2311 ) 13412 4831 4931 51 
H(2321 ) 12289 5824 5100 51 
H(233 1 ) 13287 5773 4263 51 
H(311 ) 8542 6515 3149 22 
H(3311 ) 12086 7577 1371 41 
H(3321 ) 12388 6330 1510 41 
H(3331 ) 10984 6716 936 41 
H(411 ) 7504 4885 2054 23 
H(431 1 ) 5083 7112 352 32 
H(432') 6681 7565 712 32 
H(4331 ) 5110 7723 1225 32 
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